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Pathogenesis
R2126 The use of the PREVI™ Isola system in faecal and genital
samples
E.A. Verhoef-Verhage °, A.P. van Boxtel (Utrecht, NL)
Introduction: This study is a follow up of the study with urine samples
in which the value of the PREVI Isola (bioMe´rieux) system in the routine
diagnostic laboratory was analyzed (ECCMID 2009 − Ab.Nr. 1459).
PREVI Isola is a system for automated inoculation and streaking and
is able to process any material from patients (liquid format). For urine
samples we observed less sub culturing and earlier identiﬁcation resulting
in saving labor time and costs. The aim of this study was to explore the
usefulness of the PREVI Isola for more difﬁcult samples as feces and
genital swabs.
Methods: Feces or genital swabs from 100 different patients were
processed manual and by the PREVI Isola. Fecal samples were cultured
for Campylobacter (Campylobacter agar), Salmonella and Shigella
(XLD-agar) and Yersinia (Yersinia agar). Genital swabs were cultured for
aerobic bacteria (blood agar), anaerobic bacteria (anaerobic blood agar),
Neisseria gonorrhoeae (GO agar), Gardnerella vaginalis (Gardnerella
agar) and for yeasts (Sabouraud agar). For the PREVI Isola both feces
(20 ml) and the genital swabs were suspended in 2.5ml NaCl.
Results for fecal samples: All samples could be evaluated. No
Salmonella or Shigella was found. In 5 samples a Campylobacter was
found but with the PREVI Isola individual, suspected colonies were
better distinguished and were seen earlier (after 1 day). High counts
of Yersinia were found in 1 sample but only with the PREVI Isola
method. Results for genital swabs: In general counts of the different
bacteria were somewhat higher (+) with the PREVI Isola method than
after manual inoculation. With PREVI Isola individual colonies of
the different bacteria were much better distinguished No difference in
the isolation of gonococci (3 samples) was seen with both methods.
Gardnerella was 1 day earlier seen and much easier distinguished from
other bacteria with the PREVI Isola method.
Conclusions: As with urine samples PREVI Isola leads to better readable
results for the more difﬁcult cultures of feces and genital swabs:
individual suspected colonies were better distinguished and counts were
higher. Cultures were also often 1 day earlier positive for suspected
colonies. Therefore PREVI Isola is very useful in the time consuming
culture of especially genital swabs but also for fecal cultures in which
identiﬁcation can be done earlier.
R2127 Study of aetiologic agents in chronic osteomylitis
N. Veis Ahmadi, M. Izadi, A.A. Imani Fooladi °, S.A. Mousavi (Zanjan,
Tehran, IR)
Objectives: Osteomyelitis refers to an infection of the bone marrow
which may spread to the bone cortex and periosteum via the haversian
chanals. Osteomyelitis is an inﬂammation of bone caused by a payogenic
organism. Osteomyelitis has been categorized as acute, sub acute or
chronic, with the presentation of each type based on the time of disease
onset. (Occurrence of infection or injury). Investigation of prevalent
factors which produce infection, also, Estimation and comparison of disk
diffusion agar method and E-test method in order to determination of
antibiotic sensibility about isolated bacteria from osteomyelitis infections
are the main purpose of this study.
Methods: 131patients with osteomyelitis infection disease were selected
for this study during 2008–2009. Samples were collected from
bone (14.6%), tissue (7.3%), wound (66.1%), secretions (11.3%) and
body ﬂuid (0.7%). In order to microbiologic studies all of samples
were cultured according to standard procedure. Some disks with especial
antibiotics were chosen for each bacterium during the study of antibiotic
sensibility via disk diffusion agar (kirby bauer). Minimum inhibitory
concentration via E-test method was used for especial antibiotic and
ﬁnally compared two antibiogram methods together.
Results: Most isolated bacterium was S. aureus (33.6%), Pseudomonas
aeruginosa (14.5%), and least isolated was Eikenella, Morganella,
Showenella (0.8).
Conclusion: There are a number of possible pathogens but Staphylococ-
cus aureus is by far the most common, that our study showed same result.
Comparison of Antibiogram results that Treatment and evaluation of
osteomyelitis infection according to E-test method was more successful
than kirby bauer method. We found that Eikenella corrodens can be
cause of Chronic Osteomylitis.
R2128 Seroprevalence and risk factors of Helicobacter pylori
infection among schoolchildren in Algiers
S. Nait-Kaci °, N. Lamdjadani, Z. Guechi (Algiers, DZ)
Objective: The aim of our study is to evaluate the seroprevalence and
risk factors of Helicobacter pylori (Hp) infection in schoolchildren in
Algiers.
Material and Methods: We investigated 647 children (aged from 5 to
18 years; mean age 11.5±3.3 years; sex ratio 0.85) from different public
schools, located in different districts of Algiers, chosen by drawing of
lots. IgG anti Hp antibodies were detected by ELISA (Platelia Hp IgG
Biorad). Risk factors, collected from a questionnaire including: mother’s
and father’s education levels, source water, presence or not of domestic
animals, and the localisation of the school. For statistical analysis we
used Epi Info.
Results: Over all 70% of children were Hp seropositive. There was
not statically signiﬁcant difference according to sex P = 0.06. The
seroprevalence according to age was 42.85% among children 5 and
6 years aged, 60.57% among 5−11 years; 77% among 12−15 years
and 85% among 16−18 years. There was not statically signiﬁcant
difference according to water source and presence of animals. The
seroprevalence decreased when mother’s or father’s education level
increased (respectively P = 0.002 and P = 0.003). The seroprevalence rate
of Hp infection differed from a district to another one P = 0.04. Also we
ﬁnd again a statically signiﬁcant difference according to the promiscuity’s
rate P = 0.02.
Conclusion: The seroprevalence rate in the school is high. Almost half
of the children are infected at the age of schooling and rates increased
with age. The infection is fond linked to poor socioeconomic conditions
and to educational attainment of parents.
Animal models including experimental
treatment
R2129 Clinical study on therapeutic effect of mycocidine in
treatment of ringworm in cattle
J. Akbarmehr ° (Sarab, IR)
Ringworm or dermatophytosis is an infectious and zoonotic disease
caused by different species of ringworm fungi. Many species of animals
including humans are susceptible to ringworm infection. Cattle, horses,
cats, dogs and domestic livestock are the most commonly affected
animals. Lesions of ringworm is usually found on the head, muzzle,
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ears, neck, trunck and particulary around the eyes of infected animals.
These lesions are generally circular and oval in shape. Gray and dry to
red and crusty hairless patches are typical of ringworm.
This study was conducted to determine the therapeutic effect of
mycocidine(plant extracted antifungal drug)in treatment of ringworm in
cattle. 150 infected cattle with skin lesions of ringworm were treated
by mycocidine. Skin scales were collected by scraping of the lesion
usig a strile scalpel in to apetri dish. Samples were used for direct
microscopic examination and cultured on sabarouds dextrose agar for
isolation of ringworm fungi. All animals in this study were divided in
two age groups (under 2years old and over 2 years old). Infected animals
were subjected for treatment with two times daily applications(locally
and topical)of mycocidine. Our resuls showed that rapid and effective
cure in the most affected animals occurred 4−5 weeks after use of
drug. Morever there was no signiﬁcant difference in therapeutic rate
of two different age groups. Overall mycocidine was effective in both
age groups.%78cattle in over 2 years age and %81 those under 2years
age were cured completely after 5 weeks application of mycocidine. In
conclusion the present study revealed that mycocidine is more effective
in treatment of ringworm and its application should be recommended.
R2130 Chlamydia and Burkholderia pulmonary diseases of the
Mycobacterium tuberculosis-susceptible I/St mice
L. Nesterenko °, T. Stepanova, J. Alyapkina, D. Balunec, E. Kondratieva,
M. Kapina, N. Zigangirova, J. Romanova, A. Apt (Moscow, RU)
Objectives: To ﬁnd out whether TB-susceptible I/St mice are susceptible
to other pulmonary pathogens, we investigated manifestations of
experimental infections caused by microorganisms taxonomically distant
from mycobacteria: Chlamydia pneumoniae (intracellular pathogen) and
Burkholderia cepacia (not intracellular bacteria). For challenge we used
mutant Burkholderia cepacia with dramatically increased capacity of
bioﬁlm formation.
Methods: Real time PCR, ﬂow cytometry, sandwich ELISA assays,
histochemical staining. For intranasal inoculation we used I/St and TB-
resistant A/Sn inbred mice (~10 g body weight).
Results: Comparison of TB-susceptible I/St and TB-resistant A/Sn mice
demonstrated that the former are more susceptible to chlamydia, but not
burkholderia infection, displaying a signiﬁcantly shortened survival time
following chlamydia challenge. Chlamydia infection: severe lung pathol-
ogy rapidly developed in I/St, but not in A/Sn mice. In agreement with
higher macrophage content in the lungs, signiﬁcantly more macrophage-
derived cytokines TNF-a and IL-6 were detected in I/St lung tissue.
Burkholderia infection: the increasing virulence of mutant with super
ability for bioﬁlm formation was demonstrated both for I/St and A/Sn
mice. Both I/St and A/Sn mice are more susceptible to mutant burkholde-
ria infection, displaying a signiﬁcantly shortened survival time following
challenge. It was shown that the mutant strain with increased ability
of bioﬁlm formation more virulent for I/St and A/Sn mice than parent
burkholderia strain. The equal mortality of I/St and A/Sn mice correlated
to equal bacterial load in lungs and spleens in both mice strains.
Conclusion: Gained results probably indicates the common mechanism
of control of different intercellular pathogens by I/St mice.
Bioﬁlm
R2131 Bioﬁlm formation of Escherichia coli O111 on food-contact
stainless steel and high-density polyethylene surfaces
M.H. Movassagh Ghazani ° (Shabestar, IR)
Objectives: A bioﬁlm can be deﬁned as a sessile bacterial community
of cells that live attached to each other and to surfaces. Attachment and
bioﬁlm formation by food-borne pathogens and spoilage microorganisms
on food contact surfaces in processing plants are a public health and
cross-contamination concern. Bioﬁlm formation by Escherichia coli
O111 on commonly used surfaces viz Stainless steel and high density
polyethylene were studied.
Methods: For this study 12 stainless steel chips and 12 HDPE chips
were used. E. coli strain was added to the beakers with TSB and the
samples.
Results: Escherichia coli O111 formed bioﬁlm with a mean cell density
of 4.14±0.80, 7.69 ±0.19 log CFU/cm2 on stainless steel and HDPE
respectively. There was signiﬁcant difference (p< 0.05) between bacterial
counts of two type surfaces.
Conclusion: Based on the results, it can be concluded that Escherichia
coli O111 can survive on milk contact surfaces e.g. stainless steel and
HDPE surfaces forming bioﬁlm. This is the ﬁrst report, as far as we are
aware, of bioﬁlm formation by Escherichia coli O111 on food contact
stainless steel and HDPE surfaces. We were unable to ﬁnd reports in our
search of the literature.
R2132 Evaluation of different mechanisms of bioﬁlm formation
in clinical and commensal isolates of Staphylococcus
epidermidis
M. Shahrooei °, J. Verhaegen, J. Van Eldere (Leuven, BE)
Objectives: Currently, the two best-understood mechanisms of S. epi-
dermidis bioﬁlm formation are ica (intercellular adhesin)-dependent and
ica-independent proteinaceous bioﬁlm formation. Ica-dependent bioﬁlm
formation is characterized by ica-encoded polysaccharide synthesis;
the second mechanism is characterized by surface proteins such as
accumulation-associated protein (Aap), bioﬁlm-associated protein (Bap)
or Bap-homologous protein (Bhp). Glucose induces both mechanisms,
whereas NaCl abolishes ica-independent bioﬁlm formation completely.
In this study, we examined the characteristics of bioﬁlm formation of 39
S. epidermidis isolates.
Methods: Species identiﬁcation was done by VITEK 2 (bioMe´rieux).
Study isolates included 3 previously described S. epidermidis strains
(10b, RP62A, and ATCC12228), 25 isolates from blood cultures of
hospitalized patients and 11 isolates from skin of healthcare personnel.
The presence of ica operon, aap and agr (accessory gene regulator)
operon genes were investigated by PCR in all isolates.
Using a semi-quantitative microtiter plate method, bioﬁlm formation of
isolates in BHI, BHI supplemented with 4% NaCl or 1% glucose was
quantiﬁed at OD595nm. Isolates with OD595< 0.4 (negative control;
non-bioﬁlm-forming ATCC12228 strain), 0.4OD5951 (positive
control; bioﬁlm-forming RP62A strain), and OD595> 1 (strong bioﬁlm-
forming 10b strain) were classiﬁed as non, moderate and strong bioﬁlm-
forming isolates, respectively.
Results: Four isolates were non-bioﬁlm-forming. There was no
signiﬁcant difference in bioﬁlm formation between clinical or commensal
bioﬁlm-forming isolates. All tested isolates were agr-positive. Prevalence
of the ica operon was twice as high in clinical isolates than in commensal
isolates. Mechanism of bioﬁlm formation in different isolates was studied
based on the effect of NaCl or glucose. It was ica-dependent for 9
isolates, and ica-independent for 20 isolates include 5 ica-positive. Six
ica-negative isolates could produce bioﬁlm in BHI whereas NaCl and
glucose reduced their bioﬁlm formation.
Conclusion: Our results show that presence of the ica operon doesn’t
always ensure the ability of the isolates to form bioﬁlm via the ica-
dependent mechanism. The presence of bioﬁlm-forming isolates that
are ica-negative, aap-positive or ica-negative, aap-negative and of which
bioﬁlm formation can’t be affected by NaCl or glucose suggests a novel
mechanism of bioﬁlm formation.
R2133 Surface properties and bioﬁlm formation in Candida
albicans and Candida parapsilosis bloodstream isolates
F. Ruzicka °, V. Hola´, M. Horka´, R. Tejkalova´ (Brno, CZ)
The yeasts of the genus Candida belong among important ethiological
agents of the nosocomial bloodstream infections. Indwelling medical
devices are considered one of the main predispositions to yeast
infections. Therefore, the adhesion and the bioﬁlm formation are
important virulence factors in these microorganisms.
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We assessed the bioﬁlm formation in Candida albicans and Candida
parapsilosis blood stream isolates by two commonly used methods −
the polystyrene microtiter plate method (MTP) and the cultivation on
PVC plastic discs. The bioﬁlm layer structure was examined by the
scanning electron microscopy (SEM) after processing of samples by
freeze-drying technique. Simultaneously, hydrocarbon (xylene) adhesion
assay was used for the hydrophobicity assessment of selected strains.
The isoelectric points (pI) in these two yeast species were evaluated by
capillary isoelectric focusing (CIEF).
The bioﬁlm formation on the surface of the plastic discs was detected
in all tested strains. On the other hand, we did not detect the bioﬁlm
formation in a number of strains by the microtiter plate method. Only
21.6% of C. albicans strains and 53.6% of C. parapsilosis strains
were found as bioﬁlm-positive by the microtiter plate assay. This is
probably due to the differences in both culture surfaces and different
manipulation with the samples. Our SEM observations showed that some
strains, considered as bioﬁlm-negative by MTP, formed a thin rudimental
bioﬁlm layer on the PVC discs. We found out that the bioﬁlm-negative
C. parapsilosis strains and all C. albicans strains are less hydrophobic in
comparison with bioﬁlm-positive C. parapsilosis strains. The isoelectric
points were determined as 2.8 for all C. albicans strains. The clearly
bioﬁlm-negative C. parapsilosis strains focus near pI value of 3.8, while
the pI value of the clearly bioﬁlm-positive strains is near 3.6. The
results of the CIEF correspond well with the cell surface hydrophobicity
(p< 0.001).
R2134 The effect of sub-inhibitory concentrations of tigecycline
and vancomycin upon Staphylococcus epidermidis
intercellular adhesin and lipoteichoic acid gene expression
in planktonic and bioﬁlm cells
J. Rollason °, A.C. Hilton, T. Worthington, A.B. Vernallis, T.S. Elliott,
P.A. Lambert (Birmingham, UK)
Objectives: The pathogenesis of Staphylococcus epidermidis (S. epi-
dermidis) is enhanced by its ability to attach to the surface of
biomaterials forming a multilayered structure with increased resistance
to antimicrobials and the host immune response. Lipoteichoic acid
(LTA) enables ionic binding to artiﬁcial surfaces and cell to cell
adhesion is part mediated by a polysaccharide intercellular adhesin
(PIA). This study investigates the effect of sub-inhibitory concentrations
of tigecycline and vancomycin upon the expression of genes involved
in the synthesis of PIA (icaA) and LTA (ltaS) in S. epidermidis RP62A
bioﬁlm and planktonic cells. Additionally the expression of icaA and
ltaS in planktonic and bioﬁlm cells was compared.
Methods: Planktonic S. epidermidis cells were grown for 8 hours at
37ºC in sub-inhibitory concentrations of tigecycline (0.003mg/ml; 0.125
x planktonic MIC), vancomycin (0.125 mg/ml; 0.125 x planktonic MIC)
and a broth control. RNA was extracted using Trizol and converted to
cDNA using a cDNA synthesis kit (Stratagene). Quantitative real-time
PCR was carried out using gyrB as an internal control.
Results: Sub-inhibitory concentrations of tigecycline and vancomycin
had no effect upon the expression of icaA (1.1 and 1.2 fold) and ltaS
(1.0 and 1.0 fold) in planktonic cells. Sub-inhibitory concentrations of
tigecycline and vancomycin had a weak effect upon the expression of
icaA (1.9 and 2.2 fold) and ltaS (1.4 and 1.6 fold) in bioﬁlm cells.
When compared to planktonic cells grown in broth alone, bioﬁlm cells
demonstrated an 8.1 fold increase in the expression of icaA and no
signiﬁcant change in the expression of ltaS (1.1 fold).
Conclusion: Sub-inhibitory concentrations of tigecycline and van-
comycin had a minimal effect upon the expression of icaA and ltaS in
planktonic and bioﬁlm cells providing re-assurance for the application
of these antimicrobials in bioﬁlm related therapy. The observed increase
in icaA expression in bioﬁlm cells when compared to planktonic cells
provides further evidence for genotypic phase variation between the
two cell states. In contrast when compared to planktonic cells, bioﬁlm
cells demonstrated no increase in ltaS indicating conserved expression
regardless of cell state.
R2135 Sub-inhibitory concentrations of tigecycline reduce
Staphylococcus epidermidis bioﬁlm formation
J. Rollason °, A.C. Hilton, T. Worthington, A.B. Vernallis, T.S. Elliott,
P.A. Lambert (Birmingham, UK)
Objectives: Staphylococcus epidermidis (S. epidermidis) is an oppor-
tunistic pathogen and a lead cause of indwelling device and prosthetic
infections. Tigecycline is a novel glycylcycline antibiotic with broad
range antibacterial activity. With steadily increasing antibiotic resistance
within the clinical environment, tigecycline may be considered as an
alternative treatment option in prophylaxis and treatment of bioﬁlm
related infection. This study investigates the effect of sub-inhibitory
concentrations of tigecycline and vancomycin upon bioﬁlm formation.
Methods: A planktonic culture of S. epidermidis RP62A (5×104 cfu/ml)
was exposed to sub-inhibitory concentrations of tigecycline (0.003mg/ml;
0.125 x planktonic MIC), vancomycin (0.125 mg/ml; 0.125 x planktonic
MIC) and a Mueller-Hinton broth control. Cells were grown aerobically
at 37ºC for 12 hours in a microtitre plate. Bioﬁlm cells were washed three
times. Following manual scraping and 30 minutes of mild sonication for
cell dispersal, viable cell counts were determined by serial dilution and
colony counting on Mueller Hinton agar.
Results: When compared to the broth control, sub-inhibitory concentra-
tions of tigecycline reduced S. epidermidis bioﬁlm formation by 39% at
12hrs (p = 0.0135). Sub-inhibitory concentrations of vancomycin had a
minimal effect upon S. epidermidis bioﬁlm formation (1% reduction at
12hrs).
Conclusion: Tigecycline may have a secondary effect upon S. epider-
midis bioﬁlm growth distinct from protein synthesis inhibition. Further
work must now be employed to determine the genetic mechanisms by
which low concentrations of tigecycline illicit this effect upon bioﬁlm
growth. Tigecycline is effective in reducing bacterial bioﬁlm formation
even at sub-inhibitory concentrations and its pronounced tissue retention
makes it a potential candidate for use in prophylactic therapy.
The effect of sub-inhibitory concentrations of tigecycline upon
S. epidermidis bioﬁlm growth.
R2136 Investigation of slime production by Candida strains
isolated from various clinical samples
A. Ayyildiz °, M.H. Uyanik, A.E. Aktas, H. Uslu, H.K. Malcok
(Erzurum, TR)
The aim of this study was to determine the slime production of different
C. albicans and non-albicans Candida species isolated from various
clinical samples, and to compare the intensity of bioﬁlm layer produced
by these yeast strains.
In the study, a total of 173 Candida species recovered from different
clinical specimens were tested. Slime production of microorganisms
was evaluated by modiﬁed tube adherence test. Brieﬂy, the organisms
were growth in Sabouraud broth supplemented with glucose (ﬁnal
concentration, 8%). After removal of liquid medium, the tubes were
gently washed with distilled water and stained with 1% safranin. Then
each tube was examined visually for the presence of the viscid slime
layer on the internal wall. Slime production was scored as negative,
weak positive (1+), moderate positive (2+ or 3+) or strong positive (4+)
according to the intensity of bioﬁlm layer.
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Slime production was demonstrated in 114 (65.9%) of 173 Candida
isolates tested. Thirty-eight (58.5%) of the 65 C. albicans strains and
76 (70.4%) of the 108 non-albicans candida strains were slime positive.
Of the 65 C. albicans strains, slime production was weak in 18 strains
(27.7%) whereas it was moderate in 20 strains (30.8%). Strongly slime
production was not determined in C. albicans strains tested. In non-
albicans Candida strains intensity of bioﬁlm layer was weak, moderate
and strong in 16 (14.8%), 32 (29.6%) and 28 (25.9%) respectively.
No signiﬁcant difference was found between C. albicans and non-
albicans candida species in terms of slime activity. Bioﬁlm activity for
non-albicans strains obtained from the bloodstream was signiﬁcantly





R2137 Accumulation of sulphobutylether-b-cyclodextrin in
critically ill patients with acute renal insufﬁciency
undergoing extended daily dialysis and treatment with
intravenous voriconazole
O. Burkhardt °, S. Thon, J. Burhenne, T. Welte, J. Kielstein (Hanover,
Heidelberg, DE)
Objectives: Cyclodextrin derivates are used as solvent vehicle for
poorly water-soluble drugs such as voriconazole or itraconazole.
They are mainly cleared by the kidney with the consequence of
accumulation in patients with renal insufﬁciency. Therefore, use of
intravenous administration forms of voriconazole and itraconazole are
not recommended for this patient population. In addition, there are
very limited pharmacokinetic (PK) data regarding of cyclodextrin
accumulation in patients receiving any form of hemodialysis.
Methods: In this investigation 4 critically ill patients (3 women, age
60−79 years) with anuric acute renal failure were treated empirically
with 4mg per kg body weight intravenous voriconazole twice a day
for invasive fungal infections. Extended daily dialysis (EDD) over a
period of 8 h was performed daily using the GENIUS® batch dialysis
system (Fresenius Medical Care, Germany) with a polysulphone high-
ﬂux dialyzer (F60S, surface area 1.3 m2; Fresenius Medical Care), a
dialysate ﬂow of 180mL/min and a blood ﬂow of 180mL/min. On days
1 and 5 blood samples were collected before and at different time points
up to 12 h after medication. sulphobutylether-b-cyclodextrin (SBECD)
and voriconazole plasma concentrations were determined by a validated
HPLC method.
Results: Tolerability of the treatment with intravenous voriconazole was
good. No serious or dialysis related adverse events were observed. The
SBECD plasma concentration–time curves of days 1 and 5 are shown in
Figure 1. There was a clear accumulation of cyclodextrin on day 5 to see
on higher peak and trough levels. The AUC0−12 (1598 vs. 4584mg x
h/L) and the terminal elimination half-life (8.7 vs. 15.1 h) were increased,
too. Single and multiple dose PK parameters of voriconazole, however,
were comparable with those from healthy control groups given in the
literature.
Conclusions: Our data indicate an accumulation of SBECD in renal
insufﬁcient critically ill patients treated with intravenous voriconazole
and EDD. Fortunately, no toxic effects were observed, although the
accumulated dose was lower but comparable with those used in previous
toxicity studies with animals. On the other hand EDD does not affect
the pharmacokinetics of voriconazole.
Mechanisms of action and resistance
R2138 Clonal spread of carbapenem-resistant OXA-40 positive
Acinetobacter baumannii in a Croatian university hospital
B. Bedenic °, J. Vranes, A. Budimir, Z. Herljevic, S. Kalenic, P. Higgins
(Zagreb, HR; Cologne, DE)
Objectives: Carbapenems have a potent activity against and are often
used as last resort for the treatment of infections due to multiresistant
Acinetobacter baumannii (MDRAb). From July-October 2008, 43
A. baumannii isolates were involved in an outbreak at the Clinical
Hospital Center, Zagreb. Thirty-four of these isolates were carbapenem
resistant. The aim of the study was to characterize the mechanisms of
carbapenem resistance and molecular epidemiology of these isolates.
Methods: Antibiotic susceptibilities were determined by broth microdi-
lution. Oxacillinase genes were detected by multiplex PCR. Genotyping
of the strains was performed by pulsed-ﬁeld gel electrophoresis (PFGE),
rep-PCR and determination of sequence groups by multiplex PCR.
Results: Thirty-three carbapenem resistant isolates were positive for
blaOXA-40 and one unrelated isolate was positive for blaOXA-
58. Nine carbapenem sensitive isolates possessed only the naturally
ocurring OXA-51 b-lactamase which was associated with ISABaI
insertion sequence in ﬁve isolates. No MBLs were found. Only
OXA-58 b-lactamase was inhibited by sodium chloride. Chromosomal
AmpC b-lactamases did not affect the susceptibility to carbapenems.
ISAbaIII i was found upstream of blaOXA-58 gene. OXA-40 like
producing isolates were uniformly resistant to ceftazidime, cefotaxime,
ceftriaxone and piperacillin/tazobactam. Strains producing only OXA-
51 b-lactamase were susceptible or intermediate to carbapenems but
resistant to ciproﬂoxacin. These isolates showed variable degrees of
susceptibility/resistance to ceftazidime and gentamicin. The blaOXA-40
positive isolates were shown to be clonally related by rep-PCR and PFGE
and were part of the EU clonal lineage II. The single OXA-58 isolate
and isolates possessing only OXA-51 type b-lactamase displayed distinct
RAPD and PFGE ﬁngerprints and were mainly EU clonal lineage I.
Conclusions: On the basis of susceptibility testing, b-lactamase
characterization and genotyping of the isolates, we can conclude that
clonal spread of endemic isolates was responsible for the high frequency
of OXA-40-like positive MDRAb in this setting. Most of the isolates
originated from the ICU indicating local dissemination within the
hospital and pointing to the potential source of isolates.
Infection control measures should be introduced and restriction of
meropenem use is recommended to reduce the spread of OXA-40-like
positive A. baumannii isolates within the hospital.
R2139 Fluoroquinolone non-susceptibility in Streptococcus
pneumoniae isolated in Turkey: should we change
susceptibility testing methods to detect subtle mechanisms?
M. Bicmen, H. Sanli Avci, Z. Gulay ° (Izmir, TR)
Objective: Although resistance rates of S. pneumoniae to various
antibiotics have increased during the recent years in Turkey and in Izmir;
ﬂuoroquinolone (FQ) resistance rates seem to be low despite the wide
usage. Therefore, in this study, our aim was to investigate whether the
testing levoﬂoxacin susceptibility solely is efﬁcient in determining the
susceptibility of S. pneumoniae to FQs.
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Method: A total of 247 S. pneumoniae isolates recovered in the
Bacteriology Laboratory of Dokuz Eylul University between 2003 and
2009 were analysed by levoﬂoxacin (LVX) disk and by a modiﬁed disk
diffusion test which was reported by Varon et al and in which suscep-
tibility to norﬂoxacin (NOR), peﬂoxacin (PEF), ciproﬂoxacin (CIP) and
sparﬂoxacin (SPX) were also determined. It was implicated that the mod-
iﬁed method also shows the molecular mechanism of resistance. After
the phenotypic test the results were also conﬁrmed by sequence analysis
of parC, E and gyrA and B genes of the resistant isolates. Presence of
efﬂux pumps were also determined by the verapamil inhibition assay.
Results: Although the rate of LVX resistance was 0.8% among
the isolates, when we analysed the susceptibilities of the additional
ﬂuoroquinolones, ﬂuoroquinolone nonsusceptibility rate increased to
18.2% (15.8% for efﬂux type, 1.6% for single topoisomerase IV
mutation type, 0.8% for topoisomerase IV and gyrase dual mutation
type). Sequence analysis also conﬁrmed our results. No mutation was
detected in the QRDR region of the susceptible isolates and the isolates
with efﬂux, whilst parC genes of isolates with topoisomerase IV type
resistance contained mutations such as S79F and D83N. An additional
S81F mutation in the gyrA gene was found in case of topoisomerase IV
and gyrase A dual mutation type. In isolates with an efﬂux type of
resistance, verapamil has reduced CIP MICs by 2−8 fold.
Conclusion: Although the clinical signiﬁcance is not known, the FQ
nonsusceptibility rate in S. pneumoniae isolates was higher than thought
(0.8% versus 18.8%). LVX does not detect ﬁrst step mutants and
efﬂux type resistance in S. pneumoniae. Low level resistance usually
facilitates the acquisition of higher resistance, so the potential risk of
high prevalence of FQ resistance is shown by our study. In determining
ﬂuoroquinolone susceptibility in S. pneumoniae NOR disk (5 mg) should
also be used in addition to LVX.
R2140 Characterization of macrolide resistance genes in
Staphylococcus saprophyticus
A. Le Bouter, R. Leclercq, V. Cattoir ° (Caen, FR)
Objectives: From January 2005 to May 2009, 33 of 72 (45.8%)
Staphylococcus saprophyticus clinical isolates, recovered from urine
samples in our institution, were resistant to macrolides and/or
related compounds (i.e. lincosamides, streptogramins). Mechanisms of
macrolide resistance have been poorly investigated in this species. The
aim of this study was to identify macrolide resistance genes as well as
their genetic supports among the isolates of this collection.
Methods: For all 33 strains, MICs of erythromycin (ERY), spiramycin,
lincomycin (LIN) clindamycin (CLI), dalfopristin (DAL), quinupristin
(QUI), and dalfopristin-quinupristin were determined by the agar dilution
method on Mueller-Hinton agar according to the recommendations of
the Antibiogram Committee of the French Society for Microbiology.
Induction of lincomycin resistance by erythromycin was checked by
the D-zone test and clindamycin inactivation was tested by the Gots
test. Resistance genes erm(A), erm(B), erm(C), msr(A), and lin(A) were
ampliﬁed using PCR with speciﬁc primers. Plasmid analysis was carried
out by using a modiﬁed Kieser technique.
Antibiotic MIC (mg/L)
MIC50 MIC90 Range
Erythromycin 64 256 0.12−256
Spiramycin 4 8 0.5–128
Lincomycin 0.25 8 0.12−256
Clindamycin 0.03 0.06 0.03−256
Dalfopristin 2 4 0.5−16
Quinupristin 4 8 1−8
Quinupristin–Dalfopristin 0.25 0.5 0.12−0.5
Results: Out of 33 isolates tested, 32 (97.0%) were resistant to ERY
including 3 (9.4%) also resistant to LIN but susceptible to CLI and one
resistant to ERY, LIN and CLI. A single strain was only resistant to
LIN. All isolates were susceptible to DAL and QUI. The MIC50 and
MIC90 values are reported in the Table. The erm(A), erm(B), erm(C),
msr(A), and lin(A) genes were detected among 0, 0, 5 (15.1%), 29
(87.9%), and 3 (9.1%) isolates, respectively. All erm(C)-positive isolates
exhibited a positive induction test whereas all lin(A)-positive isolates had
a positive Gots test. Preliminary results of plasmid analysis suggested
that msr(A) genes were borne by small-size plasmids (<10 kb) whereas
larger plasmids (>30 kb) harboured erm(C) and lin(A) genes.
Conclusion: Our study showed a high-level prevalence of resistant
strains, especially those harbouring a msr(A) gene. This species might
constitute a reservoir for macrolide efﬂux genes among coagulase-
negative staphylococci.
R2141 V240H replacement, by site-directed mutagenesis, increases
resistance toward carbapenems in TEM-149 ESBL
producing E. coli
M. Perilli, C. Pellegrini °, P.S. Mercuri, M. Galleni, S. Rainaldi, C. Di
Lisio, G. Celenza, R. Calabrese, A. Pompilio, G. Di Bonaventura,
M.M. Tavı`o, B. Segatore, D. Setacci, G. Amicosante (L’Aquila, IT;
Lie`ge, BE; Chieti, IT; Las Palmas G.C., ES)
Objectives: TEM-type B-lactamases represent the most prevalent ESBLs
that are in ongoing evolution. Recently, TEM-149 ESBL has been well
characterized in our laboratory. This enzyme showed the following amino
acid substitutions E104K, R164S, M182T and an unusual valine residue
at position 240 (E240V) never found in natural and mutagenized TEM
variants. The goal of this study was to create a new mutant with a
residue of histidine at position 240 in order to assess the contribution
of this substitution on phenotypic resistance pattern in E. coli pTEM-
149V240H.
Methods: The V240H mutation of the TEM-149 B-lactamase was
generated by site-directed mutagenesis by use of the overlap extension
method. The mutated primers were used in combination with the external
primers TEM_for and TEM_rev to generate two partially overlapping
DNA fragments, which were subsequently used in an overlap extension
reaction coupled to ampliﬁcation of the entire coding sequence with the
external primers. Direct sequencing of the amplicons was performed
on both strands derived from three independent PCRs according to
the dideoxy chain termination method by using an ABI Prism 310
automatic sequencer to conﬁrm the authenticity of the sequence. The
resulting amplicon was cloned in pBC-SK vector and the recombinant
plasmid pTEM-149V240M was inserted by transformation into E. coli
HB101. The determination of MICs was performed by the conventional
microdilution broth procedure, using a bacterial inoculum of 5 x 105
CFU/mL as recommended by CLSI.
Results: A mutant of TEM-149 enzyme, in which the valine at position
240 was replaced by histidine residue, was cloned into the pBC-SK
vector and introduced in E. coli HB101 competent cells. The in vitro
susceptibilities of E. coli HB101pTEM-149V240H was tested versus
a large panel of b-lactams. Comparing these values to those obtained
for E. coli HB101pTEM-149 wild type, we noticed a decreasing of
MIC values of aztreonam (from >64mg/L to 8mg/L) and ceftazidime
(from 32mg/L to 16mg/L). A MIC value of 8mg/L was observed for
meropenem.
Conclusion: In E. coli, the production of the TEM-149V240H, was
surprisingly able to confer resistance to meropenem. The recombinant
strain is susceptible to cefotaxime and aztreonam.
R2142 Extended-spectrum b-lactamase producers among non-
typhoidal Salmonella isolated from clinical cases in Malaysia
N. Ahmad °, F. Shamsudin (Kuala Lumpur, MY)
Objectives: To determine the presence of ESBL among non-typhoidal
Salmonella sp from Malaysia.
Methods: A total of 200 non-typhoidal Salmonella isolates received
from hospitals in Malaysia from year 2005 to 2009 isolates showing
ceftriaxone zone sizes of 25mm were subjected to ESBL screening
using CLSI recommended method and PCR ampliﬁcations of blaSHV,
blaTEM, blaCTX-M and blaCMY-2 were performed using primers as
described previously.
S640 20th ECCMID, Abstracts accepted for publication only
Results: From 200 isolates, 33 were phenotypically described as ESBL
positive and 22 were AmpC positive. PCR results showed all were
positive for at least one of the b-lactamase genes, except for 3 ESBL
positive isolates. 19% of the isolates were positive for blaTEM, 12%
were positive for blaCTX-M and 6% were positive for blaSHV. All
except one isolate which were AmpC positive were also positive for the
CMY-2 gene. Seven isolates which were negative for ESBL or AmpC
phenotypically, were positive for either TEM or CTX-M gene.
Conclusion: ESBL producers are becoming increasingly common
among our local isolates of Salmonella sp. Most of the resistance
was caused by blaTEM but other resistance mechanisms are also not
uncommon. Our study also showed that strains that were phenotypically
negative for ESBL could also harbor the resistance genes. In such cases,
treatment with b-lactam antibiotics may not be effective.
R2143 First description of Asp104Gly substitution in a SHV-type
b-lactamase
V. Manageiro, D. Jones-Dias °, N. Ramdani-Bouguessa, D. Louro,
E. Ferreira, M. Tazir, M. Canic¸a (Lisboa, PT; Algiers, DZ)
Objectives: In class A b-lactamases Ambler position 104 is not an
especially conserved residue, however, it has been shown that amino
acid substitutions at this position are associated with hydrolysis of
3rd generation cephalosporins. We biochemically characterized the
Klebsiella pneumoniae SHV-99 enzyme, carrying the amino acid
substitution Asp104Gly which, in our knowledge, appeared, in nature,
in SHV b-lactamase for the ﬁrst time.
Methods: SHV-99-producing K. pneumoniae KpARG220 strain was
isolated from urine of a 35-year-old male in an intensive care unit
of the Centre Hospitalo-Universitaire Mustapha Pacha, in Algeria. The
blaSHV-99 gene was detected and identiﬁed by PCR and sequencing.
PCR products were ligated in the SmaI site of the plasmid pBK-CMV,
and the recombinant plasmids were electroporated in Escherichia coli
DH5alfa. Puriﬁcation was performed by ion exchange and gel ﬁltration
chromatography and kinetic constants were obtained by a computerized
microacidimetric method.
Results: KpARG220 clinical strain was resistant to penicillins,
cephalosporins and monobactams. Although SHV-99-producing trans-
formant (EcDH5alfa-SHV-99) exhibited a b-lactam resistance phenotype
similar to the clinical strain in respect to penicillins, it was susceptible
to cephalosporins and monobactam. The kinetic parameters showed
a lower catalytic efﬁciency for SHV-99 (kcat, 0.003 to 778 s−1),
when compared with SHV-1 (kcat, 220 to 1937 s−1). Neither one
showed the ability to hydrolyse oxyimino-b-lactams or aztreonam. The
mutation Asp104Gly seems to be responsible for the higher Km value
for oxyimino-b-lactams found in SHV-99 b-lactamase (Km, 136.0 to
196.0mM); in fact, SHV-99 presents catalytic activity (kcat, 0.5 s−1) and
catalytic efﬁciency (kcat/Km, 0.003 mMs−1·s−1) for aztreonam, whose
values were undeterminable for SHV-1.
Conclusion: The Asp104 residue is hydrogen bonded to Asn132, and it
may therefore stabilize the catalytic Ser130 of the conserved SDN loop.
The increase in oxyimino-b-lactams afﬁnity, due to the substitution of
an aspartate by glycine, seems to be the ﬁrst step in the recognition of
the side chain of those subtracts, which allows a better accommodation
of these antibiotics in the active site of class A b-lactamases. This study
showed that the Asp104Gly substitution alone is unable to generate an
ESBL proﬁle, however, it might be involved in the discrimination and
recognition of antibiotics.
R2144 Phenotype identiﬁcation of drug-resistance and inducible
MLSB mechanism of Brevibacterium strains isolated from
different clinical materials
A. Olender °, I. Letowska (Lublin, Warsaw, PL)
Introduction: The isolation of Brevibacterium strains from clinical
materials is regarded as a contamination as the microorganisms constitute
a normal ﬂora of the skin. On the other hand, the case reports describing
bacteriemias, peritonitis, ostemyelitis, call attention to these bacteria. The
study of drug susceptibility and occurred drug-resistance mechanisms in
isolated from clinical materials Brevibacterium strains are speciﬁcally
important.
Objectives: The characteristics of drug-resistance and drug-resistance
mechanisms by phenotypic methods in strains of Brevibacterium spp.
isolated from clinical materials.
Methods: Twenty strains of Brevibacterium spp. isolated as pure cultures
and in number indicating the etiologic agent of infection, isolated from
different clinical materials (blood, urine, wounds, sputum) were included
in the study. The identiﬁcation was performed by APICoryne, APIZYM
and supplementary biochemical tests. The drug susceptibility of the
strains was determined on the basis of MIC values (Etests) accepted
for Corynebacterium spp. and Staphylococcus spp. For MLSB resistance
phenotype detection the disc diffusion method was used employed for
Staphylococcus spp. and Streptococcus spp. b-lactamase production was
detected with cephinase test.
Results: Among isolated strains, the following species were identiﬁed
commonly: B. casei and B. epidermidis. The highest level of
resistance was found to: Cotrimoxazole, Chloramphenicol, Fusidic acid.
b-lactamases productions were also detected. In twelve strains, the
inducible MLSB resistance mechanism was observed. All isolated strains
were susceptible to Vancomycin, Teicoplanin.
Conclusion: On the basis of performed studies it was found that the
antibiotics speciﬁcally recommended are Vancomycin and Teicoplanin
with the highest effectives in the treatment of diseases caused by
Brevibacterium species. The macrolides, lincosamids and streptogramins
groups of antibiotics should by used with caution, because of the
possibility of inducible MLSB resistance mechanism occurrence, as
well as Cotrimoxazole, Fusidic acid, Chloramphenicol and b-lactams
as studied strains were detected resistant to these drugs.
R2145 agr-deﬁciency and expression changes in regulatory and
cell-wall genes responsible for hVISA and VISA phenotypes
V. Caﬁso, T. Bertuccio, S. Purrello, D. Spina, C. Di Pietro, M. Purrello,
S. Stefani ° (Catania, IT)
Objectives: Glycopeptides are still the gold standard to treat serious
MRSA infections, but their widespread use has led to the emergence
of glycopeptide-low-level resistant isolates (hVISA and VISA). The
molecular basis of this reduced susceptibility is not clear, but different
genetic loci encoding regulatory systems or proteins involved in
autolysis and in cell-wall turnover have been implicated. We investigated
the molecular mechanisms of glycopeptide intermediate resistance on
prototype microorganisms, i.e. NRS149 (VSSA), Mu3 (h-VISA), Mu50
(VISA) of agr-II and on our Quasi-VISA clinical isolate of agr-II.
Methods: We analyzed delta-hemolysin production on 5% sheep-
blood-agar. We investigated, with or without sub-inhibitory vancomycin
concentrations, both the autolytic activity by TRITON X-100 induction
and, by real-time RT-PCR, the expression levels of hld, graR/S
(regulatory genes), atl, SAV2095 (sceD-like gene), mprF (cell-wall
genes), all involved in h-VISA and VISA phenotypes.
Results: We observed the lack of delta-hemolysin (in sheep-blood-agar)
in the VISA and its decreased production at 48 h in the hVISA. In
both culture conditions, the VISA showed the lowest autolytic activity,
the Q-VISA an intermediate level with respect to hVISA and VISA,
whereas in hVISA an autolysis similar to VSSA was observed. These
data correlate with the gene expression showing a gradual but substantial
hld down-regulation as follows: VISA < Q-VISA < hVISA < VSSA.
An atl down-regulation was found in VISA, whereas a low level of sceD
transcripts was found in hVISA only with vancomycin. The regulator
graR/S down-regulation, related to the atl down-regulation, was found in
VISA. mprF up-regulation was found in all phenotypes towards VSSA.
Conclusions: Among agr-II, hVISA had a dysfunctional agr-locus and
a regular autolytic activity, but, with vancomycin, this strain reduced its
cell-wall turnover. In VISA, the lack of agr functionality and reduced
autolysis were independent from the presence of vancomycin. The
increased expression of mprF in hVISA and VISA could be related
to a lower vancomycin binding than in VSSA.
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R2146 The presence of GES enzymes in Pseudomonas aeruginosa
strains isolated from patients in Warsaw hospitals
A.E. Laudy, P. Borkowska, D. Dzierzanowska, S. Tyski °, J. Patzer
(Warsaw, PL)
Objectives: The GES-type enzymes have been found mainly in
P. aeruginosa, but such enzymes have been also isolated from
Enterobacteriaceae. Generally, genes coding GES b-lactamases are
located on class 1 integrons. The aim of this study was to identify
strains producing GES-type ESBLs, among P. aeruginosa isolates from
two Warsaw hospitals.
Methods: The MDR P. aeruginosa strains (n = 332) were isolated from
clinical specimens obtained from patients in two Warsaw hospitals.
The MICs values of b-lactams were determined by agar dilution
method, according to CLSI recommendation. The presence of ESBLs
was detected by a double-discs synergy test (DDST) with inhibitors:
clavulanic acid, sulbactam, tazobactam and imipenem. The presence of
integrons and genes coding GES-type ESBLs was detected by PCR.
Gene cassettes were identiﬁed by sequencing of the obtained amplicons.
Standard plasmid analysis was performed.
Results: The ESBL-type enzymes were detected among 53 isolates by
DDST. Eighteen out of all tested isolates were resistant to all b-lactams.
These strains (n = 71) were screened for the presence of genes coding
ESBL-type enzymes. In 8 isolates (seven from hospital A and one
from hospital B) bla genes coding GES-type enzymes were identiﬁed.
All found blaGES genes are located in class 1 integrons. Moreover,
seven of them are present on plasmid. Among strains from hospital
A enzymes as GES-1 (in 5 strains), GES-5 (in one) and the new
ESBL-type b-lactamase GES-15 were detected. The complete nucleotide
sequence of blaGES-15 was determined (NCBI GenBank Acc. No
GU208678). Sequencing showed that GES-15 was identical to GES-5
except one amino acid. All of above-mentioned seven strains are resistant
to ceftazidime and cefepime. The GES-15 carrying strain exhibited the
most clear inhibitor-sensitive phenotype. Moreover, blaGES-1 gene in
one strain from hospital B was identiﬁed, also in this case blaGES-1
gene is located in class 1 integron on plasmid.
Conclusions: The new extended-spectrum b-lactamase GES-15 encoded
by class 1 integron-located gene was found in P. aeruginosa clinical
isolate. Moreover, the GES-5 producing P. aeruginosa strain was
identiﬁed in Poland for the ﬁrst time. The presence of plasmid-located
blaGES-1, blaGES-5 and blaGES-15 genes, within integrons in 8 clinical
isolates from two hospitals suggests the possibility of spreading these
ESBLs in Polish hospitals.
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R2148 Serotype distribution and antimicrobial resistance rates
of human gastrointestinal Salmonella enterica isolates.
A 3-year study from Crete, Greece
I. Neonakis °, S. Maraki, A. Georgiladakis, D. Spandidos (Heraklion, GR)
Objective: Crete is the biggest Greek island attracting millions of
tourists year-round. The aim of the present study was to determine
the serotype distribution and the susceptibilities of Salmonella enterica
strains isolated from patients with gastroenteritis.
Methods: All isolates of Salmonella spp. from fecal samples of patients
with diarrhoea cared for at the University Hospital of Heraklion
over the last three years (2006–2008) were included in the study.
Identiﬁcation and susceptibility testing were performed using the Vitek II
(Biomerieux, France). Isolates with either intermediate or full resistance
to an antibiotic were characterized as non-susceptible to this agent.
Serotyping was performed using commercial antisera (Statens Serum
Institut, Denmark) and the Kauffmann-White scheme.
Results: A total of 110 isolates were analyzed. S. enteritidis (63/110;
57.3%), S. typhimurium (20/110; 18.2%), S. bardo (5/110; 4.5%),
S. newport (4/110; 3.6%), and S. blockley (3/110; 2.7%) were the
ﬁve most common types encountered. Other types encountered were:
S. altona, S. anatum, S. arizonae, S. bredeney, S. bovis-morbiﬁcans,
S. etterbeek, S. hadar, S. haardt, S. inpraw, S. kottbus, S. muenchen,
S. pomona and S. uganda. Among the 110 patients 18 (16.4%)
were of foreign nationality. The non-susceptibility rates found were:
cotrimoxazole, 5.5%; amoxicillin, 16.4%; amoxicillin+clavulanic acid,
6.4%; ticarcillin+clavulanic acid, 10.0% and piperacillin+tazobactam,
2.7%. All isolates were susceptible to third generation cephalospirins and
carbapenems, whereas relatively high percentages of non-susceptibility
were found for tetracycline (20.9%) and ciproﬂoxacin (30.0%).
Conclusion: In our geographical area Salmonella enterica serotype
Enteritidis continuous to be the most common bacterial enteropathogen.
Although we did not observe any resistance to third generation
cephalosporins, the sizeable number of strains resistant to quinolones
is worrisome and emphasizes the importance of continuous monitoring
of antibiotic resistance of Salmonella isolates.
R2149 Resistance rates of Campylobacter spp. and Yersinia entero-
colitica human isolates. A 3-year study from Crete, Greece
I. Neonakis °, S. Maraki, A. Georgiladakis, D. Spandidos (Heraklion, GR)
Objective: Crete is the biggest Greek island attracting millions of
tourists year-round. The aim of the present study was to determine the
susceptibilities of Campylobacter spp. and Yersinia enterocolitica, which
are two of the major causes of bacterial diarrhea.
Methods: All isolates of Campylobacter spp. and Y. enterocolitica
from different patients in the University Hospital of Heraklion over the
last three years (2006–2008) were included in the study. Cultures and
identiﬁcation of the isolates were done using standard microbiological
methods. Susceptibility testing was performed with the disk diffusion
method following the recommendations of the CLSI. Isolates with either
intermediate or full resistance to an antibiotic were characterized as non-
susceptible to this agent.
Results: A total of 109 Campylobacter and 12 Yersinia isolates were
analyzed. C. jejuni (93/109; 85.3%), and C. coli (16/109; 14.7%) were
the types encountered. Among the patients with Campylobacter and
Yersinia 4.6% and 50% were of foreign nationality, respectively. The non-
susceptibility rates found for Campylobacter were: amoxicillin, 33.9%;
amoxicillin+clavulanic acid, 5.5%; tetracycline, 34.9%; gentamicin,
0.9%; ciproﬂoxacin, 54.1% and erythromycin, 19.3%. All isolates
were susceptible to carbapenems. The non-susceptibility rates found
for Yersinia were: amoxicillin, 100.0%; amoxicillin+clavulanic acid,
100.0%; ticarcillin+clavulanic acid, 75.0%; piperacillin+tazobactam,
33.3%; ceftazidime, 25%; imipenem, 25.0%; tetracycline, 25.0%;
gentamicin, 0.0%; ciproﬂoxacin, 0.0% and cotrimoxazole, 50.0%.
Conclusion: The increased rates of resistance in Campylobacter and
Yersinia isolated from humans in our region emphasizes the need
of systematic surveillance of antibiotic resistance for determining
appropriate therapeutic regimens.
R2150 Changes of multidrug-resistant Pseudomonas aeruginosa
O serogroup dependence in a university hospital, 2003–2008
A. Vitkauskiene °, E. Skrodeniene, D. Jomantiene (Kaunas, LT)
Objectives: The aim of our study was to analyse prevalence of O
serogroup dependence of multidrug resistant (MDR) Pseudomonas
aeruginosa (P. aeruginosa) strains during 2003 and 2008 year periods
in a tertiary intensive care unit (ICU).
Methods: P. aeruginosa strains isolated from respiratory tract patient’s
treated in Kaunas Medical University Hospital ICU were analysed.
Antibiotic sussceptibility testing by disc diffusion method was performed
accoding to the National committee for clinical laboratory standards
(NCCLS, USA). Isolates resistant to three or more antipseudomonal
antibiotics were considered as MDR. Serogroups of P. aeruginosa strains
were established using serums, containing antibodies against O-group
antigens of P. aeruginosa (Bio-Rad, USA).
Results: During the study 18 of 90 in 2003 year (20%) and 25 of
101 (24.76%) in 2008 year P. aeruginosa strains were determined as
MDR. P. aeruginosa strains, belonging to O:11 serogroup were more
often considered as MDR (38.9%, n = 7 compare with 2.8%, n = 2
in 2003 and 56%, n = 14 compare with 27.6%, n = 21 in 2008 year,
p< 0.05). 16.7% (n = 15) in 2003 year and 28.7% (n = 29) in 2008
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year P. aeruginosa strains were resistant to carbapenems. Carbapenem
resistant P. aeruginosa strains more often were determined as O:11
serogroup dependency (33.3%, n = 5 in 2003 year and 51.7%, n = 15
in 2008 year). P. aeruginosa strains, belonging to the serogroups O:1,
O:2 and O:3 were more often isolated in 2003 compare with 2008 year
(23.3%, 27.8%, 12.2% and 9.9%, 10.9%, 4.0%, respectively, p< 0.05).
P. aeruginosa strains, belonging to serogroups O:6 and O:11 were more
often isolated in 2008 compare with 2003 year (27.6%, 34.7% and 4.4%,
10.0%, respectively, p< 0.05).
Conclusions:
1. Pseudomonas aeruginosa strains belonging to the serogroup
O:11, were determined to be more resistant to the majority of
antipseudomonal antibiotics, then other serogroups’ dependency
Pseudomonas aeruginosa strains.
2. Multidrug resistant Pseudomonas aeruginosa strains not increased
in Kaunas Medical University Hospital during 5 years period,
but increased multidrug resistant Pseudomonas aeruginosa strains
belonging to O:11 serogroup.
R2151 Resistance to antimicrobials for veterinary or human use
among S. aureus isolated from cows with clinical mastitis
in central Italy
S. Preziuso °, J. Kandhavelu, A.R. Attili, C. Valente, V. Cuteri (Matelica,
Perugia, IT)
Objectives: Acquired antimicrobial resistance in bacteria is an increasing
threat in human as well as in veterinary medicine. S. aureus is one
of the most causes of bovine mastitis. Although the main attention is
directed to S. aureus resistant to methicillin (MRSA), the report of
strains resistant to macrolide, lincosamide and streptogramin (MLS)
antibiotics are increasing in humans. The aim of this work was to verify
the antimicrobial susceptibility of S. aureus isolated from bovine clinical
mastitis to antibiotics used in veterinary or human medicine.
Methods: 163 S. aureus isolated from milk of cows with clinical mastitis
and identiﬁed by PCR were analyzed by the disc diffusion method for
clindamycin (C), erythromycin (E), gentamycin (G), methicillin (M),
oxytetracyclin (O), vancomycin (V) and quinupristin/dalfopristin (Q/D).
Results: The resistance rates were 42.4% for C, 69.9 for E, 69.9% for
G, 11.6% for M, 47.2% for O, 8.0% for V, and 47.3% for Q/D. The
susceptible strains were 14.1% for C, 1.3 for E, 14.2% for G, 88.4% for
M, 13.5% for O, 92.0% for V, and 6.7% for Q/D. 12.9% strains were
susceptible to all the antibiotics, while 54.0% was resistant to at least 3
antibiotics. All 19 MRSA were resistant to at least 4 antibiotics, 52.6%
of which was resistant to Q/D. 62.3% Q/D resistant strains were also
resistant to both E and C.
Conclusion:MRSA were detected in bovine with clinical mastitis. Many
MRSA strains were multi-resistant and would be a problem for the
antimicrobial treatment. The high resistance to E, G, O and C was
probably related to the large use in veterinary medicine, while the ﬁnding
of a high resistance to Q/D was surprising, because Q/D is for human
use only. Genes conferring resistance to one of the MLS antibiotics
may confer cross-resistance to others, because they have similar effects
on bacterial protein synthesis. The high resistance to Q/D+E+C found
in our strains is concordant with this hypothesis, and molecular tests
are in progress. The chance that the large use of some macrolide (e.g.
E) and lincosamide (e.g. C) antibiotics in animals increases the rate of
S. aureus resistant to other MLS should be better evaluated in order to
prevent the selection of multi-resistant strains. In particular, there is the
risk that livestock becomes a reservoir of S. aureus resistant to some
streptogramin, that are used very carefully in humans as the last chance
for the treatment of infections not responding to other antibiotics.
Antibiotic name Antibiotic class Resistant Intermediate Susceptible Total
n % n % n %
Clindamycin Lincosamide 69 42.3 71 43.6 23 14.1 163
Erythromycin Macrolide 114 69.9 47 28.8 2 1.3 163
Gentamycin Aminoglycoside 114 69.9 26 15.9 23 14.1 163
Methicillin beta-Lactam 19 11.6 0 0 144 88.4 163
Vancomycin Glycopeptide 13 8.0 0 0 150 92.0 163
Oxytetracyclin Tetracycline 77 47.2 64 39.3 22 13.5 163
Quinupristin/dalfopristin Streptogramin 77 47.2 75 46.0 11 6.7 163
R2152 Trends of resistance in methicillin-resistant Staphylococcus
aureus (hospital-acquired MRSA versus community-
acquired MRSA) in Southeast Austria, 2002–2008
G. Zarfel °, G. Feierl, E. Leitner, L. Masoud, M. Ho¨nigl, K. Krziwanek,
E. Marth, A.J. Grisold (Graz, Linz, AT)
Objectives: Aim of this study was to determine any trends in resistance
and in MIC-distribution of clinical isolates of Hospital acquired (HA)
and Community-acquired (CA) Methicillin-resistant Staphylococcus
aureus (MRSA) to non-b-lactam antibiotics within a 7 year period.
Methods: 156 non-duplicated clinical isolates of MRSA (84 HA-MRSA,
72 CA-MRSA) were analyzed, detected from January 2002 to December
2008 at the Institute of Hygiene Graz, Austria. HA-MRSA and CA-
MRSA were deﬁned applying the CDC criteria. Resistance testing and
interpretation of the results were performed according to CLSI criteria.
MICs of 12 (non-b-lactam) antibiotics were determined using the Etest
method (AB Biodisk, Solna, Sweden).
Results: Within the 156 MRSA strains, no resistance was found for
vancomycin, teicoplanin, quinopristin/dalfopristin, daptomycin and the
newer antibiotics tigecycline and linezolid. Resistance to tetracycline
was rare in HA-MRSA, whereas in CA-MRSA resistance raised from
0% in 2002 to 41.7% in 2008, reﬂecting the occurrence of MRSA ST398
(life-stock associated MRSA) in the local setting.
For ciproﬂoxacin resistance in HA-MRSA remained on a stable high
level of 83.3% to 91.7%, by contrast resistance in CA-MRSA decreased
from 25% in 2004 to 0% in 2008. Resistance to rifampicin was only
found in rare cases of HA-MRSA (8.3% in 2005) and was not detected
in CA-MRSA.
Inducible macrolide-lincosamide-streptogramin B (MLSB) and constitu-
tive MLSB resistance were found to be more associated with HA-MRSA,
for clindamycin and erythromycin resistance ranged from 83.3% in 2002
to 100% in 2008. In CA-MRSA MLSB resistance was found in 8.3%
to 16.7%. Resistance to fusidic acid was found in 0% to 8.3% of HA-
MRSA, and 25% to 33.3% of CA-MRSA, respectively. Focusing and
analyzing the MIC50 and MIC90 values of the tested antibiotics, no
statistically signiﬁcant variances could be observed during observation
period.
Conclusion: Resistance to non-b-lactam antibiotics varies between HA-
MRSA and CA-MRSA. No resistance was found vancomycin, te-
icoplanin, quinopristin/dalfopristin and the newer antibiotics tigecycline
and linezolid. Resistance was also rare for rifampicin. Resistance to
ciproﬂoxacin, erythromycin and clindamycin were more common in HA-
MRSA, in contrast resistance to fusidic acid and tetracycline was found
more often in CA-MRSA. Concerning the MIC50 and MIC90 values
of the tested antibiotics no MIC creeping could be observed during
observation period.
R2153 Rapid molecular screening for methicillin-resistant
Staphylococcus aureus among intensive care unit-admitted
patients: preliminary results
P. Stano °, M. Avolio, R. De Rosa, M. Modolo, A. Camporese
(Pordenone, IT)
Objectives: Colonization with methicillin resistant Staphylococcus
aureus (MRSA) is a risk factor associated to severe morbidity and
mortality, excess length of stay as well as extra costs of care, especially
in patients admitted to critical areas such as intensive care units (ICU).
Nasal screening for MRSA, as current guidelines recommend (Calfee
DP et al. Infect Control Hosp Epidemiol. 2008), is the most powerful
strategy to prevent and limit the spread of infections if combined with
major control measures such as isolation, decolonisation from carriage
sites and hand hygiene programs. The aim of this study was to evaluate
the MRSA colonization rate among patients admitted to ICU using a
new rapid molecular method.
Methods: From April through October 2009, a total of 154 patients were
screened for MRSA carriage at admittance to ICU. All nasal swabs were
analyzed by molecular method (GeneXpert MRSA, Cepheid), able to
Resistance surveillance S643
amplify by real-time PCR the target sequence for MRSA at the SCCmec-
orfX junction. Samples were tested also by cultural analysis, plating
swabs onto Columbia agar with 5% Sheep Blood and Mannitol Salt
Agar (Kyma). Identiﬁcation and oxacillin testing were performed on
suspicious colonies using VITEK2 (bioMe´rieux).
Results: Our data with the GeneXpert MRSA showed high sensitivity
and speciﬁcity of the new molecular method. Among the 154 patients
examined for MRSA, 5 had a positive screening result by both, molecular
and culture-based method, 19 were identiﬁed as MSSA and had a
negative result by the molecular test. All samples negative by molecular
method were negative also by cultures.
Conclusion: GeneXpert MRSA showed high efﬁciency and efﬁcacy
compared with the culture method. In fact it requires only seventy
minutes to complete the analysis allowing a shorter turnaround
time (TAT) and, by improving patient management, a better clinical
and therapeutic outcome. This study allowed us to benchmark the
colonization level among ICU patients at the admission. This is a start
point for infection control strategies to prevent MRSA spread and for
developing more focused therapeutic measures in all colonized patients.
R2154 Antibiotic susceptibility monitoring using a Microsoft
Access® database
J.S. Cargill °, J. Sandoe (Leeds, UK)
Objectives: The clinical effectiveness of antimicrobial therapy is
constantly being undermined by the development of antimicrobial
resistance. Appropriate antibiotic prescribing is critical to good patient
outcomes and a signiﬁcant factor in the battle against emerging
resistance. As resistance is a constantly evolving problem active, real
time surveillance of susceptibility rates is necessary to optimise empirical
treatment and prophylactic regimens. We aimed to develop a local
surveillance system for monitoring our susceptibility rates and present
here the tool and some initial ﬁndings.
Methods: All microbiology sample results are retrieved from the
laboratory computer system (Telepath, iSoft Laboratory Systems) using
the list generation function for either hospital or community (general
practice) locations. Microsoft Access databases are used to process
these results and allow simple searching for antibiotic susceptibility
rates and trends over time. De-duplication of results is achieved by
identifying samples from the same hospital number with the same
antibiogram to leave single episodes within the selected time frame
(either monthly or quarterly). Twenty-three antibiotics and two antifungal
agents are imported into the hospital database and cumulative results
can be reported across the whole trust, by location (down to ward or
speciality level). Eighteen antibiotics are imported into the community
database, and cumulative results can be reported across the whole city or
by Primary Care Trust. The databases are reported via a separate Access
interface, allowing users to select locations and organisms and generate
bespoke reports.
Results: Graphical results are obtained to display both the numbers of
isolates tested within a time frame, the absolute susceptibility rate and
the trend over the time period. An example of the output is shown in the
Figure, which displays the susceptibility rate of Staphylococcus aureus
from wound swabs to ﬂucloxacillin.
Conclusions: The reporting of trends in antibiotic susceptibilities using
Microsoft Access has shown to be both feasible and useful. A simple
source for susceptibility rates has proved useful for the development of
empirical prescribing guidelines and to allow proactive changes in local
prescribing guidelines for both treatment and prophylaxis in response to
observed trends.
R2155 Activity of common UTI agents against enteric urinary
isolates from Europe and impact of patient population on
activity proﬁle
N. Brown °, D. Draghi, C. Pillar, D. Sahm (Chantilly, US)
Objective: A concern of empiric treatment of urinary tract infections
(UTI) is resistance (R) among Enterobaceriaceae spp. (EN). R can
vary by patient population. Furthermore, organisms harboring extended-
spectrum b-lactamases [ESBL] or exhibiting multi-drug resistance
[MDR] pose an additional threat. The GLOBAL Surveillance initiative
monitors susceptibility of EN to agents commonly utilized to treat UTI.
This study evaluates the current susceptibility of enteric UTI in EU
to select agents and the impact of patient age and location on activity
proﬁle.
Methods: 2056 EN urinary isolates (906 E. coli [EC], 388 Klebsiella
pneumoniae [KP], 448 Proteus spp., 314 other EN) were collected
from 2005–2009 across six EU countries. Susceptibility of isolates
was determined by broth microdilution (CLSI M7-A8; M100-S19) for
a variety of agents (levoﬂoxacin [LVX], ciproﬂoxacin [CIP], amox-
icillin/clavulanate [AMC] and trimethoprim/sulfamethoxazole [SXT]).
Multi-drug resistance (MDR) was deﬁned as R to 3 separate classes
of agents. Isolates were analyzed by patient location (outpatient [OP],
inpatient [IP], and ICU), and age [pediatric (PED) patients 17; adult
(ADT) 18−64; and elderly (ELD) 65)].
Results: Overall, % R among urinary EN were: LVX 13.9; CIP 17.2;
AMC 13.5; SXT 34.6. Among EC/KP, %R was: LVX 22.5/9.8; CIP
24.8/14.4; AMC 5.4/7.5; SXT 38.1/19.8. ESBL rates among EC and
KP were 4.5% and 11.9%, respectively, and 3.6% of EN were MDR.
LVX, CIP, amoxicillin–clavulanate (AMC), and SXT MIC90s were
all 16mg/L for EC. There was a trend towards increased R with
increasing age among EN (PED/ADT/ELD %R: LVX 9.4/11.5/16.6;
CIP 9.4/14.2/20.8; AMC 6.3/12.9/14.1; SXT 18.8/33.8/35.2). R was
generally highest among ICU patients relative to IP and OP (OP/IP/ICU
%R: LVX 13.0/13.3/14.7; CIP 17.5/16.4/17.2; AMC 11.4/13.6/16.4; SXT
32.8/34.3/34.5). For EC/KP, ESBL were most common among ELD and
IP (6.7%/12.3% and 4.8%/12.8%, respectively). MDR ranged between
2−4% across the subpopulations.
Conclusions: R to UTI agents among EN varied, with lower R to
LVX/CIP/AMC relative to SXT. R among EN increased with patient age.
ESBL rates were higher among KP compared with EC, and were more
common among ELD and IP populations. MDR rates were relatively
low (<4%) across the evaluated populations. As the activity proﬁle of
UTI agents is impacted by both patient age and patient location, it is
important to consider these factors when treating UTI empirically.
R2156 First detection of VIM-1 producing Pseudomonas
aeruginosa isolate in Slovenia
J. Ambrozie` Avgustin °, D. Zgur-Bertok, S. Lorencic Robnik, A. Golle,
M. Pirs, M. Mueller Premru, V. Krizan Hergouth, K. Seme (Ljubljana,
Maribor, SI)
Objective: Twenty years ago carbapenemases were described as species-
speciﬁc, chromosomally encoded b-lactamases. However, the identiﬁca-
tion of plasmid encoded carbapenemases has changed our perception
of the patterns of resistance genes dissemination predominantly through
interspecies dispersion rather than clonal spread. The aim of our study
was, therefore, to evaluate the prevalence of carbapenemase resistance
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determinants among 37 ertapenem resistant or intermediate Gram-
negative isolates.
Methods: A total of 33 Klebsiella pneumoniae, three Escherichia coli
and one Pseudomans aeruginosa ertapenem resistant or intermediate
isolates were tested for the presence of carbapenemases by phenotypic
(Hodge test) and genotypic methods (PCR). Speciﬁc primers were
used under standard PCR conditions to detect class A carbpenemases
(NMC, SME, IMI, KPC and GES), class B metallo-b-lactamases (IMP-1,
IMP-2, VIM-1, VIM-2, SPM-1, GIM-1 and SIM-1) and class D OXA
b-lactamases (OXA-23, OXA-24, OXA-69, OXA-58, OXA-55, OXA-48,
OXA-50 and OXA-60). PCR products were puriﬁed and sequenced.
Results: Among the 37 isolates tested by the Hodge method, 35 gave
negative results, one was positive (K. pneumoniae) and one could not be
clearly interpreted (P. aeruginosa). The analysed nucleotide sequences
revealed the presence of blaVIM-1 gene in the P. aeruginosa isolate.
Conclusions: The presence of the screened carbapenemase genes could
not be conﬁrmed in E. coli and K. pneumoniae isolates, although one of
the K. pneumoniae isolates gave a positive Hodge test. However, the ﬁrst
detected metallo-b-lactamase gene blaVIM-1 in a P. aeruginosa isolate
indicates the need to perform further screenings to control the emerging
carbapenemase resistance determinants, which are becoming a major
public health issue.
R2157 Antimicrobial susceptibilities of Gram positive bacteria
and antibiotic consumption in a Greek tertiary hospital,
2001–2008
S. Miyakis, C. Moschopoulos, M. Gatsiou, D. Alexiadou,
S. Charalampidou, C. Trakatelli °, V. Koulourida, M. Sion (Thessaloniki,
GR)
Objective: To examine differences in antibiotic susceptibility of Gram
positive bacteria and in antibiotic consumption in a Tertiary Hospital,
within 7 years of operation.
Methods: All clinical samples from inpatients. Identiﬁcation and
susceptibility testing, using the Wider® semi-automated system with
CLSI breakpoints. Antibiotic consumption expressed as Deﬁned Daily
Doses (DDD) per patient-day.
Results: 841 and 413 isolates identiﬁed during 2008 and 2001,
respectively.
Methicillin Resistant S. aureus (MRSA) rates were signiﬁcantly higher
in 2008 (56.5%, 74/131 isolates) than in 2001 (36.6%, 15/41; p = 0.026).
The proportion of community-acquired strains among MRSA also
increased in 2008 (32.4%, 24/74 vs. 26.3%, 4/15 in 2001). One MRSA
in 2008 had reduced susceptibility to Vancomycin (MIC=8); and 1 to
Linezolid (MIC> 4). No such strains were found in 2001.
S. aureus resistance increased for Penicillin (121/131 isolates, 92.4%
in 2008 vs. 30/40, 75% in 2001; p< 0.01), Erythromycin (53.8% vs.
35.9%; p< 0.05) and Clindamycin (42% vs. 32.5%).
Among hospital strains (>48 hours from admission) Coagulase-Negative
Staphylococci (CoNS) resistance to Methicillin increased in 2008 (81%,
222/274 isolates vs. 72.4%, 121/167 in 2001; p< 0.04). CoNS in 2008
had high rates of non-susceptibility to several antibiotics tested (ranging
from 47.1% for Cotrimoxazole to 92.3% for Penicillin). 4 CoNS strains
were non-susceptible to Vancomycin in 2008, and 1 in 2001. All CoNS
were susceptible to Linezolid.
Non-susceptibility rates of Enterococcus sp. hospital strains increased
for Amoxycillin/Clavulanate (37.4%; 49/131 isolates in 2008 vs.
22.2%; 14/63 in 2001, p = 0.035), Erythromycin (87.8% vs. 82.5%)
and Rifampicin (70.3% vs. 64.8%). 2/192 Enterococci in 2008 were
resistant to Vancomycin (VRE) and Teicoplanin (VanA phenotype).
9/192 Enterococci in 2008 had MIC 2 to Linezolid.
There was only 1 S. pneumoniae isolate (non-CNS) with Penicillin
MIC=2 in 2008; all S. pneumoniae isolated in 2001 had MIC;0.12.
Consumption of wide-spectrum antibiotics increased by 28.8% (17.9
DDD/100 hospital-days in 2008 vs. 13.9 in 2001). Consumption of anti-
MRSA antibiotics also increased (1.94 in 2008 vs. 1.64 in 2001).
Conclusion: Within 7 years, there was a marked increase of non-
susceptibility rates of Gram-positive bacteria, including MRSA. This
paralleled the increased consumption of wide-spectrum antibiotics and
of antibiotics with activity against multi-resistant Gram-positive bacteria.
Surveys of molecular epidemiology of
resistance and resistance genes, strains or
serotypes
R2158 Isolation of blaCTX-M group 8 extended-spectrum
b-lactamase among clinical isolated Enterobacteriaceae in
a 1,000-bed hospital in Thailand
P. Santanirand °, T. Wongsuk, P. Chongtrakool, S. Srisangkeaw
(Bangkok, TH)
Objectives: The CTX-M-type encoding Extended-spectrum b-lactamases
(ESBLs)-producing in Gram negative bacteria, particularly among
members of Enterobacteriaceae family have become more recognized.
Distribution of these genes varies in different countries. However, rare
and uncommon CTX-M-type ESBLs such as CTX-M-8, 40 and 63 have
been reported scattering in various parts of the world. Therefore, it
came to our attention to investigate the existence of these rare genes
in Thailand.
Method: Four hundred and seventy ESBL-phenotypic positive clinical
isolates of Enterobacteriaceae members were detected for the presence
of blaCTX-M groups including 1, 2, 8, 9 and 25 and upstream region
using PCR method. In addition, ERIC-PCR analysis was performed.
Result: Among tested organisms, sixteen isolates (4%) were detected
carrying an uncommon CTX-M group 8. These included K. pneumoniae
(9 isolates), M. morganii (4 isolates), E. coli (2 isolates), and P. mirabilis
(1 isolate). Interestingly, the sequence of blaCTX-M of all CTX-M
group 8 positive M. morganii, E. coli and P. mirabilis showed a strict
identity with the CTX-M-63, AF189721 (100% similarity). In contrast,
only 2 isolates of K. pneumoniae were found containing CTX-M-63
while the other seven isolates revealed revealed a strict identity with the
CTX-M-40, AB205197 (100% similarity) PCR and sequencing of the
upstream region showed the presence of transposase gene (tnpA) of the
ISEcp1-like element.
Conclusion: To our knowledge, this is the ﬁrst report of clinical isolates
producing CTX-M-40 and CTX-M-63 ESBL in Thailand. In order to
gain clearer view of the distribution of these genes, further larger scale
of investigation throughout the country may be required.
R2159 Detection of OXA carbapenemases in multidrug-resistant
clinical isolates of Acinetobacter baumannii from Krakow,
Poland
P. Nowak, P. Paluchowska, M. Tokarczyk, W. Mudyna, M. Maciuszek,
A. Budak ° (Cracow, PL)
Objectives: Acinetobacter baumannii is an increasingly important
nosocomial pathogen often causing outbreaks in intensive care
units. Many clinical isolates are resistant to almost all antibiotics
including carbapenems. The most common mechanism responsible
for carbapenem-resistance are carbapenem-hydrolysing b-lactamases
belonging to molecular class D (OXA enzymes). Drug resistance of
A. baumannii strains may also be associated with the presence of an
insertion sequence (ISAba1). The aim of the study was detection of:1)
OXA encoding genes; 2) presence of ISAba1.
Methods: The study included the total of thirty isolates of multidrug
resistant A. baumannii. All strains were carbapenem-resistant. These
isolates were obtained from patients hospitalized in ICU of Specialized
Hospital in Krakow. A. baumannii identiﬁcation and sensitivity test
(VITEK-2 Compact, bioMe´rieux, Poland) were performed by standard
criteria (CLSI). All strains were tested for MBL (metalo-b-lactamases)
production by disk-diffusion synergy test. Multiplex PCR described
by Woodford at al. (2006) was applied for detection of OXA
carbapenemases encoding genes (blaoxa-51-like, blaoxa-24-like and
blaoxa-23-like). All strains were tested for presence of 549-bp fragment
containing a portion of ISAba1.
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Results: Resistance rates to piperacillin, piperacillin–tazobactam,
ceftazidime, cefepime, imipenem, meropenem, gentamicin, tobramycin,
amikacin, ciproﬂoxacin were 100% (30), 90% (27), 90% (27), 100%
(30), 97% (29), 100% (30), 93% (27), 20% (6), 57% (17), 100% (30)
respectively. Phenotypic test for MBL production was negative for all
strains. Multiplex-PCR analysis showed the presence of gene encoding
a b-lactamase belonging to OXA-51-like group in all the isolates. Nine
and 18 of 30 isolates carried a gene blaoxa-23-like and blaoxa-24-like
respectively. Two of 30 isolates carried both of acquired OXA genes. All
of the isolates contained the insertion sequence ISAba1.
Conclusions: Our results support the theses that detection of the
blaoxa-51-like can be used as efﬁcient method for identiﬁcation of
A. baumannii strains. Carbapenem resistance in tested isolates might
be associated with: 1) expression of acquired oxacillinases belonging
to OXA-23-like and OXA-24-like groups; 2) extended expression of
intrinsic oxacillinases belonging to OXA-51-like group supported by the
presence of insertion sequence ISAba1.
R2160 Distribution of capsular serotypes, clones and macrolide
resistance mechanisms among macrolide-resistant
Streptococcus pneumoniae clinical isolates
M. Telli °, M. Eyigo¨r, B. Gu¨ltekin, N. Aydin (Aydin, TR)
Objectives:Macrolide resistance in S. pneumoniae has become a clinical
problem in Turkey and other countries. The aim of this study was to
analyze the distributions of capsular serotypes, clones, phenotypes and
macrolide resistance genes among macrolide-resistant S. pneumoniae
clinical isolates in our hospital.
Methods: A total of 89 S. pneumoniae clinical isolates were isolated
from clinical samples between 2007 and 2009. Minimum inhibitory
concentrations of erythromycin, clindamycin and penicillin were
determined by agar dilution method according to the CLSI guidelines.
Susceptibility of azithromycin, telithromycin, tetracycline, linezolid,
vancomycin, and levoﬂoxacin were determined by disc diffusion method.
CLSI criteria were used for the interpretation of susceptibility testing
results. Serotyping was performed using the capsular swelling procedure
(quellung reaction). The double-disk method with erythromycin and
clindamycin disc was used for determination of macrolide resistance
phenotypes. Macrolide resistance genes (mefA/E, ermA, ermB, ermC,
ermTR) were detected by PCR reaction. All erythromycin resistant
strains were genotyped by pulsed-ﬁeld gel electrophoresis (PFGE) after
digestion with SmaI.
Results: Thirty ﬁve (40%) isolates were resistant to erythromycin.
Penicillin, clindamycin, azithromycin tetracycline and levoﬂoxacin
resistance ratio were 13%, 30%, 40%, 36%, 9% respectively. All isolates
were susceptible to linezolid, vancomycin and telithromycin. Serotype
distribution among erythromycin-resistant isolates were 16 (45%) strains
serotype 19, 4 (10%) strains serotype 23, 3 (9%) strains serotype 6,
2 (6%) strains serotype 14, 2 (6%) strains serotype 16, 1 (3%) strain
serotype 18 and 1 (3%) strain serotype 33 and 3 (9%) strains nonvaccine
serotype or not typied. Macrolide resistance phenotypes, erythromycin
resistance genes and MIC 50/90 values among erythromycin-resistant
S. pneumoniae isolates are presented in table 1. Twenty nine genotypes
were detected among erythromycin-resistant S. pneumoniae isolates by
PFGE. Clonal spreading of resistant strains could not be demostrated.
Table 1: Macrolide resistance phenotypes, erythromycin resistance genes
and MIC50/90 values among 35 erythromycin-resistant S. pneumoniae
isolates








































cMLSB 26 (73) 64–128 32 0.03−4 128/128 32/32 1/2 26 7
iMLSB 3 (9) 64–128 0.03–0.06 0.03–0.25 ND ND ND 3 0
M 6 (18) 1−4 0.03 0.03−4 ND ND ND 0 5*
*One strain in M phenotype was not include resistance genes. ND: not determined.
Conclusions: This study showed that the most common mechanism
of erythromycin resistance in S. pneumoniae isolates were cMLSB
(constutive) phenotype encoded by ermB gene (73%). Serotype 19
(45%) was predominant in erythromycin resistant S. pneumoniae isolates.
However, clonal dissemination of resistant strains were not found.
R2161 First report of carbapenem resistance in Klebsiella
pneumoniae due to porin loss from Croatia
K. Dobrovic °, B. Bedenic, S. Sestan Crnek, S. Sardelic, J. Skrlin,
S. Kalenic, L. Martinez Martinez (Zagreb, Split, HR; Santander, ES)
Objectives: To study the mechanisms of reduced susceptibility to
carbapenems in an ESBL producing K. pneumoniae obtained from a
patient at the Dubrava University Hospital, Zagreb, Croatia, that was
isolated during meropenem therapy.
Methods: An ESBL-producing K. pneumoniae (as determined by a
double disk assay) was isolated from a blood culture of patient with
a cardiac transplant. The patient was treated with meropenem twice in
six weeks. Two weeks later K. pneumoniae with reduced suscepeptibility
to carbapenems was isolated from an anal swab. MICs were determined
by broth microdilution according to CLSI. Modiﬁed Hodge Test(MHT)
was used to screen for production of carbapenemases. MBL E-test was
used to screen for production of metallo-b-lactamases. The presence of
blaSHV, blaTEM, blaCTX-M, blaACT-1, blaMIR, blaCMY, blaDHA,
blaKPC-1, blaOXA-48, blaIMP and blaVIM was determined by PCR
and the obtained amplicons were sequenced. The genetic relatedness of
the strains was investigated using PFGE. To study porin content of the
strains, outer membrane proteins (OMPs) were extracted and separated
by SDS-PAGE.
Results: The initial isolate was susceptible to ertapenem (MIC
0.125mg/L), meropenem (MIC 0.032mg/l) and imipenem (MIC
0.25mg/l). MICs of carbapenems for the strain obtained after
meropenem treatment were: ertapenem MIC 32mg/l, meropenem MIC
16mg/l, and imipenem MIC 8mg/l. PFGE showed that the two strains
were highly related. Both strains were shown to possess blaSHV-11 and
blaCTX-M-15/28 genes. MHT was negative in both strains. The PCR
reactions with primers speciﬁc for Amp-C, KPC and oxacillinase were
negative. Both isolates produced an OMP-A like protein. The initial
isolate expressed one single porin (OmpK36) while second isolate did
not produce any of the two major porins of K. pneumoniae (OmpK35
or OmpK36).
Conclusion: K. pneumoniae with decreased carbapenem susceptibility
was isolated from a surveillance culture (anal swab) after prolonged
meropenem therapy. Since no carbapenemases were produced by the
strains, carbapenem resistance is attributed to be due to hyperproduction
of CTX-M b-lactamase combined with complete porin loss. This study
highlights the need to establish an antimicrobial resistance survellance
network for K. pneumoniae and to further monitor the trends and new
types of resistance mechanisms.
R2162 Prevalence and molecular characteristics of faecal-
colonizing plasmid-mediated quinolone-resistant
Enterobacteriaceae in ﬁve tertiary care hospitals in Korea
H.S. Jeong, I.K. Bae, S.H. Kim, C.L. Chang, C.H. Lee, S. Kim,
N.H. Ryoo, J. Jeong, J.N. Lee, W.G. Kho, J.H. Shin ° (Busan, Seoul,
Daegu, Jinju, Ulsan, KR)
Introduction: The aims of this study were to investigate the prevalence
and molecular characteristics of fecal Enterobacteriaceae bearing
plasmid-mediated quinolone resistance that had colonized patients in
ﬁve tertiary-care hospitals in Korea.
Methods: We collected 500 non-duplicated Enterobacteriaceae isolates
from stool samples between March 2008 and May 2008 in ﬁve
hospitals and screened for the qnr (qnrA, qnrB, qnrS), aminoglycoside
acetyltransferase aac(6′)-Ib-cr, and plasmid-mediated qepA genes by
PCR ampliﬁcation. All positive results were conﬁrmed by direct
sequencing of the PCR products.
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Results: The qnr gene was detected in 85 (17.0%) of the 500 isolates.
Among 85 qnr-positive strains, K. pneumoniae (N = 39) was the most
common, followed by E. coli (N = 18), C. freundii (N = 10), C. braakii
(N = 9), and others (N = 9). These were ﬁnally identiﬁed as qnrA1 (N= 7),
qnrB subtype (N= 70), and qnrS1 (N= 8). Nine strains revealed new
variants, which were qnrB like with amino acid mutations. The aac(6′)-
Ib-cr and plasmid-mediated qepA genes were detected in 58 (11.6%)
and 3 (0.6%) strains, respectively. A total of 30 strains were positive in
both qnr and aac(6′)-Ib-cr, and 1 strain showed a positive result for all
three genes. The resistance rates of qnr-positive strains to ciproﬂoxacin,
levoﬂoxacin, norﬂoxacin, and nalidixic acid were 55.2%, 36.8%, 40.2%,
and 49.4%, respectively. The resistance rates of aac(6′)-Ib-cr-positive
strains were higher than those associated with qnr genes.
Conclusion: The qnr and aac(6′)-Ib-cr genes were highly prevalent in
stool specimens. We presumed that the wide spread of plasmid-mediated
quinolone resistance in clinical isolates was associated with high rates
of fecal colonization in the hospital.
R2163 Characterization of b-lactamases and integrons in
amoxicillin–clavulanic acid-resistant Salmonella enterica
isolates of three Spanish hospitals
M. de Toro °, Y. Sa´enz, E. Cercenado, B. Rojo-Bezares, M. Garcı´a-
Campello, E. Undabeitia, C. Torres (Logrono, Madrid, Pontevedra, ES)
Objective: To characterize b-lactamases and integrons in S. enterica
isolates resistant or intermediately resistant to amoxicillin–clavulanic
acid (AMCI/R) recovered during 2007–2009 from three Spanish
hospitals of different geographical areas.
Methods: 90 AMCI/R S. enterica isolates [serovars Typhimurium,
80; Enteritidis, 6; Thompson, 1; Gnesta, 1; Salmonella spp, 2] were
recovered from faecal (71), blood (4), urine (1) and other (14) origins.
Susceptibility testing to 19 antibiotics was performed by disc-diffusion
and microdilution methods (CLSI). ESBL phenotype was determined
by double disc synergic method. The presence of blaCTX-M, blaTEM,
blaCMY, blaSHV, blaPSE, blaOXA-1 genes; the genetic environment of
blaCTX-M and the detection and characterization of class 1, 2 and 3
integrons were studied by PCR and sequencing.
Results: The percentages of resistance found in the 90 isolates were
as follows: sulfamides (96%), tetracycline (89%), chloramphenicol
(76%), streptomycin (64%), nalidixic acid (23%), co-trimoxazole (6%),
ciproﬂoxacin (1%) and gentamicin, tobramycin, kanamycin, amikacin
(range 1−3%). Two AMCI/R isolates also showed resistance to third
generation cephalosporins, exhibited an ESBL phenotype and harboured
blaCTX-M-15 plus blaTEM-1, and blaCTX-M-14a genes, respectively.
The surrounding regions of these blaCTX-M genes were: ISEcp1-
blaCTX-M-15-orf477 and ISEcp1-blaCTX-M-14a-IS903. The remaining
88 AMCI/R isolates harboured (no. of isolates): blaPSE-1 (44),
blaOXA-1 (24), blaTEM-1 (13), blaPSE-1 plus blaOXA-1 (1) and
blaPSE-1 plus blaTEM-1 (3). Class 1 integrase was detected in 73
AMCI/R isolates (81%). The blaPSE-1-positive isolates (n = 48) included
this gene in one class 1 integron, and aadA2 gene in another integron,
a structure related to Salmonella genomic island 1 (SGI1). The other
gene cassette arrangements found in class 1 integrons were (no. of
isolates): blaOXA-1+aadA1 (23), aac(6′)-Ib-cr+blaOXA-1+catB3+arr3
(1) and dfrA12+orfF+aadA2 (1).
Conclusions: Among clinical S. enterica isolates, AMC resistance is
mainly due to the production of the PSE-1 b-lactamase. The blaPSE-1
gene was always found inside a class 1 integron related to SGI1. Other
b-lactamases are also implicated in AMCI/R phenotype. ESBL is an
emergent problem in S. enterica, and blaCTX-M-15 and blaCTX-M-14a
were detected.
R2164 Prevalence of plasmid-mediated quinolone resistance and
extended-spectrum b-lactamase determinants in Escherichia
coli and Salmonella spp. isolated from processed food
products and food-animals
N. Mendonc¸a °, S. Pio, G. Da Silva (Coimbra, PT)
Objective: Esherichia coli and Salmonella spp. are important causes
of gastrointestinal illness and are often found in production animal
settings. Thus, the aim of the study was to investigate the presence of
plasmid-mediated quinolone resistance (PMQR) and extended-spectrum
b-lactamases (ESBL) determinants in E. coli and Salmonella spp.
isolated from processed food products and food-animals.
Methods: From a total of 77 isolates collected between August 2008
and April 2009, from food producing animals, processed food and
mud, 37 were E. coli and 40 Salmonella spp. strains. Antibiotic
susceptibility tests were performed for b-lactams, quinolones and
aminoglicosides, according to CLSI guidelines. Isolates were screened
for PMQR (qnr, aac(6′)-Ib-variant and qepA) and ESBL (blaTEM,
blaSHV and blaCTX-M) determinants using speciﬁc primers. qnr genes
were identiﬁed by nucleotide sequencing.
Results: Eighty-ﬁve percent of Salmonella spp. strains were isolated
from processed food, 10% from animals and 5% were isolated from
mud. Forty percent of strains were resistant to nalidixic acid, while 8%
and 5% showed resistance to 3rd generation cephalosporins, ceftazidime
and cefotaxime, respectively. All strains were susceptible to netilmicin
and imipenem. Five percent of strains were multirresistant. PMQR
determinants were not detected among Salmonella spp. strains, however
it was possible to detect four blaTEM genes. For E. coli strains, 95%
were isolated from animals and 5% from processed food. Seventy-six
percent of strains were resistant to nalidixic acid, 27% to ciproﬂoxacin
and 8%, 3% and 5% were resistant to cefotaxime, ceftazidime and
netilmicin, respectively. All strains were susceptible to imipenem.
Fourteen percent of strains presented multirresistance. Two QnrB2
encoding genes were identiﬁed in strains from pigs, one of which
presenting multidrugresistance phenotype. Two QnrS1 encoding genes
were identiﬁed in strains recovered from poultry, which presented only
resistance to quinolones. The determinants aac(6′)-Ib-variant and qepA
were not detected. Forty-six percent of strains presented a blaTEM gene,
8% a blaSHV and 5% a blaCTX-M gene. Both strains expressing QnrB2
presented also a blaTEM gene and one of them a blaSHV.
Conclusion: This study demonstrates the increase in the dissemination
of PMQR and ESBL determinants among foodborne zoonotic pathogens,
constituting a major risk factor for public health.
R2165 Epidemiology of resistance to third-generation
cephalosporins in Enterobacteriaceae from critically ill
medical patients
M.M. Sole´ °, N. Cobos, A. Fa`brega, A. Mons, E. Triana, P. Castro,
J.M. Nicolas, A. Soriano, J. Mensa, J. Vila, J.A. Martinez (Barcelona, ES)
Objectives: To evaluate the epidemiology of resistance to third-
generation cephalosporins (CEF3) in enteric Gram-negative bacilli
(EGNB) from critically ill medical patients.
Methods: During 21 months, patients admitted to an 8-bed medical ICU
were subjected to qualitative surveillance cultures of nares, pharynx,
tracheal aspirates and rectum thrice weekly. Selective media were used
to isolate CEF3-EGNB. ESBLs and plasmid-encoded cephamycinases
were characterized by PCR. Clonality was determined by PFGE.
Results: 633 patients were included in the study. 78 isolates were
recovered from 72 (11%) patients, almost all (n = 68, 94%) from
rectal swabs. CEF3-resistant organisms included E. coli (n = 46, 76%),
K. pneumoniae (n = 13, 17%), E. cloacae (n = 9, 12%), E. aerogenes
(n = 2, 3%), H. alvei (n = 2, 3%) and others (1 C. diversus, 1 C. freundii,
1 S. marcescens, 1 S. fonticola, 1 M. morgagnii, 6%). 35 (76%) strains
of E. coli possessed an ESBL (CTX-M group 9 in 28, CTX-M group 1
in 3 and SHV in 6) and 9 (20%) a cephamycinase (8 CIT group,
1 DHA), either alone (n = 5) or with a CTX-M group 9 enzyme. In
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K. pneumoniae, 10 (77%) isolates had an ESBL (3 CTX-M group 9, 4
CTX-M group 1, and 3 SHV) and 5 (38%) a cefamycinase (2 EBC; 3
DHA, 2 with a SHV). In 40 (51%) patients, a CEF3-resistant EGNB was
not detected on admission but apparently acquired thereafter. Acquisition
was less frequent for E. coli (45%) than for K. pneumoniae (62%)
or other species (76%) (p = 0.08). Molecular epidemiology revealed 2
clusters of 2 patients each among 46 E. coli isolates (9%), 1 cluster of
2 patients among E. cloacae (22%) and 1 cluster of 5 patients among
K. pneumoniae (38%). However, clinical epidemiology was consistent
with intra-ICU transmission in only one patient with K. pneumoniae.
Conclusions: In our setting, plasmid-encoded AmpC b-lactamases
have become prevalent (20%) among CEF3-resistant E. coli and.
K. pneumoniae carried by critically ill medical patients. Apparent
acquisition was unrelated to clonal transmission, which may indicate
poor sensitivity of admission cultures. Conversely, clustering in
K. pneumoniae should not be blindly attributed to intra-ICU horizontal
transmission.
R2166 Prevalence of class 2 integrons and multidrug resistance
among Salmonella enterica isolates from clinical cases in
Iran
A. Naghoni °, R. Ranjbar, B. Tabaraie (Karaj, Tehran, IR)
Objective: The main objective of this study was to investigate the
prevalence and diversity of class 2 integrons in Salmonella enterica
isolated in Iran during 2007–2008.
Methods: Salmonella strains were isolated from several hospitals in
Tehran, Iran. The isolates were identiﬁed by standard biochemical tests
and agglutination using speciﬁc antisera. The strains were tested for sus-
ceptibility to the following antimicrobial drugs: ampicillin, streptomycin,
gentamycin, kanamycin, tobramycin, chloramphenicol, tetracycline,
ciproﬂoxacin, nalidixic acid and sulfamethoxazole-trimethoprim, by the
disc diffusion method, according to CLSI (Clinical and Laboratory
Standards Institute). Class 2 integrons were detected by PCR with
speciﬁc primers for the int2 gene, and subsequently the cassette regions
were ampliﬁed using primers hep74 and hep51 for the attI2-orfX region.
Results: In this research, 103 Salmonella strains were isolated. The most
common resistance phenotypes detected were to nalidixic acid (64%),
tetracycline (50%), streptomycin (42%), sulfamethoxazole-trimethoprim
(29%), kanamycin (24%), ampicillin (16%) and chloramphenicol (13%).
75 (72.8%) of bacteria were resistant to two or more antibiotics that is
considered as MDR. Twenty-one (20.3%) of the 103 isolates had a 2161
bp class 2 integron, containing four open reading frames, namely dhfI,
satI, aadA and orfX.
Conclusions: Our ﬁndings showed that class 2 integrons are widely
spread among Salmonella enterica isolated in Iran. Integron positive
isolates were included into ﬁve different serotypes of S. enterica:
Albany, Infantis, Muenchen, Reading and Typhimurium. Surveillance
and monitoring of antimicrobial drug resistance, including screening for
integrons as likely indicators of drug resistance and acquisition of new
resistance traits, are necessary steps in planning effective strategies for
containing this phenomenon within food-borne infection organisms.
R2167 Detection of carbapenemases and analysis of resistance in
Acinetobacter baumannii
W. Liu °, Z. Chen, Y. Zhang, M. Zou (Changsha, CN)
Objective: To investigate carbapenemases and antimicrobial resistance
in clinical isolates of Acinetobacter baumannii in our hospital, study the
molecular epidemiology and resistance mechanisms.
Methods: 179 Acinetobacter baumannii clinical isolates were collected
from January to June 2009 in our hospital. Modiﬁed Hodge test was
used to screen the strains producing carbapenemases. Antimicrobial sus-
ceptibility test was performed by disk diffusion method. Carbapenemase
genes were ampliﬁed using PCR and sequenced, plasmid conjugation
experiments were done to study the transfer of carbapenemase genes,
and the homology of these isolates was analyzed by ERIC-PCR, in order
to explain the molecular mechanism of drug resistance.
Results: 74 of 179 strains were positive in modiﬁed Hodge test;
74 strains maintained highly sensitivity to cefoperazone/sulbactam
and minocycline and their resistance rates were 16.2% and 13.5%
respectively, and the resistance rates to other antimicrobial agents were
more than 78.0%. OXA-23 gene was found in 71 strains but OXA-24,
IMP-1, IMP-2, VIM-1 or VIM-2 genes were not found in 74 bacteria;
Carbapenemase genes were unable to transfer via plasmid; 74 strains
were identiﬁed as 4 predominant clones by ERIC-PCR and they had
spread in many wards in our hospital widely.
Conclusions: OXA-23 gene was the popular carbapenemase genotype
and clonal spread was the main reason for carbapenem resistance to
Acinetobacter baumannii in our hospital.
R2168 Double resistance conferred by CTX-M and
plasmid-mediated AmpC
P.J. Edquist °, A. Brolund, L. Gezelius, H. Hallin, C.G. Giske,
B. Olsson-Liljequist, K. Tegmark Wisell (Stockholm, SE)
Objectives: Plasmid-mediated antibiotic resistance within Enterobac-
teriaceae is globally accelerating. Of great concern is E. coli
and Klebsiella pneumoniae producing classical extended-spectrum
b-lactamases (ESBL_A) or AmpC enzymes (ESBL_M) both which
commonly are plasmid-mediated and confer resistance to 3th generation
cephalosporins. ESBL-producing Enterobacteriaceae are since 2007
mandatorily notiﬁable by the laboratories according to the Swedish
Communicable Diseases Act. In 2008 an incidence of 32 cases per 100
000 inhabitants was noted, which was a clear increase as compared
to 2007. At the Swedish Institute for Infectious Disease Control
we receive and further characterize clinical isolates with extended
spectrum b-lactam resistance providing an overview of the Swedish
expanding ESBL situation. Of notice is six isolates containing both
blaCTX-M and blaAmpC, two different apparent plasmid-mediated
resistance mechanisms towards extended spectrum b-lactams.
Methods: Our collection consists of extended spectrum cephalosporin
resistant clinical isolates sent from different Swedish laboratories for
further ESBL characterization. Susceptibility testing was performed by
both Etest and disc-diffusion methodology. Breakpoints were applied
according to EUCAST and SRGA, respectively. Phenotypic ESBL
characterization was performed by double disc synergy tests. All isolates
were further screened for the presence of bla_CTX-M and plasmid-
mediated bla_AmpC using real-time PCR. PFGE was performed for
assessment of genetic relatedness between the isolates.
Results: Between October 2007 and November 2009 six clinical isolates,
ﬁve E. coli and one K. pneumoniae, with bla_CTX-M group 1 in
combination with apparent plasmid-mediated bla_AmpC were detected.
The isolates had clavulanic acid reversible resistance to cefotaxime
and/or ceftazidime, indicating the presence of ESBL_A in combination
with cloxacillin reversible resistance to cefoxitin, indicating the presence
of an AmpC-enzyme. Genetic screening for CTX-M and apparent
plasmid mediated AmpC demonstrated the presence of a bla_CTX-M
gene of group 1 in all isolates and a gene coding for the bla_AmpC
enzyme CIT in the ﬁve E. coli isolates and DHA in the K. pneumoniae
isolate. All six isolates were multiresistant and the patients were of
varying ethnicity, gender, medical record and their age range from 2 to
91 years. Analysis with PFGE and conﬁrmation of the apparent plasmid
origin of the bla_CTX-M and bla_AmpC genes are ongoing.
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In vitro antibacterial susceptibility and drug
interaction studies
R2169 In vitro efﬁcacy of combination with various antimicrobial
agents against trimethoprim/sulfamethoxazole-resistant
Stenotrophomonas maltophilia
M.K. Joung °, C.I. Kang, Y.E. Ha, J.A. Lee, S.Y. Moon, H.L. Lee,
K.S. Ko, D.R. Chung, J.H. Song, K.R. Peck (Seoul, KR)
Objectives: Although trimethoprim/sulfamethoxazole (TMP/STX) is
considered the treatment of choice of serious infections caused
by Stenotrophomonas maltophilia, TMP/STX-resistant isolates have
emerged and became challenging in management of S. maltophilia
infections. Thus we evaluated in vitro activity of the interactions with
various antimicrobial agents on TMP/STX-resistant S. maltophilia.
Methods: The susceptibility tests of TMP/STX using microdilution
method were performed with 73 clinical isolates of S. maltophilia
collected from January 2006 to March 2009 at Samsung Medical
Center. Among TMP/STX-resistant S. maltophilia isolates, 3 non-
duplicated isolates were evaluated for in vitro activities of single and
combination antibiotics of tigecycline (TGC), ticarcillin–clavulanic acid
(T/C), levoﬂoxacin (LEV), and colistin (CL), using time-kill assay.
The time-kill assays of 0.25, 0.5 and 1XMIC at each antibiotic were
performed for each isolate. In vitro activities of two-drug combinations
were evaluated using 0.5XMIC.
Results: Among 3 isolates tested, 1 isolate showed in vitro resistance to
TGC and T/C, 2 isolates showed resistance to LEV and all isolates
showed resistance to CL. The interactions of antimicrobial agent
combinations are shown in table.
Conclusion: The growth of TMP/STX-resistant S. maltophilia was
signiﬁcantly inhibited by the combination of colistin and levoﬂoxacin,
compared with other combinations. Given the limitation of therapeutic
options against TMP/STX-resistant S. maltophilia, further investigation
is warranted to ascertain the clinical relevance of our ﬁndings.
Isolates TGC+T/C TGC+LEV TGC+CL T/C+LEV T/C+CL LEV+CL
1. Indifference Antagonism Antagonism Antagonism Indifference Synergism
2. Indifference Antagonism Antagonism Indifference Indifference Synergism
3. Indifference Antagonism Indifference Indifference Indifference Synergism
R2170 Acinetobacter-associated infections in the Republic of
Belarus: state of the problem
Y. Gorbich, I. Karpov °, O. Kretchikova (Minsk, BY; Smolensk, RU)
Objectives: The purpose of our research was to evaluate Acinetobacter
baumannii antibiotic resistance level in hospitals of the Republic of
Belarus.
Methods: The subject of the study was a group of patients with
clinical and laboratory documented nosocomial infections caused by
A. baumannii. All patients were treated in 12 Minsk hospitals between
December, 2008 and July, 2009. The total number of researched
patients is 73 (65.7% males; middle age 51.7±4.4 years old). Pathogen
identiﬁcation and antibiotic resistance surveillance were performed
at the microbiological laboratory of the Institute of Antimicrobial
Chemotherapy (Russian Federation). Strains collected from different
specimen sources of the same patient were excluded.
The isolates were identiﬁed by conventional methods. Antimicrobial
resistance was evaluated by disk-diffusion method and determined
according to the guidelines of the National Committee for Clinical
Laboratory Standards (NCCLS, USA). Intermediately susceptible
isolates were recognized as resistant.
Results: None of the tested antibiotics achieved high activity (80%
susceptible) against nosocomial isolates of A. baumannii. The most of
the examined strains were resistant to ceftazidime (91.7%), ciproﬂoxacin
and amikacin (89% and 86.8% respectively). Susceptibility to gentamicin
and carbapenems was relatively higher, but also under 50%. So 37% of
the collected isolates were susceptible to gentamicin, 47.9% to imipenem
and 46.6% to meropenem.
The difference in susceptibility to carbapenems was documented in
three cases. Two strains were imipenem-susceptible and one strain was
meropenem-susceptible.
It’s interesting, that 9 of 73 collected isolates were susceptible only to
gentamicin. It was also active against 14 carbapenem-resistant strains.
Conclusion: A. baumannii isolates from Minsk hospitals are character-
ized by high resistance to all studied antibiotics. We found out, that
carbapenems have the highest activity against nosocomial strains of
A. baumannii. It seems that gentamicin activity is relatively high, because
it’s not commonly used during the last ten years in our country. However,
the resistance level to these antimicrobials was extremely high.
R2171 Antimicrobial activity of daptomycin against multidrug-
resistant Gram-positive strains collected in Bulgaria
V. Dimitrova °, T. Velinov, M. Petrov, N. Hadjieva, T. Kantardjiev (Soﬁa,
BG)
Objectives: Daptomycin is a cyclic lipopeptide with potent activity
and broad spectrum against Gram-positive bacteria currently used for
the treatment of complicated skin and skin structure infections and
bacteremia, including right sided endocarditis. We evaluated the in vitro
activity of this new compound against clinical strains of staphylococci
and enterococci collected from Bulgarian medical centers in the National
Reference Laboratory for “Control and Monitoring of Antimicrobial
Resistance” at the National Center of Infectious and Parasitic Diseases,
Soﬁa.
Methods: A total of 100 fresh, non-duplicate clinical strains,
including 60 Staphylococcus aureus (MRSA), 40 Enterococcus spp.
(20 Enterococcus faecium, 15 E. faecalis and 5 E. avium) from
different medical centers were tested for susceptibility by reference agar
microdilution methods according to Clinical and Laboratory Standards
Institute guidelines and interpretative criteria.
Results: All S. aureus strains were inhibited at a daptomycin MIC of
1mg/l. Among tested E. faecium strains the highest daptomycin MIC
value was 2mg/l (MIC50 under 0.5mg/l), while among E. faecalis and
E. avium the highest MIC value was 1mg/l (Table 1).
Conclusion: Daptomycin showed excellent in vitro activity against
staphylococci and enterococci collected in the National Reference
Laboratory for “Control and Monitoring of Antimicrobial Resistance”
and appears to be an excellent therapeutic option for serious infections
caused by methicillin-resistant staphylococci and vancomycin-resistant
enterococci. During this National study no resistant bacteria were
found in Bulgaria and 100% of the tested strains were susceptible to
Daptomycin.
Strain Susceptible at concentration (mg/ml): Positive control
0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 (without antibiotic)
Enterococcus spp. (40 strains)
E. faecium (20 strains) 4 5 1 10 20
E. faecalis (15 strains) 1 2 12 15
E. avium (5 strains) 5 5
MRSA (60 strains) 9 31 18 2 60
R2172 Update on antimicrobial susceptibility rates among
Gram-negative and Gram-positive organisms in Belgium
and Luxembourg: results from the 2nd tigecycline
evaluation & surveillance trial (2B-TEST)
F. Surmont ° for the Belgian T.E.S.T. Study Group
Background: Surveillance studies provide invaluable information in the
tracking of antimicrobial susceptibility. The aim of this study was to
measure in vitro activity of a panel of antimicrobial agents including
Tygacil against Gram-positive and Gram-negative agents, collected in
Belgium in 2008 and compare the results with a similar survey in 2006.
Establishing the local prevalence of in vitro susceptibility is essential
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in order to predict potential local efﬁcacy, promote appropriate use and
deﬁne a place amongst available antibiotics.
Methods: 12 major hospitals from Belgium (11) and Luxemburg
(1) collected 2122 clinically relevant, consecutive isolates from the
study list of Gram positive and Gram negative pathogens over a 6
month period (January 1st to November 10th 2008). Minimal Inhibitory
Concentrations (MIC) were determined using a microdilution method
(Sensititre®). Pathogens originated from all wards and all infections, with
a maximum of 20 urinary isolates per hospital. E. coli, Klebsiella spp
and Enterobacter spp. were screened for extended spectrum b-lactamase
(ESBL) activity using local methodology.
Results: Tigecycline was the most active agent tested against Gram
positive pathogens. Cumulative % with reference to the European Com-
mittee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints
were 100% for E. faecalis (n = 119), 97% for E. faecium (n = 75),
for S. aureus − MSSA 98% (n = 121) & MRSA 95% (n = 120).
Tigecycline was very active against Gram negative pathogens as well,
with a cumulative % at EUCAST breakpoint of 95% for A. baumannii
(n = 81), 100/98% for E. coli ESBL-/+(n = 215/82), 96/89 for Klebsiella
spp ESBL-/+(n = 15/61). and 90/75% for Enterobacter spp ESBL-
/+(n = 173/64).
Conclusion: Tigecycline continues to show excellent in vitro activity
against Gram positive and more than reliable activity against Gram
negative pathogens when collected consecutively in daily practice
in Belgium and Luxemburg. These results will enable Belgian and
Luxemburg physicians to use tigecycline appropriately in hospitalized
patients.
R2173 Effects of human polymorphonuclear neutrophils alone
or in combination with amikacin against Pseudomonas
aeruginosa bioﬁlms
A. Chatzimoschou °, E. Georgiadou, N. Vavatsi-Christaki, T.J. Walsh,
E. Roilides (Thessaloniki, GR; Bethesda, US)
Objectives: Chronic Pseudomonas aeruginosa (PA) airway infections
remain the primary cause of morbidity and mortality in the cystic
ﬁbrosis (CF) patients. The growth state of PA in CF airways consists
of a bacterial bioﬁlm (BF), which differs from that exhibited under
conventional susceptibility testing conditions. Within the BF, PA cells
are protected from polymorphonuclear neutrophils (PMNs) and exhibit a
high level of resistance to antimicrobial agents. We examined the in vitro
activity of PMNs alone and in combination with amikacin (AMK) against
PA BF and compare them to the free-living planktonic (PL) counterparts.
Methods: Two clinical PA isolates, a resistant (AMKR, CLSI MIC:
64mg/l) and a susceptible (AMKS, CLSI MIC: 8mg/l), derived from two
CF patients, were grown by incubation in cation-adjusted Mueller-Hinton
broth in 96-well ﬂat-bottomed plastic plates under constant shaking for
48 h at 37ºC in order to form BF. PMNs from healthy donors at an
effectors to target (E:T) ratio of 1:10 or 1:20 were incubated further
for 24 h alone or in combination with 2, 8 or 32mg/l of AMK. Percent
damage of BF or PL was assessed by metabolic XTT assay. Damage
50% indicated drug susceptibility. Synergy was concluded when the
observed bacterial damage was signiﬁcantly higher to the expected sum
of damages, respectively; whereas, additivity was deﬁned when the
observed bacterial damage was signiﬁcantly higher than each component
but where synergy was not achieved. ANOVA (n = 6) with Dunnett’s test
was performed.
Results: PMNs induced lower percent damage to BF than to PL cells of
both isolates (at 1:10 ratio, mean±SE: 20.0±3.3 vs 15.0±2.4, p< 0.05
for AMKR; 27.0±2.9 vs 13.0±1.8, p< 0.001 for AMKS). AMK at
8mg/l for AMKS (54.0±3.2 vs 26.0±5.8) and at 32mg/l for both isolates
(42.0±2.5 vs 33.0±1.6 for AMKR and 57.0±4 vs 40.0±4.6 for AMKS)
induced lower damage (p< 0.001) to BF than to PL cells. The combined
effects of PMNs with various concentrations of AMK for both isolates on
damage of BF was lower than that on the damage of PL cells (p< 0.005).
Synergy was observed when PMNs (at 1:10) were combined with AMK
(8 or 32mg/l) for both AMKR and AMKS isolates in BF and PL cells.
Conclusions: BF of both resistant and susceptible isolates are
signiﬁcantly less susceptible to PMNs and to AMK than are PL cells.
Both PL and BF growth forms of the resistant PA are less susceptible
to AMK than that of the susceptible organism. Synergy is exhibited
between PMNs and AMK in BF and PL cells.
R2174 Fosfomycin: the issue of emergence of antimicrobial
resistance
D. Karageorgopoulos °, P. Rafailidis, A. Kastoris, A. Kapaskelis,
M. Falagas (Athens, GR)
Objective: The reevaluation of older antimicrobial agents may provide
at least temporary solutions to the challenge of advancing antimicrobial
drug resistance among common bacterial pathogens. Fosfomycin is
used rarely for the treatment of systemic infections, despite substantial
antimicrobial activity against common pathogens. The emergence of
mutational resistance to this agent is of concern. We aimed to evaluate
the magnitude of the issue of emergence of bacterial resistance to
fosfomycin.
Methods: We performed a systematic review of relevant published
in vitro studies, clinical studies and studies examining trends of resistance
over time were included.
Results: In 7 in vitro studies identiﬁed, development of bacterial
resistance to fosfomycin after exposure to this agent was observed by
various methods for 65/629 (10.3%) Escherichia coli isolates, 82/86
(95.3%) Staphylococcus aureus isolates, 32/33 (97.0%) Serratia spp.
isolates, 15/17 (88.2%) Pseudomonas aeruginosa isolates, and all 3
Klebsiella pneumoniae isolates. In 5 clinical studies identiﬁed, failure
of fosfomycin therapy associated with the emergence of resistance to
this agent was observed in 31/1161 (2.6%) patients with various types
of infections who received fosfomycin therapy. In 10 studies examining
resistance trends over periods of 5−10 years, the absolute differences in
the susceptibility rate to fosfomycin for most of the pathogens examined
(mainly E. coli), were within 10 percentile units.
Conclusion: The development of mutational resistance to fosfomycin
appears to be frequent in vitro, particularly for pathogens other than
E. coli. However, the clinical relevance of this phenomenon appears to
be of minor signiﬁcance, supporting further research on fosfomycin use
for systemic infections.
R2175 In vitro synergism of various antibiotics against
Stenotrophomonas maltophilia clinical isolates
S. Banerjee °, C. Todd, C.L. Marodi (Middlesbrough, UK)
Objective: Stenotrophomonas maltophilia is an emerging hospital
pathogen. Susceptibility testing is difﬁcult as it is affected by both
temperatures and the medium. Though some antibiotics has been shown
to be effective in treating patients, there is no good evidence to support
a relationship between laboratory susceptibility testing and clinical
outcome due to lack of clinical trial and standardised susceptibility
testing. Our aim was to study the in vitro interaction among various
antimicrobials against clinical isolates using an E-test method speciﬁcally
modiﬁed for this project.
Methods: 30 S. maltophilia clinical isolates were collected over a period
of 5 months and identity was conﬁrmed with Vitek2. Isolates were
refrigerated until use. A day prior to the experiments the isolates and a
reference strain were subbed on blood agar to provide a fresh growth.
0.5 McFarland suspension was prepared from each isolate and they
were inoculated on Muller Hinton agar plates marked and templated
appropriately. co-trimoxazole (SXT) and ceftazidime (CZ) strips were
applied to the designated template area using sterile technique. The
plates were left at room temperature for 1 hour and then from all but
SXT strips in template 1 and CZ in template 2 were removed. Then
4 strips [ciproﬂoxacin(CIP), moxiﬂoxacin (MX), minocycline (MN),
chloramphenicol (C)] were applied on the empty slots in template 1
and 4 strips [piperacillin/tazobactam(PT), ticarcillin/clavulinate (TIM),
aztreonam (ATM), amoxicillin/clavulinate (AMC)] were applied in
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template 2 after scale adjustment. The plates were then incubated for
24 hours at 27ºC and MICs were read (80% inhibition for SXT and
complete inhibition for CZ). The experiment was standardised with a
reference strain from National Collection of Type Cultures, Colindale.
Results: In the SXT group combination of SXT with MX was more
effective than SXT alone and in CZ group combination of CZ with PT,
TIM, ATM were more effective than CZ alone (Table 1).
Conclusions: The synergistic result yielded from this project appears to
be active in vitro but there is no good evidence available to suggest a
relationship with clinical outcome. This call for further investigation and
clinical trials. Different antibiotics and combination could be tested to




MIC 2 dilution lower
than MIC of SXT/CZ
alone
Indifference
MIC within ±1 dilution of





SXT+MX 71% 26% 3%
SXT+CIP 29% 52% 19%
SXT+MN 29% 52% 19%
SXT+C 23% 45% 32%
CZ+PT 68% 16% 16%
CZ+TIM 55% 19% 26%
CZ+ATM 55% 19% 26%
CZ+AMC 36% 19% 45%
R2176 Antimicrobial activity of herbal plants used in traditional
medicine in Uzbekistan
N. Mamadalieva °, D. Egamberdieva, V. Edwards Jones (Tashkent,
UZ; Manchester, UK)
Objectives: We chose 23 promising and widely used medicinal plants of
Uzbekistan used traditionally by local inhabitants for treating conditions
likely to be associated with microorganisms, and evaluated them for
potential antimicrobial activity, in order to conﬁrm their popular use and
to detect new sources of antibacterial agents.
Methods: Plant material (20 g) was extracted with 80% methanol
and the extracts were dissolved in 10% (v/v) solution of DMSO to
create a concentration of 10mg/ml of stock solution. The preliminary
antimicrobial activity of the extracts was carried out by disc diffusion
test. The plant extracts which showed inhibitory effect were further
investigated for MIC using the broth microdilution method. For
comparative purposes standard antibiotic discs viz., tetracycline (20
mg/disc), ampicillin (10 mg/disc), were used as positive and DMSO (10%,
v/v) as the negative controls.
Table 1. In vitro antimicrobial activity of plant extracts against human
pathogenic bacteria (mg/ml)
Plant Ko Kp Ec Pr Cf Ab Pa Sa Ef Efc Se Sar Ml Ca Ka Hp
Achillea millefolium L. na na 5 5 na na 5 1.2 2.5 5 na 5 na na na na
Asparagus persicus Baker na na na na na na na na 5 2.5 5 5 5 5 na na
Betula verrucosa Ehrh na na na na na 2.5 1.2 1.2 1.2 2.5 na 2.5 2.5 1.2 na na
Biden tripartite L. na na na 5 na na 5 2.5 na 5 5 na na 5 2.5 na
Calendula ofﬁcinalis L. na 2.5 2.5 na na na 5 5 1.2 2.5 2.5 1.2 1.2 2.5 na na
Centaurea belangeriana Stapt. na 5 5 na na na na 5 5 na 5 na 5 na na na
Dianthus tetralepis Nevski na 5 5 na na na na 5 2.5 2.5 5 5 na na na na
Erodium hoefﬁtianum CAM na 2.5 5 na na na na na na 2.5 na na 2.5 2.5 na na
Helichrysum arenarium L. na na na na na na na na na 1.2 5 na na na 1.2 na
Hypericum perforatum L. na na na na na 5 5 2.5 2.5 1.2 5 5 2.5 5 na 5
Leonurus turkestanicus L. na na na 5 2.5 na 5 2.5 2.5 2.5 5 5 5 na 5 na
Matricaria chamomilla L. na 5 na 5 na na na 5 1.2 1.2 5 2.5 2.5 2.5 1.2 5
Melissa ofﬁcinalis L. 5 na na 5 5 na na na 5 5 na 5 na na na 5
Origanum tyttanthum L. 2.5 2.5 2.5 2.5 5 2.5 2.5 5 2.5 1.2 1.2 2.5 1.2 2.5 2.5 2.5
Peganum harmala L. 2.5 5 2.5 na 5 1.2 2.5 2.5 1.2 5 2.5 2.5 na 2.5 5 na
Plantago ovata L. na 5 – na 2.5 na 5 na 5 5 5 1.2 5 na na na
Scrophyllaria striata Boiss na 5 5 na na na na na na 2.5 5 2.5 na 2.5 5 na
Tanacetum vulgare L. 5 na 2.5 na na na 2.5 1.2 1.2 2.5 2.5 1.2 1.2 na 2.5 5
Thymus vulgaris L. na na na na na 2.5 na na 5 2.5 na 5 5 na na na
Trifolium pretense L. na na na 5 2.5 na 2.5 2.5 2.5 1.2 1.2 2.5 5 na 2.5 na
na: not active; Ko: K. oxytoca 6653; Kp: K. pneumoniae 40602; Ec: E. coli NCTC9001; Pr: P. rettgeri
NCIMB9570; Cf : C. freundii 82073; Ab: A. baumannii 60649; Pa: P. aeruginosa NCTC6749; Sa: S. aureus
MRSA16; Ef : E. faecalis NCTC775; Efc: E. faecium 8; Se: S. epidermidis NCTC7944; Sar: S. aureus MRSA462;
Ml: M. luteus; Ca: C. albicans NCVC1467; Ka: K. aerogenes NCTC8172; Hp: Helicobacter pylori NCTC12823.
Results: Most of plant extracts were able to inhibit the growth of
one or more of the tested strains at 2.5mg/ml that corresponds to a
concentration of 0.25% (Table 1). The plant species such Equisetum
arvense, Polygonum aviculare and Limonium otolepis did not show any
antibacterial activity against tested bacterial strains. The extract from
Origanum tyttanthum showed the broadest spectrum of action against
bacteria, inhibiting all of the strains tested with MICs ranging from 1.2
to 5mg/ml, suggesting their potential as antimicrobial compounds. The
extracts from aerial part of Betula verrucosa L. Calendula ofﬁcinalis,
Hypericum perforatum, Leonurus turkestanicus, Matricaria chamomilla,
Tanacetum vulgare and Trifolium pretense were more active against
Gram-positive, including S. aureus and MRSA (MICs ranging from
1.2 to 5mg/ml) than against Gram-negative bacteria. They were also
active against the fungus Candida albicans. Other plant species such
Calendula ofﬁcinalis, Hypericum perforatum, Melissa ofﬁcinalis and
Achillea millefolium have been reported and antimicrobial activities have
been found. Among plant extracts only 5 species Matricaria chamomilla,
Melissa ofﬁcinalis, Hypericum perforatum, Tanacetum vulgare and
Origanum tyttanthum inhibited the growth of H. pylori NCTC 12823.
Conclusion: The obtained results conﬁrm the presence of antimicrobial
principles in the examined herbal plants native habitats of Uzbekistan
mainly against Gram-positive bacteria, which supports their traditional
use as wound healing and skin infections in Central Asia.
R2177 In vitro susceptibility of bacterial blood isolates from
patients with sepsis against often-used antimicrobial agents
for empirical therapy
H. Haefner, S. Scheithauer °, T. Schwanz, S. Lemmen (Aachen, DE)
Background: Inadequate initial antibacterial therapy is associated with
increased mortality in patients (pts) with serious infections, in vitro
resistance being the major driver.
The aim of this study was to evaluate the susceptibility of blood culture
isolates against antibiotics often used as empirical therapy for patients
with clinical sepsis.
Methods: Susceptibility testing of blood culture isolates from pts with
sepsis, severe sepsis or septic shock being hospitalized at the University
Hospital Aachen, Germany, was performed against nine antimicrobials
(BD Phoenix ™ expert system or by Etest®). Results were interpreted
according to CLSI breakpoints.
Results: Out of 205 pts enrolled consecutively between March and
September 2009, 127 pts (62%) had sepsis, 51 pts (25%) severe sepsis
and 27 pts (13%) septic shock, respectively. Bacteraemia was hospital-
acquired in 136 (66%) pts. Main infection sites were catheter-related
(32%), urinary tract (17%), abdomen (15%) and lung (13%). Twenty
pts (10%) had a polymicrobial infection; in total 228 clinically relevant
pathogens were isolated: S. aureus (57/228, including 19 MRSA),
E. coli (45/228), CNS (26/228), Enterococci (26/228) and Klebsiella spp.
(22/228).
In 160/205 pts (78%) the blood culture isolates were susceptible to the
Carbapenems (see Figure 1), followed by Moxiﬂoxacin with 144/205
pts (70%). However, often used regimen like Ampicillin/Sulbactam or
Cefuroxime demonstrated adequate in vitro activity in only 50/205 pts
(50%) and 58/205 pts (58%), respectively. In community-acquired sepsis
Moxiﬂoxacin showed adequate activity in 99/116 pts. (85%).
Comparison of in vitro susceptibilities (n = 205 patients).
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Conclusion: In this study population with pts with bacteraemia and
different clinical stages of sepsis, antibiotic monotherapy showed in vitro
activity in only 78% of the patients enrolled, thus leaving at least
22% pts. without adequate therapy. Thus a combination therapy e.g. a
broad-spectrum b-lactam antibiotic and a ﬂuoroquinolone seemed to be
warranted. In patients with community-acquired sepsis, especially with
pneumonia moxiﬂoxacin is a potent therapeutic option.
R2178 Rapid detection of extended-spectrum b-lactamase
producing bacteria by means of ﬂow cytometry
M.J. Espinar °, I. Faria-Ramos, F. Fontes Carvalho, A.G. Rodrigues,
C. Pina Vaz (Porto, PT)
Objectives: The reliable detection of extended-spectrum B-lactamases
(ESBLs) producing bacteria represents a major clinical challenge.
Inappropriate treatment such as empiric administration of unspeciﬁc or
wide spectrum antibiotics can lead, apart from therapeutic failures, to
the promotion of multiresistent organisms. Phenotypic detection methods
take at least 48 to 72 hours providing results that can be considered
unspeciﬁc, thus demanding additional conﬁrmatory tests. Molecular
methods are expensive and time-consuming as several genes are involved
in bacterial resistance. Flow cytometry allows a rapid analysis of a
large number of individual cells using light scattering and ﬂuorescence
measurements. Our aim was to develop a ﬂow cytometric protocol to
provide an easy, fast and reliable detection of ESBL producers.
Methods: Forty clinical strains of Escherichia coli and Klebsiella
pneumoniae, classiﬁed as positive (n = 20) and negative (n = 20) ESBL
producers by phenotypic methods were tested. Strains genetically
typed as belonging to the most common ESBLs genotypes (SHV,
TEM and CTX-M) were used as controls. The bacterial strains were
incubated in Muller-Hinton broth and exposed to cefotaxime and
ceftazidime at several concentrations during one and two hours, with
and without clavulanic acid (an ESBL-inhibitor). Bacterial suspensions
were analysed by ﬂow cytometry after staining during thirty minutes
with Bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DIBAC4), a
ﬂuorescent dye that penetrates the cell membrane as a result of
membrane depolarization.
Results: ESBL positive strains showed an increase of the intensity
of ﬂuorescence only after incubation with clavulanic acid. The Flow
Cytometry method was able to provide a fast (soon after one hour of
treatment) and correct classiﬁcation of the strains.
Conclusion: Flow Cytometry proved to be an excellent tool, being
accurate and speciﬁc for the rapid detection of the most common ESBLs
producing bacteria, avoiding the routine delays and high cost.
R2179 Clinical failure of daptomycin in the treatment of
endocarditis due to susceptible Enterococcus faecalis
E. Vryonis °, E. Kakalou, E. Perivolioti, E. Platsouka, M. Samarkos,
K. Papanikolaou, I.G. Baraboutis, V. Papastamopoulos, A. Skoutelis
(Athens, GR)
Objective: To present a case of clinical failure of daptomycin in the
treatment of endocarditis due to susceptible Enterococcus faecalis.
Case report: An HIV HCV co-infected 35 year old IV drug user
presented with fever and general symptoms of fatigue two months
after he had successfully completed treatment for right-sided MSSA
endocarditis. He had been treated with vancomycin due to serious
b-lactam allergic reaction. The patient had a CD4 >800 and undetectable
viral load without antiretroviral treatment.
Upon admission a new episode of right-sided endocarditis was conﬁrmed
and the patient was started on daptomycin 8mg/kg/day. Enterococcus
faecalis was isolated from consecutive blood cultures susceptible to
ampicillin, gentamicin, vancomycin and daptomycin (MIC< 0.5mcg/ml).
Six days later phenotypic and genotypic (PFGE) identical isolate of
E. faecalis continue to be isolated from his blood cultures. The patient
was shifted to vancomycin (targeting trough levels >15mg/L) and serum
bactericidal activity of daptomycin and vancomycin were performed
according to the Clinical and Laboratory Standards Institute guidelines.
Our results suggested a higher serum bactericidal activity of vancomycin
compared to daptomycin, a fact that was conﬁrmed by the clearance of
bacteraemia and the full clinical response of our patient.
Conclusions: Previous reports have shown the possibility of either
emergence of resistance to daptomycin during treatment for enterococcal
and MRSA infections or the limited reliability of present breakpoints
for the detection of resistance. We believe that in our case the second
possibility is the case. Clinicians and microbiologists should be aware of
those issues and monitor closely the susceptibilities of isolates. Serum
bactericidal activity appears to be a useful test in difﬁcult clinical
cases where the expected clinical response is delaying, besides in vitro
susceptibility testing.
R2180 Antimicrobial susceptibility of streptococcal strains of
mitis group isolated from respiratory tract infections in
paediatric patients
G. Bancescu °, A. Bancescu, A. Neagu, M. Radu-Popescu, A. Dascalu,
M. Nica, C. Sarafoleanu, I. Nistor (Bucharest, RO)
Objective: The mitis group belongs to the oral streptococci, which are
commensal bacteria, but sometimes can be involved in the aetiology
of serious infections. The aim of the present study was to investigate
the antimicrobial susceptibility of 39 mitis group streptococcal strains
belonging to: Streptococcus oralis, S. mitis and S. sanguinis species (the
last one being included by R. R. Facklam in the sanguinis group), which
were isolated from different respiratory tract infections (pneumonia,
sepsis of pulmonary origin, peritonsillar abscess, rhinosinusitis, otitis
media etc.) in paediatric patients from three hospitals in Bucharest, in
2009.
Methods: The susceptibility of the isolates was tested against: penicillin
G (PG), ampicillin (AM), cefotaxime (CT), erythromycin (EM),
clindamycin (CM), tetracycline (TC), levoﬂoxacin (LE), linezolid (LZ)
and vancomycin (VA), using the Etest (AB Biodisk, Sweden).
Results: The ranges of the minimum inhibitory concentrations were:
0.047−32mg/l for PG, 0.032−32mg/l for AM, 0.032−24mg/l for CT,
0.016–256mg/l for EM, 0.016−64mg/l for CM, 0.25−48mg/l for TC,
0.19−1mg/l for LE, 0.064–0.75mg/l for LZ and 0.5−1mg/l for VA.
About half of the isolates were resistant to the three b-lactam antibiotics.
Only a quarter of the strains were susceptible to EM, while more
than 90% and about 60% were sensitive to CM and TC, respectively.
Resistance to: PG, AM, CT, EM and TC was found among the strains
belonging to the three species, while all S. mitis isolates were susceptible
to CM.
Conclusion: Since there is a great concern regarding the increased
number of oral streptococci resistant to b-lactam antibiotics or multidrug-
resistant, it is necessary to test the sensitivity of the isolates of clinical
importance, especially to the commonly used antibiotics. LE, LZ and VA
were the only antimicrobial agents fully active against the mitis group
isolates investigated in the present work, which was a study supported by
the project ID_2652 no. 1136/12.01.2009 from the Exploratory Research
Projects of the National University Research Council and the Executive
Agency for Higher Education and Research Funding from Romania.
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R2181 New enzymatic principle for the synthesis of novel
antimicrobials
V. Hahn °, A. Mikolasch, F. Schauer (Greifswald, DE)
Objectives: Still today the treatment of choice for Candida infections
are azoles. However, emerging resistance, decreasing susceptibility and a
national cost of nosocomial candidemia of over $200 million per year [1]
all increase the need for new antifungals. For this purpose we developed
a new process for the synthesis of antimicrobials using fungal laccase
as biocatalyst. Laccases [E.C. 1.10.3.2] are polyphenoloxidases which
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oxidize hydroxylated aromatic compounds. The resulting radicals can
undergo various non-enzymatic reactions. A heteromolecular coupling
reaction was used successfully for the derivatization of morpholines [2]
and some of the products had antimicrobial and cytotoxic activities which
were higher than the activities of the reactants. We therefore then applied
the process to the synthesis of new azoles.
Methods: The laccase was obtained from the ligninolytic fungus
Pycnoporus cinnabarinus (Pcl). The reaction mixtures were analyzed
using an HPLC system with DAD and a RP18 column. For mass
spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy
the products were isolated by solid phase extraction and dried by
lyophilization. The antifungal susceptibility testing was performed with
a modiﬁed method of the E.Dis. 7.1 [2].
Results: 1-Aminobenzotriazole (1) was used as model substance for
the derivatization by Pcl. During laccase-catalyzed transformation of
the para-dihydroxylated substrates 2,5-dihydroxybenzoic acid methyl
ester (2a) and 2,5-dihydroxybenzoic acid ethyl ester (2b) into quinones
a nucleophilic attack of the azole occurs, resulting in C-N-coupled
heteromolecular products 3a and 3b respectively (yields up to 34%).
Their structures were conﬁrmed by MS and NMR analysis. The
antifungal activity of 3a,b against Candida species exceeded that of the
reactants (Table 1).
Table 1. Results of the antifungal screening of MIC determination by
a modiﬁed method according to the EUCAST discussion document
E.Dis. 7.1 (test concentration: maximum 1000mM, test organism:
Candida maltosa) for products 3a,b and reactants 1, 2a,b
MIC MIC50
[mg/ml] [mM] [mg/ml] [mM]
1 >134.14a >1000
2a >168.15 >1000
2b >182.17 >1000 182.17 1000
3a >298.26 >1000 237.09 794.91
3b >312.29 >1000 78.79 252.30
aThe MIC was higher than the tested concentration of 1000 mM.
Conclusions: This novel synthesis principle makes it possible to produce
compounds with antimicrobial activity. Our future aim is to amplify this
effect by laccase-catalyzed derivatization of compounds which already
show high biological activity to synthesize products with increased
activity, improved bioavailability and reduced side effects. In particular
the laccase-catalyzed synthesis of substances which are not available by
conventional chemical methods permits the creation of completely new
biological active agents.
Reference(s)
[1] Rentz AM et al. Clin Infect Dis 1998; 27: 781–788.
[2] Hahn V et al. Biotechnol Appl Biochem 2009; DOI: 10.1042/
BA20090219.
R2182 In vitro antimicrobial activity of a-melanocyte stimulating
hormone and its mechanism of action against potent
human pathogen Candida albicans
P. Kanaujia °, K. Mukhopadhyay (New Delhi, IN)
Objectives: To establish a-melanocyte stimulating hormone (a-MSH)
as a novel agent for control of Candida albicans infection.
Methods: We examined in vitro antimicrobial activity of a-MSH by
varying several parameters, viz., fungal cell densities, pH and ionic
composition against C. albicans strain CAF2−1. Antifungal activity
of a-MSH was also examined on its pathogenic (hyphal) form. To
understand the mechanism of action of a-MSH on C. albicans cells
we perform membrane permeabilization and ATP efﬂux assays.
Result: Our results shows that a-MSH possesses signiﬁcant and rapid
antifungal activity against both pathogenic (hyphal) and non-pathogenic
(yeast) form of C. albicans (12mM a-MSH exhibits 80% killing in
yeast and 68% in hyphal form for 2 hr). Antifungal activity of a-MSH
was dependent on fungal cell density and killing of C. albicans is
ion selective. pH change from 7.4 to 4 increased candidacidal activity
of a-MSH by 19%. We also found that when a-MSH added to
C. albicans under hyphal conditions, the hyphal formation was inhibited.
From membrane permeabilization assays we found that there is no
signiﬁcant membrane permeabilization observed on incubation with
a-MSH, suggesting that candidacidal activity was not through membrane
damage. ATP efﬂux assay reveals that on incubation of C. albicans with
lethal dose of a-MSH, there was considerable amount of ATP efﬂux.
Furthermore, in presence of energy metabolism inhibitors such as azide
and carbonyl cyanide m-chlorophenylhydrazone; there was substantial
decrease in the ATP efﬂux.
Conclusion: These observations suggest that candidacidal activity
of a-MSH may mediate through energy depletion and not through
membrane damage. Thus we concluded that a-MSH emerges as excellent
therapeutic agent against potent human pathogen C. albicans.
R2183 Antibiotic susceptibility including tigecycline and
MALDI-TOF MS of E. coli and S. aureus isolates
E. Chiriseri °, R.O. Jenkins, M.A. Minassian (Northampton, Leicester,
UK)
Objectives:
1. To test tigecycline against ESBL producing E coli and MRSA isolates
and compare results to those of the E-test programme
2. To carry out antibiotic susceptibility to commonly used antibiotics
using the Vitek 2 analyser
3. To carry out MALDI-TOF-MS on the isolates and evaluate its
potential in discriminating organisms
Methods: A total of 50 MSSA, 50 MRSA, 50 ESBL-producing
E. coli and 20 non-ESBL producing E. coli isolates were obtained
from Northampton hospital and county, from various specimen types.
Presumptive identiﬁcation of isolates was on chromogenic agar (Oxoid).
Conﬁrmation of MRSA and E. coli isolates identiﬁcation and assessment
of antimicrobial susceptibility was by Vitek 2 analysis. Tigecycline E-test
was carried out on conﬁrmed ESBL E. coli and MRSA isolates according
to manufacturer’s instructions (AB Biodisk, Solna, Sweden). For MALDI
analysis, organisms were grown on Columbia blood agar plates with
5% horse blood overnight. Direct inoculation technique was carried
out by emulsifying a single isolated colony using a 5ml loop onto a
MALDI target well. This was left to dry before addition of 0.5ml of
CHCA matrix. MALDI-TOF-MS analysis was carried out using 95%
laser power, a maximum of 120 proﬁles per minute and 5 shots per
proﬁle.
Results: MSSA was sensitive to most of the antibiotics, with reduced
susceptibility to penicillin. MRSA isolates showed increased resistance
to antibiotics e.g. ciproﬂoxacin but were sensitive to vancomycin,
teicoplanin and linezolid. ESBL producing-E. coli isolates were 100%
sensitive to meropenem and ertapenem, and 97% sensitive to piperacillin/
tazobactam. Tigecycline exhibited 100% potency against 50 MRSA and
50 ESBL producing E. coli isolates with mic values of less than 1mg/l.
Tigecycline results were comparable to those of the E-test programme,
e.g. Spain and Canada.
The MALDI ﬁngerprints derived from 120 isolates produced rich
peaks with high reproducibility. Hierarchical cluster analysis categorized
the MALDI spectra precisely into groups according to the antibiotic
sensitivity patterns of S. aureus and E. coli isolates as well as b-lactamase
production.
Conclusion: This study highlighted the problem of antibiotic resistance
and potency of tigecycline against resistant isolates. Furthermore,
MALDI-TOF-MS was shown as a rapid method for identiﬁcation of
bacteria at species and subspecies level and useful for characterization
according to antibiotic susceptibility pattern.
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R2184 Detection and characterization of methicillin-resistant
Staphylococcus pseudintermedius in healthy dogs in Spain
E. Go´mez-Sanz °, C. Lozano, F. Ruiz-Larrea, M. Zarazaga, C. Torres
(Logron˜o, ES)
Objectives: To identify and characterize methicillin-resistant coagulase-
positive staphylococci (CPS) recovered from healthy dogs in Spain.
Methods: 160 samples from external nares of healthy dogs were obtained
in La Rioja (Spain) in March-August 2009. Following enrichment in
nutrient broth with 6.5% NaCl, samples were cultured on ORSAB
plates (OXOID) for methicillin-resistant CPS recovery (one/sample).
Susceptibility for 17 antibiotics was tested by disk-diffusion agar method.
Molecular identiﬁcation of the isolates was performed by ampliﬁcation of
nuc gene of S. intermedius. Discrimination between S. pseudintermedius
and S. intermedius was done by PCR-RFLP (pta gene digested with
either MboI or AluI), being identiﬁcation conﬁrmed by sequencing
of hsp60 or sodA genes. All methicillin-resistant isolates were tested
for mecA gene by PCR. SCCmec typing was performed by PCR.
The presence of 27 resistance genes was tested by PCR. Leukotoxin
and exfoliative toxin genes for S. intermedius (lukS-I/lukF-I and siet,
respectively), as well as lukS/lukF-PV, tsst1, eta, etb, hla, hlb, hld, hlg
and hlg-2 genes were investigated by PCR.
Results: 9 methicillin-resistant Staphylococcus pseudintermedius
(MRSP were isolated from the 160 studied samples (5.6%), being
the only methicillin-resistant CPS species recovered. Comparison of
restriction patterns using MboI versus AluI showed the same species
identiﬁcation in all tested isolates. They were typed as SCCmecV (1
isolate), SCCmec III (7 isolates) or non-typable (1 isolate, although the
ccrC gene was detected). A multiresistant phenotype (at least 5 families
of antibiotics) and the following resistant genes were detected (number
of isolates): mecA (9), blaZ (9), ermB (9), tet(K) (7), tet(M) (2), aph(3′)
(9), aac(6′)-aph(2′) (9), ant(6′) (9), str (9), dfrA (9), dfrD (2), dfrG
(9), dfrK (9), cat(pC221) (1), being ermA, ermC, mph(C), mrsA, msrB,
linA′, vga(O), tet(L), tet(O), ant(4′), ant(3’), fexA and cfr genes negative
for all MRSP. All isolates harboured the exfoliative toxin gene siet and
both leukocidin genes LukS-I and LukF-I, but not the Panton-Valentine
leukocidin genes lukS/lukF. Toxin hlg-2 was detected in two MRSP. PCR
for other toxin genes were negative.
Conclusions: MRSP is a relatively common colonizer of healthy dogs,
frequently harbouring a high number of antibiotic resistance genes
and some virulence genes what represents public health and treatment
concerns. Siet toxic gene was presented in all the isolates and its role in
disease requires further study.
R2185 The risk factors of methicillin-resistant Staphylococcus
aureus infection in patients with bacterial spondylitis
accompaning bacteraemia
H. Kim °, S. Jin, Y. Chae, H. Choi, B. Chin, S. Han, M. Kim, C. Kim,
Y. Song, J. Choi, J. Kim (Gangnam-gu, Seoul, KR)
Background: Recently, the incidence of methicillin-resistant Staphy-
lococcus aureus (MRSA) infection of spine has been reported to be
increasing, but risk factors of MRSA spondylitis have not been studied
well yet.
Methods: Medical records of patients with bacterial spondylitis
accompaning bacteremia treated in tertiary care hospitals from 2004
to 2008 were reviewed retrospectively. All patients had radiological
evidence of the spondylitis including vertebral osteomyelitis, spinal
epidural abscess, paravertebral abscess, and discitis. Patients with spinal
postoperative infection were excluded. Clinical and microbiological
variables were analyzed as the predisposing factors of MRSA infection
by univariate analysis with 95% conﬁdence interval (P = 0.05).
Results: Of 463 patients with bacterial spondylitis, there were 46
patients (10%) found with bacteremia. The mean patient age was
64.8 (range, 40−87, male-to-female ratio, 2.3:1). 28 cases (61%)
were caused by Staphylcoccus aureus, 11 of them were methicillin-
resistant. Age, diabetes mellitus, hemodialysis, alcoholism, soft-tissue
infection, previous antibiotics use, and a history of hospitalization were
not correlated with MRSA infection. However, vertebral osteomyelitis
was more frequently accompanied by MRSA bacteremia among the
spondylitis entities with statistical signiﬁcance (P = 0.037).
Conclusions: There was no signiﬁcant risk factor related with MRSA
spondylitis accompaning bacteremia. However, vertebral osteomyelitis
was more frequent in spondylitis with MRSA bacteremia and this
ﬁnding might contribute to appropriate empirical antibiotics selection
in pyogenic spondylitis.








Mean age (mean±SD) 64.8±10.7 63.4±9.6 65.3±11.1
Male:Female 32:14 8:3 24:11
Comorbidities
Diabetes mellitus 16 5 11 0.40
Chronic renal disease 8 1 7 0.38
Chronic lung disease 2 0 2 –
Cardiac disease 7 1 6 0.50
Chronic liver disease 6 0 6 –
Neurologic disease 2 0 2 –
Malignancy 4 0 4 –
Rheumatic disease 3 1 2 0.70
Charlson comorbidity index (mean±SD) 1.48±1.82
Infected site of spine 0.49
Cervical 5 1 4 0.83
Thoracic 4 2 2 0.23
Lumbar 37 8 29 0.47
No. of levels involved in spine 0.89
1–2 37 9 28
Above 2 9 2 7
Classiﬁcation of spondylitis
Vertebral osteomyelitis 4 3 1 0.04
Paraspinal abscess 19 5 14 0.75
Spinal epidural abscess 12 3 9 0.92
discitis 36 8 28 0.62
R2186 Genetic characterization of methicillin-resistant Staphylo-
coccus aureus isolated at a university hospital in Casablanca,
Morocco: spread of a single multidrug-resistant clone
S. Bouhali Zriouil °, K. Zerouali, M. Timinouni, M. Bekkali, S. Breurec,
B. Garin, N. El Mdaghri (Casablanca, MA; Dakar, SN)
Background: Methicillin resistant Staphylococcus aureus (MRSA) is
often involved in the Hospital Aquirred infections in Morocco. At the
Ibn Rochd University Hospital, the prevalence of MRSA is high (17.6%).
Objectives: To determine the genetic and toxin proﬁles and the antibiotic
susceptibility of MRSA strains isolated at the Ibn Rochd University
Hospital.
Materials and Methods: A prospective study was carried out
between January and July 2007. Sixty three MRSA were isolated
from various samples of inpatients at the university hospital. The
antibiotic susceptibility of each isolate was determined by the disc
diffusion method. The agr systems as well as the Stahylococcal Cassette
Chromosome mecA (SCCmec, mediating-methicillin resistance), were
typed by multiplex PCR. The isolates were also screened for toxins
genes. The clonal relationship between the isolates was determined by
Multilocus Sequence Typing (MLST).
Results: The MRSA strains were mainly isolated from nasal swabs
(55.5%) and from infected skin and soft-tissue (34.9%). All MRSA iso-
lates showed a multidrug resistance phenotype. The prevalence of antibi-
otic resistance was high: Peﬂoxacine (96.8%), Aminosides (Kanamycine,
Tobramycine, Gentamycine) and Minocycline (93.6%), Rifampicine
(92.1%), Cotrimoxazol (65.1%) and Erythromycine (61.9%).
The molecular typing revealed that 61 isolates had the agr 1 allele,
and were SCCmec III or SCCmec III/mercury. All of them had either
the Sequence Type 241 or 239 (ST241 being a single-locus variant of
ST239), and showed the same proﬁle than Hungarian and Brazilian
clones. All MRSA isolates had the staphylococcal enterotoxin K (sek)
and the staphylococcal enterotoxin like Q (selq). No PVL toxin was
detected among these isolates. For 2 isolates the genetic proﬁle was: agr
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2, SCCmec IV and ST 5. These isolates harboured the gene encoding
for PVL toxins.
Conclusions: The high prevalence of MRSA at the Ibn Rochd University
Hospital is related to the spread of a multidrug resistant clone, which
is genetically similar to the Hungarian/Brazilian clones. This multidrug
resistance of MRSA clones has some consequences on the choice of an
effective antibiotherapy for the treatment of MRSA infections.
R2187 Phenotypic and molecular characterization of methicillin-
resistant Staphylococcus aureus isolates in a northern
region of Italy
M. Monaco °, M. Sarti, A. Sanchini, C. Gagliotti, M.L. Moro,
A. Pantosti (Rome, Modena, Bologna, IT)
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is a
signiﬁcant problem in healthcare settings around the world. The aim of
this work was to study the molecular epidemiology of MRSA isolated
from clinical samples in a region of northern Italy (Emilia Romagna).
Methods: We studied a total of 107 MRSA strains collected in a
two month period (February-March 2009) from 13 hospital laboratories
in Emilia Romagna. The sources of isolates were: blood (25 strains),
pus/exudate (37 strains), tracheoaspirate (23 strains), bronchoalveolar
lavage (15 strains), sputum (7 strains). Antibiotic susceptibility was
determined by automated systems and E-test. Different PCR strategies
were applied to conﬁrm the species S. aureus and the methicillin-
resistance status, to determine spa type, SCCmec type and to detect
Panton Valentine Leukocidin (PVL) encoding genes. MLST was
performed on selected strains.
Results: By spa typing, the majority of MRSA were assigned to t008
(34%) and t041 (25%). Among blood isolates, 9 strains were assigned
to t008 and contained SCCmec type IV; 7 were characterized by t041
and SCCmec type I; 9 strains were assigned to 9 different spa types;
no strains harboured PVL toxin genes. Of 82 strains isolated from
pus/exudate and respiratory tract, 28 were assigned to t008 and harboured
SCCmec type IV; 20 were characterized by t041 and contained SCCmec
type I; 34 strains were assigned to 21 different spa type and harboured
SCCmec types I, II and IV. One strain, isolated from an exudate, assigned
to t044, harboured SCCmec type IV and was PVL positive. t008 isolates
were more susceptible than those of t041; major differences between t008
and t041 regarded erythromycin (59% vs 89%), gentamycin (40% vs
89%) and rifampicin (3% vs 18%). Clindamycin resistance was inducible
in t008 (57% of strains) while in t041 was constitutive (89% of strains).
Conclusions: In this study, t041 which was the most common and well-
established “old” spa type in the Italian hospitals has been outnumbered
by the “new” t008. t008 strains are less resistant to antibiotics than
t041. Although t008 isolates resemble the prototype CA-MRSA USA300
they differ from the latter for the lack of the PVL genes and for being
multi-drug resistant. Infact, these t008 isolates belong to a well-adapted
hospital clone recently emerged in Europe. The only PVL positive
strain of this study belonged to the CA-MRSA European clone ST80,
conﬁrming that CA-MRSA are infrequent in Italy.
R2188 Evaluation of the risk factors associated with
community-acquired Staphylococcus aureus infections
T. Demir °, N. Coplu, H. Bayrak, T. Buyukguclu, M. Turan, H. Sakar,
N. Balaban, E. Guner, U. Cinar, D. Caliskan, B. Yalcin, M. Eksioglu,
N. Atakan, S. Kilic, B. Esen (Ankara, TR)
Objectives: The epidemiology of S. aureus infections has changed
worldwide and MRSA is now frequently found as a community
associated (CA) pathogen. The aim of this study was to assess the risks
for CA-S. aureus infections.
Methods: 150 outpatient wound samples from skin and soft tissue
infections were studied. The patients were classiﬁed as CA and
hospital acquired (HA) for MRSA infection by CDC criteria. Methicillin
resistance was determined by disk diffusion (DD) method with oxacillin
and cefoxitin disks and conﬁrmed with oxacillin salt screen agar test
according to the CLSI guideline. The mecA gene was detected by
PCR. Categorical data were compared by the chi-square test or Fisher’s
exact test, using SPSS 15.0. All hypotheses were two-tailed and were
considered signiﬁcant at the P< 0.05 level.
Results: 92 samples were identiﬁed as S. aureus. mecA gene was
detected in 11 isolates. 13 isolates were identiﬁed as methicillin resistant
with oxacillin, cefoxitin DD tests and oxacillin salt screen agar test.
The most prevalent lesion and underlying disease was abscess and
diabetes mellitus. 70 patients had risk factors associated with MRSA
infection. According to CDC case description ﬁve isolates out of
11 were true CA-MRSA strains. As for the potential risk factors;
variables associated with evidence of MRSA were hospitalization (4.69;
0.98–22.4), surgery (8.0; 0.46–138.1), hospitalization of close relatives
(3.95; 0.328–47.593), recurrent skin infections (17.78; 1.463–216.017)
(p0.05). The signiﬁcant risk factor for the acquisition of CA-MRSA
was (17.78; 1.46–216.01)(p = 0.037) among hospital attendants.
Conclusion: This study showed that combination of both phenotypic and
genotypic tests must be performed for methicillin resistance detection.
Although CA-MRSA is not a critical problem in Turkey, it is crucial
to screen outpatient clinics to prevent the distribution of antibiotic
resistance.
R2189 Nosocomial bloodstream infections by methicillin-resistant
(MRSA) and methicillin-sensitive Staphylococcus aureus:
further exploring the role of prior antibiotic usage as a
predictor of MRSA bacteraemic infection
I.G. Baraboutis °, E.P. Tsagalou, E. Mylona, C. Gogos,
V. Papastamopoulos, E. Vrionis, A.T. Skoutelis, S.B. Johnson (Athens,
Patra, GR; Chicago, US)
Objectives: Both total antimicrobial use as well as speciﬁc antimicrobial
classes have been implicated as risk factors for nosocomially-
acquired MRSA (NA-MRSA) infection and bacteremia. The aims
of the study were: 1. to explore predictors of a new NA-MRSA
bloodstream infections (BSI) in comparison with a new nosocomially-
acquired methicillin-sensitive Staphylococcus aureus (MSSA) BSI, 2. to
thoroughly assess recent antibiotic use (within the last 30 days of the
positive culture date) qualitatively and quantitatively.
Methods: The time-period for our study was from October 1997 through
September 2001. From the infection control records, we identiﬁed two
groups of inpatients, one with a new positive MRSA blood culture and
one with a new positive MSSA blood culture. We considered the BSI
acquired in-hospital if 1) the culture was taken more than 48 hours after
admission and 2) if it was taken less than 48 hours but the patient had
been hospitalized within the last month. We recorded data pertinent to
widely accepted risk factors for Staphylococcus aureus colonization and
infection considering events up to 30 days before the positive culture
date. We used the electronic pharmacy records to obtain detailed data
on intravenous antibiotic use during the month before the culture date.
Results: We identiﬁed 28 patients with a new NA-MRSA BSI and 32
patients with a new NA-MSSA BSI eligible for further analysis. In
univariate analysis, signiﬁcant differences were noted in age, nursing
home residency, presence of chronic wounds, rates of hemodialysis,
intubation, enteral feeding receipt and presence of indwelling urinary
catheter for more than 24 hours, receipt of at least 1, 2 or 3
antibiotics, qualitative and quantitative use of penicillins, b-lactams
and antibiotics as a whole, qualitative use of aminoglycosides and
ﬂuoroquinolones, and quantitative use of cephalosporins, clindaycin and
b-lactam/b-lactamase inhibitors. In 2 models of multivariate analysis,
including either quantitative or qualitative use of total antibiotics or
individual classes, the only independent predictor of NA-MRSA BSI
was the prior receipt of at least 3 antibiotics. No siginiﬁcant differences
in outcome were noted.
Conclusion: From the comparative analysis of these strictly deﬁned
patient groups deriving from a highly homogeneous population, we
conclude that prior receipt of at least 3 antibiotics was the strongest
predictor of a subsequent NA-MRSA BSI, more than individual
antibiotic usage or other traditional risk factors for NA-MRSA infection.
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R2190 Colistin-resistant isolates of Klebsiella pneumoniae,
Acinetobacter baumannii and Pseudomonas aeruginosa
emerging in the ICU of a Greek hospital
A. Kyratsa °, M. Orfanidou, M. Katramadou, S. Bazigos, G. Ganteris,
E. Vagiakou, A. Karabinis, H. Malamou-Lada (Athens, GR)
Objectives: The isolation of multidrug-resistant (MDR) Gram-negative
pathogens has been increasingly described worldwide. The aim of the
study is the retrospective analysis of colistin resistance of Gram-negative
bacteria in our ICU, during 3 years.
Methods: Between January 2007 and October 2009, 326 strains
of Klebsiella pneumoniae, 972 Acinetobacter baumannii and 650
Pseudomonas aeruginosa were recovered from an equal number of
samples in our laboratory. Identiﬁcation and MIC determination were
performed by automated identiﬁcation system (VITEK II). Colistin
MICs were evaluated using the E-test methodology (AB Biodisk,
Solna, Sweden). Resistance to colistin was deﬁned as MIC> 2mg/L
for Klebsiella pneumoniae (EUCAST breakpoints) and Pseudomonas
aeruginosa, Acinetobacter baumannii (CLSI breakpoints).
Results: Thirty-nine strains of Klebsiella pneumoniae (12%), 3 Acineto-
bacter baumannii (0.3%) and 10 (1.5%) Pseudomonas aeruginosa were
found resistant to colistin. MDR Gram-negative pathogens were isolated
from the following clinical specimens: bronchial secretions (25), blood
cultures (12), catheter tips (18) and CSF(2). Colistin MICs for Klebsiella
pneumoniae ranged between >2−16mg/L, for Acinetobacter baumannii
>2−>256mg/L and for Pseudomonas aeruginosa >2−16mg/L. All
strains of Klebsiella pneumoniae were susceptible to tigecycline, while
resistance to meropenem was 82%, gentamicin 18%, amikacin 64%
and ciproﬂoxacin 84%. All strains of Acinetobacter baumannii were
susceptible to doxycycline and minocycline. Resistance to meropenem
was 92%, ampicillin/sulbactam 31%, gentamicin 7.5%, amikacin 7.5%
and tigecycline 54%. Resistance of Pseudomonas aeruginosa to
meropenem was 50%, piperacillin/tazobactam 50%, ceftazidime 80%,
aztreonam 70%, amikacin 40% and gentamicin 100%.
Conclusions:
1. In our ICU setting MDR Gram-negative pathogens are increasingly
isolated, especially K. pneumoniae, with 12% resistance to colistin
which remained susceptible to tigecycline.
2. Therefore the development of new antimicrobials against MDRs, the
appropriate use of colistin and the strict implementation of hand
hygiene rules in ICU, are mandatory.
R2191 Emergence of KPC-2 carbapenemase-producing Klebsiella
pneumoniae strains and spread of an isolate of sequence type
258 in the neuro-rehabilitation unit of an Italian hospital
A. Marchese °, E. Coppo, R. Barbieri, E. Debbia (Genoa, IT)
Objectives: To investigate the molecular nature of the ﬁrst mini-outbreak
caused by multidrug-resistant (MDR) Klebsiella pneumoniae producing
class A carbapenemase, occurring in the neuro-rehabilitation unit of a
tertiary care hospital in Liguria, a northern region of Italy.
Methods: Carbapenemase production was screened by a modiﬁed Hodge
test together with an imipenem-EDTA disc synergy test and conﬁrmed
by PCR and sequencing. PFGE and MLST were used to study the genetic
relatedness of the strains and epidemiological comparisons.
Results: Five cases of infections caused by MDR KPC-2 carbapenemase-
and SHV-5 extended-spectrum b-lactamase-producing K. pneumoniae
strains were identiﬁed. All isolates were intermediately susceptible to
imipenem, resistant to all the other b-lactams antibiotics, ciproﬂoxacin,
co-trimoxazole and were susceptible only to gentamicin, tigecycline and
colistin. PFGE and MLST showed that four out of ﬁve isolates were
clonally related and belonged to the international hyperepidemic clonal
group of sequence type 258.
Conclusion: This is the ﬁrst report on dissemination of KPC-2-
producing K. pneumoniae clinical isolates in an Italian hospital.
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R2192 Reduction of bacterial resistance by 15-th month
replacement of third-generation cephalosporins with
fourth-generation cephalosporin
N. Dmitrieva, Z. Grigoryevskaya °, I. Petukhova (Moscow, RU)
The 3rd-generation cephalosporins have been used in the treatment of
broad range of infections in 1000-bed hospital of Cancer Research Center
of Russia for more than 10 years.
Aim: To evaluate the inﬂuence of replacement 3rd-generation
cephalosporins (ceftazidime and cefotaxime) with cefepime on bacterial
susceptibility.
Materials and Methods: We replaced ceftazidime (Cfz) and cefotaxime
with cefepime (Cfp) from July 2008 till now (October 2009) and
compared the susceptibility of Escherichia coli (209 strains), Klebsiella
pneumoniae (123 strains) and Pseudomonas aeruginosa (222 strains) to
Ctz and Cfp in the ﬁrst half of 2008 (Jan-June 2008, the 1st period of
time) and the second and third quarters of 2009 (April–September 2009,
the 2nd period of time). Identiﬁcation and susceptibility testing has been
performed with VITEK-2 system (bioMe´rieux, France).
Results: The susceptibility of E. coli to Cfp and Ctz was the same:
32% of strains were susceptible to both antimicrobials (24/75 and 25/75
strains) in the 1st period of time and percentage of susceptible strains
increased to 64 and 66% (86/134 and 88/134 strains) in the 2nd period
of time, p< 0.0001. The same tendency was noted in K. pneumoniae
and P. aeruginosa. The percentage of K. pneumoniae strains susceptible
to Cfp and Ctz increased from 28% (18/65 strains for both) to 46%
(27/58strains for both), p< 0.002. The percentage of P. aeruginosa strains
susceptible to Cfp and Ctz increased from 40% and 49% (36/90 and
44/90 strains) to 77% and 66% (101/132 and 87/132 strains), p< 0.005.
Between the 1st and the 2nd periods of time the susceptibility of all
strains analysed was similar to that one in the 1st period of time.
Conclusion: Replacement of 3rd generation cephalosporins to 4th
generation cephalosporin resumed susceptibility to this antibiotics in the
most problematic pathogens − E. coli, K. pneumoniae and P. aeruginosa
in 6−9 month after removal of 3rd generation cefalosporins (ceftazidime
and cefotaxime) from hospital utilization, that can lead to reduction in
carbapenem utilization and ﬁnancial beneﬁt.
R2193 A better documentation of the reassessment of antibiotic
therapies does not improve the quality of prescription
C. Pulcini °, J. Dellamonica, L. Marcq, N. Molinari, A. Sotto (Nice,
Nıˆmes, FR)
Objectives: To assess the impact of an intervention designed to improve
the documentation of the reassessment of inpatient empiric antibiotic
prescriptions on the quality of these prescriptions.
Methods: A prospective before and after intervention 7-month study
on two wards (Internal Medicine and Medical Intensive Care Unit
(ICU)) in one French University Hospital. The intervention consisted
of a quality improvement project led by one doctor on each ward,
aiming at improving the documentation of four process measures in the
medical records: antibiotic plan, review of the diagnosis, adaptation to
microbiological results and iv-po switch.
Results: 171 antibiotic prescriptions were assessed, 57 on the Internal
Medicine ward and 114 in the ICU, 90 before and 81 after the
intervention. The reassessment of antibiotic prescriptions was more often
documented in the ICU after the intervention (58% vs 79%, P = 0.03),
but not on the Internal Medicine ward (32% vs 45%, P = 0.48). The
prevalence of appropriate antibiotic prescriptions was not statistically
different on the two wards before and after the intervention (25% vs
31%, P = 0.83 and 44% vs 38%, P = 0.72 respectively).
Conclusions: A better documentation of the reassessment of antibiotic
prescriptions was achieved on one ward, but it did not lead to a better
quality of antibiotic prescriptions.
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R2194 Inaccuracies in dosing drugs with teaspoons–tablespoons
M. Falagas, E. Vouloumanou °, E. Plessa, G. Peppas, P. Rafailidis
(Athens, GR)
Objective: We aimed to evaluate the potential inaccuracies in
administering the desired dose of drugs with teaspoons and tablespoons.
Methods: We collected all the different teaspoons/tablespoons that were
available in 25 households in the area of Attica, Greece and measured
their volume capacity (ml).
Results: A total of 71 teaspoons and 49 tablespoons were provided from
the 25 female (mean age 48.0 years) study participants. When these
utensils were ﬁlled with water, the volume capacity of the 71 teaspoons
ranged from 2.5 to 7.3ml; mean volume was 4.4ml; median was 4.4ml.
When the standardized teaspoon was used, the volume ranged from 3.9
to 4.9ml among the total of the 25 study participants. When a subset of
5 study participants ﬁlled this teaspoon with paracetamol syrup, mean
volume was 4.8ml.
Conclusions: Teaspoons and tablespoons are unreliable dosing devices
and thus their use should no longer be recommended.
R2195 A novel approach to antimicrobial stewardship programme:
smart computerized decision support system
D.C. Lye °, T.M. Ng, C.B. Teng, L.M. Ling, I.J. Hsieh, S.C. Yeak,
H.Y. Tai, Y.S. Leo, B.S. Ang (Singapore, SG)
Objectives: Our 1200-bed hospital has high rates of MRSA, ESBL
Escherichia coli and Klebsiella, and multidrug-resistant Acinetobacter,
with very high ceftriaxone and ﬂuoroquinolone usage, and rising
carbapenem and piperacillin–tazobactam usage. Daily antibiotic orders
averaged 218 over 9 weeks, making manual review and feedback
laborious.
Methods: Our hospital has comprehensive information technology (IT)
systems including electronic inpatient medication record (eIMR). We
designed ARUS_C integrated in doctors’ work process to guide them
in antibiotic use by adopting evidence-based medicine and real-time IT
data.
Results: Doctors launch ARUS_C from eIMR to select empiric,
deﬁnitive or prophylactic antibiotic, and infectious disease (ID) condition
to treat. By entering data unavailable in IT systems, doctors can view
antibiotic recommendation including renal dose adjustment, duration
of therapy, allergy, antibiotic toxicity and monitoring, therapeutic
duplication, and antibiotic and microbiological data summary. ARUS_C
checks for healthcare-associated infection, prior antibiotic-resistant
bacteria, and illness severity inﬂuencing antibiotic selection. It provides
clues to diagnosis, investigation and referral for selected ID condition,
and interpretation of positive microbiological cultures. From empiric to
deﬁnitive antibiotic use, ARUS_C provides guidance to treat culture-
positive infections using narrow-spectrum culture-guided antibiotic, step-
down therapy in culture-negative infections with improvement, and
recommend referral and further investigation in non-improving culture-
negative infections. It advises antibiotic for multiple bacteria, including
route and duration, based on ID condition, culture site and clinical
response. Doctors are able to over-ride ARUS_C. Usage of ARUS_C
rose from 76 episodes in week one to 216–295 from weeks 4−9, with
over-rides ranging from 8−40 per week. Daily usage ranges from 30−36
for week days, and 24−25 for weekends. Screen shots of ARUS_C in
action, and data on efﬁcacy and safety will be presented.
Conclusions: Voluntary ARUS_C use was hampered by IT errors,
and doctors’ mindset. Mandatory ARUS_C use may be needed to
achieve signiﬁcant reduction in overall and broad-spectrum antibiotic
use. Further evaluation of ARUS_C is under way.
R2196 Comparison of antibiotic prescription behaviour between
general practitioners and specialists: data from the
European Surveillance of Antimicrobial Consumption
(ESAC) Nursing Homes subproject
E. Broex °, K. Latour, A. Muller, N. Drapier, V. Vankerckhoven,
R. Stroobants, H. Goossens, B. Jans on behalf of the ESAC Nursing
Homes Subproject group
Objectives: To deﬁne in European nursing homes (NHs) who prescribes
antibiotics (ABs), and to deﬁne differences between prescribers related
to the indication, type, and route of administration.
Methods: A survey, including a point prevalence study, on AB use,
characteristics of residents and characteristics of the NH was conducted
in European NHs in 2009.
Results: Results from 270 NHs in 16 European countries, with 1740
NH residents receiving ABs, were available. Results showed that
76% of the ABs in NHs was prescribed by the general practitioner
(GP), 19% by a specialist and 5% by another prescriber (n = 1749
substances). The majority of prescribed indications (n = 1649) for ABs
by both GPs and specialists were empirical treatments (53% and 44%,
respectively). Specialists prescribed signiﬁcantly more frequently ABs
for microbiologically documented infections (25%) than GPs (14%,
p< 0.0001). Results on all AB treatments (n = 1666) showed that GPs
prescribed signiﬁcantly more frequently extended-spectrum b-lactam
penicillins (J01CA, 11%) than specialists (6%, p = 0.0027). For GPs,
72% of the J01CA prescriptions were amoxicillin (J01CA04), compared
to 53% of prescriptions by specialists. Combinations of penicillins and
b-lactamase inhibitors (J01CR) were prescribed in similar amounts by
GPs and specialists (14% and 15% respectively, p = 0.68). This was
also the case for the prescription of quinolones (J01M) (14% by both,
p = 0.94). Specialists prescribed cephalosporins (J01D) slightly more
often than GPs (12% and 9%, respectively, p = 0.063). Finally, GPs
and specialists prescribed other antimicrobials (J01X) in almost equal
proportion (28% and 26%, respectively, p = 0.45). GPs opted in 94% of
the cases for oral ABs. Oral administration was also the predominant
route of administration (80%) for specialists, although they combined
this with a substantial proportion of parenteral AB administration (20%)
causing a signiﬁcant difference between GPs and specialists (p< 0.001).
Conclusion: Compared to specialists, GPs prescribed comparable classes
of ABs in NHs, with the exception of extended-spectrum b-lactam agents
(e.g. amoxicillin), probably because GPs prescribed more empirical ABs.
Specialists prescribed more frequently parenteral AB administration
compared to GPs.
R2197 Detection of an antimicrobial residue in Irish hospital
efﬂuent using high-performance liquid chromatography
with tandem mass spectrometry
S. Galvin °, L. Barron, B. Paull, D. Morris, M. Cormican (Galway,
IE; London, UK; Dublin, IE)
Background: The presence of antimicrobial compounds in the envi-
ronment may exert selective pressure on bacteria and contribute to the
emergence and dissemination of antimicrobial resistance. Antimicrobial
agents are used extensively in hospitals and previous reports of both
the parent drug and related metabolites in hospital efﬂuent make it
a signiﬁcant point source of pharmaceuticals to the environment. The
aim of this research was to examine hospital efﬂuent for two such
antimicrobials, ciproﬂoxacin and trimethoprim.
Methods: Efﬂuent samples were collected from Hospital A sewers;
municipal sewers at points upstream and downstream of hospital efﬂuent
discharge; intake efﬂuent (untreated, stage 0) to secondary waste water
treatment plant; primary treated efﬂuent (stage 1); post return efﬂuent
(stage 2) and ﬁnal treated efﬂuent (stage 3). Efﬂuent was ﬁltered using
glass-ﬁber ﬁlters, acidiﬁed to pH 2.5 and pre-concentrated using solid
phase extraction on a mixed-mode reversed phase-strong cation exchange
sorbent before analysis by liquid chromatography with both single and
tandem mass spectrometry (using secondary product ion scan mode).
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Results: Ciproﬂoxacin (parent m/z = 332; 2o ions m/z = 228 and 314)
was not detected in any efﬂuent sample indicating either rapid
degradation, sorption to solid material (log P≈ 2.3) or insufﬁcient
sensitivity of the method. Trimethoprim (parent m/z = 291; 2o ion
m/z = 123) however was detected in efﬂuent from Hospital A only,
with both parent and fragment ions detected. The concentration of
trimethoprim in Hospital A efﬂuent was estimated at ~270 ng/L.
Conclusions: Trimethoprim can be detected at sub-inhibitory concen-
trations in hospital efﬂuent samples in Ireland. The implications of this
ﬁnding for the emergence and spread of antimicrobial resistance merit
further investigation and it may be appropriate to consider measures to
mitigate discharge of antimicrobial substances from hospitals.
R2198 Evaluation of culture results and empirical antimicrobial
therapy in the Surviving Sepsis Campaign
L.B. van der Velden °, M. Tromp, C.P. Bleekers-Rovers, L. Peters,
M. Hulscher, B.J. Kullberg, J.W. Mouton, P.D. Sturm, P. Pickkers
(Nijmegen, NL)
Objectives: The international Surviving Sepsis Campaign (SSC) is a
triage system to identify patients with sepsis and ensure rapid initiation
of empirical antimicrobial therapy. Besides diagnostic purposes, cultures
for microbiology should be collected to enable de-escalation of broad
spectrum therapy. We evaluated the culture collection and compliance
to local antimicrobial guidelines after implementation of the SSC.
In vitro susceptibility of isolated pathogens to recommended therapy
and prescribed therapy was evaluated.
Methods: All adult patients diagnosed with sepsis at the emergency
department (ED) of the Radboud University Nijmegen Medical Centre
between November 1, 2006 and May 10, 2007 were included. Electronic
medical charts were reviewed to collect the clinical diagnosis at the
ED and the prescribed therapy. Culture collection, culture results and
susceptibility results were retrieved from the laboratory information
system. Culture results were evaluated for clinical signiﬁcance. Empirical
therapy was classiﬁed as according to guideline therapy (AGT) or not
according to guideline therapy (NGT).
Table 1: Patient demographics, clinical diagnosis, numbers of positive





















































































Mean age (y) 59 58 64 54 54 61 64 58 61
Sex (% male) 71 88 67 60 79 68 43 63 52
Mortality (%) 14 0 0 7 3 0 10 6 13
AGT (%) 57 38 40 80 52 97 62 38 30
Pos BC/BC obt 2/7 4/8 3/13 3/15 3/28 9/36 6/21 15/126 10/43
Pos UC/UC obt 0/3 0/6 0/6 1/8 2/14 28/33 4/17 1/62 13/39
Pos SC/SC obt 1/1 1/2 1/1 0/2 18/34 1/4
Pos LC/LC obt 4/6 0/4 0/1
Pos OC/OC obt 2/4 2/2 5/7 1/1
Microbiological
diagnosis
57% 50% 33% 33% 34% 76% 38% 22% 41%
SUO: sepsis of unknown origin, SOI: source of infection, AGT: according to
guideline therapy, BC: blood culture, UC: urine culture, SC: sputum culture,
LC: liquor cerebrospinalis culture. OC: other culture, Pos: positive, Obt: obtained.
Results: There were 8570 visits to the ED. Of these, 400 patients
(5%) presented with sepsis. In 43 patients no antimicrobial therapy was
initiated: 8 went for immediate surgery, 20 were diagnosed with a viral
infection and 15 with fever of unknown origin. The ED diagnosis of 21
patients was not deﬁned in the guidelines. Insufﬁcient information was
available from another 18 patients.
ED diagnosis, culture collection and results of the 318 patients are shown
in table 1. A microbiological diagnosis was established in 115 patients
(36%). When blood cultures (BC) were obtained and the suspected site
of infection was accessible and cultured, a pathogen was found in 59/81
patients (73%). BC were positive for a different pathogen or the only
positive culture in 30 patients (9%). NGT was prescribed in 51% of
the patients and was more broad spectrum than AGT in 74%. Isolated
pathogens were equally susceptible to NGT (40/45; 89%) and AGT
(39/45; 87%).
Conclusion: To establish a microbiological diagnosis in patients with
sepsis it is important to collect cultures from the suspected site of
infection. Adherence to local antimicrobial guidelines results in effective
therapy. A multidisciplinary effort should be made to improve appro-
priate collection of cultures and compliance with local antimicrobial
guidelines to reduce the use of broad spectrum antimicrobials.
R2199 Characteristics of outpatient antibacterial use in Hungary,
1996–2007
M. Matuz, R. Benko, E. Horvath, E. Hajdu °, G. Soos (Szeged, HU)
Objectives: To analyse the changes in the amount and structure of
antibacterial consumption in the ambulatory care sector in Hungary
between 1996 and 2007.
Method: Crude consumption data on systemic antibacterial use (i.e.
ATC group J01) were retrieved from a wholesaler database. Antibiotic
use was standardized as Deﬁned Daily Dose (DDD) per 1000 inhabitant-
days. Trend analysis was used to investigate the trends in the national
ambulatory antibiotic utilization through the study period. We also used
the ESAC deﬁned quality indicator (ratio of the consumption of broad
spectrum penicillins, cephalosporins and macrolides to the consumption
of narrow spectrum penicillins, cephalosporins and macrolides: B/N
ratio). International comparison was made by the online available
European Surveillance of Antimicrobial Consumption (ESAC) database
(URL link: http://www.esac.ua.ac.be).
Results: During the study period only minor ﬂuctuations in the
national ambulatory antibiotic use could be observed (mean±standard
deviation: 18.6±1.5 DDD per 1000 inhabitant-days). Macrolides,
ﬂuoroquinolones, penicillin plus b-lactamase combinations and third-
generation cephalosporins showed increasing trend in use. The share of
narrow spectrums antibiotics (N) decreased from 15.3% to 6.6% and
parallel the Broad/Narrow ratio was increased from 2.2 in 1996 to 9.3
in 2007.
Hungarian aggregated national antibiotic use was in the middle range
of European countries. The relative use of some antibiotic groups (e.g.
second and third generation cephalosporins) was outstanding compared
to other European countries.
Conclusion: The quantitative antibiotic use is quite reasonable in
Hungary, while some trend of the pattern of use is unfavourable which
should be reversed.
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R2200 Multiplex real-time PCR: a practical approach for rapid di-
agnosis of tuberculous and brucellar vertebral osteomyelitis
J.D. Colmenero °, J.D. Ruiz-Mesa, M.I. Queipo-Ortun˜o, J.M. Reguera,
A. Plata, P. Bermudez, R. Sanjuan, P. Morata (Ma´laga, ES)
Objectives: To analyze the diagnostic yield of a multiplex real-time PCR
in the differential diagnosis of tuberculous vertebral osteomyelitis (TVO)
and brucellar vertebral osteomyelitis (BVO).
Methods: Fifteen vertebral samples from patients with TVO or BVO
and nine from pyogenic and non-tuberculous mycobacteria VO were
studied by multiplex PCR and conventional microbiological techniques.
To identify Brucella DNA we used a fragment of 207 bp from the
gene coding for an immunogenic membrane protein of 31 kDa of
B. abortus (BCSP31) and for M. tuberculosis complex a fragment of 164
bp from SenX3-RegX3 genes. Ampliﬁcation and melt curve analysis
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were performed using a LightCycler 2.0 instrument. To guarantee the
reliability of the results, all samples were processed in duplicate. Positive
controls were included in all tests and comprised serial dilutions of
B. abortus B-19 and M. tuberculosis DNA; negative controls were
also included and contained all the elements of the reaction mixture
except template DNA. Universal precautions and one-way ﬂow of DNA
extraction and ampliﬁcation were used to prevent contamination. To
avoid potential observer bias, the status of each patient for Brucella
and Mycobacterium infection was unknown during the PCR assay.
Results: Of the 24 vertebral samples included, 5 (20.8%) were
percutaneous biopsies and 19 (79.2%) were taken during surgery. The
aetiological diagnosis of VO was established prior to vertebral biopsy in
just 9 cases (39.1%); 6 from blood cultures (4 patients with PVO and 2
with BVO), one case of TVO detected by baciloscopy and sputum culture
and another 2 cases of BVO detected by serological tests. In the other
14 cases (60.9%), the aetiological diagnosis required a bone biopsy. The
histopathological ﬁndings were inconclusive in 4 of 14 cases (26.6%)
with TVO or BVO and cultures were positive in 11 of 15 cases (73.3%).
Multiplex PCR correctly identiﬁed 14 of the 15 samples from patients
with TVO and BVO and was negative in all the control samples. Thus,
the overall sensitivity and speciﬁcity of the multiplex PCR were 93.3%
and 90%, respectively, with an accuracy of 92% (95%CI, 81.4%-100%).
Conclusions: Multiplex real-time PCR is far more sensitive than
conventional cultures, and this, together with its speed, makes this
technique a very practical approach for the rapid differential diagnosis
between TVO and BVO.
R2201 Direct detection of Mycobacterium tuberculosis in
paucibacillary forms of tuberculosis by real-time PCR
M. Nica °, T. Biolan, E. Mozes, A. Toderan, V. Melinte, D. Duiculescu,
S. Erscoiu, O. Nicolaescu, L. Popescu, P. Calistru, E. Ceausu
(Bucharest, RO)
Objective: The early conﬁrmation of diagnosis in paucibacillary forms
of tuberculosis, directly in clinical specimens, by Real Time PCR.
Methods: The results of the conventional methods (Ziehl–Neelsen smear
microscopy, Lowenstein-Jensen and MB/BACT cultures, biochemical
and cytological parameters) were correlated with detection and
quantiﬁcation of Mycobacterium tuberculosis/ MTB speciﬁc sequences,
by Real Time PCR technique, directly from the clinical specimens. The
MasterPure™ Complete DNA and RNA Puriﬁcation Kit (Epicentre,
Madison, Wisconsin) and Total Nucleic Acids Puriﬁcation Protocol
were used. The Primer Design™ Kit (Primer Design 2X Precision™
MasterMix) is designed for the in vitro quantiﬁcation of Tb genomes.
The RT PCR method used LightScanner 32 Instrument/LS32 (Idaho
Technology, Salt Lake City, UT).
Results: 46 consecutive patients (17 HIV positive and 27 non-HIV)
with clinical and imagistic diagnosis of tuberculosis were enrolled in
this study, between 1st September and 15 November 2009. The same
bacteriologic and molecular analyses were performed on 53 clinical
samples: cerebrospinal ﬂuid/23; pleural liquid/13; peritoneal liquid/2,
lymphatic node/3; bronco-alveolar aspirate/6, gastric aspirate/2; urine/3;
blood/1. As compared to 7.5% positively with demonstration of AFB
(Ziehl–Neelsen smear microscopy) and 9.4% to 22.6% mycobacterium
positive cultures (Lowenstein-Jensen, MB/BACT, respectively), RT PCR
has been found to be positive in 62.2% of specimens from cases
with typical features as well as biochemical, cytological, and imagistic
evidence of tuberculosis. Using the RT PCR method, we obtained 62.2%
true positive results (44 to 869 number of copies); 30.2% true negative
results, and 7.5% false negative results. The latter required the repetition
of the analyses to clarify the ﬁnal results. There were no false positive
results in the RT PCR. Detection of MTB speciﬁc sequences was founded
in 13/33 MTB specimens from HIV-positive patients, and 18/33 MTB
clinical samples from non-HIV patients.
Conclusions: Real Time PCR can usefully complement standard micro-
biologic methods for early conﬁrmation of diagnosis in paucibacillary
forms of tuberculosis, and contribute to speciﬁc management in patients
with negative cultures.
R2202 Using real-time PCR to decrease time to appropriate
management with staphylococcal blood cultures
S. Larkin °, M. Weinbren (Coventry, UK)
Objectives: Blood cultures (BCs) are key in directing antibiotic therapy,
often affecting the sickest patients in hospital. Staphylococci are the most
common organism seen in Gram stain. Data from University Hospital
Coventry and Warwick, June-August 2008, showed roughly 80% of
these are contaminants. At the time of phoning the clinician to discuss
an unwell patient, it can be difﬁcult to differentiate a contaminant,
a possible methicillin sensitive Staphylococcus aureus(MSSA) or
methicillin resistant Staphylococcus aureus(MRSA). A more rapid test
could:
1. Reduce time spent by laboratory staff, microbiologists and clinicians
working on and reviewing these results
2. Prevent unnecessary anti-staphylococcal antibiotics commencing
3. Allow earlier institution of optimal antibiotic therapy for
MSSA/MRSA
All of this must be in conjunction with infection control teaching about
correct technique for taking a BC to reduce the rates of contamination
in the ﬁrst instance.
Methods: A pre-study period for 1 month was observed before 100
sequential BCs were tested by GeneXpert Cepheid. This machine
differentiates coagulase negative Staphylococci (CNS), MSSA and
MRSA in 1 hour.
For each relevant Gram stain during these periods:
1. Standard questionnaire was ﬁlled in: last MRSA screen, current
antibiotics
2. Advice given to clinicians based on clinical picture was documented,
including changes made prior to PCR or culture results
3. Consultant on duty was blinded from the PCR result
4. PCR results reviewed and changes made to management as
appropriate
5. Time to review a single patient, contact clinicians and input data was
assessed
Results: See tables.
There were 10 failures with the PCR kit (10%). The cause is not known.
1 mismatch of PCR result to culture results occurred. Repeat PCR
concurred with the culture results. Dealing with initial Gram stains took
20minutes/culture on average.
Conclusion: Throughout the study a substantial number of BC were
misinterpreted by microbiologists and clinicians. Up to 55% of MSSAs
were not identiﬁed until further testing was obtained, a 24hour delay
to best treatment. Time spent phoning contaminated BCs equates to
5.15PAs/month=£884 (average consultant salary). If all 71 BCs a month
were tested at £29/ test=£2059. A saving of 1.7 bed nights/month would
make this test cost efﬁcient (Bed stay=£691/night) Importantly reducing
the rate of contamination is key for best practice, which would in turn
reduce the number of BCs that would require testing.
Pre-study period Study period
Number of methicillin sensitive Staphylococcus aureus (MSSA) 9 9
Number of MSSA that were not thought to be signiﬁcant initially 2 (22.2%) 5 (55.6%)
Number of methicillin resistant Staphylococcus aureus (MRSA) 1 2
Number of MRSAs not thought to be signiﬁcant initially 0 (0%) 0 (%)
Number of GPC not MSSA or MRSA on PCR or culture 51 89
Number of above not thought to be signiﬁcant initially 48 (94%) 80 (90%)
Total number of BC with likely staphylococci 71 100
Number where advice was changed after the culture result was available 8 (71%) 14 (14%)
Thought to be signiﬁcant isolates but were not after culture 6 (8.4%) 9 (9%)
Thought not to be signiﬁcant but were after culture 2 (2.8%) 5 (5%)
R2203 Signiﬁcance of rapid detection of group B Streptococcus
E. Trajkovska-Dokic °, G. Jankoska, T. Grdanoska, K. Icev (Skopje, MK)
Introduction: Streptococcus group B (GBS) is a part of normal ﬂora
of the gut and harmlessly colonize the genital tract in about 20–40% of
healthy women. The objective of our study was to evaluate the rapid and
simple assay (SpeedOligo chromatography test, Vircell) for the detection
of GBS in vaginal smears in pregnant women.
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Material and Methods: In the study we involved 30 pregnant
between 28th and 35th week of gestation. Double vaginal swabs from
each pregnant women were analyzed. The ﬁrst one was inoculated on
Columbia blood agar and incubated for 24 h. Suspicious colonies were
used for performing the bacitracin susceptibility test for identiﬁcation
of GBS. The second swab was used for proceeding SpeedOligo GBS
assay. Bacterial DNA was extracted by elution the swabs in a sample
solution provided in the kit followed by heating at 94ºC for 5 minutes
and centrifuging on 14,000 rpm for 2 minutes. Only 10 microL of DNA
template were used for PCR. For that purpose were used 15 microL
of reconstituted PCR mix which contained all that was needed for
ampliﬁcation of speciﬁc cfb gene of GBS which was the princip of the
test. PCR reactions were performed in a termocycler with the following
temperature proﬁle: 1 cycle at 92ºC for 1.5min; 35 cycles consisted
of three steps (92ºC for 20 s; 55ºC for 20 s; 72ºC for 20 s); 1 cycle at
72ºC for 2min and 1 cycle at 95ºC for 1min. The hole ampliﬁcation
time was less than 30 minutes. Amplicons were detected by a process
of hybridization in a dipstick for a 5 minutes. Positive results were
conformed according to the red lines on the sticks.
Results: 3 out of 30 (10%) swabs cultured for GBS revealed positive
results. They were positive by SpeedOligo assay too. 5 out of 30 (16.6%)
swabs used for SpeedOligo assay were positive for GBS. 3 of them were
positive by culture too, but in two positive cases by SpeedOligo the
results were negative by culture. Comparison of this rapid and simple
assay by culture as a gold standard for detection of GBS revealed
sensitivity of 100% and speciﬁcity of 92.6%.
Conclusion: SpeedOligo GBS proved to be a rapid, sensitive and speciﬁc
assay for the detection of GBS based on nucleic acid ampliﬁcation
technique. This test could be very useful for detecting colonization
and infection with GBS in pregnant women during the hole time of
pregnancy. It would be especially important for pregnant women with
pretermed delivery, rupture of membranes and high fever during the
delivery.
R2204 Distribution of virulence protein secretion systems in a
collection of Pseudomonas aeruginosa clinical strains
G. Scalet °, O. Jousson (Verona, Trento, IT)
Objectives: Protein secretion systems are virulence determinants that
mediate interactions between bacteria and eukaryotic host cells and
contribute to the severity of infections. Among the 8 secretion systems
known to date, type I, II, III, IV, V and VI have been reported in
P. aeruginosa. These secretion systems have been intensively studied
in a small number of reference strains, but there is, with the exception
of type III secretion system, a lack of data regarding their distribution
and relevance in clinical strains. This study is aimed at identifying
genes encoding components and effectors of protein secretion systems
in P. aeruginosa isolated from acute infections.
Methods: P. aeruginosa strains were isolated from patients hospitalized
in at high-risk departments such as intensive care unit and hematology.
Genotyping was performed using SpeI-PFGE and rep-PCR with BOX
and ERIC primers. A total of 8 multiplex PCR assays were designed
to target from 1 to 3 genes encoding structural and secreted proteins of
secretion systems I-VI.
Results: A total of 113 P. aeruginosa strains were isolated from 69
patients. Genotyping using rep-PCR and PFGE allowed to assign 78
strains to 13 clusters, while 37 strains showed an unrelated, unique
proﬁle. All strains possessed the genes encoding effectors associated
with type V and VI secretion systems. Genes encoding proteins secreted
by type II were found in all clones examined, except for gene lapA,
which is located in a Region of Genomic Plasticity. The presence of
genes encoding effector proteins ExoS, ExoY, and ExoU transported
by type III secretion system was certiﬁed in the 58% of the strains, in
the remaining ones there seems to be an incompatibility between exoS
and exoU. Type I secretion system haspA, aprA and aprX genes were
present in 100%, 84% and 91% of the strains respectively and for type
IV secretion system the prevalence of genes D4 and B2 was 10% and
3% for Trb.
Conclusion: Rep-PCR results were conﬁrmed by PFGE, supporting the
reliability of the method. Genotyping revealed the presence of a clone
isolated both from hematology and intensive care unit indicating that
it has been cross-transmitted within the nosocomial environment. A
remarkable heterogeneity of the distribution of secretion systems I-IV
was observed, suggesting that genomic plasticity may contribute to the
speciﬁcity of P. aeruginosa infections.
R2205 Frequency of Helicobacter pylori vacA genotypes in Iranian
patients with gastric and duodenal ulcer
M.H. Shirazi ° (Tehran, IR)
Objective: Helicobacter pylori infection is a risk factor for developing
chronic peptic ulcers and gastric cancer. The purpose of this study was
to investigate the frequency of Helicobacter pylori vacA genotypes in
patients with gastric and duodenal ulcer.
Methods: A total of 100 biopsy specimens of patients with gastric
(n = 50) and duodenal (n = 50) ulcer were collected. The specimens
were cultured on selective media and incubated in a microaerophilic
atmosphere at 37ºC for 5−10 days. The isolates were characterized to
species level by conventional biochemical tests. The extracted DNA
from isolates was used to perform a polymerase chain reaction based,
simultaneous analysis of the cagA status, allelic variation of the signal
regions (s1, s2) and the middle regions (m1, m2) of the vacA gene.
Results: Helicobacter pylori isolated from 50 specimens of patients
and the vacA gene was detected in all isolates. Among vacA genotypes
the s1/m1 was the most common in Helicobacter pylori isolates from
patients with gastric ulcer (56%) and duodenal ulcer (68%).
Conclusion: This study demonstrated that vacA slml is common
genotype of Helicobacter pylori in patients with peptic ulcer and the
vacA allele s1 of this bacterium is associated with ulcer.
R2206 Molecular analysis of faecal microbiota from breastfed
Brazilian children
C. Taddei, F. Oliveira, D. Runga, E. Harummyy, I. Irino, K. Brandt,
M. Carneiro-Sampaio, M. Martinez ° (Sao Paulo, BR)
The human intestinal microbiota plays an important role in body healthy
and differences in its composition are related to different levels of
environmental contamination and different endogenous factors. The
establishment of this microbiota occurs in the ﬁrst two years of life.
Objective: In this study, we analyze the establishment of the fecal
microbiota in a group of 14 children during the ﬁrst year of life, living
in low socio-economic conditions in Sa˜o Paulo, Brazil, based on 16S
rDNA gene libraries analysis.
Methods: Fecal samples were collected from healthy and exclusively
breastfed children at different time point: 2nd, 7th, 30th days and 3, 6 and
12 months of life. Bacterial DNA was extracted directly from samples,
and 16S rDNA libraries were constructed using bacterial-speciﬁc primers
27F and 1492R. Randomly selected clones were partially sequenced.
Real-time PCR for Biﬁdobaterium spp. was performed in the 30th day
samples and 3 months.
Results: The main phylogenetic group identiﬁed in all time point
samples was E. coli. Clostridium and Streptococcus were detected at
high rates at 30th day and 3th month of life, respectively. At 6th and 12th
months of age, high rates of OTUs classiﬁed as uncultured bacteria were
detected, showing the increase of diversity microbiota. Biﬁdobacteria
was not detected in 16S rDNA libraries but was present in all samples
analyzed by Real Time PCR.
Conclusion: This molecular approach allowed the analysis of the fecal
microbiota implantation in a group of children from Sao Paulo, Brazil.
This bacterial proﬁle may differ to what is described in developed
countries, and it may be attributed to a highly contaminated environment,
and neonate contamination may have been favored by hygiene habits.
Financial Support: FAPESP/Brazil.
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R2207 Phylogenetic study on matrix gene of H9N2 isolates in Iran
A. Ghalyanchi-Langeroudi °, K. Majidzadeh (Tehran, IR)
Objectives: H9N2 AI outbreaks have been one of the major problems
in Iranian poultry industry. The association of high mortality and case
report of H5N1 and H9N2 inﬂuenza virus in wild birds in recent years
raised the specter of a possible new genetic modiﬁed AI virus.
Methods: In this study, we do phylogenetic analysis on full-length
Matrix (M) genes genes of 8 H9N2 isolates from Broilers in Iran, Tehran
province during 1998–2008. Sample collection was performed according
to the standard method from suspected clinical broiler specimens. Ten-
day-old embryonated chicken eggs were inoculated and incubated at
37ºC for 48 h. Viral RNA was extracted from infected allantoic ﬂuid.
RT-PCR was done. Puriﬁed PCR products were cloned into plasmid for
TA subjected to nucleotide sequencing for bioinformatic studies.
Results: The nucleotide sequences for all H9N2 inﬂuenza viruses used
in this study are available GenBank under accession numbers GQ206302
through GQ206309. Comparison of nucleotide sequences of isolated
viruses revealed a substantial number of silent mutations, which results
in high degree of homology in amino acid sequences. In addition, the
cluster of Iranian H9N2 isolates could be present into one subgroups.
The high degree of similarity between the M genes of the Iranian
H9N2isolates supports the hypothesis that these genes originated from
a single predecessor.
Conclusion: Our result provides useful molecular epidemiological data
to understand the dynamics of H9N2 evolution during years in Iran and
support earlier phylogenetic observations.
R2208 Prevalence and type distribution of human papillomaviruses
types in women with abnormal cytology results in Greece
I. Dendrinos, E.T. Piperaki °, N. Spanakis, V. Pitiriga, A. Antsaklis,
A. Tsakris (Athens, GR)
Objectives: Several epidemiological studies have been conducted
worldwide in order to estimate the prevalence of human papillomaviruses
(HPV) infection. The aim of this study was to evaluate the prevalence
of HPV types and its possible association with the grade of histological
lesions in a cohort of 148 women proceeding to gynaecology clinics
of “Alexandra” Hospital for a 6 month period (03/2009–09/2009) with
previous abnormal cytology ﬁndings, using a highly sensitive detection
method based on nested PCR.
Methods: Cervical swabs were collected from all participants. HPV
DNA detection was carried out by PCR and nested PCR using kit of
AB Analitica. The detection limit of this method is 100 copies of viral
genome/mL. HPV positive samples were genotyped for 32 different HPV
types by reverse hybridization of speciﬁc probes with the ampliﬁed viral
region L1 acquired from nested PCR (AB Analitica Padova, Italy).
Results: The mean age of the population was 37.3±11.6 years (range
20−76 years). Ninety six of 148 samples were graded as LGSIL, 15 as
CIN I, 10 as CIN II-III and 27 belong to women which underwent loop
excision for treatment. HPV was found in 67 out of 96 patients with
LGSIL (69.8%), in 15 patients with CIN I (100%), in 10 patients with
CIN II-III (100%) and in 19 out of 27 patients which underwent loop
excision (70.3%). Twenty two (22) different genotypes were identiﬁed.
The most prevalent types in LGSIL cases were HPV16 (26%), HPV31
(17.7%) and HPV54 (14.6%), in CIN I cases were HPV16 (40%), HPV58
(33.3%) and HPV31 (20%), in CIN II-III cases were HPV16 (50%),
HPV31 (30%) and in patients with loop excision were HPV16 (37%)
and HPV31 (7.4%). Multiple HPV infection was found in 30.2% of
patients with LGSIL, in 20% of patients with CIN I, in 50% of patients
with CIN II-III and in 29.6% of patients with loop excision. HPV16 and
HPV31 were found in 58.7% and in 60% respectively of patients with
multiple HPV infection. An association was indicated between multiple
HPV infection and histological lesion (p = 0.078). The mean age was
36.7±12.4 years in the HPV infected group and 39.6±8.5 in the non
HPV infected group (p = 0.002).
Conclusions: According to our ﬁndings HPV16 was the most frequent
type followed by HPV31. HPV was present in most of the patients
underwent a loop excision for treatment. Moreover, multiple HPV
infection was a common ﬁnding among the participants.
R2209 Survey of viral gastroenteritis in childhood in Turkey using
Multiplex RT PCR methods
M. Altindis °, D.C. Lewis, A. Hale, R. Koken, R. Kalayci, Y. Yoldas
(Afyonkarahisar, TR; Leeds, UK)
Objectives: Enteric viruses that have been reported as a cause
of nonbacterial acute gastroenteritis include rotaviruses, noroviruses,
sapoviruses, astroviruses and enteric adenoviruses. The purpose of this
study is to determine the prevalence and the distribution of viruses
responsible for gastroenteritis in children.
Methods: A molecular epidemiological study on common diarrheal
viruses was conducted in Afyon City, Turkey between January and
November 2008. One hundred and forty-four faecal samples from
children under 6 years of age(mean age, 2.18±SD 3.64 years, range: 1–
72 months)(negative for the presence of pathogenic bacteria by standard
culture methods) were tested by novel multiplex RTPCR methods for
detection of − Norovirus G1, G2, Rotavirus group A, Sapoviruses(SaV),
Astroviruses(HAstV), Adenovirus Group F, Adenovirus genus and an
internal control phage RNA (MS2). The assays were one-step RTPCR
reactions based on detection of four different ﬂuorophores in real-time on
an ABi 7500. RTPCR negative samples were also examined by electron
microscopy (EM).
Results: Among the diarrheal viruses detected, NoV GII was the most
common, with a proportion of 27.7%(n:40), whereas group A ro-
tavirus(28), adenovirus F(1), adenovirus GNS(8), SaV(5), and HAstV(2)
were also found in 19.4, 6.25, 2.8, and 1.4%, respectively. Overall 82
(57%) samples were positive by RTPCR and of the 62 negative samples
53 had sufﬁcient volume to be examined by EM. Of these 4 were
positive for a virus of which 2 were group C Rotavirus(1.3%) and 2
were Reovirus (conﬁrmed by speciﬁc PCR’s) and no other additional
positives were found.
Seventeen of 144 (11.8%) samples were found positive with more than
one viral agent, in which 14 samples contained both group A rotavirus
and NoV GII. By sequencing of 299 bp at the 5′ end of ORF2, of
these 16 were Bristol GII.4, 13 were Toronto GII.3 and 1 was Virginia
Beach-like GII.
Conclusion: These ﬁndings provide evidence that Noroviruses can be
a leading cause of gastroenteritis, and highlight the need to implement
norovirus and rotavirus ELISA detection assays in association with rapid
EIA rotavirus and adenovirus EIA detection for the clinical diagnosis and
the nosocomial prevention of gastroenteritis viral infections in paediatric
departments. It is noteworthy that the group C rotavirus was ﬁrst reported
in Turkey, with a proportion of in this study.
R2211 Enhancing sensitivity of Clart® Entherpex for detection of
human herpesvirus and enterovirus using DNA microarrays
printed in strips
N. Manjo´n, A.I. Moraga, R. Benito, O. Salazar, M.L. Villahermosa °,
R. Cospedal (Coslada-Madrid, Zaragoza, ES)
Introduction: The Herpesviridae viruses are widely spread among
human population and have the ability to establish lifelong latent
infections. In immunocompetent individuals, the virus reactivation
is usually harmless and undetectable. Human herpesviruses and
enteroviruses are the major causative agents of the central nervous
system (CNS) viral infections. The common clinical symptoms caused
by these viruses make necessary the optimization of molecular methods
that allow multiple, sensitive, and rapid identiﬁcation of these viruses.
Objective: To improve sensitivity and automate a system for simultane-
ous detection of Human Herpesviruses (HSV-1, HSV-2, VZV, CMV,
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EBV, HHV-6, HHV-7 and HHV-8) and Enteroviruses (Echoviruses,
Poliovirus and Cosxackievirus), CLART® ENTHERPEX.
Method: Virus detection is performed by multiplex RT-PCR and
improved PCR. We have developed an array detection system
(ArrayStrip) for the simultaneous processing of multiple samples in
microplate or individual strips. We have analyzed 40 samples and
QCMD samples in order to determine the new diagnostic parameters
of the kit: reproducibility, repeatability, sensitivity, and speciﬁcity. All
the discrepancies were validated with sequencing, homemade PCR and
nested-PCR. Furthermore, we have compared results from our kit,
CLART® ENTHERPEX, with real-time qPCR results.
Results: We determined an analytical sensitivity of HSV1 and VZV of
10 copies. A 100% value of analytical sensitivity ranging from 10 to 100
copies was obtained in the detection of rest of viral specimens. Analyzing
the diagnostic sensitivity and speciﬁcity, the behaviour of each virus after
the validation of clinical specimens showed that most of viruses show
sensitivity higher than 83%, speciﬁcity higher than 97%, reproducibility
higher than 92% and repeatability higher than 95%.
Conclusion: CLART® ENTHERPEX is a useful tool for rapid screening
and simultaneous detection of a Human Herpesviruses and Enteroviruses
in clinical setting, being able to process up to 96 samples simultaneously
in a working day. A new optimized version of the kit with improved
ampliﬁcation and detection makes this tool highly sensitive and useful
for clinical diagnostic purposes.
R2212 Evaluation of the Roche cobas® 4800 HPV test for cervical
HPV detection from SurePath liquid-based cytology
specimens
J. Fuller °, G. Yung, S. Howse, D. Thompson, G. Tyrrell (Edmonton,
Red Deer, CA)
Objective: The cobas 4800® system is an automated platform that
combines sample preparation with real-time PCR detection. The
cobas® 4800 HPV Test is a multiplex assay that detects HPV 16, HPV
18, and 12 other high-risk (12-HR) carcinogenic HPV genotypes with
separate reporter dyes. The purpose of this study was to investigate
the correlation of the cobas 4800® HPV Test results obtained from
direct testing of cervical cytology specimens collected in SurePath
LBC medium (BD Diagnostics) to results obtained using the residual
processed cell-pellet of the same SurePath sample.
Methods: A convenience sample of paired unprocessed and pelleted
SurePath LBC cervical specimens were collected from a pool of cervical
cancer screening specimens following cytological interpretation. Paired
unprocessed and pelleted specimen fractions were tested by the cobas
4800 HPV® Test. Data analysis included percent agreement of paired
HPV results and their association with cervical cytology. Discordant
results and paired HPV 16 and HPV 18 positive results were validated
using the Linear Array (LA) HPV genotyping assay (Roche Molecular
Systems).
Results: A total of 300 paired specimens were tested and 274 were
included for data analysis; the remaining 26 were deemed ‘invalid’ by
the cobas 4800 due to specimen inadequacy. Overall, the percent total
agreement between unprocessed and pelleted specimen pairs was 96.5%.
The percent positive agreement for paired HPV 16, HPV 18, and HPV
12-HR tests was 92% (38 of 42), 75% (16 of 21), and 87% (98 of 105),
respectively. The unprocessed SurePath specimen was HPV negative for
thirteen of the 18 discordant HPV paired results. Cytological results
showed an equal distribution of Normal, LSIL, and ASCUS ﬁndings for
92% of total specimens. Notably, 88% of HPV 12-HR positive paired
specimens were associated with LSIL/ASCUS cytology. Operationally,
we did not encounter any signiﬁcant processing or technical difﬁculties
during this evaluation of the cobas 4800 system.
Conclusion: This is the ﬁrst report to describe the performance of the
cobas® 4800 HPV Test using unprocessed SurePath LBC specimens,
in comparison to results obtained following a routine concentration
process performed to enhance cytological analysis. The excellent overall
agreement between paired SurePath specimens in this study has identiﬁed
an expanded utility of the cobas® 4800 HPV test that may, in time,
accommodate a broader range of diagnostic algorithms.
R2213 Evaluation of the Artus Inﬂ./H1 LC/RG RT-PCR kit, a
reliable and sensitive method for detection of inﬂuenza
virus using real-time PCR
A. Heitmann °, G. Luc, H. Said, P. Nissen, S. Muenz, S. Ullmann,
A. Lukas (Hamburg, Hilden, DE)
Objectives: Flu is an acute respiratory disease caused by Inﬂuenza
viruses A, B and C, with symptoms ranging from mild to lethal. Inﬂuenza
type A is usually the most common of the circulating inﬂuenza types.
A number of different subtypes are classiﬁed within the Inﬂuenza A
type based on two viral surface proteins: hemagglutinin (H) and
neuraminidase (N). Yearly epidemics occur in part due to antigenic drift
within these proteins. A novel Inﬂuenza A H1N1 subtype emerged in
March 2009 and is the causative agent of the current inﬂuenza pandemic.
The artus Inﬂ./H1 LC/RG RT-PCR Kit is designed for the speciﬁc
detection of all known Inﬂuenza A and B types, using primers and probes
directed to regions of the matrix gene, as well as for the speciﬁc detection
of a region of the hemagglutinin gene (H1) of the pandemic 2009 H1N1
Inﬂuenza virus. The presence or absence of the H1-signal provides the
basis for differentiation between pandemic 2009 H1N1 Inﬂuenza virus
and other inﬂuenza A strains.
Methods: We developed a real-time RT-PCR assay for the detection of
Inﬂuenza RNA in clinical samples and differentiation of the pandemic
2009 H1N1 Inﬂuenza virus. RNA extraction, reverse transcription
and ampliﬁcation is controlled by use of an internal RNA control.
Performance evaluation of the artus Inﬂ./H1 LC/RG RT-PCR Kit covered
determination of analytical sensitivity, reactivity, crossreactivity and
precision for the LightCycler 2.0 instrument (Roche) and also for the
RotorGene Q (QIAGEN). For these analyses virus and bacterial cultures
of deﬁned identity and concentration were used. Clinical performance
was analyzed by retrospective testing of routine diagnostic specimen.
Nucleic acid extraction was done using the EZ1 DSP Virus Kit and the
QIAamp Viral RNA Mini Kit (both QIAGEN).
Results: Analytical sensitivity of the artus Inﬂ./H1 LC/RG RT-PCR Kit
is <250 TCID50/ml. Detection is highly speciﬁc for Inﬂuenza A and
B and for pandemic 2009 H1N1, respectively. Intermediate precision
is <3.5% based on Ct-values. Retrospective studies demonstrated high
concordance between results obtained using the artus Inﬂ./H1 LC/RG
RT-PCR Kit and methods used for pre-testing, including virus culture
and sequencing.
Conclusion: The artus Inﬂ./H1 LC/RG RT-PCR Kit (RUO) is a reliable
and sensitive method for detection of inﬂuenza virus RNA using real-
time PCR.
R2214 Comparison of Linear Array HPV genotyping test and
Hybrid Capture 2 assay for detection of high-risk human
Papillomavirus genotypes in different clinical settings
M.L. Modolo °, S. Sulfaro, L. Giol, R. De Rosa, W. Marus,
V. Carnelutto, T. Lucchese, S. Zamparo, M. Avolio, P. Stano,
A. Camporese (Pordenone, IT)
Objectives: To assess concordance and performance of two commer-
cially available assays with different genotype coverage for detection
of carcinogenic HPV in patients referred to colposcopy for abnormal
Pap smear result (ASCUS or more) or for a follow-up after a cervical
intraepithelial neoplasia (CIN) diagnosis.
Methods: 458 cervical samples (331 from women with abnormal Pap
tests [AP group] and 127 in follow-up for CIN [FU group], respectively)
were analyzed by Roche Linear Array HPV (LA-HPV) genotyping test,
a qualitative PCR technique able to detect the 37 most prevalent low,
intermediate and oncogenic high-risk (HR) HPV genotypes [6, 11, 16,
18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62,
64, 66, 67, 68, 69, 70, 71, 72, 73 (MM9), 81, 82 (MM4), 83 (MM7), 84
(MM8), IS39 e CP6108], and by Digene Hybrid Capture II assay (HC2)
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detecting 13 oncogenic HR HPV (16, 18, 31, 33, 35, 39, 45, 51, 52, 56,
58, 59, 68) types. All tests were performed in the same cervical samples
collected in PreservCyt® liquid media. External Quality Assessment was
evaluated according to NEQAS and QCMD panels.
Results: 360 out of 458 samples examined (78.6%) showed positive (207
cases) and negative (153 cases) concordant results. In the remaining
98 cases we found discordant results: 93 LA-HPV positive/HR HC2
negative and 5 LA-HPV negative/HR HC2 positive. AP and FU groups
concordance was 85.2% (282/331) and 61.4% (78/127) respectively.
Overall concordance in detecting HR-HPV genotypes was 76.3%
(184/241): 85.4% (164/192) in AP and 40.8% (20/49) in FU groups.
Sensitivity for HR-HPV detection was 97.9% (LA-HPV) vs 87.5%
(HC2) in AP group and 99.9% (LA-HPV) vs 42.8% (HC2) in FU group,
respectively.
Conclusion: LA-HPV and HC2 showed a substantial agreement in the
AP group, thus conﬁrming that both methods can be used in the triage
of abnormal pap-tests. LA-HPV was more sensitive than HC2 in the FU
group.
Nevertheless, several future studies are needed to demonstrate the
potential clinical impact of our results.
R2215 Differential detection of 19 respiratory viruses including
the new inﬂuenza A strain H1N1 2009 with the ResPlex II
Plus panel
C. van deSand °, M. Boehm, M. Maehl, K. Helmerichs, M. Ehrenberg,
T. Grewing (Hamburg, DE)
Objective: The ResPlex II Plus panel uses proprietary QIAplex
technology for multiplex ampliﬁcation of nucleic acids from 19
respiratory viruses and following differential detection by suspension
bead hybridization on the LiquiChip 200 workstation. The ResPlex II
Plus Panel was developed by implementation of an additional H1 target
into ResPlex II v2.0 for differential detection of the newly identiﬁed
Inﬂuenza A strain H1N1 primary described in Mexico, 2009.
The aim of this study was to evaluate the performance of the ResPlex
II Plus Panel for differential detection of 19 respiratory viruses.
Method: Analytical speciﬁcations were addressed using pre-character-
ized real virus samples of all 19 respiratory viruses including the newly
identiﬁed H1N1 strain. Eluted nucleic acids were analyzed for the
presence of Inﬂuenza A/B virus, H1N1 2009, PIV-1/2/3/4, RSV-A/B,
hMPV (A, B), Rhinovirus, Coxsackievirus/Echovirus, Adenoviruses (B,
E), Coronaviruses 229E, HKU1, OC43, NL63 and Bocavirus. An internal
control based on an unrelated RNA sequence is part of the panel to
monitor the puriﬁcation process and to proof enzymatic activity. The
overall performance was directly compared to the ResPlex II Panel v2.0.
In addition analytical sensitivity was evaluated for the new target of
ResPlex II Plus, H1-Mexico. Dilution series of viral culture were
generated in order to determine the limit of detection for new H1-Mexico
target. In parallel different Inﬂuenza strains (Flu B, Flu A H3N2) were
tested to prove speciﬁcity for the newly identiﬁed H1N1 strain showing
no cross-reactivity to common Inﬂuenza strains.
Results: Both panel versions showed a high degree of concordant results.
The ResPlex II Plus Panel provides improved performance by extended
panel content for differential detection of the new identiﬁed H1N1 strain.
After extraction of real virus specimens we found overall good
concordance between the ResPlex II v2.0 results and the ResPlex II
Plus results. Discordant results will be listed and discussed.
Conclusion: QIAplex technology combines user friendly handling with
analytical performance needed for the detection of respiratory viruses.
Our work illustrates that the ResPlex II Plus Panel provides excellent
options for parallel detection of 19 different viral nucleic acids including
speciﬁc identiﬁcation of the new H1N1 strain (2009) from respiratory
samples.
*The ResPlex II Plus Panel is intended for research use only. Not for
use in diagnostic procedures.
R2216 Minor genotypes of human papillomavirus can be recovered
by hybrid capture technology according to phylogenetical
afﬁnity
F. Galan-Sanchez, M. Roman-Enri, S. Garcı´a-Valdivia,
M. Rodriguez-Iglesias ° (Cadiz, ES)
Mucosal or genital genotypes of Human Papillomavirus (HPV) can be
classiﬁed as Alphapapillomavirus. In these genera several groups (A5−7,
A9 and A11) are related with oncogenic potential whereas other (A1, A8
and A10) are associated to benign lesions. However, oncogenic and non-
oncogenic groups can be closely related (A9 and A10) due to similarity
in envelope genes. The molecular diagnostic is based in these genes
and then show an analytical inaccuracy with cross-reactivity between
groups. Hybrid capture 2 (hc2) (Qiagen) expresses the results of tested
high-risk (HR) or low-risk (LR) HPV genotypes as positive or negative.
In this work we show signiﬁcant analytical inaccuracy, mainly due to
cross-reactivity with several untargeted HPV genotypes.
We have included 699 cervical specimens obtained from women
undergoing routine gynecological examination and recognized as HPV
positive using the hc2 high- and low-risk probe cocktails. All the
specimens were genotyped using INNO-LiPA HPV (Innogenetics) and
Linear Array HPV (Roche Diagnostics) capable of recognizing 27 and
37 different a-HPV genotypes respectively.
Five-hundred-fourteen samples (77.9%) were correctly identiﬁed with
HR and LR probes. Untargeted genotypes more frequently found were
HPV53 (9.7%), HPV66 (9.4%), HPV61 (4.2%), HPV84 (4.0%) and
HPV54 (3.8%). Other HPV genotypes detected by frequency order were
62, 73, 89, 55, 82, 40, 70, 67, 81, 71, 72, 74, 83, 26, 69, 85 and 64.
The genotypes untargeted more prevalent corresponding to A9 (HPV54),
A8 (HPV40) and A10 (HPV55 y 74) were detected jointly by HR and
LR probes. However A5 (HPV26, 69 and 82), A6 (HPV53 and 66), A7
(HPV70), A11 (HPV64 and 73) and HPV54 were detected only by HR
probes, probably due to A7 (HPV18, 45 and 39), HPV 51 and 56 are
present in the HR cocktail. Interestingly in A3 (not included in hybrid
capture), HPV61, 62, and 89 were detected by HR probe. Also, A15
(low risk genera next to A5) was recognized by HR probes.
We concluded that the low speciﬁcity of hc2 probes, could be useful
for to recover genotypes primarily untargeted. This property can be
very interesting to detect minor genotypes but potentially important in
vaccinated individuals.
R2217 Detection of HSV-1 and HSV-2 from cerebral spinal ﬂuid
and swab specimens using the 3M integrated cycler
Y. Chen, P. Lee, C. Cheng, Y. Parocua, B. Han, R. Martin, M. Exner °
(Cypress, US)
Objectives: Herpes simplex viruses (HSV) can cause severe dissem-
inated infections in neonates and in immunosuppressed patients, with
spread to the central nervous system resulting in potentially fatal cases
of encephalitis and meningitis. Rapid detection of infections is critical
since mortality and morbidity is signiﬁcantly decreased when antiviral
therapy is started early in an infection. In an effort to aid diagnosis,
we developed a rapid molecular test (Simplexa™ HSV-1 and 2 assay),
using the 3M integrated cycler, to detect HSV-1 and 2 in both CSF and
swab specimens. In this study, we sought to determine the sensitivity
and speciﬁcity of this newly developed assay.
Methods: Dilutions of quantiﬁed HSV-1 and 2 virus were used in
analytical studies to determine the limit of detection of the assay.
Analytical speciﬁcity was determined by testing a panel of related
pathogens to determine whether any cross reactivity was observed.
Clinical sensitivity was determined by comparison to an HSV-1 and
2 PCR assay developed in the Focus Diagnostics reference laboratory,
with discordant samples being analyzed by DNA sequencing.
Results: Analytically, the assay was able to detect viruses down to 100
copies/ml, and no cross reactivity was observed with other pathogens.
Method comparison studies showed that this assay is comparable to the
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assay run on an alternate platform, although more rapid throughput could
be achieved using the integrated cycler.
Conclusions:. The Simplexa™ HSV-1 and 2 assay showed excellent
sensitivity and speciﬁcity and appears to be an effective tool for
diagnosing HSV related disease. The small footprint of the 3M integrated
cycler facilitates its placement in a laboratory, and its capacity for rapid
cycling aids in providing expedited diagnostic results, which is beneﬁcial
to disease management.
Molecular typing
R2218 Characterization of endemic Shigella boydii strains in Iran
by serotyping, antimicrobial resistance, plasmid proﬁle,
ribotyping and pulsed-ﬁeld gel electrophoresis
R. Ranjbar °, C. Mammina, M.R. Pourshaﬁe, M.M. Soltan Dallal,
M. Izadi, N. Jonaidi (Tehran, IR; Palermo, IT)
Objective: Shigellosis is one of the major causes of morbidity in
children with diarrhea in Iran. The present study was undertaken to
characterize apparently sporadic Shigella boydii strains isolated from
pediatric patients in Iran and to compare different methods of subtyping.
Methods: Serotyping, antimicrobial susceptibility testing, plasmid
proﬁle analysis, ribotyping and PFGE. have been carried out for typing
of Shigella boydii strains isolated from cases of gastroenteritis and acute
diarrhea in Tehran occurring between December 2002 and November
2003.
Results: Ten out of 302 isolates of Shigella recovered from pediatric
cases were identiﬁed as S. boydii and selected for the study. Seven
isolates were attributed to serotype 2, whereas the remaining three
belonged to serotypes 14, 18, 19, respectively. Six drug resistance
phenotypes (R1 to R6) were deﬁned with R4 − streptomycin, ampicillin,
sulfamethoxazole-trimethoprim − being the most prevalent. Plasmid
analysis resulted in seven different plasmid proﬁles with three to 10
DNA bands. All strains, but one, shared the same ribotype, but PFGE
differentiated them in four groups.
Conclusion: The results indicated that PFGE patterns well corresponded
to serotypes. Antibiotic resistance testing and plasmid proﬁle analysis
appeared to have a good discriminatory power for differentiation of
Iranian strains of S. boydii.
R2219 Evaluation of a PCR-based approach to study the
relatedness among S. sonnei strains isolated in Tehran
N. Sadeghifard, R. Ranjbar °, M.M. Soltan Dallal, M. Izadi, N. Jonaidi
(Ilam, Tehran, IR)
Objectives: Infections caused by Shigella are a major cause of diarrhoeal
disease in the developing and developed countries. The present study
was conducted to apply and evaluate Arbitrarily primed PCR (AP-PCR)
for investigation of genetic relatedness among the strains of S. sonnei
isolated from cases of acute diarrhea occurred in Tehran during 2003.
Methods: A random sample of 60 S. sonnei strains isolated from enteritis
cases in children at ﬁve hospitals in Tehran during 2003 and two sporadic
isolates recovered in 1984 was selected for the investigation. Molecular
typing was performed by AP-PCR. Depending on the number and size of
ampliﬁed DNA bands, the strains were clustered into AP-PCR proﬁles.
Results: All strains of S. sonnei were typeable with this method. AP-
PCR generated nine indistinguishable bands ranged from 0.35 to 2.5
kbp in all the strains under study. Only a single AP-PCR pattern was
observed among the S. sonnei strains recovered in 2003. Two sporadic
isolates recovered in 1984 showed different AP-PCR patterns compared
to recent clinical isolates.
Conclusion: The results suggest that a very homogeneous AP-PCR
cluster types might be responsible for shigellosis caused by S. sonnei
in Tehran in 2003. Further molecular analysis conducted on a larger
selection of isolates could conﬁrm our ﬁndings.
R2220 Genotyping of Chlamydia trachomatis and human papilloma-
virus in clinical specimens from north-eastern Croatia
Z. Bosnjak, D. Pavlinic, M. Peric, N. Ruzman °, S. Dzijan, D. Vukovic,
I. Roksandic-Krizan, J. Burazin, G. Lauc, A. Antolovic Pozgain (Osijek,
HR)
Human papillomavirus (HPV) and Chlamydia trachomatis (Ct) are major
causes of sexually transmitted diseases. Clinical consequences of high-
risk HPV (HR HPV) infection, especially with HPV types HPV 16
and HPV 18, include abnormal Pap test results, low and high-grade
cervical intraepithelial neoplasia and cervical cancer, for which Ct may
sometimes be a cofactor. The aim of the study was to determine the
prevalence of Ct and age-related proﬁles of HR HPV infections among
cases of other sexually transmitted infections in our county.
Due to the chronic and “silent” infection of Ct, fast molecular diagnostics
and adequate therapy of the infected individuals are the crucial steps
in the Ct spread control. During three-year period we tested 2327
genitourinary samples for Ct and 945 gynaecological samples for
HR HPV with normal and abnormal cervical cytological diagnosis.
Subsequently all Ct positive samples were analysed by sequencing of
the ampliﬁed omp1 fragments using Applied Biosystem 3130 Genetic
Analyser. Genotyping and sequence mutation analysis were performed
using ABI SEQSCAPE software and compared with the reference
sequences of all known Ct serotypes. HR HPV positive samples with
abnormal cervical cytological diagnosis were genotyped by Linear Array
HPV Genotyping Test (Roche Diagnostics).
The determined serotype of Ct and HPV genotypes distribution were
compared with the Ct and HPV distribution pattern in other regions of
the world. The association between certain HPV genotype and cervical
intraepithelial neoplasia was determined as well as mixed infections with
four or more HPVs. The most prevalent Ct genotype in Osijek-Baranya
County was serotype E (in concordance with Sweden and Taiwan data),
followed by F, K, G, D, B and J (differs from Sweden and Taiwan
data). The sequence of omp1 gene showed limited variation. HPV 16
and HPV 18 were the most common HR HPV genotypes in the cervical
specimens with abnormal cervical cytological diagnosis. Obtained results
also determined mixed infection of four HR HPV with one or more low
risk HPV.
The obtained results for Ct and HPV and further analyses in this
ongoing project could be useful tool for clinical and epidemiological
characterization of circulating pathogens in our community.
R2221 pmpH real-time PCR assay using LightCycler 480 to
diagnose and sequence Lymphogranuloma venereum
N. Ortiz °, G. Ezpeleta, M. Imaz, V. Esteban, R. Cisterna Cancer
(Bilbao, ES)
Objective: The focus of this study is the identiﬁcation of the
Lymphogranuloma venereum (LGV), by means of LGV-speciﬁc pmpH
real time PCR assay, using LightCycler 480 and sequencing that can
easily identify LGV strains.
Material and Methods: Sixteen clinical samples from different
anatomical sites (cells of cervical, urethral, penis, rectal, and ulcerative
proctitis), sent to the Microbiology’s laboratory of the Basurto Hospital,
Bilbao Spain, were genotyped. The polymorphic membrane protein H
gene (pmpH) was used as the PCR target for the real time PCR assay
based on a unique 36-bp deletion region occurring only among LGV
strain. Two sets of PCR primers were selected to amplify only LGV
serovars: A set (pmpH) to amplify 168-pb DNA fragment and another
(LGV) to amplify 130-pb. The PCR reaction was carried out in a volume
of 20 mL and was performed in a LightCycler 480. The ﬁnal product
was puriﬁed and sequenced using BigDye Terminator V. 3.1 chemistry
according to the kit instructions. Sequencing reactions were puriﬁed
with AutoSeq G-50 and sequenced on an ABI 3130 Genetic Analyzer.
DNA sequences obtained were aligned to obtain full-length sequence
information of each sample and queried against the BLAST database.
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Results: The design of the pmpH real time PCR target with the
LightCycler 480 instrument detected LGV DNA of 3 specimens (3/16;
18.5%). The software checked the speciﬁcity of ampliﬁed products by
melting curve analysis. And shows a dissociation curve for LGV. The
product melts at 86.5. Sequencing showed that the sequences from the
three LGV cases were identical and a Blast search revealed that there
were of the L2b type.
Conclusion: Our results suggest that the pmpH real time PCR can be
used for the sensitive detection of all LGV strains and could prove
useful in the detection of LGV −L2b in clinical specimens. Sequence-
based using LGV speciﬁc pmp H primers can discriminate between LGV
serovars and less invasive C. trachomatis species can help detect cases
and prevent further transmission of LGV.
R2222 Utilization of Raman spectroscopy for the rapid
differentiation of clonal relationships among
Salmonella spp. from human and animal sources
T.R. Fritsche °, R.P. Radcliff, L.C. Ivacic, V.B. Tillema, J.K. Meece,
S.K. Shukla, M.E. Stemper (Marshﬁeld, US)
Objectives: To evaluate the use of Raman spectra (RS) generated
by the SpectraCell RA system (River Diagnostics BV, Rotterdam,
The Netherlands) for subspecies evaluation of outbreak-associated
Salmonella spp. (SS) compared with standard pulsed ﬁeld gel
electrophoresis (PFGE) and serotyping schema. RS reﬂect the overall
molecular constituents of the bacterial sample being studied by laser
interrogation. Rapid and technically simple typing of gastrointestinal
pathogens with a high degree of interlaboratory comparability is needed
to enhance outbreak investigations.
Methods: RS for 31 unique SS isolates from human, animal and food
processing sources representing 16 PFGE clonal groups (deﬁned using
established guidelines) were determined in triplicate. Study isolates were
harvested from overnight growth on tryptic-soy agar plates, suspended
in sterile water, spun down and 3ul of a heavy suspension loaded onto
24-well test slides. Spectral ﬁngerprints were recorded for each specimen
with an average read time of 4−7 minutes. Analysis of RS was performed
using a squared Pearson correlation coefﬁcient of 0.9996 and compared
with results for PFGE and traditional serotyping.
Results: RS of the tested outbreak isolates displayed 11 clusters
compared with the 16 clusters identiﬁed by PFGE. Multiple PFGE
clusters found within a smaller number of RS clusters in most all cases
comprised the predominant PFGE type and related subtypes (A, A1; B,
B2, B3; F, F1; C, C1, C2). Among the 16 PFGE clusters, 80 of 83
(96.4%) replicates were concordant within their respective RS clusters.
Serotyping was less discriminatory than either RA or PFGE, with certain
serotypes (e.g., S. enterica sv Montevideo, S. enterica sv Typhi Ty2,
S. typhimurium LT2) occurring among multiple PFGE and RS clusters
(2 and 3; 3 and 4; 5 and 4, respectively).
Conclusions: Epidemiological monitoring using RS as determined
by the SpectraCell RA system was extremely rapid and technically
unambiguous when testing SS outbreak specimens. Results were largely
concordant with PFGE, highly reproducible and with the potential for
>70 isolates to be processed in one working shift.
Molecular biology − others
R2223 Effect of culture medium and environmental factors in
the patterns of outer membrane proteins expression of
multi-resistant clinical isolates of E. coli
B. Ruiz del Castillo °, E. Roma´n-Paucar, L. Martı´nez-Martı´nez
(Santander, ES)
Background: Current models of outer membrane proteins (OMP)
expression and regulation in E. coli are mainly derived from the K12
strain. Preliminary information suggests that this may not apply to
clinical isolates. This may difﬁcult our understanding of the importance
of OMP in antibiotic resistance and other relevant issues. The aim of
this study was to compare OMP patterns of multiresistant E. coli and of
E. coli K12 grown in different environmental conditions.
Methods: Clonally-unrelated (as deﬁned by Rep-PCR/PFGE) multirre-
sistant E. coli cultured from diferent patients, producing (n = 48) or not
(n = 64) extended-sprectrum b-lactamases (ESBL) were studied. E. coli
K12 (EcK12, strain MKW505) was used as a control. OMPs were
obtained from sonicated cells treated with sarcosyl, concentrated by
centrifugation and separated in SDS-PAGE (running gels with 12%
poliacrilamide and 6M urea). All 112 isolates were grown overnight
at 37ºC in Mueller-Hinton broth (MH) or in Nutrient broth (NB). Six
isolates representative of the more frequent patterns were selected for
additional studies, evaluating OMP expresion in different conditions
of osmolarity (bacteria grown in NB alone or NB plus 20% sorbitol),
temperature (cultures incubated in NB or MH at 30ºC, 25ºC or 41ºC)
and pH (isolates grown in NB or MH adjusted to 8.5, 7.2, 5.5 or 5.0).
Results: SDS-PAGE showed 11 and 8 different OMP patterns in clinical
isolates of multirresistant E. coli producing or not ESBLs, respectively.
In most cases no differences were observed when isolates had grown
in MH or in NB, in contrast to the results observed in EcK12, were
OmpF expression was downregulated in MH. OMP patterns from clinical
isolates grown in NB-20% sorbitol were not different of those from
bacteria grown in NB alone, while OmpF downregulation was noted
for EcK12 in the high osmolarity medium. Incubation at 41ºC caused
decreased expression of OmpC in some (4/6) organisms (not including
EcK12 when OmpF expression is affected) grown in MH, but no
signiﬁcant changes were observed at 30ºC or 25ºC. Variations in the
expression of OmpF were also observed when organisms were grown in
media with pH of 5.5 or 5.0.
Conclusions: OMP expression patterns in clinical isolates of multirre-
sistant E. coli are usually different of the pattern observed in E. coli
K12. In the clinical isolates we have studied, osmolarity changes do not
signiﬁcantly affect OMP expression, while high temperature and low pH
affect OmpC and OmpF expression, respectively.
Diagnostic/laboratory methods (other than
molecular)
R2224 A study of various commercially available transport swabs
for the recovery of fastidious organisms
D. Williams ° (Leicester, UK)
Objectives: The Sigma Transwab ® is a liquid medium transport swab
and uses 1ml of Liquid Amies Transport medium, which is based on
the original formulation of Amies, but without the charcoal and is
intended for processing by some of the new automated plating systems.
The swab is foam tipped which allows the ﬂow through of the liquid
medium, reagents and microorganisms, thus increasing the sensitivity
and recovery of organisms. The preliminary study used the principles of
CLSI’s M40-A standard, inoculating the swabs with speciﬁed dilutions
of target organisms, and holding at either room temperature or 40C. For
the preliminary study the organisms used were: Staphylococcus aureus,
Haemophilus inﬂuenzae, b Haemolytic Streptococcus. Fresh overnight
cultures were used in each case. The organisms were from Clinical
specimens not NCTC or ATCC organisms.
Method: A McFarland standard 0.5 was made in sterile 0.85% saline
from a fresh overnight culture of each of the organisms used.
Tenfold dilutions were made for the viability studies from the 0.5
McFarland’s standard.100ul of these dilutions were lawned on to the
appropriate agar plate to ensure the organism was viable from the saline
dilution and used as the Growth Control. The 105, 106 and 107 cfu/ml
dilutions were used to inoculate the swabs with 100ul (0.1ml) using
3× 1/2 tubes. The swab was placed in the 100ml inoculum for 10
seconds and then returned to the transport media. Swabs were kept
at room temperature and at 4 0C for the following holding times.
5−15 minutes (Zero Time), 4 hours, 24 hours, 48 hours, and 72 hours.
Each set of dilutions were performed in duplicate. On completion
of the holding time, the swab inoculated on to a plate appropriate
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to the organism (Blood agar, Chocolate blood agar) in a lawn and
incubated in the appropriate atmosphere − Aerobically at 370 C for
Staphylococcus aureus and b haemolytic streptococcus, and CO2 at 370
C for Haemophilus inﬂuenzae. The plates read and colonies counted
manually at 24 and 48 hours.
Results and Conclusion: The initial results showed that recovery was
seen for all the organism/dilution/temperature combinations at 24 hours,
and for most at 48 hours, and that Sigma Transwab ® would be a suitable
transport device for these organisms. Further studies will be done and
data presented for other organisms using more fastidious organisms, and
a comparison of results obtained with standard transport swab devices
(Eurotubo, Spain and Technical Service Consultants, UK).
R2225 Evaluation of frequency of anti-Babesia microti antibodies
in serum of forest workers − a preliminary study
S. Pancewicz, A. Moniuszko °, M. Kondrusik, S. Grygorczuk,
P. Czupryna, R. Swierzbinska-Pijanowska, J. Zajkowska (Bialystok, PL)
Babesiosis is a tick-borne disease caused by Babesia bovis, Babesia
divergens, Babesia equi and Babesia microti. Increase in babesiosis
incidence in USA and Europe is considered to be correlated with
increasing Lyme disease incidence. Pathogenesis and clinical symptoms
of babesiosis are still not well known.
Objective: The objective of our study was to measure frequency of
presence of anti-Babesia microti antibodies in serum of people exposed
to tick bite.
Method: Study group consisted of 114 foresters (95 men, 19 women)
working in area of Bialowieza parish in north-eastern Poland and in
The Swietokrzyski National Park in central Poland, in whom IgM and
IgG anti-Babesia microti antibodies were detected by immunoﬂuorescent
method. (Babesia microti IgG IFA kit Fuller Laboratories Fullerton
Kalifornia USA). Results were analyzed statistically with Statistica 6.0
PL9 software (p< 0.05 was considered statistically signiﬁcant). In the
same group, antibodies against Borrelia burgdorferi were searched for
with two-step procedure (ELISA and Western-blot) and found in 51
foresters (44.7%) (IgM in 28 and IgG in 33).
Results: Anti-Babesia microti IgG antibodies were found in only 4 forest
workers (3.5%) in the analyzed group. In no case IgM class antibodies
were found. Anti-Babesia microti antibodies were found only in patients
with detectable anti-Borrelia burgdorferi antibodies.
Conclusion: Foresters, who are at high risk of repeated tick bites, may
be asymptomatically infected with Babesia microti.
R2226 Technical and diagnostic performance of ﬁve commercial
anti-diphtheria toxoid IgG ELISA kits
A. Faruq, H. Cox, F. Alcock, L. Dadson, A.R. Parker ° (Birmingham, UK)
Objectives: Accurate measurement of anti-diphtheria toxoid IgG levels
is of immense value in (a) determining the rates of immunity within
broad populations and therefore the immune status of individuals who
may be at risk of infection especially as immunity can decrease over
time in the absence of a booster; (b) in assessing immunisation schedule
efﬁcacy and; (c) in assessing the immune response to vaccination as
part of the diagnostic protocol for primary immunodeﬁciency disorders.
Five commercially available ELISA kits for the measurement of anti-
diphtheria toxoid IgG antibodies were evaluated for performance.
Methods: ELISA kits, manufactured by Euroimmun, Scimedx, Serion,
Binding Site and Virotech were evaluated for intra- and inter-precision,
recovery of the NIBSC 00/496 international reference material and
measurement of titres in pre- and post-vaccination samples.
Results: The imprecision of the ﬁve assays ranged from 0.7% to 27.4%
for intra-assay and 4.9% to 26.6% for inter-assay. Recovery of the NIBSC
international reference (00/496) across the kit speciﬁc calibration curves
varied from 66.1% to 114.7% across the ﬁve assays. Evaluation of nor-
mal sera samples showed a signiﬁcant difference existed between mean
values obtained in the ﬁve assays. The accuracy and interpretation of the
pre- and post-vaccination measurements differed among the ﬁve assays.
Conclusion: The data suggests that there are manufacture dependent
characteristics which can affect the performance of the assays and may
result in differing clinical and diagnostic interpretations.
R2227 Comparative studies for the serodiagnosis of Chlamydophila
and Mycoplasma pneumoniae infections
P. Huynen °, M.R. Goebel, C. Meex, P. Melin, M.P. Hayette, P. De
Mol (Lie`ge, BE)
Mycoplasma pneumoniae and Chlamydophila pneumoniae have world-
wide distribution and infect the upper and lower respiratory tract.
Serology is still the most widely used method to diagnose both infections,
even if its interpretation is difﬁcult.
Objectives: M. and C. pneumoniae serology testing is currently
carried out in our institute by microplate analyzer (ETI-Max® 3000,
DiaSorin), used together with Virion M. pneumoniae antibodies assays
using native antigens, as well as with Medac total Chlamydia and
C. pneumoniae antibodies assays. The objectives of this study are
to evaluate Mycoplasma antibody kits using recombinant antigens to
improve speciﬁcity of results, and to review our current algorithm for
Chlamydia serology.
Methods: One hundred and ﬁfteen sera were tested with M. pneumoniae
antibody kits from Virion, Medac, Savyon and AniLabsystems.
Hemagglutination assay was used as reference method to conﬁrm
discordant results. Sixty-one sera from 52 patients, including 15 with
documented respiratory infection, were tested with C. pneumoniae IgA
and IgG kits from Medac, Savyon and Euroimmun. MIF was used as
reference method to conﬁrm discordant results.
Results: Agreement for at least 3 results or conﬁrmation with
hemagglutination assay established reliable diagnosis. Sensitivity was
100%, 100%, 90% and 90% and speciﬁcity was 92%, 96%, 100%
and 96% for M. pneumoniae IgM from Virion, Medac, Savyon, and
AniLabsystems kits respectively. Medac and Savyon M. pneumoniae IgG
kits discriminated healthy from sick patients better than did Virion kit;
agreement between Medac and Savyon was 89.5%, 91.4% and 81.9%
for IgM, IgA and IgG respectively. Sensitivity of Medac, Savyon and
Euroimmun C. pneumoniae IgA was 92%, 100%, 59%; accuracy, using
MIF as reference test, was 90%, 94% and 67% respectively. Agreement
between Medac and Savyon was 93.1%. Sensitivity of Medac, Savyon
and Euroimmun for C. pneumoniae IgG was 100%, 100% and 80%;
accuracy was 97%, 87% and 77% respectively.
Conclusion: Savyon M. pneumoniae kits show less or no threshold
results compared with the 3 other methods. The IgG assay discriminates
sick from healthy patients well, with good correlation with the Medac
kit. To facilitate interpretation of the results, we decided to perform
C. pneumoniae Savyon IgA kit, well correlated with MIF, while Medac
C. pneumoniae IgG kit was preferred because of better speciﬁcity and
quantitative determination.
R2228 Initial MIC and disc diffusion quality control ranges for BC-
3781 using the CLSI Multi-Laboratory M23-A3 study design
J. Ross, R. Jones °, Z. Ivezic-Schoenfeld, S. Paukner, R. Novak,
S. Putnam, H. Sader (North Liberty, US; Vienna, AT)
Objectives: To establish the disk diffusion (DD) and MIC quality
control (QC) ranges for BC-3205, a novel semi-synthetic pleuromutilin
derivative in the early stage clinical development for oral treatment of
skin and skin structure infections (SSSI).
Methods: These QC studies for the 20-mcg BC-3205 disk and broth
microdilution method follow the CLSI M02-A10 (2009), M07-A8 (2009)
and M23-A3 (2008) document using eight laboratories, two lots of BC-
3205 disks, three or more different medium lots. The results are presented
as proposed QC ranges for four ATCC strains: S. aureus ATCC 25923,
H. inﬂuenzae ATCC 49247, S. pneumoniae ATCC 49619 and S. aureus
ATCC 29213 (MIC only). BC-3205 DD and MIC QC ranges were
established per a CLSI M23-A3 study design. Ten replicates with each
of 3 QC strains produced 1,440 zone diameters for two disk lots of
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BC-3205 (20-mcg disk) provided by the Mast Group. Clindamycin (CL;
2-mcg disk), azithromycin (AZ; 15-mcg disk) and linezolid (LZ; 30-mcg
disk) were utilized as control agents for DD, while retapamulin, AZ and
levoﬂoxacin were the control agents for MIC testing.
Results: Proposed QC ranges are listed in the Table. No signiﬁcant
differences (>1mm) were noted between media or disk lots when testing
either BC-3205 or control agents. S. aureus ATCC 25923 produced larger
variations between laboratories with the most extreme laboratory modes
having a 7mm difference. One laboratory submitted signiﬁcantly larger
zone diameters for H. inﬂuenzae ATCC 49247 and was excluded from
evaluation leaving seven laboratories for a valid CLSI QC study. MIC
values for H. inﬂuenzae 49247 showed trailing endpoints of at least
one dilution step. One laboratory was excluded from analysis due to
outlier values. A 7mm zone diameter is proposed for S. pneumoniae
ATCC 49619 which includes 99.7% of all results. Excluding one aberrant
laboratory from the MIC testing analysis produced all seven participant
results within the proposed 0.06–0.25mg/L range. All but one MIC result
for the control agents were within expected ranges, when applicable. The
control disks (LZ, AZ, CL) provided a valid internal control for the study,
with 97.7 to 100.0% of zones within CLSI published QC ranges.
Conclusions: An acceptable QC range was established for the four QC
organisms that will guide clinical and reference laboratories involved in
clinical trials and facilitate the regulatory review process of BC-3205.
QC organism MIC/Disk diffusion zone diameters for BC-3781:
Proposed range % in range
MIC (mg/L) Zone diameter (mm)
H. inﬂuenzae ATCC 49247 0.5−2 22−28 88.0 / 91.5 (94.3 / 99.8)a
S. aureus ATCC 25923 NA 25−33 − / 97.3
S. aureus ATCC 29213 0.06−0.25 NA 100.0 / −
S. pneumoniae ATCC 49619 0.06−0.5 20−26 98.6a /96.0
aOne laboratory was excluded from analysis, H. inﬂuenzae QC range for MIC tests was not acceptable. NA = Not
applicable.
R2229 Evaluation of four chromogenic media for the presumptive
identiﬁcation and differentiation of yeasts
M. Doluca Yu¨cesoy °, M.C. Ergon, S. Gu¨lat (Izmir, TR)
Objectives: Several commercial chromogenic media have been de-
veloped for species identiﬁcation of clinical yeasts. In this compar-
ative study, four chromogenic media, CHROMagar Candida (CAC)
(CHROMagar, France), Albicans ID2 agar (AID) (bioMe´rieux, France),
Candiselect medium (CS) (Biorad, France) and chromID Candida
Agar (CAN2) (bioMe´rieux, France) were evaluated for the presumptive
identiﬁcation of yeasts.
Methods: Totally 125 clinical yeast isolates, 62 Candida albicans,
18 C. tropicalis, 17 C. glabrata, 13 C. parapsilosis, ﬁve C. krusei,
ﬁve Trichosporon spp., three C. kefyr, one C. guilliermondii and one
Geotrichum candidum were included in the study. The isolates were
identiﬁed by germ tube test, morphological characteristics on corn meal
tween 80 agar and API 20 C AUX system. The isolates were cultured to
Sabouraud dextrose agar from stock cultures and after 48 hours streaked
onto CAC, AID, CS and CAN2 plates. The plates were evaluated by
considering the colour, texture of the colonies and the existence of halo
around the colony by three different people after 24, 48 and 72 hours of
incubation at 37ºC in the dark.
Results: All of the isolates grew well on the four media tested. The
sensitivity and speciﬁcity values for C. albicans were detected as 100%
and 100% for CAC; 98.4–100% and 96.8–100% for AID; 96.8–100%
and 96.8% for CS; 98.4% and 96.8 for CAN2 at different incubation
periods, respectively. These values for C. tropicalis were 94.4–100%
and 100% for CAC; 83.3–94.4% and 96.3–98.1% for CS, respectively.
CAC was found to be 11.8–88.2% sensitive and 100.0% speciﬁc for
C. glabrata; 100% and 92.2% sensitive and speciﬁc for C. krusei. The
sensitivity and speciﬁcity for C. tropicalis and C. kefyr were able to be
calculated together as these species grow by forming the same colour on
CAN2 and these values were found to be 90.5% and 99.9%, respectively.
Conclusion: In our study, CAC, AID, CS and CAN2 plates showed
similar performances with respect to C. albicans identiﬁcation and CAC
and CS to C. tropicalis. As a result, CAC can be recommended as a
reliable medium for the presumptive identiﬁcation of Candida species
as it can differentiate four species, C. albicans, C. tropicalis, C. glabrata
and C. krusei successfully.
R2230 Incubation of fungal cultures: how long is long enough?
P.P. Bosshard ° (Zurich, CH)
Objective: Fungal cultures are traditionally incubated for 4 weeks or
longer in order to maximize recovery of slowly growing fungi. However,
the data in support of this is scarce. The purpose of this study was to
determine the optimum incubation time for specimens in which moulds
or yeasts are suspected.
Methods: 2216 dermatological and 820 non-dermatological specimens
were prospectively analyzed. The day on which fungal growth was ﬁrst
noted, was recorded.
Results: Of a total of 1172 fungal isolates, 826 (70.5%) were detected
by day 7, 1108 (94.5%) were detected by day 14, and 1165 (99.4%) were
detected by day 21. Ten non-dermatological specimens were positive in
the third week; all grew a fungus which was considered clinically non-
relevant.
Conclusion: The results indicate that for specimens sent for detection of
yeasts or moulds (except dermatophytes and systemic dimorphic fungi)
an incubation period of 2 weeks is sufﬁcient, whereas for dermatophytes
4 weeks are necessary. Based of these results and previous literature an
algorithm for the incubation time of fungal cultures is proposed.
Table 1. Fungi isolated and time to detection
Species No. isolated No. detected by week
1 2 3 4
Candida spp. 424 392 25 7 −
Cryptococcus spp. 4 3 − − 1
Yeasts, others 56 30 19 5 2
Aspergillus spp. 121 88 28 5 −
Moulds, others 348 217 104 26 1
Dermatophytes 216 94 105 14 3
Dimorphic fungi 3 2 1 − −
Total 1172 826 282 57 7
R2231 Identiﬁcation of Streptococcus agalactiae and investigation
of intra-species variability using MALDI-TOF MS proﬁling
M.F. Lartigue °, M. Kostrzewa, M. Salloum, G. He´ry-Arnaud,
E. Haguenoer, A.S. Domelier, P.O. Schmit, N. Van der Mee, P. Lanotte,
L. Merghetti, R. Quentin (Tours, FR; Bremen, DE; Wissembourg, FR)
Objectives: Streptococcus agalactiae is the main cause of neonatal
infections and an increasingly frequent pathogen also in non-pregnant
humans. A large number of different Sequence Types (STs) distributed
over several major phylogenetic lineages or clonal complexes (CC) have
been identiﬁed by multilocus sequence typing (MLST). STs 17 and 19
account for the majority of cases of S. agalactiae meningitis in infants
while CCs 1, 12, 17, 19 and 23 are mostly associated with infections in
adults. The presented study intends to investigate if MALDI-TOF mass
spectrometry proﬁling (i) is suited for secure species identiﬁcation of
S. agalactiae and (ii) can also be used for analysis on the subspecies
level.
Methods: 197 S. agalactiae strains characterized by MLST were
analysed by MALDI-TOF mass spectrometry. Data processing was
performed using the MALDI Biotyper 2.0 software (Bruker Daltonics,
Germany). Mass spectra of each strain were compared with the mass
spectra stored in the MALDI Biotyper database. To improve the
database, new entries from different clonal complexes were created and
introduced into the library. Further, to investigate subspecies variability,
the spectra sets of isolates from different STs were investigated using
the ClinProTools 2.0 and FlexAnalysis 3.0 (Bruker Daltonics, Germany)
software to ﬁnd characteristic markers for the different subtypes.
Diagnostic/laboratory methods (other than molecular) S667
Results: MALDI-TOF MS correctly identiﬁed all the 110 S. agalactiae
isolates of a ﬁrst set at the species level with good [log(score) >2.0]
to very good [log(score) >2.3] conﬁdence. By introducing further
references into the database characteristic for the major sequence types
(ST1, ST10, ST17, ST19, and ST23), the identiﬁcation results could
be further improved [about 99% log(score) >2.3]. A second set of 87
S. agalactiae strains were identiﬁed at the species level with a very good
log(score). Investigation of mass spectra from different STs revealed
markers characteristic for two STs (ST1 and ST17, respectively) but
also some minor variability inside the groups.
Conclusion: MALDI-TOF MS proﬁle analysis is a very reliable tool
for species identiﬁcation of S. agalactiae but it also has a signiﬁcant
capability for subspecies identiﬁcation. To evaluate the full potential of
this, further studies will be necessary.
R2232 Seroprevalence and seasonal variation of Chlamydia pneu-
moniae and Mycoplasma pneumoniae infection in Germany
M. Boettcher °, U. Weber, O. Baetz, J. Kramer, M. Hempel, S. Dettlaff,
N. Wellinghausen (Wedel, Ravensburg, Geesthacht, Goettingen, DE)
Objective: Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae
(MP) cause respiratory tract infections including community-acquired
pneumonia in children and adults. Despite the availability of molecular
diagnostic methods, detection of antibodies against CP and MP is
a mainstay of diagnosis, especially in outpatients. We performed a
laboratory-based multicenter surveillance in Germany to determine the
prevalence of antibodies against CP and MP, detect seasonal variations,
and age-dependent differences in seroprevalence.
Materials and Methods: Results of IgM, IgA, and IgG antibodies
against CP and MP, determined by ELISA (medac, Wedel, Germany)
were evaluated in 16,039 patients (55% female, 45% male, 0−96 years)
in three medical laboratories located in North and South Germany. All
serum samples submitted to the laboratories for CP and MP serology
between June 2008 and May 2009 were included.
Results: The total seroprevalence indicating infection with CP and
MP was 68% and 31%, respectively. The prevalence of CP infection
increased with the age of patients (up to 85% above 90 years). Acute
CP infection was determined in 9% of all patients respectively 13% of
the seropositive patients and occurred predominantly in the age group of
1−10 years. Seroprevalence of acute infection showed peak rates between
September and December. In contrast, past CP infection (52%) and
current but inconspicuous ﬁndings (35%) in seropositive patients did
not show seasonal variation. The prevalence of MP infection increased
up to 50% between 16 and 30 years and declined with increasing age.
Acute MP infection was determined in 4% of all patients respectively
12% of seropositive patients and occurred predominantly in the age
group of 1−10 years. Seroprevalence of acute infection showed peak
rates between November and December. Past MP infection was found
in 75% and current ﬁndings in 13% of seropositive patients without
seasonal variation. Serological evidence of acute coinfection with CP
and MP occurred in less than 1% of patients.
Conclusion: According to our serological data, acute infection by CP
and MP both occur all-season with a predilection in winter period.
The prevalence of CP infections is increasing with age. In contrast MP
infections decline in older population. The prevalence of acute CP and
MP infections in our surveillance is comparable to results of international
studies.
R2233 Detection of IgG antibodies to herpes simplex virus
type 1 and 2 in various HIV-positive African populations
by the BioPlex 2200 multiplexing immunoassay platform
J. Le Goff, G. Gre´senguet, C. Gody, L. Be´lec ° (Paris, FR; Bangui, CF)
Objectives: The performances of commercial immunoassays in detecting
herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2) antibodies have
been seemingly inconsistent for African and HIV-infected populations.
We herein evaluated the new BioPlex 2200 immunoassay system (Bio-
Rad Laboratories, CA, USA) to detect herpes-speciﬁc antibodies.
Methods: Sera were obtained after informed consent from HIV-1-
positive patients followed in health care clinics of Bangui, the capital
city of the Central African Republic, a country of high prevalences
for HIV-1, HSV-1 and HSV-2 infections, including: (i) 51 adults
clinically asymptomatic for herpes disease; (ii) 220 children born
from HIV-infected mother clinically asymptomatic for herpes disease;
(iii) 220 patients suffering from HSV-2 PCR-proven genital ulcer
(recurrences); and (iv) 25 patients suffering from HSV-2 PCR-proven
primary genital ulcer. All sera were tested for HSV-1 and HSV-2 speciﬁc
antibodies by the fully automated bead-based multiplexing immunoassay
BioPlex 2200 system.
Results: Among adults clinically asymptomatic for herpes disease,
90.2% and 45.1% were seropositive for HSV-1 and HSV-2, respectively.
Among children clinically asymptomatic for herpes disease, 81.3% and
only 5% were seropositive for HSV-1 and HSV-2, respectively. These
observations are consistent with the natural history of HSV-1 and HSV-2
infections in sub-Saharan Africa, demonstrating early acquisition of
HSV-1 in children, whereas HSV-2 infection appears largely acquired
in later age of sexual life. Among patients suffering from HSV-2 genital
recurrences, 95.9% were seropositive for HSV-2. Finally, among patients
suffering from HSV-2 primary genital ulcer, 24.0% were seropositive for
HSV-2 at inclusion. Thus, HSV-2 seropositivity appears highly sensitive
to predict HSV-2 recurrency in patients with clinically symptomatic
genital ulcer, and may also be found very early in seroconverting
patients with HSV-2 primary genital ulcer. Comparisons of BioPlex 2200
results with those obtained by conventional HerpesSelect glycoprotein
G2 immunoassay will be discussed.
Conclusion: The BioPlex 2200 immunoassay system provides a useful
tool for HSV type-speciﬁc serology to be used in clinical care of
African patients suffering from herpectic genital disorders, as well as
in intervention studies in the ﬁeld conceived to control genital HSV-2
infection representing the main modulatory co-factor of heterosexual
HIV transmission in sub-Saharan Africa.
R2234 Evaluation of modular CMV IgG and IgM assay on
challenging patient samples
E. Verhoye, K. Van Vaerenbergh, H. De Beenhouwer °, A. Boel (Aalst, BE)
Objectives: Automated assays for cytomegalovirus (CMV) IgG and IgM
determination in serum and/or plasma have been developed by several
companies. The purpose of this study was to compare the performance
of the Roche CMV IgG and IgM immunoassays with the Beckman
Coulter, bioMe´rieux and Siemens assays using speciﬁcally selected
patient samples. We focused on sample results in the intermediate range
(grey zone) as determined by Vidas.
Methods: CMV IgG and IgM determination was performed on Access
(Beckman coulter), Immulite (Siemens), Modular (Roche) and Vidas
(bioMe´rieux) using 71 patient sera. We selected similar quantities of
sera in the negative, the doubtful, the weakly positive (deﬁned as
positive <2× cut-off) and positive reference interval, determined by
our routine method (Vidas). Relative agreement was calculated as the
number of concordant samples/number of all tested samples (grey zone
results considered as positive). The correlation between positive sera was
calculated as number of concordant positive samples/number of samples
tested positive by one method (grey zone results not taken into account).
Results: The relative agreement (%) for CMV IgG/IgM between
Modular on one hand and Access or Immulite or Vidas on the
other hand was respectively 94/83, 79/68 and 91/79. The correlation
(%)between positive sera for IgG/IgM between Modular and Access
or Immulite or Vidas was respectively 94/81, 76/61 and 88/87. For
both assays, 79% of positive samples on Modular were positive with
all methods. For IgG/IgM respectively 0/0, 3/5, 1/0 and 9/5 samples
were exclusively reactive on Access, Immulite, Modular and Vidas. For
IgG/IgM respectively 2/3, 7/4, 2/6 and 1/0 samples were exclusively
negative on Access, Immulite, Modular and Vidas. From the selected 28
samples with doubtful or weakly positive result on Vidas, respectively
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6, 3 and 5 remained doubtful or weakly positive for Access, Immulite
and Modular (table 1).
Conclusion: Using selected patient samples, based on Vidas results, the
relative agreement for both IgG and IgM assays is the greatest between
Modular and Access. The amount of results in the grey zone is similar
for Access, Immulite and Modular. The limited amount of sera that are
exclusively reactive on Modular supports a good speciﬁcity, similar to
the Access.
Table 1. Overview of results of CMV IgG and IgM determinations
of 71 selected patient samples by Roche (Modular), Beckman
Coulter (Access), Siemens (Immulite) and bioMe´rieux (Vidas)
CMV IgG (U/ml)
Modular Access Immulite Vidas
<11 11–<15 15–<30 30 <0.9 0.9−<1.0 1.0–<2.0 2.0 <4 4–<6 6–<12 12
<0.5 17 1 0 1 14 1 3 1 8 6 5 0 19
0.5−1.0 3 0 1 0 2 0 1 1 1 1 2 0 4
1.0–<2.0 1 0 1 0 1 0 0 1 0 2 0 0 2
2.0 1 2 3 40 7 1 6 32 1 2 10 33 46
22 3 5 41 24 2 10 35 10 11 17 33 71
CMV IgM (cut-off index)
Modular Access Immulite Vidas
<0.8 0.8−<1.0 1.0–<2.0 2.0 <0.9 0.9−<1.0 1.0–<2.0 2.0 <0.7 0.7−<0.9 0.9–<1.8 1.8
<0.7 28 4 2 1 21 2 4 8 20 11 2 2 35
0.7−<1.0 2 1 3 1 2 0 2 3 0 1 3 3 7
1.0–<2.0 2 1 0 5 2 0 0 6 0 3 1 4 8
2.0 1 0 3 17 2 0 3 16 0 0 7 14 21
33 6 8 24 27 2 9 33 20 15 13 23 71
R2235 Comparative study between three automated immunoassays,
the new Vidas, and Liaison tests for the detection of EBV
antibodies
S. Gonzalo °, S. Tronchet, C. Bena (Lyon, FR)
Objectives: The aim of the study was to compare the new VIDAS tests
for the detection of VCA / EA IgG, VCA IgM, and EBNA IgG antibodies
with the IMMULITE and LIAISON tests on characterized samples, in
terms of sensitivity, speciﬁcity and concordance with the patient clinical
status.
We also evaluated the three techniques on 7 seroconversion panels.
Methods: 286 retrospective samples from outpatients were tested with
the 3 methods. The sample status was determined according to the
Bioplex 2200 reagent (Biorad) routinely used in our laboratory. The
samples consisted of 95 acute infections (AI), 97 negative patients (Neg)
and 94 past infections (PI). Seven seroconversion panels characterized
by Enzygnost EBV IgG/IgM and BMD EBNA IgG reagents were tested
with the 3 methods.
Results: The sensitivity obtained on AI for VIDAS VCA IgM,
IMMULITE VCA IgM and LIAISON VCA IgM was 100%, 74.2% and
100% respectively; the speciﬁcity on Neg was 100% for all reagents,
and the speciﬁcity on PI was 94.4%, 96.7% and 96.6% respectively.
The sensitivity on PI for VIDAS VCA IgG, IMMULITE VCA IgG
and LIAISON VCA IgG was 98.9%, 97.9%, 98.9%. Concerning primo-
infections, among 95 samples, only 38 samples were detected VCA/EA
IgG >0 with the Bioplex technique considered as the reference method.
Therefore, reporting VCA IgG relative sensitivity results was not
considered. The speciﬁcity was 100% on Neg for VIDAS and LIAISON
and 93.75% for IMMULITE. The sensitivity on PI for VIDAS EBNA
IgG, IMMULITE EBNA IgG and LIAISON EBNA IgG was 98.9%,
100%, 100% respectively, the speciﬁcity on Neg was 100%, 97.9% and
98.9% respectively, and the speciﬁcity on AI was 95.6%, 91.4% and
98.7% respectively.
Concordance to clinical status is as follows:
VIDAS EBV: 100% on Neg, 100% on AI and 98.8% on PI.
IMMULITE EBV: 94.7% on Neg, 75.9% on AI and 97.7% on PI.
LIAISON EBV: 100% on Neg, 100% on AI and 100% on PI.
The seroconversion panels did not show any delay in IgM detection with
the 3 methods compared with the reference method.
Conclusion: VIDAS and LIAISON showed good performance in terms
of sensitivity and speciﬁcity. Concordance with the reference status was
highly acceptable.
IMMULITE showed poor VCA IgM sensitivity and EBNA IgG
speciﬁcity results in the primary infections group, leading to poor
concordance with the reference status. A high number of equivocal
results were obtained with LIAISON EBNA IgG. In conclusion, VIDAS
appears to be a very reliable automated method for EBV serology.
R2236 Comparison of two rapid assays used for the diagnosis of
Clostridium difﬁcile infections
S. Garcia-Bujalance °, A. Garcia-Arias, A. Rico, J.R. Pan˜o,
J. Mingorance, A. Gutierrez (Madrid, ES)
Introduction: The rapid detection of toxin-producing strains of
Clostridium difﬁcile is very important for management of infected
patients. The rapid test that detect toxin A+B are a alternative to
convencional culture. Recently, a rapid membrane enzyme immunoassay
has been developed for the simultaneous detection of toxins A+B and
glutamate dehydrogenase antigen (GDH), a C. difﬁcile speciﬁc enzyme.
Objectives: The aim of this study was to compare a new rapid membrane
enzyme immunoassay (method 1) and an immunochromatographic assay
(method 2) for the diagnosis of Clostridium difﬁcile infection from
clinical specimens. The samples with discordant results between both
assays were analyzed by a third method, a commercial real time PCR
technique that detects toxin B gene.
Material and Methods: 92 stool samples from patients with diarrhea
were analyzed between January 2008 and March 2008 for diagnosis of
Clostridium difﬁcile infections (CDI) in the routine laboratory practice.
The samples were studied for TechLab C. Diff Quik Chek Complete™
test (method 1) and Remel X/pect Toxin A/B immunochromatographic
assay (method 2) according to the manufacter’s instructions. The Xpert™
C. difﬁcile assay, performed on the Cepheid GeneXpert DX System is a
multiplex real-time PCR assay for detection of genes for Toxin B (tcdB),
Binary Toxin (cdt) and tcdC gene delection nt 117 in less than 1 hour.
The system requires the use of single-use disposable cartridge that hosts
the processes of DNA extraction and PCR.
Results: 76 samples were negative with both methods, 3 samples were
positive with both methods and 12 samples were negative with method 2
and positive with method 1 (8 GDH(+) with toxAB(+) and 5 GDH(+)
with toxAB(−)). In the 12 discordant results, the PCR assay detected
Toxin B gene and the patients were diagnosed of Clostridium difﬁcile
infection in conjunction with the patient clinical history. The incidence
of CDI using method 1 was 16% (15 of 92) and 3.2% (3 of 92)
using the method 2. Comparison between the two methods was done
using McNemar’s test with the continuity correction (p = 0.0015). The
difference was found to be very statistically signiﬁcant.
Conclusions: The TechLab C. Diff Quik Chek Complete™ test detected
more positive results for diagnosis of C. difﬁcile infection than the X/pect
Toxin A/B immunochromatographic assay. These results were conﬁrmed
by real time PCR.
R2237 Development and qualiﬁcation of an immunodiagnostic
assay for the detection of 13 Streptococcus pneumoniae
serotype-speciﬁc polysaccharides in human urine
M. Pride °, P. Wong, C. Tinder, K. Wu, E. Song, V. Souza, S. Passador,
R. Menton, M. Bonten, S. Huijts, K. Jansen (Pearl River, US; Utrecht, NL)
Objectives: To improve detection rates of pneumococcal infection we
developed a sensitive multiplex assay that can identify 13 serotype-
speciﬁc S. pneumococcal polysaccharides (PnPs: 1, 3, 4, 5, 6A, 6B,
7F, 9V, 14, 18C, 19A, 19F, 23F) in human urine.
Methods: Based on Luminex technology, this assay was developed using
microspheres coated with PnP speciﬁc monoclonal antibodies (mAbs),
to detect all 13 types in a single well of a urine sample. Positivity for a
speciﬁc serotype was based on cutoff values established from a panel of
400 control urine samples which were calculated relative to a standard
curve run on each assay plate. Although designed as a qualitative assay,
this method is able to quantify the amount of PnPs in a sample and was
qualiﬁed to address speciﬁcity, accuracy and precision.
Results: The assay was speciﬁc in that signiﬁcant signals were detected
only when each polysaccharide was paired with its homologous mAb-
coated microsphere. The lower limit of linearity ranged from 0.10−8.5
Diagnostic/laboratory methods (other than molecular) S669
pg/mL. Qualiﬁcation experiments showed that the assay has acceptable
accuracy (bias ratio: 76.5−<138%) and precision (%RSD: 6.8−<30%).
Preliminary assessments of clinical samples obtained from CAP patients
demonstrate that this assay is signiﬁcantly more sensitive than blood
culture in identifying S.Pn. serotypes.
Conclusions: Results demonstrate that this assay is a noninvasive,
sensitive and reproducible method to detect the presence of S.Pn.
polysaccharides in urine and has the potential to be a useful diagnostic
test to support clinical as well as epidemiological evaluation of
pneumococcal disease.
R2238 Performance of Vitek 2 for the detection of carbapenemase
and extended-spectrum b-lactamase activity in selected
Klebsiella pneumoniae isolates and evaluation of different
methods
O. Karatuna °, G. Altinkanat, G. Soyletir (Istanbul, TR)
Objectives: We have previously isolated a genetically related cluster
of blaIMP-1 metallo-b-lactamase and extended spectrum-b-lactamase
(ESBL) positive Klebsiella pneumoniae isolates (n: 12) which initially
were detected as imipenem (IPM) and/or meropenem (MEM) resistant
by Vitek 2 (bioMe´rieux). Manual tests like disc diffusion (DD) and
Etest failed to conﬁrm these results and to resolve the discrepancies we
investigated these isolates in detail using different cards and versions of
Vitek 2 along with various phenotypic methods.
Methods: The isolates were tested with different cards (AST-GN09,
GN13, N091, N092) and versions of Vitek 2 (AIX 4.01, AIX 4.03, PC
3.01). ESBL activity was explored using double disc synergy test, CLSI’s
ESBL conﬁrmatory test (ECT) using ceftazidime (CAZ) and cefotaxime
(CTX) discs in combination with clavulanic acid (CLA) and also by Etest
ESBL strips (AB Biodisk). Carbapenemase activity was investigated
with modiﬁed Hodge test (MHT), EDTA-based combined disc (CD)
assay with different concentrations of EDTA, and by IPM/IPM+EDTA
Etest strips. MIC values for IPM and MEM were established with broth
dilution, additionally IPM, MEM, ertapenem and doripenem MIC values
were determined with Etest strips.
Table. Investigation of carbapenem susceptibility by different methods



















































MIC by broth dilution (ug/ml)
Imipenem 4 4 4 4 4 4 4 4 2 4 4 4
Meropenem 8 16 16 16 16 16 16 16 16 8 16 16
MIC by Etest (ug/ml)
Imipenem 1 0.5 0.5 0.5 0.38 0.75 0.38 0.75 0.5 1 0.75 1
Meropenem 2 0.5 0.5 0.5 0.75 1 0.5 0.75 1 2 1.5 1.5
Ertapenem 3 4 4 12 3 32 0.19 2 6 3 6 2
Doripenem 0.5 0.5 0.75 2 0.5 4 0.016 0.75 0.75 0.5 1 1
Disc diffusion zone diameter (mm)
Imipenem 18 19 20 17 21 19 22 19 20 18 19 18
Meropenem 19 18 19 19 18 19 20 19 18 18 17 19
Ertapenem 15 14 14 13 15 17 19 13 13 12 14 14
AST-GN09 card, Vitek 2 ver. AIX 4.01
Imipenem 8 8 16 16 16 16 16 16 16 16 16 8
Meropenem 1 1 2 2 2 2 16 2 8 2 2 2
Carbapenemase* No No No No No No No No No No No No
AST-GN09 card, Vitek 2 ver. AIX 4.03
Imipenem 8 4 2 8 4 4 2 8 8 4 4 8
Meropenem 2 2 1 4 2 1 1 4 4 4 2 2
Carbapenemase No Yes No Yes Yes No No Yes Yes No Yes Yes
AST-GN13 card, Vitek 2 ver. AIX 4.03
Imipenem 8 4 2 8 4 4 2 4 4 4 4 4
Ertapenem 4 8  8 8 8 8 4 8 8 8 8 8
Carbapenemase Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
AST-GN09 card, Vitek 2 ver. PC 3.01
Imipenem 8 8 4 4 2 4 2 4 4 4 8 8
Meropenem 1 2 1 2 1 1 1 1 1 1 1 1
Carbapenemase No Yes No Yes No No No No No No No Yes
AST N091 card, Vitek 2 ver. PC 3.01
Imipenem 4 4 2 4 4 4 1 4 8 2 4 8
Meropenem 1 1 2 2 1 1 1 2 4 1 1 2
Ertapenem 4 8 8 8 8 8 4 8 8 8 8 8
Carbapenemase Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
AST-N092 card, Vitek 2 ver. PC 3.01
Imipenem 4 4 4 8 8 8 1 8 16 4 8 16
Meropenem 1 1 2 1 2 1 1 1 4 1 1 2
Ertapenem 8 8 8 8 8 8 4 8 8 4 8 8
Carbapenemase Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
*Vitek 2 expert system warning for carbapenemase production as recognized by the phenotype.
Results: All Vitek 2 cards containing an ESBL well (AST-GN13, -N091,
-N092) failed to detect any ESBL activity. Also, Etest ESBL strips (both
CAZ/CAZ+CLA and CTX/CTX+CLA) yielded indeterminate results for
all isolates and ECT failed in 9 isolates with CAZ/CAZ+CLA discs
and in 10 isolates with CTX/CTX+CLA discs. However; synergy was
observed between aztreonam and amoxicillin+CLA in all strains. DD
and Etest methods failed to detect the carbapenem resistance in most
instances whereas Vitek 2 showed overall a good performance with
accompanying warnings for carbapenemase activity triggered by the
expert system (Table). MHT revealed carbapenemase activity in all
isolates. CD assay was most successful when 10 ul of 0.5 M EDTA
was used. The IPM/IPM+EDTA Etest method remained futile because
of the low IPM MIC values obtained.
Conclusion: CLSI’s ECT, Etest ESBL strips and Vitek 2 ESBL
wells all yielded unsatisfactory results for the challenge strains we
tested. In the other hand, carbapenem resistance detected by Vitek 2
would remain undetected if only DD or Etest methods were used. An
automated susceptibility system, with an expert system incorporated,
seems very helpful in occasions where an unusual resistance mechanism
is encountered.
R2239 Protein S100B feasibility in the diagnostics of central
nervous system infection
J. Pavelka °, L. Homola, P. Mikolasek, Z. Cermakova, L. Krbkova,
I. Capovova, L. Klapacova, D. Bartosova (Brno, CZ)
Objectives: The aim of the study is to evaluate the feasibility of S100B
protein (S100B) as a marker of the central nervous system infection. The
S100B is the serum marker used in rapid diagnostics of the traumatic
or ischaemic damage of the central nervous system (CNS). The CNS
marker would be great improve in the diagnostic before performing a
lumbar puncture in ill-deﬁned cases. The research tested whether the
level of S100B is higher in serum and spinal ﬂuid in patient with the
CNS infection compared to those without.
Methods: The S100B was tested in 65 child patients in Child infectious
diseases departement. 51 patiens were admitted due to suspected
CNS infection. 14 were healthy controls. Patients underwent standard
diagnostic procedures including blood sampling, lumbar puncture,
serology, cultivation and PCR. All patients were tested for S100B
from serum and spinal ﬂuid with electroimunoassay method. The CNS
infection was conﬁrmed in 43 of 51 patients. The CNS infection was
not proved by standard methods in 8 patients. These patiens were added
to the control group. Values of S100B in the serum and in the spinal
ﬂuid were then compared for both groups.
Results: No signiﬁcant difference of S100B values was found between
the group of patients with the CNS infection and control group. From 43
patiens with conﬁrmed CNS infection only 6 had level of S100B above
cutt-off value for their age.
Conclusion: The results indicate that the protein S100B is not promising
marker of the central nervous system infection.
R2240 Detection of anaerobic bacteria in patients with pericoronitis
C. Guilarte °, G. Pardi, M. Castro, R. Garcia-Arocha (Caracas, VE)
The oral cavity is one of the most complex and heterogeneous body
parts inhabited predominantly anaerobic microorganisms, these may act
synergistically to produce a series of purulent infections of mixed origin
from which it is worth noting the pericoronitis. Has recently increased
aid to dental patients pericoronitis therefore for the general dentist to
the oral surgeon is important to continue therapy for the prevention and
treatment of this entity, so the detection and identiﬁcation of infectious
agents that cause is critical because it guides us towards a correct
antibiotic avoiding unnecessary use of antibiotics, thus avoiding the risk
of bacterial resistance. Outside our borders have been made studies on the
detection and identiﬁcation of microorganisms involved in pericoronitis,
being the most recent studies published in France and the United States of
America which are highlighted in both the predominance of anaerobic
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bacteria such as microorganisms producers of this condition, but not
in our country where there are few studies performed. While it is
true that there have been numerous studies related to detection and
identiﬁcation of microorganisms in other lesions of the oral cavity in
dental caries, subprothesic stomatitis, periodontal disease, pulpal and
periapical infections, has not been given importance to the microbiota
associated with pericoronitis There is fully justiﬁes this study as well
as enabling the detection and identiﬁcation of the causative agents of
pericoronitis also serve to identify the associated microbial species,
which help in selecting the most appropriate antimicrobial therapy for the
treatment of this infection and serve as a starting point or background
for other studies of the microﬂora of this entity. Biﬁdobacterium spp.
(42%) B adolescentes (17%), Veillonellas spp (17%), P. loeschii (8%),
P. melaninogenica (8%) y P. oralis (8) were detecte in this study.
R2241 Innovative Elecsys CMV IgM assay design using
recombinant antigens reduces signiﬁcantly the detection of
mature anti-CMV IgM antibodies
L. Grangeot-Keros, C. Vauloup-Fellous, P. Meylan, Y. Dickstein,
I. Lipkin, W. Melchior, U. Schmitt, C. Scholz, E. Pfaffenrot °,
T. Lazzarotto (Clamart, FR; Lausanne, CH; Petach Tikva, IL;
Penzberg, DE; Rotkreuz, CH; Bologna, IT)
Objectives: Primary acute maternal CMV infection during pregnancy
carries a high risk of intrauterine transmission which may result in
severe fetal damage. In the absence of acute clinical manifestation, CMV
infection is usually diagnosed by means of serology. A positive IgM
result is normally caused by acute or recent primary infections, but
also can occur due to recurrent CMV infections or due to unspeciﬁc
polyclonal stimulation. Likewise, CMV IgM antibodies may persist for
several months after acute infection. These multiple causes of IgM
positivity in CMV serology hamper the reliable and straightforward
diagnostics of acute/recent primary CMV infection and necessitate
further conﬁrmation analysis.
The performance of the Elecsys CMV IgM assay was evaluated with
samples of pregnant women containing persistent or reactivation-induced
CMV IgM antibodies.
Methods: Elecsys CMV IgM is an electrochemiluminescence im-
munoassay using recombinant antigens in a m-capture format. A new
concept of recombinant CMV antigen design reduces signiﬁcantly the
detection of mature anti-CMV IgM antibodies as induced by persistent
infection or reactivation.
116 frozen serum samples without clinical evidence of a recent primary
CMV infection, however, presenting with low CMV IgM values and
high-avidity IgG in routine assays, were tested with Elecsys CMV IgM,
DiaSorin Liaison CMV-IgM, Siemes Enzygnost A-CMV-IgM, Medac
CMV-IgM-ELA and Abbott Architect Anti-CMV IgM.
Results: Elecsys CMV IgM yielded fewer positive results with samples
of pregnant women with past CMV infection (characterized by low
CMV IgM and high-avidity IgG in routine assays) when compared to
comparison assays.
Conclusion: Elecsys CMV IgM uses highly innovative assay design
based on recombinant antigens, which signiﬁcantly reduces the detection
of anti-CMV IgM in patients with past CMV infections. As a
consequence, less conﬁrmatory testing is required.
Methods for antibacterial susceptibility
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R2242 Antibiotic susceptibility of Clostridium difﬁcile
L.T. Erikstrup °, K. Fuursted, B. Kristensen (Aarhus, DK)
Objectives: Reports of resistance to metronidazole and intermediate
resistance to vancomycin emphasize the need for surveillance of
antibiotic susceptibilities of C. difﬁcile, CD027 and other hyper virulent
or epidemic strains. The aim of the study was to evaluate the use of disk
diffusion in detecting resistance against C. difﬁcile.
Methods: Primary clinical isolates of C. difﬁcile (n = 122) from Danish
hospitalised patients with diarrhoea in 2008 were characterized by E-test
and disk diffusion. The isolates were tested against vancomycin, metron-
idazole, clindamycin, erythromycin, and moxiﬂoxacin as recommended
in Denmark. Disk diffusion method was performed on both Anaerobe
agar (Statens Serum Institut, Denmark) and Sensitivity agar with NAD
(Biome´rieux). MIC determination by E-test was performed on Brucella
agar (Statens Serum Institut, Denmark). Disk diffusion was compared to
E-test by linear regression and using interpretive criteria available from
the CLSI.
Results: All strains were susceptible to metronidazole and vancomycin
with MIC< 2mg/L.
See Table.
Table. Antibiotic susceptibility of C. difﬁcile and correlation between
E-test and disk diffusion
Antimicrobial agent MIC (mg/L) Susceptible r2 VME1 (%) ME2 (%)
MIC 50 Range (%) NAD3 AA4 NAD AA NAD AA
Clindamycin 4 0.75–256 86 0.65 0.59 3 4 4 5
Erythromycin 0.38 0.094–256 89 0.80 0.81 0 0 0.8 0.8
Moxiﬂoxacin 0.75 0.25−32 89 0.72 0.76 0 0 0 0
1VME: Very major error. Sensitive by disk diffusion. Resistant by E-test. 2ME: Major error. Resistant by disk
diffusion. Sensitive by E-test. 3NAD: Sensitivity agar with NAD. 4AA: Anaerobe agar.
There was an acceptable to good correlation between ﬁndings from disk
diffusion and E-test for all antibiotics on both media, but for clindamycin
we found an unacceptable high frequency of VME and ME.
Conclusions: Disk diffusion was a reliable method when evaluating
susceptibility to moxiﬂoxacin and erythromycin. However, disk diffusion
was inadequate for the detection of clindamycin resistance and should
therefore be supplemented with either E-test or broth dilution method.
R2243 Use of standardized method for testing the sporicidic activity
of new hybrid materials with embedded silver nanoparticles
D. Pencheva, R. Bryaskova, T. Kantardjiev ° (Soﬁa, BG)
Objectives: The use of standardized method for testing the sporo-
cidic activity of new hybrid materials based on polyvinyl alcohol
(PVA)/tetraethyl orthosilicate (TEOS) with embedded silver nanopar-
ticles (AgNp’s), synthesized by two different methods, will allow to
compare the results obtained and the choice of the appropriate method
of synthesis.
Methods: Hybrid materials on the basis of PVA and TEOS with em-
bedded AgNp’s with different silver concentrations (3.7mg AgNO3/ml,
1.8mg AgNO3/ml, 0.9mg AgNO3/ml) were synthesized using sol-
gel method by two strategies. The ﬁrst strategy was based on in-situ
formation of AgNp’s via thermal annealing of the PVA/TEOS hybrid
ﬁlms. The second strategy consists of forming AgNp’s in PVA/TEOS
matrix without any thermal annealing of the ﬁlms. The standard paper
disks (d = 6±0.5mm) were impregnated with 5ml of the solutions and
allowing them to dry at room temperature. For the thermal treated
materials, disks were annealed at 100ºC for 1 h. Thus prepared disks were
used for testing the sporicidic activity of these hybrid PVA/AgNp’s/TEOS
materials by the pour agar method with test microorganism Bacillus
subtilis ATCC 6633 (B. subtilis).
Results: The results obtained by triple testing of the samples, showed
that all tested hybrid materials with embedded AgNp’s possessed
sporicidic activity. The synthesized materials demonstrated sporicidic
activity against B. subtilis in all used silver concentrations by the
appearance of an inhibition zone (ranging from 10.5 to 11.5mm). The
difference in the zone at different silver concentrations was in the range
of 0.5 to 1mm regardless of the methods.
Conclusion: The most pronounced zones of inhibition were demon-
strated at hybrid PVA/AgNp’s/TEOS materials with highest silver
concentration (3.7mg AgNO3/ml) in the both methods. The proved
sporicidic activity extends the possible applications of such hybrid
materials as coatings in the clean rooms like surgery, industrial and
laboratory places where the contaminations with spore cultures could
affect negatively.
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R2244 Evaluation of the VITEK® 2 system for the
susceptibility testing of various Streptococcus sp. including
S. pneumoniae 1
D. Shortridge °, R. Grifﬁth, S. Messina-Powell, D. Creely, L. Beiner,
D. Kingsley, M. Dante (Hazelwood, US)
Objective: The VITEK 2 System provides rapid, automated iden-
tiﬁcation and susceptibility testing of bacterial isolates including
S. pneumoniae (SPN). With the increasing prevalence of antimicrobial
resistance, the ability to quickly and easily perform susceptibility testing
on other species of streptococci is becoming more important. The
purpose of this study was to determine whether susceptibility testing
on VITEK 2 could be expanded to include Streptococcus viridans
(VIR) group and b-hemolytic streptococci (BS) for 11 antimicrobials:
ampicillin (AM), cefotaxime (CTX), ceftriaxone (CRO), linezolid
(LNZ), penicillin (PEN), trimethoprim/sulfamethoxazole (SXT), clin-
damycin (CM), erythromycin (E), levoﬂoxacin (LEV), tetracycline
(TE), vancomycin (VA) and the detection of inducible clindamycin
resistance (ICR).
Methods: Over 600 isolates representing 34 species were tested in
VITEK 2 investigational use only (IUO) cards containing varying
concentrations of the different antimicrobials. All strains were tested
on both IUO cards and the CLSI broth microdilution reference method.
Growth data were collected from the VITEK 2 cards and compared to the
reference MIC results. Analyses were then developed using these data.
Results: Overall essential agreement from the development isolates for
each group is shown in Table 1.
Conclusion: Essential agreement for all drugs with the three organism
groups exceeded 93%. These development data indicate that the
VITEK 2 can accurately determine susceptibility to the above-mentioned
drugs for various Streptococcus sp.
1 These new tests are not yet available for commercial use and the United
States FDA has not cleared them for use with the VITEK 2.
Table 1
%EA
AM CTX CRO LNZ PEN SXT CM E ICR LEV TE VA
SPN 94.5 95.6 99.3 100 100 97.9 95.8 98.9 N/A 99.6 99.6 97.7
VIR 98.4 97.4 94.7 100 97.4 N/A 98.5 99.5 N/A 100 95.5 93.3
BS 100 99.4 100 100 100 98.5 97.6 98.2 100 98.8 95.1 97.6
R2245 Evaluation of a MicroScan Dried Overnight panel for de-
tection of inducible clindamycin resistance in staphylococci
J. Hindler, K. Ward, D. Bruckner, K. Sei, H. Bains, M. Bacsafra,
L. Mann, B. Zimmer ° (Los Angeles, West Sacramento, US)
Objectives: The CLSI recently added a broth microdilution reference
method as an alternative to the disk approximation or D-Zone disk test
to detect inducible clindamycin resistance in staphylococci. The accuracy
of a test for detection of inducible clindamycin resistance (ICd) on
MicroScan Dried Overnight Gram Positive panels was examined with
a set of challenge staphylococci.
Methods: 75 erythromycin nonsusceptible, clindamycin susceptible
challenge staphylococci [41 S. aureus, 17 S. epidermidis, and 17 other
coagulase-negative staphylococci (CNS)] were tested and the MicroScan
test results were compared to a pre-determined, expected D-Zone result.
Panels were inoculated using both turbidity and the Prompt methods
of inoculation, and the panels were read by the WalkAway System, the
autoSCAN-4 instrument, and visually.
Results: Agreement for challenge isolates was 100% for all inoculum
and read methods.
Conclusion: The ICd test on MicroScan Dried Overnight Gram Positive
panel demonstrated excellent correlation with the CLSI D-Zone test for






Manual Turbidity 75 100 100 100
WalkAway Turbidity 75 100 100 100
autoSCAN 4 Turbidity 75 100 100 100
Manual Prompt 75 100 100 100
WalkAway Prompt 75 100 100 100
autoSCAN 4 Prompt 75 100 100 100
R2246 Comparison of MicroScan LabPro AlertEX System software
rules to EUCAST expert rules for Enterobacteriaceae and
b-lactam antimicrobial agents
B. Zimmer °, M. Arndt, J. Driscoll, J. Haislet, D. Larribas,
K. Manoharan, E. McFadyen, C. Royer (West Sacramento, US)
Objectives: The EUCAST Expert rules provide assistance to clinical
microbiologists in the interpretation of antimicrobial susceptibility
testing (AST). Automated microbiology AST systems such as MicroScan
likewise have software to assist in interpretation of results, and can also
be customized by the user. It is important for the user of the software to
know the concordance.
Methods: Rules listed in EUCAST Expert rules, version 1, April 2008
for Enterobacteriaceae and b-lactam drugs were compared to those
in MicroScan LabPro AlertEX System multiregional software, v3.01
(France v3.03).
Results: EUCAST Expert Rule Table 1 lists intrinsic resistance present
in 16 species of Enterobacteriaceae with 8 b-lactams. There is complete
concordance with the AlertEX software including separate alerts and
expert rules for 7 drugs and for 15 of the organisms. Concordant rules
exist for the 8th drug, cefamandole, but the drug is not available for
testing. MicroScan additional rules are listed for antimicrobial agents not
detailed by EUCAST, and correspond to antimicrobial class. Additional
rules are also listed for ampicillin/sulbactam. Some differences exist for
C. freundii, Enterobacter spp. and Providencia spp. with cefuroxime,
and S. marcescens with cefoxitin. There are no AlertEX system rules
for Escherichia hermannii.
EUCAST Expert Rule Table 5 only lists 1 exceptional phenotype
that applies to Enterobacteriaceae: resistance to ertapenem and
meropenem, and resistance to imipenem for Enterobacteriaceae other
than Proteus spp. The AlertEX system has both a general alert for
carbapenem resistance, as well as speciﬁc rules based on MIC and
not interpretation that correspond to the current CLSI-recommended
detection of KPC enzymes based on MIC. The AlertEX system excludes
Morganella as well as Proteus spp. from the imipenem rule.
EUCAST Expert Rule Table 9 lists interpretive rules. ESBL-positive
Enterobacteriaceae susceptible to cephalosporins and aztreonam are to be
reported as Intermediate, and intermediate results reported as Resistant.
The AlertEX system reports 16 of the more common Enterobacteriaceae,
including K. oxytoca and C. koseri, as resistant, and includes penicillins.
EUCAST indicates ESBL-negative organisms are to be reported as
found, and the AlertEX system follows that guideline.
Conclusion: System-provided MicroScan AlertEX rules correspond to
those recommended by EUCAST Expert rules with some minor noted
differences.
R2247 Vancomycin MICs for methicillin-resistant Staphylococcus
aureus
M. Avolio °, S. Grosso, A. Camporese (Pordenone, IT)
Objectives: In a recent letter (Prakash V, et al. AAC, 2008) and more
recently in an article by Leonard et al. (Leonard SN, et al. JAC,
2009) the signiﬁcant differences found between microdilution and Etest
have clearly been highlighted in the detection of vancomycin MIC for
Staphylococcus aureus, with an overestimate of the results obtained with
Etest compared to those obtained by microdilution.
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Given that the increase in vancomycin MICs below the breakpoint level
seems by now to be extended inexorably everywhere (Rybak MJ, et al.
Am J Health-Syst Pharm. 2009), it is fundamental that the microbiologist
makes the best diagnostic options available to the clinician in order to
correctly detect the phenomenon. As a result of the kinetic/dynamic
studies that have clearly shown a greater probability of reaching an
optimal AUC/MIC ratio when vancomycin MIC is 1mg/L than when
the MIC is >1−2mg/L, whilst being aware that the difference of even
just one dilution in the MIC can lead to a potential failure of therapy
especially in case of respiratory or systemic infections (Pea F, et al.
CID. 2006; Soriano A, et al. CID. 2008), we have recently decided to
compare three different methods to assess concordance/discordance in
the measurement of the level of vancomycin MIC below the sensitivity
breakpoint.
Methods: Sensititre, GPALL1F panel (Trek Diagnostic System), Vitek 2,
card AST-P580 (bioMe´rieux), and Etest, vancomycin strip on Mueller-
Hinton agar plates (bioMe´rieux), using a 0.5 McFarland standard to
prepare inoculum. For the evaluation we used 80 nonduplicate MRSA
clinical isolates collected in 2008, kept at −80ºC and subcultured twice
prior to being tested. Quality control of each antimicrobial method used
was performed, as stated by the manufacturer, using Staphylococcus
aureus ATCC 29213.
Results: The comparison of the three methods, whose results are
highlighted in Table 1, conﬁrms the overestimate of Etest compared to
broth microdilution, according to the literature (Prakash V, et al. AAC,
2008) and of Rybak group (Leonard SN, et al. JAC, 2009), whilst it also
shows that Vitek 2 cannot correctly detect MIC below the sensitivity
breakpoint.
Conclusion: Microdilution, in this case undertaken with Sensititre, a
commercial semi-automated microtitre broth dilution method that can
be easily used in all microbiology laboratories, actually represents the
most suitable method correctly measuring the level of vancomycin MIC
below the sensitivity breakpoint.
Vancomycin MIC (mg/L) Etest (%) Sensititre (%) Vitek 2 (%)
0.5 0 (0) 12 (15) 48 (60)
1 7 (9) 64 (80) 31 (39)
1.5 44 (55)
2 29 (36) 4 (5) 1 (1)
R2248 Detection of resistance to mecillinam in E. coli using the
BD Phoenix™ automated microbiology system
F. Alrashidi, W. Brasso, G. Mangum, B. Turng °, J. Reuben (Sparks, US)
Objective: Mecillinam (MEC), a semisynthetic b-lactam antibiotic
with activity against many Gram-negative bacilli, provides an effective
therapeutic option for uncomplicated urinary tract infections. Though
resistance to MEC is unusual in most wildtype Escherichia coli, the
ability to detect true resistance is imperative. The unique, comparatively
slow bactericidal activity of MEC can result in elevated false resistance
rates in vitro in broth-based AST methods. In this study, MEC,
an antibiotic under development for use in the BD Phoenix™
Automated Microbiology System (BD Diagnostics, Sparks, Maryland),
was evaluated against E. coli isolates and the recommended agar dilution
reference method.
Methods: A total of 203 clinical and challenge set E. coli isolates,
including 61 MEC non-susceptible strains, were included in the
evaluation. Among these, 29 were previously conﬁrmed as ESBL
and AmpC-producing strains. Phoenix MEC reproducibility was also
evaluated with 7 isolates, and daily QC was monitored. Each strain was
tested in parallel in both the Phoenix System and the CLSI-recommended
agar dilution reference method (ADM). Bacterial suspensions were
adjusted to the equivalent of a 0.5 McFarland standard, then inoculated
simultaneously into the BD Phoenix System and the ADM. Phoenix
panels containing MEC were placed into the BD Phoenix instrument
for incubation and automated reading to completion. ADM plates were
incubated at 35ºC for 18–20 hours in ambient air and read manually
for MIC endpoint determination. Mecillinam breakpoints and QC strain
ranges were based on those recommended in the current CLSI standard
(M100-S19).
Results: The Phoenix MEC yielded essential (EA) and categorical (CA)
agreements of 94.1% and 93.1%, respectively, when compared to the
ADM. Very major error (VME) and major (ME) rates were 2.0% (1/49)
and 1.4% (2/142), respectively. Both MEs were identiﬁed as ESBL-
producing strains, while the single VME was conﬁrmed as a plasmid-
mediated AmpC producer (CMY-2). Reproducibility and daily QC rates
were both 99.5%.
Conclusions: The BD Phoenix System provides an acceptable level of
agreement for mecillinam to the reference agar dilution method results,
and is able to detect resistance to the antibiotic in Escherichia coli.
Public health and community-acquired
infections
R2249 Seroepidemiology of hepatitis A virus in Iranian children
A. Ramezani °, A. Aghakhani, M. Soﬁan, A.A. Farazi, G. Etemadi,
A. Khadem-Sadegh, M. Banifazl (Tehran, Arak, IR)
Objective: Hepatitis A is one of the most frequently reported vaccine-
preventable diseases worldwide and remains endemic in many areas of
the world. Geographical areas can be characterized by high, intermediate,
low and very low levels of prevalence of HAV infection. Studies
in various communities have shown that Hepatitis A virus (HAV)
prevalence rises with age. It may cause signiﬁcant morbidity and
mortality among both adolescents and adults. Now, the current available
data regarding hepatitis A epidemiology in Iran are limited. The aim
of this study was to determine the seroepidemiology of hepatitis A in
children of different age groups in Tehran, Iran.
Methods: Plasma samples of 1065 children between ages of 6 months
and 20 years were tested for the presence of total anti-HAV. The children
were separated to four age groups: Group 1 (6 months–5.9 years;
n = 276), Group 2 (6.0–10.9 years; n = 344), Group 3 (11.0–15.9 years;
n = 279) and Group 4 (16.0–20.9 years; n = 166).
Results: The overall prevalence of total anti-HAV was 61.6% (95%CI:
63.25–68.94%). HAV prevalence rates according to age groups were
as follows: Group 1, 55.1%; Group 2, 52.9%; Group 3, 65.2% and
Group 4, 85%. The HAV seroprevalence among 6 months to 10 years old
children was 52.9–55.1%, reaching 65.2% in the 11−15 year age group
and 85% in the 16−20 year age group. Except the 6−10 year age group,
older age was associated with higher seroprevalence of HAV. Total anti-
HAV positivity in terms of age groups was signiﬁcantly different from
each other (P< 0.001). For all age groups, there was no statistically
signiﬁcant difference between genders regarding to anti-HAV positivity.
Conclusion: Our study ﬁndings indicate that hepatitis A is prevalent in
children of Tehran, Iran and hepatitis A infection is an important public
health problem in this region. Our survey also showed that Tehran is a
region with moderate endemicity for hepatitis A infection. So for HAV
prevention, vaccination of children will be beneﬁcial.
R2250 The association between Helicobacter pylori seropositivity
and the frequency of cardiac adverse events in patients with
coronary artery diseases in a 1-year follow-up: a cohort
study
M. Keshtkar-Jahromi, H. Vakili, M. Razavi °, S. Gholamin,
A. Eskandari, M. Rahnavardi, R. Sadeghi, T. Mokhtari (Tehran, IR)
Objectives: Coronary artery disease (CAD) is the major cause of
death worldwide. Infection and the following inﬂammation in coronary
arteries, as one of leading basis of atherosclerosis, is a matter of ponder
in recent studies. Here we evaluate antibody titer against helicobacter
pylori (HP) in patients with CAD compared with normal coronary artery
subjects (NCAS) and its association with adverse cardiac events in CAD
after a 1 year follow up.
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Methods: In this study 117 CAD patients and 61 NCAS were
evaluated for IgG antibody (ELISA) against HP. Both groups were
angiographically assessed. NCAS were selected from those who had
undergone angiography for evaluating chest pain but was reported
normal. Those who needed HP treatment or had previously received
eradication therapy were excluded. Angina [Seattle angina questionnaire
(SAQ)] and CAD stenosis [Modiﬁed Gensini score (MGS)] severity
were recorded. CAD patients were followed for acute coronary syndrome
(ACS), coronary revascularization and cardiovascular death during one
year of follow up.
Results: HP titer was comparable in CAD and NCAS. There was no
signiﬁcant correlation between HP titer and angina severity (SAQ) in
CAD patients. Furthermore, CAD severity (MGS) and HP titer were not
signiﬁcantly correlated. During one year of follow-up, 18 (15.4%) CAD
patients were admitted to hospital with acute coronary syndrome (ACS).
HP titer was comparable in those with ACS and the other CAD patients.
Conclusion: HP infection may doesn’t play an important role in CAD
pathogenesis in endemic regions. Moreover no correlation between HP
infection and CAD stenosis severity, angina severity or adverse cardiac
events in CAD patients was found.
R2251 Outpatient parenteral antibiotic therapy for cellulitis.
A 10-year single-centre experience
A. Carlotto °, R. Ferretto, L. Timillero, F. Marranconi (Schio, IT)
Objectives: Outpatient parenteral antibiotic therapy (OPAT) for a
wide range of infections is an alternative that can avoid or reduce
hospitalization, while improving the quality of life of the patient and
family. Cellulitis refers to a frequent inﬂammatory process caused by
bacterial infection of the dermis and underlying subcutaneous tissues
of the skin, which in uncomplicated forms and by now availability of
long half-life antibiotics may beneﬁt from antibiotic treatment outside
hospital.
Methods: We conducted a retrospective analysis of clinical and
microbiologic data for cases of cellulitis treated in our 439-bed general
hospital in outpatient setting during the period 1999 to 2009.
Results: From september 1999 to march 2009 were treated in outpatient
settings 171 patients (M= 108) with a mean age of 57.3 years (±16.9,
median 60 range 17−87) with uncomplicated cellulitis. The median
distance of the patient’s home from the infusional center was 10km
(range 5−60). One or more comorbidities were ascertained in 63% of
patients (diabetes mellitus in 27%). The most common site of infection
were lower limbs (42.7%) and feet (21.8%); in 23% of cases OPAT
was preceded by a period of hospitalization and 9.6% of the cases have
required hospitalization after the start of outpatient treatment. The drugs
most frequently administered were ceftriaxone (59.8% of cases) and
teicoplanin (22.2%); in monotherapy in 38% of cases for the ﬁrst and in
23.8% of the cases for the second. The average duration of treatment was
13 days (±9, median 10, range 1−47). A culture result was obtained in
49.8% of cases and the major pathogens isolated were S. aureus (34.2%
(3.4% MRSA)), Streptococcus spp (18.1%) and CNS (17.2%). A clinical
cure was achieved in 93.7% of cases with a total saving of 2186 days
of hospitalization.
Conclusion: The use of OPAT programs in the treatment of uncompli-
cated cellulitis is likely to increase due to ongoing efforts to shorten
hospital stays and reduce health-care costs. Selection criteria and careful
medical monitoring of patients are critical in determining the success
of any OPAT program and also in case of cellulitis. Our experience
suggests that OPAT programs can be promoted in uncomplicated forms
of cellulitis with advantage.
R2252 Three cases of Crimean-Congo haemorrhagic fever with
renal impairment
C. Ataman Hatipoglu °, C. Bulut, S. Altun, G. Canpolat, A.T. Yazan,
Z. Tufan Kocak, F.S. Erdinc, S. Kinikli, A.P. Demiroz (Ankara, TR)
Objectives: Crimean–Congo hemorrhagic fever (CCHF) is a fatal
disease caused by a tick-borne virus. In this report, we present three
cases with renal impairment, relatively uncommon clinical presentation
of the disease.
Case 1: A 69-years-old male patient living in endemic region for
CCHF admitted with fever, fatigue, anorexia and nausea. His physical
examination was normal except fever. Laboratory investigations revealed
severe thrombocytopenia, prolonged aPTT, elevated blood urea and
creatinine. CCHF PCR was positive. Thrombocytopenia and aPTT
prolongation didn’t improve despite platelet and fresh frozen plasma
infusions. His blood urea and creatinine levels were increased day by
day. On fourth day, acute pulmonary edema and metabolic acidosis
were developed. His urea level detected as 236mg/dL and creatinine
4.8mg/dL. He couldn’t be treated with hemodialysis because of his
worsened clinical state and he died on ﬁfth day.
Case 2: A 54-years-old female patient admitted with fever, fatigue
and headache. She was febrile on physical examination. Laboratory
investigations revealed thrombocytopenia and prolonged aPTT. Blood
urea and creatinine were within normal limits. CCHF PCR was positive.
Platelet and fresh frozen plasma infusions were started. On sixth day, a
hemorrhage was developed in the biceps muscle. On sixth day, renal
impairment was occured. On tenth day, blood urea level increased
to 177mg/dL and creatinine to 5.6mg/dL and continuous ambulatory
peritoneal dialysis (CAPD) was started. All the clinical and laboratory
abnormalities of the patient were improved except renal impairment.
CAPD still goes on.
Case 3: A 30-years-old female patient admitted with fever, nausea and
headache. Her physical examination was normal except fever. Laboratory
investigations revealed thrombocytopenia and prolonged aPTT. Blood
urea and creatinine were normal on admission. CCHF PCR was positive.
Platelet and fresh frozen plasma infusions were given. On the second day,
purpura occurred on the trunk. On the fourth day, hemorrhagic bullous
lesions were developed on the trunk and spread to the whole body. On
the same day renal impairment was started. Patient’s clinical state was
worsened rapidly. After the increase of creatinine level to 2.9mg/dL,
CAPD was started on. She died during the dialyses due to cardiac arrest.
Conclusion: Renal impairment is one of the uncommon clinical
presentations of the CCHF. It can be mortal despite supportive therapy
and dialyses.
R2253 Lethal community-acquired Streptococcus agalactiae
meningitis in an adult with systemic lupus erythematosous
S. Arampatzi °, A. Kalikaki, O. Vasilaki, E. Protonotariou,
V. Ourailoglou, F. Tsiapara, F. Frantzidou, E. Diza (Thessaloniki, GR)
Objectives: Group B Streptococcal (GBS) or Streptococcus agalactiae
meningitis in adults is an uncommon manifestation of invasive GBS
disease found especially among elderly and those with signiﬁcant
underlying disease. We report an unusual case of fatal community-
acquired meningitis due to Streptococcus agalactiae in an adult with
systemic lupus erythematosous (SLE).
Methods: A 41-year-old man who quoted a 20-years history of SLE
under corticosteroid treatment and without any recent hospitalization was
transferred to the emergency department of our hospital. Seven days prior
to his admission he developed atypical gastrointestinal disorders, fever
>39.5ºC and ciproﬂoxacin was subscribed. The patient showed clinical
improvement but soon after, he developed diarrhea and another febrile
episode with drowsiness, cephalalgia and cervical stiffness. He was
transferred to the closest hospital where he was immediately intubated
with GCS: 6/15. The patient was transferred to our hospital for admission
to the Intensive Care Unit (ICU) and a brain computed tomography scan
(CT) revealed cerebral edema and signs of meningitis. Because of high
cerebral pressure no lumpar puncture was performed. Laboratory blood
evaluation revealed neutrophilic pleocytosis and increased C-reactive
protein (22.2mg/dl). Urine, blood and bronchoalveolar cultures were
all found negative for Streptococcus agalactiae. The patient showed
severe vital organs’ dysfunction and despite highly invasive treatment
he died out of multiple organ dysfunction syndrome 24 hours upon his
admission. Post mortem lumpar cerebrospinal ﬂuid (CSF) was cultured
following routine methods. Gram staining of CSF showed many WBCs
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with Gram-positive cocci. Bacterial identiﬁcation and antimicrobial
susceptibility testing with VITEK2-automated system (bioMe´rieux,
France) identiﬁed Streptococcus agalactiae susceptible to penicillin and
ceftriaxon.
Conclusion: To our knowledge, for the ﬁrst time Streptococcus
agalactiae as an aetiologic agent of lethal meningitis in SLE is being
reported. From a clinical point of view, acute bacterial meningitis caused
by GBS is indistinguishable from meningitis caused by other pyogenic
bacteria and for this we recommend that Streptococcus agalactiae should
be included in the differential diagnosis of acute bacterial meningitis in
patients with underlying disease like SLE.
R2254 Measles: did we prevent the hazard or is it more hazardous
now? Measles, spread and prevention in children of an
Afghan migrant family in Istanbul
H. Yildirim, D. Dalyanci, G. Sengoz ° (Istanbul, TR)
Objective: In Istanbul no proven measles case was detected since 2006
with the vaccination campaigns started in 2003. For the reason of measles
detection in 2 children (9 months and 3 years old) of a family living in
Istanbul, Mop-up studies performed to prevent the spread of these cases
were explicated.
Cases: In Zeytinburnu district which has a low socioeconomic level and
harbours most of the immigrants, people who has residential permit can
get health care by 13 health posts without charge.
Since 5 different vaccination campaigns performed with success, local
people supported this campaign also. Measles vaccination rates were
over 95% in last 4 years.
2 consecutive cases were detected in this immigrant family which has a
travel history to Iran in august 2009. When a secondary case was detected
a 3 years old cousin in the same family who didn’t travel, brought up
the necessity to ﬁnd out the unvaccinated children in the district.
As part of social mobilization studies, local administrative chiefs were
informed. Field work lasted for 48 days was completed in 4 subdistricts
where immigrant families lived densely. Health ofﬁcials visited 22484
house and left invitations when the resident were away. In this study we
found out that; 44 children were unvaccinated, 10 of them didn’t get
health care at all, 17 came in the last 3 months and 17 were 12−18
months old and delayed MMR vaccine.
Measles IgM was found negative in 51 children with rash in measles
surveillance until today, 2 families rejected to get measles vaccine, 9
cases showed mild reactions after vaccination and 1 case was detected
as an application mistake.
Conclusion: Some difﬁculties were lived to diagnose measles clinically
in the ﬁrst 2 cases can cause secondary cases and an outbreak. We took
the physician’s attention when some diseases are off the agenda they
shouldn’t be behind in differential diagnosis.
Vaccination in Total
Field Health Post
6−12 months (Measles) 93 596 689
1−5 year-old (MMR) 1930 4626 6556
6−14 year-old (MMR) 610 125 735
R2255 Botulismus epidemic caused by home-made canned food
and 8 members affected in a family
G. Sengoz °, M. Bakar, E. Kina Senoglu, N. Kuzgunkaya, M.T. Ersoy,
H. Yildirim, D. Dalyanci (Istanbul, TR)
Objective: Clostridium botulinum spors are heat-resistant and can
survive in inaccurately processed food and can cause a neuroparalytic
disease with its neurotoxins. Disease processes of 8 family members
were explicated after got sick of consumption of the same food.
Methods: On February 2009 patients applied to different hospital
emergency departments with complaints of dysphagia, dyspne, dyplopia,
blurred vision and weakness. Concerning botulism infection the patients
were hospitalized and Zeytinburnu Health Group Directory sent a health
team to investigate the epidemics to visit the houses. They took samples
from the food they had eaten in the last two days. Food samples were sent
to the reference laboratory. Patients’ relatives were informed about the
disease spread and preventive measures. The food left were destructed
as a precaution.
Results: Home-canned purslane was thought as the cause was prepared
in Yukari Ulupinar village in Malatya city and kept in deep freeze. Data
of 8 patients between 16−45 years old can be seen on table. National
poison information center (NPIC) sent antitoxic serum containing
antitoxin to C. botulinum type A, B and E and they were slowly perfused
to the patients. Reference laboratory detected Gram positive bacilli in
purslane with yoghurt, anaerobic culture yielded Clostridium botulinum
and animal experiment showed toxin.
Conclusion: Home-canned food preparation and consumption stil exist
in our country. This tradition carries the risk of botulism like diseases.
Early diagnosis, antitoxin infusion and follow in intensive care unit are
critically important to decrase the mortality rate. But the principal is to
lessen the consumption of home-canned food or to provide appropriate
conditions.
Patient
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8
Gender male female female male female male female male




diplopia + + + + +
dysartri + +
dispne + + + + +
emesis-nouse + + + + +
dysphagia + + + +
weakness + + + +
ICU necessary + + + + + +
Outcome recovered recovered recovered recovered recovered recovered recovered recovered
R2256 Prepared pandemic plan for H1N1 in Istanbul metropolis,
April-June 2009: procedures and ﬁrst results
G. Sengoz °, M. Bakar, E. Kina Senoglu, N. Kuzgunkaya, M.T. Ersoy,
U. Kalender, K. Kart Yasar, F. Pehlivanoglu, M.S. Alan (Istanbul, TR)
Objective: The aim of this report is to evaluate the patients with H1N1
inﬂuenza that ﬁrst reported in Istanbul/Turkey between 29th April and
22nd June 2009; to take attention to the infection control measures to
prevent transmission of the disease and to support surveillance activities
for H1N1 inﬂuenza in Istanbul metropolis. Prepared pandemic plan was
applied and consequences of it was controlled via Istanbul Provincial
Health Directorate.
Methods: Between 29th April and 22nd June 2009, probable and
conﬁrmed cases deﬁned by CDC and WHO were evaluated in terms
of age, gender, symptoms, airline agencies and nationalities, laboratory
ﬁndings.
Results: One hundred and sixty probable and 16 conﬁrmed cases were
followed up between 29th April and 22nd June 2009 in Istanbul. The
most seen age group was 20−39 years (81 cases) and male/female ratio
was 1:1. Fever was a universal symptom in patients with H1N1 virus
infection (70%); other symptoms included sore throat (40%), myalgia or
arthralgia (26%), and cough (22%). All of our patients had an identiﬁable
epidemiologic link to another conﬁrmed patient. The largest cluster of
cases of H1N1 virus infection occurred between 15−20 May and 30
May-4 June 2009. KLM was the most used one among airline agencies
in all cases. The most of patients came from USA. Only 5% of patients
were detected in thermal cameras at the airport. Airport staffs composed
10% of all cases. Probable and conﬁrmed cases were isolated in seperate
rooms and treated in referrance tertiary hospitals. Antiviral prophylaxis
was administered to the close contact persons of these cases (2000
persons).
Conclusion: In this pandemic which declared as alarm level 5 by WHO,
the spread of the disease was prevented in our city till production of
H1N1 vaccine by infection control measures and an convenient pandemic
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plan. Preventing an infection to enter a country is as important as to
prevent and slow the spread of epidemic in the global world.
R2257 Evaluation of epidemiological, clinical and laboratory
characteristics of pandemic inﬂuenza A (H1N1) cases in a
tertiary care hospital in Turkey
C. Ataman Hatipoglu °, A.G. Mutlu, C. Bulut, S. Altun, F.S. Erdinc,
G. Tuncer Ertem, S. Kinikli, B. Oral, N. Tulek, A.P. Demiroz (Ankara, TR)
Objectives: In April 2009, a novel H1N1 inﬂuenza A virus, so-called
pandemic H1N1/09 virus was identiﬁed in Mexico. The virus has since
spread throughout the world and caused an inﬂuenza pandemic. In
this report, we present epidemiological, clinical and laboratory data of
hospitalized patients in our clinic between 25 October and 18 November
2009.
Methods: Totally 41 patients hospitalized due to probable pandemic
inﬂuenza H1N1 were evaluated. Nasal and/or nasopharingeal samples
were taken from all patients. These samples were tested for Inﬂuenza A
(H1N1) in Reﬁk Saydam National Public Health Agency, National
Inﬂuenza Reference Laboratory with the real-time RT-PCR. Epidemi-
ologic, clinical and laboratory data were recorded.
Results: Of the patients, 33 were female (80.5%), 8 male (19.5%),
mean age was 39±16.5 years and mean hospital stay was 4.8±1.6
days. Most of the patients were homemaker (65.9%). Only one patient
was vaccinated with the seasonal ﬂu vaccine. One patient had travel
history and eight patients had history of close contact with persons
having symptoms of respiratory infection. Of patients, 15 (36.6%)
hadn’t any underlying condition. Ten patients (24.4%) were pregnant.
Other 16 patients (39%) had one or more underlying conditions
including DM, chronic obstructive pulmonary diseases, coronary artery
diseases, FMF, multiple myeloma, multiple sclerosis and Behcet’s
disease. On admission, most common symptoms were cough, fever,
myalgia, headache and sore throat (92.7%, 90.2%, 85.4%, 68.3% and
65.9%, respectively). Twelve patients (29.3%) had dyspnea on the
admission but none of them required mechanical ventilation. On the
physical examination, 31 patients (75.6%) were febrile; the mean degree
of the fever was 38.1±0.9ºC (36.5−40ºC). Thirteen patients (31.7%)
had crepitation on the lung. In the laboratory investigations, mean
hemoglobin, WBC, platelet, AST, ALT, ALP, blood urea, creatinine,
LDH and ferritine levels were within normal limits. Mean GGT and
CK levels were detected high and mean zinc level was detected low
than normal limits. Of patients, 32 (78%) were found PCR positive for
pandemic Inﬂuenza. Thirty-seven patients (90.2%) received oseltamivir
therapy (75mg twice daily) and 19 (46.3%) received antibiotics. No
patient dead.
Conclusion: Most of our patients had underlying conditions but they
recovered without complication. We think that pregnant women and
patients with other underlying conditions must closely follow-up.
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R2258 The ﬁrst conﬁrmed case of a human infected with
Mycoplasma suis in Serbia
G. Canak, A. Potkonjak, R. Doder °, B. Lako, S. Brkic, V. Turkulov
(Novi Sad, RS)
Objective: The pig infection with Mycoplasma suis is very well-
known and described in veterinary medicine. According to the new
classiﬁcation, the cause can be found in the group of haemotrophic
mycoplasmas, and previously it used to be classiﬁed as belonging to the
genus of Eperythozoon. During the last decade more and more reports
have conﬁrmed the presence of Mycoplasma suis among people as a
cause of a new zoonosis. Many issues are unfamiliar in connection
with epidemiology, clinical picture, diagnostics and therapy of this
infection among people. It is considered to be an opportunistic infection
that occurs among immunocompromised patients. The aim of this
research was to conﬁrm possible presence of this infection among human
population in Serbia.
Methods: In order to determine the presence of Mycoplasma suis in
EDTA human blood samples, we used a classical PCR test with primers
speciﬁc for a genetic sequence that codes MSG1 protein of Mycoplasma
suis (MSG1 is an immunodominant protein (p40) localised on the surface
of the cause with adhesive function).
Results: By applying the described PCR test in EDTA blood sample of
the patient who underwent hemodyalisis, we have conﬁrmed the presence
of Mycoplasma suis.
Conclusions: This is the ﬁrst conﬁrmed case of human infection
with Mycoplasma suis registered in Serbia. Further epidemiological
and clinical research is necessary, considering that many data on this
infection of humans are not familiar.
R2259 Clinical features of patients with conﬁrmed infection from
A/H1N1 virus
G. Kalpakou °, P. Stravopodis, V. Aggelopoulou, I. Litrokapis,
M. Verikiou, D. Gouga, A. Koutroubi, T. Bourinaris, O. Sidirokastriti,
M. Spinou (Zante, Kalamata, GR)
Objective: To describe the clinical presentation of patients with
conﬁrmed A/H1N1 infection and to compare them with other patients
who were negative for A/H1N1 virus.
Methods: More than 800 patients presented to our hospital with ﬂu-like
symptoms since the beginning of the A/H1N1 pandemic. In 156 of them
a pharyngeal sample for PCR test was obtained. Most of the samples
were obtained during the surveillance phase, in order to identify and
isolate patients and thus to prevent the spread of the disease.
Results: From the 156 samples, 103 were positive and 53 were negative.
The table summarizes the symptoms of both the patients groups.
Conclusions: Among patients with positive PCR the prominent
symptoms were malaise and fever. Generally, the more typical clinical
presentation was more likely to lead to a positive test. It should not
be ignored though, the fact that there were cases with low fever and
very mild disease that were proved to be positive, while others with
more typical clinical presentation were negative. Patients who had not
strong possibility (based on their clinical condition) to be positive but
were tested for safety reasons (e.g. people with immunocomprimised
members in their families) were most likely to be negative.
Symptoms Positive PCR Negative PCR
Fever 90 (87.3%) 41 (78.6%)
Cough 81 (78.6%) 32 (60.1%)
Sore throat 67 (64.9%) 35 (65.8%)
Myalgia 80 (77.6%) 44 (82.7%)
Malaise-weakness 96 (93.1%) 48 (90.2%)
Headache 75 (72.7%) 27 (50.7%)
Rhinorrhea 47 (45.5%) 22 (41.3%)
Vomit 9 (8.7%) 4 (7.5%)
Diarrhea 14 (13.5%) 7 (13.1%)
R2260 Cases of Waterhouse-Friderichsen syndrome over a 3-year
period
A. Petrov °, N. Vatev, M. Stoycheva, M. Pishmisheva, I. Boev,
C. Venchev (Plovdiv, BG)
Introduction: Waterhouse-Friderichsen syndrome (WFS), known in the
Anglo-Saxon literature as “hemorrhagic adrenalitis”, is a disease of the
adrenal glands, caused most often by Neisseria meningitidis. Syndrome
bears the names of the English doctor Rupert Waterhouse (1873–
1958) and Danish pediatrician Carl Friderichsen (1886–1979), who ﬁrst
described it.
Material and Methods: For three-years period 2007–2009, we discuss
four cases of Waterhouse-Friderichsen syndrome. These are children,
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respectively, 14 year, 2 year, 6 year and 3 months old, who were treated
in the intensive care ward of the Infectious Diseases Clinic − Plovdiv
and in Infectious Disease unite, Pazardjik. Hospitalization time is during
1 hour 40min to 10 hour 10min and the outcome is fatal for four cases.
Results and Discussion: 1. T.Z.Z. − 14 year. Suddenly fell ill with
high fever, repeated vomiting, fast-growing hemorrhagic rash. After a
generalized tonic–clonic convulsion − asistoliya and exitus letalis. CSF:
cells − 8.106, protein − 0.97 g/l, glucose − 4.2mlmol/l. 2. K.S.K. −
6 year old. Admission − shock, hypothermia − 35ºC, hemorrhagic rash −
petechiae, ecchymoses covering the entire surface of the body. PLT −
34.1012, ﬁbrinogen − 1.39 g/l. 3. H.A.H. − 3 months old baby. 4. I.F.A. −
2 years old − the illness begins with repeated vomiting.
Culture: CSF on BACTEC - Neisseria meningitidis.
Conclusion: In the four cases there are irresistible bacterial sepsis,
disseminated intravascular coagulation (DIC), shock and adrenal
insufﬁciency.
R2261 First detection of Lymphogranuloma venereum L2b serovar
in Madrid, Spain
M. Rodriguez-Dominguez, B. Menendez, L. Alonso, J.M. Gonzalez-Alba,
T. Puerta, P. Clavo, J. Ballesteros, F.J. Gonzalez-Sainz, R. Canton,
T. Hellin, J. Del Romero, J.C. Galan ° (Madrid, ES)
Objective: The reported number of Chlamydia trachomatis (CT)
associated with lymphogranuloma venereum (LGV) has increased in the
last decade (around 10%/year) with small outbreaks since 2003 described
in Europe. However in Spain only sporadic cases have been reported
in North and Northeast areas. We explore the presence of serovars
associated to LGV among high risk population in Madrid, Spain, and
the usefulness of molecular methods to detect and genotype CT-LGV
associated serovars.
Methods: Two high risk population groups from our city were included
in this study: i) sentinel population and ii) patients attended in the 2
Units of Sexually Transmitted Infections (STI) in two public hospitals.
496 urethral, cervix and rectal swabs from symptomatic patients were
recovered during six months (May-October, 2009). Two commercial
PCR-based methods (Abbott Molecular and Beckton Dickinson) were
performed for routine diagnostic of CT infection. An in-house TaqMan
real time-PCR (qPCR) based in a deletion on the pmpH gene was
used to speciﬁcally detect LGV related serovars (L1, L2 and L3). To
identify speciﬁc serovars, nested-PCR and sequencing of ompA gene
were applied.
Results: 34 samples from sentinel population and 20 from group-
ii yielded a positive CT ampliﬁcation, which represent 10% of
analysed samples. Among these positive samples, 6 showed also speciﬁc
ampliﬁcation for L-serovars (11%), one urethral and ﬁve rectal swabs.
These results were obtained in 6 men who have sex with men, with
multiple sexual partners during last year. Interestingly, four patients
were Spanish, indicating spread of LGV among native population. Four
of them were HIV positive and all had concomitant STI: three had
gonococcal proctitis, two infections by high risk papilomavirus and one
herpes simplex infection. BLAST analysis of the sequence of the ompA
gene shows concordance with the L2b serovar in all cases, as has been
previously described in recent outbreaks in Europe.
Conclusion: To our knowledge, the percentage of L2b serovar found in
this work (11%) is the highest value published in Spain, conﬁrming the
spread of this serovar across Europe. The high correlation between CT-
positive and L2b serovar in native population suggests that this serovar
is already established among Spanish population. From the public health
perspective, routine surveillance of LGV may be important to assess its
real prevalence in high risk population.
R2262 Isolation of Clostridium difﬁcile from marine coastal
environment (Gulf of Naples, southern Italy)
V. Pasquale, V. Romano °, K. Krovacek, I. Ciznar, F. Aliberti,
V. Saggiomo, S. Dumontet (Naples, IT; Uppsala, SE; Bratislava, SK)
Objectives: The aim of this study was to evaluate the occurence
of Clostridium difﬁcile in a coastal environment of the Gulf of
Naples (Southern Italy) exposed to different degrees of anthropic
pressure. Samples of seawater, sediments, mussels and zooplankton were
investigated for the presence of C. difﬁcile in order to provide a ﬁrst
ecological insight to the environmental behaviour of this bacteria.
Methods: Samples of water, sediment, mussels (Mytilus galloprovin-
cialis) and zooplankton were taken at 5 sampling stations in the Gulf of
Naples, on September 2009. The samples were enriched in Clostridium
difﬁcile Enrichment Broth supplemented with 0.1% sodium taurocholate
and then incubated for 10 days at 37ºC in anaerobic conditions. After
incubation, alcohol shock and centrifugation were performed for spore
selection and the resulting pellet was streaked onto a C. difﬁcile Agar
Base supplemented with Moxalactam Norﬂoxacin and 5% horse blood
and incubated for 48 h in the same conditions. Rhizoid colonies of spore-
forming Gram positive bacilli, non-hemolytic and positive to proline
aminopeptidase test (Oxoid) were identiﬁed by miniaturized system Id
Rapid 32A (bioMeriux). The identiﬁed C. difﬁcile strains were then
challenged for the detection of esotoxins by Xpect Clostridium difﬁcile
Toxin A/B Test (Oxoid).
Results: The results of this work shown a widespread presence of
C. difﬁcile in the investigated marine environment. A total of 17 samples
was taken yielding 6 isolates with a positivity rate of 40%. C. difﬁcile
has been isolated from 2 samples of water, 3 of zooplankton and 1 of
mussels, respectively. All the 4 isolates founded in water and zooplankton
samples collected in a very faecal polluted area were found able to
produce C. difﬁcile Toxin A/B. The isolates found in an area with low
faecal pollution were non toxigenic.
Conclusions: The presence of C. difﬁcile in mussels is certainly related
to the presence of this bacterium in water, as mussels are ﬁlter feeders. It
is to clarify wheter C. difﬁcile was associated to the particulate organic
matter or it can also be member of the planktonic microbial community.
The isolation of C. difﬁcile as epizootic contaminant of zooplankton
exoskeleton was never reported before. Further studies are needed to
understand how the zooplankton enables the spreading of this bacterium
in the environment, especially in areas with low or absent faecal
pollution.
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R2263 Pharmaceutical equivalence of some commercial samples of
artesunate and amodiaquine tablets in south-western Nigeria
O. Odunfa °, C. Onaga, A. Adegoke (Ibadan, NG)
Purpose: To study the physical properties and dissolution proﬁles of
commercial samples of artesunate and amodiaquine tablets.
Method: Fifteen generic brands of artesunate and ﬁve generic brands of
amodiaquine tablets were obtained from drug retail outlets in Oyo and
Ogun States of Nigeria. The tablets were subjected to various compendia
tests including identiﬁcation, weight uniformity, uniformity of content,
assay of active ingredient and uniformity of diameter. Additional tests
used as a basis of the assessment of the pharmaceutical equivalence of
the products include hardness, disintegration time and dissolution rate.
Data obtained were analysed by correlation analysis, Chi-square and
ANOVA.
Results: Thirteen generic brands of artesunate (87%) and four
amodiaquine brands (80%) investigated were imported. Two brands
of the imported artesunate brands were found to contain undetectable
amount of artesunate while another 8 samples contained overages. All
the amodiaquine brands passed the assay test as stipulated by the USP
for amodiaquine tablets while tablet disintegration time of amodiaquine
products ranged from 5.8–20.7 min. All but one artesunate sample (B2)
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passed the disintegration test too. Majority of the artesunate brands tested
had signiﬁcantly different dissolution proﬁles (P< 0.05). Four (80%) of
the amodiaquine tablet brands tested had similar dissolution proﬁles and
percent drug released within 30 min (p> 0.05). One amodiaquine brand
CC demonstrated poor dissolution proﬁle as it did not meet the essential
minimum of content dissolution within 30min.
Conclusion: The detection of substandard artesunate tablets and a poorly
formulated amodiaquine tablet amongst the few sample brands studied
highlights the need for increased drug surveillance and monitoring of the
qualities of antimalarial medicines currently in use in order to prevent
widespread treatment failure.
R2264 Nosocomial infections after colonic surgery
C. Ezpeleta °, I. Atutxa, J.A. Alava, E. Gomez, M.J. Unzaga, A. Arias,
R. Cisterna (Bilbao, ES)
Objective: The aim of this study is to know the rate of Surgical Site
Infection (SSI) and other nosocomial acquired infections (NI) after
colonic surgery in our hospital and the evolution of SSI after changes
in antibiotic prophylaxis schedule.
Patients and Methods: The Infection control team prospectively studied
all patients operated on colon surgery from October 2002 to October
2009. Variables under surveillance are age, sex, underlying illnesses,
predisposing conditions, ASA physical status classiﬁcation, NNIS risk
index, antibiotic prophylaxis, nosocomial infections, microorganisms,
length of hospital stay, treatment and outcome. Antibiotic prophylaxis
schedule in our hospital is neomycin + erythromycin po and amoxicillin
+ clavulanate IV (AMC). We have introduced the administration of a
second dose of AMC if the length of surgery is >6 hours or hemodilution
>15ml/kg or blood loss >1.5 l. Case deﬁnitions: CDC deﬁnitions for
Nosocomial infections. Surveillance after discharge: 1 month.
Results: 1541 patients were studied, 1000 of them were males, mean
age 67.6 y (SD 12.8). 345 patients (22.38%) had 485 NI: 281 surgical
site, 92 UTI, 48 bacteremia, 35 local catheter insertion site infection,
20 respiratory, and 9 other locations. Cumulated incidence of infected
patients 22.39%. Antibiotic prophylaxis was administered in 99.5% of
the cases. The dosage, time, drug and duration of the prophylaxis were
appropriated (99.9%, 99.7%, 97.3% and 93.3% respectively). Surgical
site infections (SSIs) 287 cases: superﬁcial incisional SSIs (109), deep
incisional SSIs (76) and organ/space SSIs (96). Cumulated incidence
patients with SSIs 16.87%, it decreased from 18.69% in 2003 to 9.69%
in 2009. NNIS Score 0: 560 patients, 10.5% SSIs; Score 1: 516 patients,
21.3% SSIs; Score 2: 197 patients, 31% SSIs; Score 3: 46 patients,
32.6% SSIs; score M 222 patients, 6.8% SSIs. Microorganisms in SSI:
E. coli 92, Enterococcus spp. 33, Bacteroides 39. Mean length of hospital
stay 30.1 days (SD 26) in patients with NI and 11.9 days (SD 8.6) in
patients without NI. Crude mortality 2.8%: 7.8% in patients with NI and
1.3% without NI.
Conclusions: Cumulative incidence of SSIs in our hospital decreased
from 18.69% in 2003 to 9.69% in 2009. The only change introduced
was the timing of antibiotic prophylaxis administration: 5 minutes before
surgery and the second dose of antibiotic if the length of surgery is
>6 hours or hemodilution >15ml/kg or blood loss >1.5 l.
R2265 “To pronto or not to pronto . . . ”: MRSA topical bio-burden
reducing regime failures − a clinico-economic study
S. Aggarwal °, J. Tipping, B. McAlea, A. Guleri (Blackpool, UK)
Background: Staphylococcus aureus carriage increases the potential for
post-op infections, mortality and associated costs. Since Mar 09 NHS
hospitals in UK are committed to screen all patients for elective surgery.
Cancelled/delayed surgery upon MRSA detection or failure to clear
MRSA carriage after repeated courses of topical bioburden reducing
regime(TBR) enhances patient anxiety, depression and affects quality of
life.
Since Mar 09 conventional TBR regime [mupirocin & chlorhexidine]was
replaced by Prontoderm® (BRAUN) pack[nasal gel & body/hair foam]
for elective patients. MRSA screen protocol for electives includes
nasal & perineal swab at PAC; MRSA+ve patients are offered 5-days
TBR followed by repeat screens on days 3, 7 & 14 [3-negative MRSA
screen [NMS] before booking for surgery.
MRSA TBR Failure Clinic [MTFC]: PAC orthopaedics and cardiac
surgery nurse specialists & microbiologist set this clinic following
concerns regarding TBR failure, delayed surgeries, patient safety and
experience.
MTFC protocol: Individualised plan is offered to patients failing TBR
based on the urgency of surgery. MRSA recolonisation study and source
exploration [gut carriage, partner carriage, etc]. The three 5-day regimes
used: Regime A [Prontoderm® pack]; Regime B [mupirocin nasal plus
chlorhexidine body wash/shampoo]; Regime C [Regime B + doxycycline
and rifampicin].
Method: Data collected from MTFC and the pathology database.
Results: Since Mar09, 19 patients [>1000 screened] beneﬁtted from the
clinic.
Ortho (15 pts]:27%[4/15] had 3NMS after regA; 36%[4/11]had 3NMS
following 2nd course regA; 29%[2/7] had 3 NMS after regB; 20% [1/5]
had 3NMS after regC. Remaining data pending.
Cardiac(4pts):100% failed NMS with regA; 25%[1/4] had 3 NMS after
2nd course regA; remaining 100%[3/3] failed regB. 33.3%[1/3]each had
3 NMS after regC; 2NMS then positive; data pending.
Conclusion: Ortho & cardiac PAC attendees have <3% MRSA carriage.
21%[4/19] had 3 NMS following regime A (prontoderm) whilst
79% required individualised management plans (based on urgency of
surgery, risk of SSI and MRSA recolonisation studies). The clinic has
been immensely successful (several patients requiring urgent cardiac
surgery were operated on the day after completion of regC using
Teicoplanin prophylaxis. Prontoderm® pack requires no prescription,
supplied in PAC, user friendly info leaﬂets & 38% cheaper. Patients ﬁnd
chlorhexidine shower more cleansing than prontoderm foam application
after shower on dry skin.
R2266 Stethoscope audit: do not forget to clean your third hand!
N. Altaie °, E. Roberts (Wrexham, UK)
Objective: The importance of immediate hand decontamination before
and after direct patient contact has been well accepted and practised
for many years. However comparitavely little research looks into risk of
spreading infection via stethoscopes; a medical equipment that has direct
contact with all patients examined. The aim of this audit was to assess
bacterial contamination on stethoscopes and to assess the effectiveness
of the proposed cleaning method using an alcohol wipe.
Method: Forty stethoscopes were randomly selected from a wide range
of medical personnel in the Intensive Care Unit (ICU), Medical High
Dependency Unit (MHDU), Accident & Emergency (A&E) and Medical
Department (MD). Stethoscopes were swabbed before and after cleaning
with an alcohol wipe (70% Isopropyl Alcohol). Samples were sent for
culture and results expressed as counts of colony forming units (CFU)
per 5ml ringer solution used to prepare each swab.
Results: Overall results showed 82% of stethoscopes before cleaning
were contaminated with skin ﬂora. Average contamination was 921.25
CFU. All contamination was reported as skin ﬂora which includes poten-
tially pathogenic Staphylococcus Aureus and Pseudomonas Aerginosa.
A&E had the lowest average of contamination per stethoscope with
115 CFU and 2/10 clean (0 CFU). A third (3/9) of stethoscopes in
ITU/HDU were clean. The average contamination was 411 CFU, however
1 stethoscope grew >2000 CFU. The MD had the highest number of
contaminated stethoscopes and an average of 1523.8 CFU, only 2/21
were clean.
Following cleaning the results showed 39/40 (97.5%) stethoscopes grew
0 CFU (Fig.5). The remaining stethoscope accounting for the last 2.5%,
grew 50 CFU prior and after cleaning; possibly there was an error in the
cleaning process.
Conclusion: This audit demonstrates the importance of cleaning
stethoscopes before and after patient contact as this is a plausible
vector for transmitting potentially pathogenic infections. It proves
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the effectiveness of the cleaning method which erradicates bacterial
contamination to 0 CFU in 97.5% of cases. Whilst focus must be
maintained on hand washing, we also advise cleaning stethoscopes.
Improving staff knowledge is vital and could be achieved by ward
posters, easy access to alcohol wipes and presenting the result of
this audit. Further research is required to see if conditions improve
with proposed interventions and looking speciﬁcally at transmission of
hospital acquired infections via stethoscopes.
R2267 An integrated approach to control ICU-associated infections
focusing on antimicrobial consumption and resistance rates
A. Agodi °, F. Auxilia, M. Barchitta, R. Iatta, M.D. Masia,
M.T. Montagna, V. Torregrossa, I. Mura on behalf of the GISIO/Italian
Study Group of Hospital Hygiene
Objectives: The emergence and spread of antimicrobial resistance has
become a major public health threat and antimicrobial usage is a key
factor for resistance because it allows selection or emergence of resistant
pathogens. The main objective of our study was to provide Intensive
Care Unit-speciﬁc and national benchmark data both on antimicrobial
consumption and on resistance rates (RR).
Methods: Intensive Care Units (ICUs) already participating in the ﬁrst
edition of the Italian Nosocomial Infections Surveillance in Intensive
Care Units (Sorveglianza Prospettica delle Infezioni Nosocomiali nelle
Unita` di Terapia Intensiva − SPIN-UTI), established by the Italian Study
Group of Hospital Hygiene (GISIO) of the Italian Society of Hygiene
(SItI) were invited to take part in the study. The project used an integrated
approach: a unit-based approach for the surveillance of antimicrobial
use and a patient-based approach for the surveillance of antimicrobial
resistance in Italian ICUs.
Results: The study was conducted between November 2006 and
April 2007, and included 21 ICUs, 1685 patients with length of
stay longer than two days and 18,694 patient-days, producing a total
of 79,423 deﬁned daily doses (DDDs). During the study period,
the antimicrobial usage density (AD = DDD/1000 patient days) was
4,248.47 DDD units per 1000 patient-days. The three most used drug
groups were penicillins/b-lactamase inhibitors (AD 13,921), quinolones
(AD 12,806) and glycopeptides (AD 7,453). The single most frequently
prescribed antimicrobial agent was ampicillin/sulbactam (DDDs 12,220;
AD 653.7), followed by levoﬂoxacin (DDDs 9,940; AD 531.7) and
ﬂuconazole (DDDs 8,836; AD 472.7). Susceptibility data were reported
on 353 isolates. The most frequent infection-associated pathogen was
“Pseudomonas aeruginosa” followed by “Acinetobacter baumannii”
and “Staphylococcus aureus”; “Candida” spp accounted for 4.3%.
RR were 95.3% and 48.0% for ceftazidim-resistant “A. baumannii”
and “P. aeruginosa” respectively; 83.3% and 35.2% for imipenem-
resistant “A. baumannii” and “P. aeruginosa” respectively, and 47.6%
for oxacillin-resistant “S. aureus”.
Conclusion: Comparison of resistance patterns and prescribing practices
in different ICUs underlines the need for locally adapted guidelines
on empiric antimicrobial therapy, based on the evidence of the link
between antimicrobial resistance and consumption and on international
benchmarking, in order to address effective control measures.
R2268 Utilization state of analysed data in Japan Nosocomial
Infections Surveillance (JANIS)
K. Yamane °, S. Suzuki, A. Tsutsui, M. Matsui, Y. Arakawa (Tokyo, JP)
Objectives: Nosocomial infections with drug-resistant bacteria have
become a great concern in medical facilities. The Japan Nosocomial
Infections Surveillance (JANIS) has been conducted by the Ministry
of Health, Labour and Welfare since 2000, and the system was
renewed in July 2007. JANIS consists of ﬁve divisions; the Clinical
Laboratory Division (CL), Antimicrobial-Resistant Bacterial Infection
Division (ARBI), Surgical Site Infection Division (SSI), Intensive Care
Unit Division (ICU), and Neonatal Intensive Care Unit Division (NICU).
@All analyzed data reported to each participating hospital are displayed
as gbox-plot h manner and this lets each hospital notice its position
in the distribution of participating facilities in Japan. Several data
such as isolation frequency of each drug-resistant bacterium and each
infection rate with speciﬁc antimicrobial resistant microbe are reported
periodically to each participating hospitals, together with the trends.
However, there is no data about the utilization rates of analyzed data
in participating hospitals, despite all the participants can download their
own analyzed data by PDF ﬁle through their personal website constructed
in the JANIS homepage.
Methods: We investigated the download frequencies of analyzed data in
all the participating hospitals in 2008 to estimate the utilization rate of
analyzed data in individual participating hospital.
Results: A total of 817 hospitals were participating in JANIS as of
October 2009. The number of hospitals of each division were 564 in
CL, 427 in ARI, 301 in SS, 141 in ICU, and 111 in NICU. Download
ratios of PDF ﬁle through the own homepage were 59.6% in CL, 47.4%
in ARBI, 82.9% in SSI, 75.4% in ICU, and 63.8% in NICU. In ARBI,
18.2% of participating hospitals did not download the analyzed data at
all.
Conclusion: We become aware of the fact that the JANIS participating
hospitals do not necessarily well utilize analyzed data for their infection
control measures. Our next step is to investigate the reason why several
hospitals hardly use the analyzed data. To encourage all participating
hospital to improve their infection control measures, we intend to present
good samples of efﬁcacious and prudent use of analyzed data especially
to those hospitals where analyzed data have been hardly utilized to date.
R2269 Survival of Acinetobacter baumannii with Acanthamoeba sp.
E. Cateau °, J. Verdon, B. Fernandez, C. Imbert, Y. Hechard,
M.H. Rodier (Poitiers, FR)
Objective: Acinetobacter baumannii, potentially found in water sources,
is an important emerging hospital-acquired pathogen, affecting patients
in intensive care units. It is also known that protozoa can inﬂuence
the growth of microorganisms as bacteria or yeasts, but little is known
about the inﬂuence of free-living amobae on A. baumannii. We therefore
explore in this study the relationships during a coculture of two strains
of Acanthamoeba (A. castellanii or A. culbertsoni) and one strain of
A. baumannii.
Methods:
– The ﬁrst experiment was a coculture of A. castellanii (ATCC 30234) or
A. culbertsoni (ATCC 30171) trophozoites and A. baumannii in PBS
at 27ºC. After 24, 48 or 72 h, the cocultures were plated on Mueller
Hinton medium to count CFU. Controls were realized by incubating
bacteria in the same conditions without amoebae.
– The same experiment was then conducted, but after 24 h, the
cocultures were transferred in encystment medium, and CFU of
A. baumannii were counted after 1, 3, 5, 7, 14, 21, 30 and 60 days
of incubation at 27ºC. Moreover, at various times, samples of the
suspensions were examined in electron microscopy.
Results:
– In the coculture experiments realized in PBS at 27ºC, the presence
of A. castellanii or A. culbertsoni induced a major increase in
A. baumannii growth, compared to the control.
– Concerning the incubation in encystment medium after 24 h of
coculture, the results showed a marked persistance of the viability
of A. baumannii in the presence of Acanthamoeba. The electron
microscopy showed internalized bacteria in trophozoites after 24 h of
coculture. After 10 days in encystment medium, bacteria were found
within cyst wall.
Conclusion: Under certain conditions, the survival and growth of
A. baumannii is favored by Acanthamoeba strains. So, in hospital water
systems, a special attention should be paid to the presence of free living
amoebae, which can promote A. baumannii growth.
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R2270 Laboratory-based surveillance system of sexually
transmitted infections in Italy
M.C. Salfa, M. Giuliani, V. Regine, L. Camoni, M. Raimondo,
M.A. Latino, G. Audisio, P. Clerici, I. Caola, M.L. Modolo, R. De
Rosa, M. Busetti, A. Sensini, P. Pauri, C. Fontana, C. Giraldi,
R.A. Leone, P. Minchella, L. Tagliaferro, A.R. Bruno, B. Suligoi °
(Rome, Turin, Collegno, Legnano, Trento, Pordenone, Trieste, Perugia,
Jesi, Cosenza, Lamezia Terme, Lecce, Galatina, IT)
Objective: To assess the prevalence of Chlamydia trachomatis (Ct),
Neisseria gonorrhoeae (Ng) and Trichomonas vaginalis (Tv) infections
among Italian general population using a Laboratory-based Surveillance
System.
To evaluate the role of this system to add knowledge on the circulation of
Sexually Transmitted Infections (STIs), already monitored by a National
Surveillance System based on STI clinics.
Methods: In 2009, the Istituto Superiore di Sanita`, in collaboration with
the Associazione Microbiologi Clinici Italiani, launched a programme
for the surveillance of new case of Ct infection, as well as Ng and Tv.
The data are provided by 13 large clinical microbiology laboratories,
with high clinical-diagnostic standards, located in the main areas of Italy
(Northern, Central and Southern), which collect data on all individuals
who undergo testing for Ct, Ng and Tv infections. Socio-demographic,
clinical and behavioural informations are also collected. For each
individual, laboratories may report the possible identiﬁcation of more
than one pathogen.
Results: From 1 April to 30 September 2009, 9,570 individuals have
been tested, 90.0% of these were female and 11.6% were non-nationals.
The median age of individuals was 34 years (IQR=29−40 years). A
total of 4,275 individuals (50.0%) were asymptomatic and 29.8% of
the women were pregnant. Of the individuals, 76.4% had no used any
contraceptive and 90.1% reported having had one sexual partner, in the
previous six months.
In total, 8,490 (88.7%) individuals were tested for Tv infection, 7,333
(76.6%) for Ct and 5,178 (54.1%) for Ng. The prevalence of Tv, Ct and
Ng was 0.7%, 3.5% and 0.5%, respectively. The highest prevalence was
observed among symptomatic and asymptomatic males, for Ct (15.5%
and 6.4%, respectively) and Ng (4.4% and 0.5%, respectively), and
among symptomatic and asymptomatic women for Tv (0.9% and 0.5%,
respectively).
The positivity for Ct was associated (p value for c2 < 0.001) with younger
age (14−24 years vs. >24 years of age, 9.0% vs. 2.7%), having had two
or more partners in the previous six months (2 vs. 0−1 partners, 12.5%
vs. 2.6%) and having used oral contraceptive in the previous six months
(oral contraceptive vs. other, 5.4% vs. 2.8%).
Conclusions: Preliminary results from the Laboratory-based Surveil-
lance System of STIs seem to suggest important data on the circulation
of these infections among individuals more like to general population
than those consulted in STI clinics.
R2271 Employing ATP detection technology (3M Clean-Trace)
to improve cleaning standards and practices in different
clinical areas
H. O’Connor °, R. Manzoor, F.M. Awadel-Kariem (Stevenage, UK)
Background: To control hospital infections new ways to improve
cleaning processes are needed. The 3M Clean-Trace Clinical Hygiene
Monitoring System, which employs ATP detection technology, has been
validated by the rapid review panel to provide a rapid quantiﬁable
assessment of the quality of the cleaning process as part of a structured
approach to hygiene monitoring. Our hospital has recently introduced
generic ward and clinic based cleaning schedules, designed by the
Infection Prevention & Control Team, to focus all staff on cleaning the
patient equipment and on being able to demonstrate that they had done
so through documentation.
Objectives: To use Clear-Trace technology as a tool to look at the
value of implementing ward based cleaning schedules with the aim of
improving the cleaning standards of medical equipment.
Methods: Two clinical areas were selected: a minor surgery treatment
room and a surgical ward. Ten sites in each clinical area were identiﬁed.
A written plan was produced to enable the swabs to be taken at the
exact same sites and at the same time every day for 2 weeks prior
to the schedules being implemented. Following the introduction of the
schedule, swabs were collected daily for 5 days per week for 4 weeks.
No feedback was given to staff for the ﬁrst two weeks post-schedule. For
the last 2 weeks post-schedule daily feedback was given to the senior
nurse and the manager of the cleaning staff.
Results: The background swabbing of sites identiﬁed the areas where
cleaning needed to be improved upon. The commencement of the
cleaning schedules did focus staff on cleaning, which led to improved
documentation of the cleaning process, as expected. However, some sites
continued to give high signal in the ATP swabs. When feedback was
given to staff cleaning improved on all sites, with low ATP signals. Ease
of access for cleaning of particular pieces of equipment was found to
affect the likelihood of cleaning taking place. An example of this was
the x-ray light box which was sited too high for most staff. The box was
removed following discussion with staff.
Conclusions: The study identiﬁed the beneﬁt of introducing the cleaning
schedule as it refocused staff on the need to be vigilant in cleaning
equipment between patients and on the value of documenting equipment
cleaning practices. The Clean-Trace system has been useful as it provided
a tool to audit the cleaning quality.
R2272 Mupirocin resistance in methicillin-resistant Staphylococcus
aureus and use of intranasal mupirocin
T. Delgado °, I. Montesinos, M. Cuervo, S. Campos, M. Miguel,
A. Sierra (La Laguna, ES)
Objectives: To determine the rates of mupirocin resistance in
methicillin-resistant Staphylococcus aureus (MRSA) and the efﬁcacy
of intranasal mupirocin (3 days versus 5 days) in reducing nasal
colonization with MRSA.
Methods: Hospitalized patients admitted at a university hospital (650
beds) were screened for MRSA nasal colonization according to
established hospital guidelines. Isolation and identiﬁcation of MRSA
were based upon standard microbiological procedures. All isolates were
tested for resistance to mupirocin (Mup) with a 5 mg disk (zone of
inhibition 13mm). Mup resistance organisms underwent MIC analysis
by the Etest (high-level resistance was deﬁned as a MIC of 512mg/L
and low-level resistance was deﬁned as a MIC of 8 to 256mg/L).
MRSA nasal carriers received mupirocin ointment applied to the anterior
nares 3 times daily for 3 days (April 2000 to January 2003) or for 5
days (February 2003 to December 2004). Follow-up nasal samples for
culture were obtained two days after completing treatment and successful
decolonization was considered to have been achieved if results were
negative.
Results: Between April 2000 and December 2004 we detected 326
nasal carrier of MRSA. Overall, 84.36% were susceptible to mupirocin
(93%, 90%, 87%, 76% and 82% in 2000, 2001, 2002, 2003 and 2004
respectively), 4.29% had low-level resistance and 11.35% had high-level
resistance. A total of 209 nasal carriers of MRSA Mup susceptible were
treated with mupirocin and follow-up samples were obtained (from April
2000 to January 2003, 118 patients were treated for 3 days and from
February 2003 to December 2004, 91 patients were treated for 5 days).
After treatment for 3-days, successful decolonization occurred in 82% of
patients and 92% of patients who received 5-days course (p = 0.03). The
other 117 patients did not received Mup treatment or were not available
for follow-up because they were lost (63 had discharged or had died),
Mup resistance (51) or they had multiple skin lesions (3).
Conclusions: Treatment with topical mupirocin for 5 days was more
effective in eradicating MRSA nasal colonization but the rate of Mup
resistance increased. In order to control increase of Mupirocin resistance,
use among patients identiﬁed as MRSA nasal carriers and continue
screening for resistance to mupirocin.
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R2273 Germinate to exterminate: the role of the tetracyclic region
of sodium taurocholate in the germination of spores of
Clostridium difﬁcile ribotype 027
C.J. Lowden °, L.J. Wheeldon, D.L. Rathbone, P.A. Lambert,
T. Worthington (Birmingham, UK)
Objectives: To investigate the germinating efﬁcacy of sodium tau-
rocholate on dormant spores of C. difﬁcile ribotype 027 at room
temperature following the partial acetylation of the compound’s
tetracyclic region.
Methods: Sodium taurocholate (ST) was partially acetylated by means
of acetyl chloride in dimethylformamide. The derivatives were then
used to prepare a germination solution comprising 2% (w/v) ST
in double strength thioglycollate medium. To assess if acetylation
of the tetracyclic region of ST affects its germination potential,
a suspension-germination test system was designed which consisted
of inoculating the derivatized germination solution with C. difﬁcile
ribotype 027 (2.6×106 cfu/mL). Control suspension-germination assays
comprised 2% (w/v) non-derivatized ST in double strength thioglycollate
germination solution. After 1 hour incubation at room temperature
the samples were re-suspended in Wilkins-Chalgren anaerobic broth,
and heated to 70ºC for 10 minutes to eliminate spores which had
germinated. Control suspensions were kept on ice. Suspensions were
then inoculated onto fastidious anaerobic agar supplemented with 5%
deﬁbrinated horse blood agar and 0.1% ST and incubated at 37ºC in
anaerobic conditions. Total viable counts from the samples comprising
derivatized sodium taurocholate and non-derivatized sodium taurocholate
were then determined.
Results: Partial acetylation of ST signiﬁcantly reduced its germination
potential compared to non-acetylation of the compound (P< 0.05).
Following exposure to the germination solutions and subsequent heat
shock, 94.7% of C. difﬁcile O27 spores remained viable in the presence
of partially acetylated ST, whilst 99.1% of spores were eliminated in the
presence of the non-derivatized formulation.
Conclusion: Germination of C. difﬁcile spores remains poorly under-
stood, however, a clear comprehension of the underlying process may
pave the way for novel prevention and treatment strategies. The results
from this investigation offer an insight into the germination of C. difﬁcile
spores and clearly indicate that the tetracyclic region (and/or hydroxyl
groups) of ST play a major role in the germination process. Further
studies are clearly warranted.
R2274 How much do healthcare workers pay attention to hand
hygiene in hospital?
M.A. Yetkin °, D. Kanyilmaz, P. Onguru, E. Akinci, A. But, G.R. Yilmaz,
S.S. Eren, N. Avci, A. Ceylan, I. Cinarbas, H. Bodur (Ankara, TR)
Objective: Optimal hand hygiene behavior is considered the cornerstone
of healthcare-associated infection prevention, but healthcare worker
(HCW) compliance with hand hygiene practices remains low for the
most part in most settings. The aim of this study was to determine hand
hygiene compliance rates of HCWs in various intensive care units in our
hospital.
Methods: This prospective study was performed in Ankara Numune
Research and Traning Hospital between March to August 2009. Hand
hygiene behavior of health care workers working at one of Medical
Intensive Care Unit (M-ICU), Surgical Intensive Care Unit (S-ICU)
or Medical/Surgical Intensive Care Units (M/S-ICU), were observed
during their patient care activities. Hand hygiene practice before and
after patient contact were observed individually.
Results: A total number of 1252 occasions for hand hygiene were
observed. The overall compliance was 30.5%, whereas this rate was
11.8% before patient contact and 29% after patient contact. Most of
the patient contacts were done by nurses (65%), followed by doctors
(23.2%) and housekeeping staff (7.2%). Compliance to hand hygiene
before versus after contact was 2.8% versus 20.7% for physicians,
13.5% versus 31.6% for nurses and 21.9% versus 32.8% for the
other HCWs respectively. The same rates for procedures such as
preparing pharmaceuticals, patient care and invasive procedures were
as follows; 12.6% vs 31%, 17.7% vs 28.5% and 9.4% vs 32.1%,
respectively. When comparing hand hygiene compliance before patient
contact with the type of procedures (invasive versus noninvasive), there
was statistically signiﬁcant difference when performing non invasive
procedures (p< 0.05). Nurses were more compatible group about hand
hygiene when compared to the other HCWs (p< 0.05). Compliance to
hand hygiene was higher after patient care in all of the groups of HCWs.
Hand hygiene compliance rates were nearly the same in all of the ICUs.
Conclusion: The results of this observational study showed us that our
hand hygiene compliance rate was low especially before patient contact
among all of HCWs. Effective strategies such as continuing educational
programs on improving hand hygiene should be developed especially
HCWs other than nurses.
R2275 Infection control procedures in European facilities designed
to deal with HIDs: EuroNHID data from a survey of 44
isolation facilities in 14 European countries
F.M. Fusco °, H.C. Maltezou, P. Brouqui, B. Bannister, H. Brodt,
R. Gottschalk, S. Schilling, G. Thomson, V. Puro, G. Ippolito for the
European Network for Highly Infectious Diseases Group
Objective: Highly Infectious Diseases (HIDs, e.g. Viral Haemorrhagic
Fevers and SARS) are life-threatening, human-to-human transmissible
diseases that may cause Public Health emergencies, requiring special
procedures for their containment. To review hospital infection control
procedures, the European Network for Highly Infectious Diseases project
conducted, through a speciﬁcally developed checklist, a survey in the
facilities designed to deal with HIDs. Data from 44 facilities in 14
European Countries are described.
Methods: The checklist, including 22 items and 62 questions, was
developed through a “networking strategy”: a project partner with
speciﬁc expertise sent drafts for comments and amendments. Final
agreement had been reached during a meeting involving all partners.
Facilities to be surveyed were selected by national authorities, and are
those planned for giving care to patients affected by HIDs. In site surveys
were conducted from March to November 2009.
Results: All facilities refer to have speciﬁc procedures for hand-
hygiene, but availability of adequate devices (non-hand operated
sinks, distributors of alcohol solution) differs among countries. About
Personal Protective Equipments, almost all facilities refer protocols for
their selection and supply, and procedures for donning and removal.
Procedures for the prevention of needle-stick injuries are in place in
all facilities, but the use of speciﬁc devices differs strongly among
countries. About 70% of facilities have protocols for the transport of
HID patients, but special vehicles are used in 5 countries only. Solid
waste are autoclaved in 14 facilities, while in the others are transported in
secure containers to incineration without prior decontamination. Liquid
waste are treated with chemical or physical processes or jelliﬁed in
34 facilities, and disposed without decontamination in the remaining.
Procedures for the management of corpses are available in 85% of
facilities, and protocols for autopsies are present in 50%. Eight facilities
have a special equipped autopsy room.
Conclusion: Infection control procedures are generally available in
European isolation facilities planned to give care to HID patients. The
main critical point remains the availability of adequate structural and
technical issues, that strongly differs among participating countries.
Further efforts should be done also for the implementation and the
monitoring of the compliance to these procedures.
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R2276 The impact of Xpert™ MRSA in the prevalence and
incidence of methicillin-resistant Staphylococcus aureus in
a Portuguese hospital
M. Monteiro, A. Read, F. Carneiro °, M. Soares, D. Peres, V. Alves
(Matosinhos, PT)
In our hospital Meticillin-Resistant Staphylococcus aureus (MRSA) is
the most frequent agent of healthcare-associated infections (HAI).
Screening for MRSA colonization in individuals admitted to hospitals is
very important to adopt infection control methods and in the prevention
of its cross-transmission.
The main aim of this study is to evaluate the impact of this new
methodology in the diminution of the tax of MRSA in Hospital Pedro
Hispano (431 beds) during the last year.
In 2007, was initiated a protocol of control of colonisation for MRSA
in the hospital admission. Screening nasal (inguinal in the impossibility
of the nasal) was effectuated in all high-risk patients (patients that came
from nursing homes or other health care institutions where they had
remained more than 48 hours).
Preemptive isolation was used. Patients who tested positive for
MRSA keep contact precautions until hospital discharge or documental
eradication of MRSA. Contact precautions were discontinued if the
results were negative. The method used was culture in chromogenic
agar ID MRSA (bioMe´rieux). These procedure take a minimum of 48 h
before the results are known. The prevalence rate of MRSA was of 66%.
With the goal of lowering this tax and the isolation days, with
infection control measures remained constant (hand hygienic and contact
precautions), a new rapid diagnostic test was adopted. The research of
MRSA was performed by real time polymerase chain reaction (PCR) in
GeneXpert (Cepheid) 24 h/7 days a week and gives a result within 2 h.
In 1674 screenings, 433 (26%) were positive, 1187 (71%) were negative
e 54 (3%) were invalid. The invalid results were repeated by culture.
The incidence of healthcare-associated MRSA colonization or infection
was compared before and after the introduction of real time PCR (table
1).
In our hospital the use of Xpert™ MRSA reduce signiﬁcantly both the
rate of MRSA and the number of patient isolation-days.
Table 1
2007 2008
No. of Staphylococcus aureus 356 285
No. of MRSA 235 177
Prevalence 66% 62%
Incidence (per 1000 patient-days) 1.8‰ 1.2‰
Cumulative incidence (per 100 patients) 1.4% 1.0%
R2277 Factors associated with the detection of Mycobacterium
tuberculosis in sputum among isolated inpatients with
suspected pulmonary tuberculosis and validation of a
clinical prediction rule
M. Lagrange-Xelot, M. Lafaurie °, R. Porcher, A. Wargnier, S. Gallien,
J. Pavie, N. De Castro, J. Molina (Paris, FR)
Objectives: Guidelines for preventing the transmission of Mycobac-
terium tuberculosis in health-care settings are successful when properly
implemented but may also result in unnecessary isolation of many
patients without tuberculosis with a signiﬁcant increase in hospital costs.
We wished to assess the prevalence and identify predictive clinical
factors of culture-proven tuberculosis among inpatients isolated for
suspected pulmonary tuberculosis (PTB) in our department. We also
wished to validate a previously published clinical decision rule (CDR)
to predict the need for respiratory isolation of these patients.
Methods: From August 1, 2005 to January 31, 2007, patients isolated
on admission to the infectious diseases ward for suspicion of PTB were
prospectively enrolled in this study. The presence of tuberculosis risk
factors, clinical symptoms, and ﬁndings form physical examination and
chest radiography were recorded on admission. The decision to isolate
patients was not based on the CDR, but made by the admitting team
which ranked the likelihood of PTB as high, low or intermediate.
Results: During the study period, 1207 patients were admitted to the
ward and 134 (11.1%) were isolated for suspected PTB. Only 1 patient
was diagnosed with PTB among those not isolated upon admission to the
ward. Of the 134 isolated patients enrolled in the study, 26 were found to
have PTB (prevalence: 19.4%, 95% conﬁdence interval (CI): 13.6–26.7).
Multivariate analysis revealed that PTB among isolated patients was
signiﬁcantly associated with cavitary lesions on chest X-ray (adjusted
OR: 32.9 (95%CI: 6.4–171), p< 0.0001), and weight loss of at least
10% of body weight (OR: 5.15, 95%CI: 1.5–17.5, p = 0.008). A high
or intermediate index of suspicion of PTB by the admitting team was
also signiﬁcantly associated with PTB (p< 0.0001) with a sensitivity
of 96.2% and a negative predictive value of 98.5%. The CDR had a
sensitivity of 96.2%, a speciﬁcity of 21.3%, a positive predictive value
of 22.7% and a negative predictive value of 95.8% for the diagnosis of
PTB. Use of the CDR would have correctly identiﬁed all but one patient
with PTB, and avoided 23 isolations (17.2%).
Conclusion: The prevalence of PTB was 19.4% among isolated
inpatients in our ward, and PTB was associated with cavitary pulmonary
lesions and weight loss. Use of a CDR in addition to clinical judgment
might avoid unnecessary isolations.
R2278 MRSA screening by real-time PCR to release patients from
preventive isolation on hospital admission
R. Lienhard °, M-L. Tritten, B. Duvillard, P. Vanderavero, P. Deriaz,
P. Erard, H.H. Siegrist (La Chaux-de-Fonds, Neuchaˆtel, CH)
Objectives: To evaluate a rapid screening test enabling hospital wards
to manage potential MRSA carriers on hospital admission.
Methods: Patients presenting MRSA carriage risks were screened
using double swabs each for nasal and inguinal samples for improved
sensitivity. One of each nasal and inguinal swabs were tested pooled
on a GeneXpert® (Cepheid) system. The second swabs were incubated
individually in enrichment saline broth (MSB) overnight at 35ºC before
subculturing on chromogenic plates (MRSA, bioMe´rieux) which were
incubated again overnight at 35ºC. On the next day, observation of green
colonies conﬁrmed the presence of MRSA.
Results: From October 2008 to October 2009, 365 samples were tested
by PCR. We obtained 49 (13.4%) positive PCR results of which 33
(67.3%) could be conﬁrmed by culture which gives a low positive
predictive value (PPV= 69.4%). Out of the 16 negative cultures, the
presence of MRSA could be detected in 7 (43.7%) samples. The
molecular technique proved to be more sensitive than routine primary
culture. Neither subsequent subcultures nor PCR on MSB succeeded
in obtaining any MRSA positivity in the 9 other initially PCR-positive
samples; suggesting culture failure or a GenXpert speciﬁcity problem
originating from ampliﬁcation or detection targets determination. In
some rare S. aureus strains, an absence of the mecA gene in their integral
chromosomal cassette mec may give false positive results. One equivocal
PCR gave negative cultures. Four invalid results (1.1%) were controlled
with the two remaining swabs to obtain ﬁnally 3 negative results and 1
(0.3%) repeatedly invalid result.
During the ﬁrst 6 months, all 186 valid PCR samples were cultured.
Among the 161 negative PCR results, only 2 samples were culture posi-
tive. We obtained another 18 positive cultures from the 25 PCR positive
samples, giving a sensitivity of 90% (18/20)for PCR versus culture.
Speciﬁcity was higher at 95.8% and the most signiﬁcant result was
obtained for the negative predictive value (98.7%). These characteristics
enable us to propose this PCR for screening in order to rapidly release
suspected MRSA carriers from isolation on hospital admission.
Conclusion: The GenXpert rapid molecular test presents a high negative
predictive value which can be used efﬁciently to improve patients’
comfort and hospital wards management without loss of security in
infection control. However, the low PPV obtained suggests that culture
remains necessary to assess strain viability.
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R2279 Comparison of a fully automated electro-chemiluminescent
immunoassay with haemagglutination inhibition for deter-
mination of Rubella virus antibody: evaluation of immune
status with commercial reagents in a clinical laboratory
J. van Helden ° (Mo¨nchengladbach, DE)
Objectives: Rubella is a common communicable disease of childhood
which is ordinarily benign in children and adults. However, for the
developing fetus the infection may be very serious. It is still important to
accurately determine the immune status of women of reproductive age,
because still a women are not vaccinated against rubella virus, and to
diagnose and conﬁrm recent infections related to congenital syndromes.
Hemagglutination inhibition (HAI) is still the most commonly used
technique for the laboratory diagnosis of rubella in some countries (e. g.
Germany or Austria). However this test is lengthy, labor intensive, and
poorly adaptable to automation. In addition, there my be considerable
variation from one laboratory to another.
The use of a fully automated electrochemiluminescent immunoassay
(ECLIA) is an improved alternative to HAI. This study describes
a comparative laboratory analysis of indirect hemagglutination and
the Elecsys Rubella IgG assay on the Roche Modular Immunoassay
platform.
Methods: A total of 599 serum specimens were studied retrospectively.
All sera were tested with a commercial HAI assay (Siemens Medical
Diagnostics, Marburg, Germany) and a fully automated Elecsys Rubella
IgG assay on Modular Analytics (Roche Diacnostics, Mannhein
Germany). Discrepant samples were additionally tested with a rubella
IgM immunoassay (Roche Diagnostics, Mannheim, Germany) and
resolved by virus neutralization assay to determine the immune status.
Results: The relative sensitivity for the detection of immunity was 100%
for both assay types. The amount of indeterminate results of the HAI
was 5.9% compared with only 1.8% of the Elecsys Rubella IgG. The
relative speciﬁcity of both assay for the detection of immunity to rubella
virus was 94.6% for the HAI and 98.3% for the Elecsys Rubella IgG
assay. The overall correlation between both assays was 96.3%.
Conclusions: IHA is still a reliable method for screening sera for
immunity to rubella virus. But today fully automated quantitative
antibody immunoassays like the Elecsys rubella IgG assay are superior
referring to sensitivity and speciﬁcity. The grade of standardization and
stability of these assays is even higher resulting in a better comparability
between different labs. In our point of view the IHA should be replaced
by quantitative IgG assays for the screening of prenatal sera for immunity
to rubella virus.
R2280 Evaluation of National Infection Prevention Week on NRIC
www.nric.org.uk: a comparative study of success of the
event during 2007/08/09
S. Wiseman °, R. Gallagher, P. Kostkova, G. Jawaheer (London, UK)
Objectives: National Infection Prevention Week (IPW) takes place in
October annually and provides an opportunity to promote infection
prevention and control as a key element of safe care for both patients and
those receiving care in the community keeping them safe and free from
healthcare associated infections. NRIC participates in this event in line
with its key aims − to provide best available evidence on management,
prevention and treatment of HAIs. After two successful IPWs in 2007
and 2008 NRIC in partnership with the Royal College of Nursing
(RCN) focused during 2009’s IPW on the contribution of two important
groups of healthcare workers, nursing students and healthcare support
workers, providing links to information on infection prevention and
control knowledge to meet their speciﬁc needs. IPS and IFH endorsed
this initiative.
Methods: The IPW 2009 was run on NRIC during October
19−23rd 2009 (http://www.nric.org.uk/IntegratedCRD.nsf/ICWeek2009
?OpenForm) previously the IPW 2008 and 2007 weeks taking place
on October of these years. The dedicated online resource included links
to best available evidence, up-to-date resources and activities for raising
awareness in hospitals and community. A qualitative methodology was
used to analyse the trafﬁc on the NRIC web server.
Results: In October 2009, the interest in the IPWs pages was the highest
so far: 1079 visitors and 3833 page views, 100% increase in comparison
to the months leading to it; 499 visitors and 1795 page views in Sep
2009, 378 visitors and 1151 page views in Aug 2009. The trafﬁc during
the actual IPW week in 2009 was the highest since the event began three
years ago; 405 visitors and 692 page views in 2009, which is 39% more
than in 2008 (291) although the number of page these visitors looked
at decreased by 37% (1096 in 2008). In 2007, we received 264 visitors
viewing a total of 1138 ICW pages. The total trafﬁc on the NRIC portal
as a whole during the IPW in 2009 was 27% above Oct average (1525
visitors, 6588 page views). The full result set will be presented at the
conference.
Conclusion: The NRIC IPWs success in 2007/09 demonstrates a clear
need for provision of these resources and raised awareness of this
important week − 27% increase visitors above NRIC average and the
number of visitors during IPW 2007 almost doubled at IPW 2009. In
2010, NRIC IPW will aim to make use of media that appeals to today’s
audiences − Twitter or FaceBook and focus on international evidence
(IFIC support).
R2281 Reducing paediatric blood culture contaminants
L.S. Moore °, N. Mughal, E. Demertzi, B.S. Azadian (London, UK)
Objective: Reducing blood culture contaminant rates and subsequent
long term maintenance of this reduction can prevent instigation of
unnecessary antimicrobial therapy. Achieving this reduction in the
paediatric setting requires different infection control interventions to
adult policies. This report describes a retrospective observational study
of 685 consecutive paediatric bacteraemias in patients attending a tertiary
referral paediatric directorate both before and after intensive infection
control measures were introduced to reduce contamination rates.
Methods: The study period covers two years from November 2007 to
October 2009 with infection control interventions introduced following
a high rate of blood culture contamination rates in October 2008. At that
point intensive training and education was carried out (induction) and
regular real time epidemiological feedback to medical and nursing staff
was implemented (maintenance). Demographic, clinical and laboratory
data was reviewed for each positive blood culture during the study period.
Results: Following the induction and maintenance phases of the infection
control interventions a reduction in blood culture contaminants with
coagulase negative staphylococci was achieved (mean 18 per month pre-
intervention to 11 per month post intervention; p-value 0.01). There was
no statistically signiﬁcant drop in overall blood cultures taken pre- and
post intervention (273 and 263 per month respectively; p-value 0.43)
nor in the isolation of any other pathogen with the exception of yeasts
(pre intervention 36 isolates in a year; post intervention 7 isolates in a
year; p-value 0.01) There was also a statistically signiﬁcant decrease in
coagulase negative staphylococcal bacteraemias from those patients with
indwelling long lines (56.1% pre-intervention to 47.6% post intervention;
p-value 0.03) − despite gross total parenteral administration within the
unit actually increasing during this period.
Conclusions: We ﬁnd infection control interventions focusing on
education and training can reduce blood culture contamination rates and
this reduction can be maintained with regular real-time epidemiological
feedback to clinical staff.
R2282 Do limited resources affect the hand hygiene performance,
beliefs and perceptions of healthcare workers?
E. Alp °, A. Ozturk, M. Guven, I. Celik, M. Doganay, A. Voss (Kayseri,
TR; Nijmegen, NL)
Objectives: To identify the beliefs and perceptions associated with hand
hygiene performance in two different institutions with limited resources
and started infection control programme later than developed institutions.
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Methods: The study was conducted in two different hospitals −
University Hospital (U-hospital) and Community Hospital (C-hospital)
in the same city by a self-administered questionnaire. Most questions
were drawn from questionnaires used previously in other studiesfrom
“industrialized” countries based on “The Theory of Planned Behavior”.
All nurses, nurse students, physicians and medical students in the
U-hospital, and all nurses in the C-hospital were included into the study.
Results: Of 1764 questionnaires, 941 (41%) were returned. The return
rate was highest for nurses in C-hospital(63.8% [303 of 475]) and lowest
for senior physicians in U-hospital (7.5% [16 of 212]). Respondents
provided demographic information and data about various behavioral,
normative, and control beliefs that determined their intentions with
respect to performing hand hygiene. Among individuals from the other
professional categories, a greater percentage of U-hospital nurses (57.6%
vs.53.9%, respectively) believed that healthcare-associated infections to
be greater than 20%, and mortality rate among infected patients to
be greater than 5%.However, all professional categories believed that
good hand hygiene effectively prevents infections (98%). In univariate
analysis, receipt of structured training in hand hygiene, perceived
colleagues adherence’s as good, adherence models good practices for
others, having been observed for their adherence (normative beliefs),
the perception that hand hygiene is relatively easy to perform (control
beliefs) was associated with good hand hygiene. However, in multivariate
analysis, high self reported adherence to hand hygiene was independently
associated with receipt of structured training in hand hygiene, perceived
good adherence by colleagues, the perception that hand hygiene is
relatively easy to perform and having been observed for their adherence.
Conclusions: In a country with limited resources, intention to comply
was associated with training and strong normative and control beliefs.
Also, in two different kinds of institution with the similar hand hygiene
promotion campaign in the same city, the believes of nurses were
different. In developing countries, more resources have to be saved for
training of HCWs and easy access for hand hygiene products.
R2283 Prospective study of surgical site infections
K. Kontopoulou °, P. Christopoulos, B. Alwadi, K. Tsepanis,
B. Stratinaki, I. Koutelidakis, P. Tsiaousis, E. Pappas, S. Atmatzidis,
C. Psillaki, M. Kriti, C. Aggouridaki, K. Atmatzidis (Thessaloniki, GR)
Objective: To examine and evaluate incidence, risk factors and
microbiology patterns of Surgical Site Infections (SSIs), in a Greek
hospital.
Methods: This prospective study included 290 patients (66% males
and 34% females) who had undergone a total of 311 general-surgery
operations during the period February 2009 to October 2009. An SSI was
deﬁned on the basis of clinical and laboratory ﬁndings. All isolates were
identiﬁed and tested for antibiotic susceptibility with Vitek-2 automated
system (bioMe´rieux, France). Conﬁrmation of MICs was determined
by E-test (AB Biodisk, Sweden). Descriptive and logistic regression
analyses were performed to determine risk factors for SSIs. A p value
0.05 was regarded as signiﬁcant.
Results: SSI occurred in 23 (7.4%) of the 331 operations. Of the
pathogens isolated, seventeen were Gram-negative rods, ﬁve Gram-
positive cocci, and one was Candida albicans. The infection was
polymicrobial in fourteen patients, while infection coexisted in another
site. Of all the isolates, we had 10 K. pneumoniae, 9 P. aeruginosa, 7
E. coli, 4 Enterococcus spp., 3 coagulase-negative staphylococci and
2 isolates of Staphylococcus aureus. Six strains of K. pneumoniae
were KPC-producers and ﬁve strains of P. aeruginosa were multi-
drug resistant. All Gram-positive cocci were methicillin-resistant but
glycopeptides-sensitive. The risk factors of signiﬁcance are summarized
in the table.
Conclusions: Despite the use of precautionary antimicrobial treatment
and the antiseptic measures, the rate of SSI is high. The efforts to
control SSIs, should be focused on hospital infections surveillance
programs and modiﬁcation where this is feasible, of the factors that affect
signiﬁcantly the development of SSIs. Awareness of risk factors before




High score of ASA (American Society of Anesthesiologists) 0.029
Prolonged pre-operative hospitalization 0.001
Prolonged operation time 0.001
Blood transfusion <0.001
ICU hospitalization <0.001
High National Nosocomial Infections Surveillance (NNIS) risk index <0.001
R2284 Is there any new evidence on the efﬁcacy of rapid screening
tests on hospital-acquired MRSA acquisition rate?
G. De Angelis °, C. de Waure, M. Cataldo, G. La Torre, R. Cauda,
E. Tacconelli (Rome, IT)
Objective: In a previous systematic review of the literature and meta-
analysis we documented that, compared with culture screening, use of
rapid screening tests was not associated with a signiﬁcant decrease in
MRSA acquisition rate. Recently, new important evidence supported the
screening by molecular method as associated with a signiﬁcant reduction
in MRSA acquisition rate. The objective of the current study was to
verify our previous results and conclusions, according to the most recent
evidence.
Methods: The computerized search was updated until July 2009. We
judged as eligible those studies that compared hospitals and wards in
which active screening for the detection of MRSA carriers was done
at hospital admission by use of a rapid molecular test to those in
which active screening was done with enrichment culture. To account
for statistical heterogeneity between studies, random-effects models were
used. Case reports, reviews and letters were excluded. Primary outcome
was deﬁned as MRSA acquisition rate per 1000 patient-days.
Results: The updated search revealed additional 193 relevant articles.
One new study including 13,952 patients was eligible for inclusion.
Overall 5 studies (3 interventional studies and two crossover trial) were
reviewed. All studies were performed between 2000 and 2007. Four
studies were done in Europe (UK) and 1 study in Canada. Only one study
was a cluster-randomised, unblinded, crossover trial. All studies used the
same commercial assay. Nasal samples were tested in all studies. In 4
studies, MRSA was associated with at least another site (eg, axillae,
perineum, groin, and skin breaks). Compared with culture screening,
use of rapid screening tests was not associated with a signiﬁcant
decrease in MRSA acquisition rate (risk ratio 0.86, 95%CI 0.67–1.10).
Heterogeneity among studies was reduced by the inclusion of the new
study.
Conclusion: Cumulative meta-analysis did not demonstrate any sub-
stantial variation in the point estimates with the addition of the recently
published study. We conﬁrm that rapid screening tests do not seem to be
effective in signiﬁcantly reducing hospital-acquired MRSA acquisition
rate when compared to culture screening.
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R2285 How long could an educational intervention improve hand
hygiene practices?
A. Erbay °, Y. Tezer Tekce, H. Cabadak, S. Sen (Ankara, TR)
Objectives: Hand hygiene is essential for the prevention of nosocomial
infections, but compliance in clinical practice is often low. This study
was planned to determine the compliance rates of hand hygiene practices,
the impact of educational programs on hand hygiene compliance rates
and the duration of the effect of the educational programs.
Methods: This prospective and observational study was performed in
Turkiye Yuksek Ihtisas Education and Research Hospital in Turkey. Hand
hygiene compliance, the effect of educational program and duration of
this effect on hand hygiene compliance were investigated. Observations
were carried out on weekdays during the working hours. Hand hygiene
practices were evaluated in following procedures; before the patient
contact, after the patient contact, after environmental contact, before high
risk contacts and after contact with blood and body ﬂuids. Compliance
of medical doctors and nursing staff were evaluated.
Results: Hand hygiene compliance was evaluated in 8893 contacts
during 6 months period. At the initial phase of the study a total of
1460 contacts were observed and in 38.2% of these contacts hand
hygiene practices were proper. After the educational program overall
compliance rates improved to 54.6% (p< 0.05). Following months
compliance rates were detected as; 47.6% and 43.3%. Four months
after intervention compliance rates decreased to 38.0%. After a repeated
educational intervention, compliance rates increased to 49.8%. Nursing
staff had better compliance rates than medical doctors overall, 57.3%
versus 32.4% (p< 0.05). Overall hand hygiene compliance after the
patient contact was greater than before the patient contact, 60.4% vs.
34.5% (p< 0.05). Hand hygiene compliance before high risk contacts
were detected 36.6% before the intervention and 51.1% after the ﬁrst
intervention (p< 0.05).
Conclusion: Continuous educational programs are needed in order to
maintain higher compliance rates of hand hygiene practices. We suggest
that educational interventions should be repeated in every 3 months.
R2286 The effect of an educational intervention to nosocomial
catheter-associated urinary tract infection rates
A. Erbay °, H. Cabadak, Y. Tezer Tekc¸e, S. Sen (Ankara, TR)
Objectives: To obtain the incidence of nosocomial catheter-associated
urinary tract infections (CAUTIs), microbiological proﬁles and bacterial
resistance in intensive care units (ICUs) and observe the effect of an
educational intervention to the CAUTIs rates.
Methods: Prospective cohort surveillance of CAUTIs was conducted in
ﬁve ICUs with 96 beds in Turkiye Yuksek Ihtisas Education and Research
Hospital in Turkey, by applying the deﬁnitions of the Centers for Disease
Control during 2 years period. Rates of CAUTIs per 100 patients and
per 1000 device days were determined. In January 2008 urinary catheter
implementations were reviewed and an educational program was carried
out.
Results: From January 2007 to December 2008 CAUTIs were followed
up. The mean age was 65.2 and 57% of the patients were male. In
2007, 4886 patients followed up in ICUs for an aggregate of 18013 ICU
days. Of these, 86 CAUTIs were detected in 73 (1.49%) patients. The
rate for CAUTIs was 7 cases per 1000 catheter-days. Urinary catheter
use rate was 0.71. In 2008, 5591 patients followed up in ICUs for an
aggregate of 21055 ICU days. Of these, 51 CAUTIs were detected in 45
(0.8%) patients. The rate for CAUTIs was 2.6 cases per 1000 catheter-
days. Urinary catheter use rate was 0.79. The period between ICU
admission and CAUTIs ranged 3–126 days. The most commonly isolated
migroorganisms were as follows; Escherichia coli, Enterococcus spp.,
Klebsiella spp., Acinetobacter baumannii, Pseudomonas aeruginosa.
E. coli isolates were resistant to cefotaxime in 64%, were resistant
to ciproﬂoxacin in 86%, and were resistant to piperacillin–tazobactam
in 26%. Seventy percent of Klebsiella spp. isolates were resistant
to ciproﬂoxacin, 62% were resistant to cefotaxime and 54% were
resistant to piperacillin–tazobactam. All of the A. baumannii isolates
were resistant to ciproﬂoxacin, and 40% were resistant to imipenem.
Fifty percent of P. aeruginosa isolates were resistant to ciproﬂoxacin, all
of them were resistant to ceftazidime and piperacillin–tazobactam, and
30% were resistant to imipenem. Ampicilin resistance was detected in
28% of the Enterococcus spp. isolates and vancomycin resistance was
not observed.
Conclusions: The CAUTIs rates in our hospital decreased after
educational intervention. However antimicrobial resistance rates were
high in this study.
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R2287 Bacteraemia without a focus: to what extent is the focus
really unobserved or just unreported?
I.K. Larsen °, G. Pedersen, H.C. Schønheyder (Aalborg, DK)
Objectives: The absence of a focus of bacteraemia is associated with
a poor outcome. However, the term is ambiguous and the aim of this
study was to evaluate the positive predictive value of ‘focus unknown’
in a bacteraemia research database.
Method: This retrospective cohort study included bacteraemias di-
agnosed in 2003 at Aalborg Hospital, a Danish university hospital.
The clinical signiﬁcance of blood culture isolates and the likely
focus of infection were determined jointly by medical doctors in
clinical microbiology and attending physicians. Episodes were recorded
concurrently with the clinical episode. The focus was classiﬁed as
unknown if unsupported by evidence at the time of registration or if the
likelihood of one focus was not superior to other foci. For all episodes
with unknown focus we re-evaluated available information with special
attention to time of death, neutropenia, procedures, foreign bodies and
results of imaging. For each episode we concluded whether one focus or
two (or more) equally plausible foci or no focus was present. The two
latter categories were regarded as ‘focus unknown’.
Results: In 184 (29%) of 645 bacteraemias the focus was recorded as
unknown in the database; the number of patients was 162, including 11
children, with 1 to 4 episodes each (median age 68 years, male/female
ratio 85/77). The re-evaluation disclosed a focus in 39 of the 184
episodes (abdomen 15, thorax and respir. tract 10, IV cath. 5, skin
and connective tissue 5, urinary tract 3, bone 1); there were two or
more plausible foci in 9 and no focus in 136. Hence, the proportion
of bacteraemias with a focus increased from 71% (461/645) to 78%
(500/645) (Chi-square, p = 0.015). The positive predictive value of ‘focus
unknown’ was 79% (145/184).
In only 2 episodes a decision had been made to decline from searching
for a focus. A search was prevented by precipitous death in 31 of the
184 episodes (17%), and localizing signs were missing in 37 (20%) due
to neutropenia. Together these two groups accounted for 65 cases (35%).
Three infants 10−16 months old had primary pneumococcal bacteraemia.
Conclusion: Using retrospective chart review as reference we found a
positive predictive value close to 80% for the category ‘focus unknown’
in the database. A high proportion of patients with an unknown focus
either died rapidly or had severe neutropenia. This contributes to the
negative prognostic impact of an absent focus and perhaps even more
than the hidden focus itself.
R2288 Epidemiological and microbiological survey of infections in
rehabilitation units of the Lombardy region, Italy
M. Tinelli ° (Sant’Angelo Lodigiano, IT)
Objectives: This report describes an epidemiological and microbiologi-
cal survey of infections occurred in Rehabilitations Units (RUs) of the
Lombardy Region during the years 2005 and 2006.
Methods: 123 RUs for 7,830 beds, 184,916 hospitalizations, 149,471
patients and 14,201 ascertained cases were considered in this study.
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The eligibility criteria for the epidemiological analysis included the
ICD-9-CM codes belonging to ten main groups of infections: UTIs,
low respiratory tract, intestinal, bone, sepsis, candidiasis, bacterial not
speciﬁed, SSTIs, iatrogenic, cardiovascular. The validation of ICD-9-CM
diagnosis, by review of 3,028 medical charts in 28 out of 123 RU, was
performed in order to assess the sensitivity of the multiple regression
method.
Results: 3,028 admissions were analyzed, 662 of whom had a diagnosis
of infection validated. Multivariate analysis showed that the presence
of “at least an infection”, during hospitalization in Rus, is positively
associated with: age 65−74 and over 85 years old (baseline under 45:
respectively OR 1.5, 95%CI 0.97–1.37 and OR 2.4, 95%CI 1.5−3.9),
general geriatric RUs and neurorehabilitation RUs vs. cardiorespiratory
RUs (respectively OR 1.35, 95%CI 0.97–1.86 and OR 2.7, 95%CI
1.2−5.8), discharge from hospital “with” or “without” intervention
surgery/invasive procedure within the week prior to admission to RU vs.
“non-patient” (respectively, OR 1.47, 95%CI 1.02–2.11 and OR 1.38,
95%CI 1.09–1.75); discharge within the week prior to admission with a
diagnosis of infection vs. “non-diagnosis of infection or hospitalization”
(OR 2.8, 95%CI 2.0−3.8). In the adopted model, the single settings were
included as “random effects”. A logistic regression model, similar to the
incident, highlighted associations comparable to those estimated for the
prevalence. The UTIs were the most frequent (14.8%, 95%CI = 13.4–
16.2). The distribution of isolated microrganisms showed respectively:
E. coli 48%, P. mirabilis 13%, K. pneumoniae 5.4%, E. faecalis 13.8%,
S. aureus 3.1%, P. aeruginosa 9.5%, A. baumannii 0.45%. The
prevalence rates of MDR showed that uropathogens were the most
frequently isolated.
Conclusion: The frequency of nosocomial infections in RUs is positively
associated with host characteristics, settings and health care, including:
age, ward, recent discharge from hospital and with diagnosis of infection
(surgery/invasive procedures). UTIs and uropathogens are signiﬁcant in
RUs.
R2289 Changing epidemiological features of nosocomial
candidaemia at an Italian tertiary care hospital
S. Cavinato, A. Maggiore, M.L. Deiana, F. Cian, G. Boscaro,
R. Luzzati ° (Trieste, Padua, IT)
Objectives: To evaluate incidence, demographic features, causative
species, risk factors, treatment and outcome of nosocomial candidemia.
Methods: Retrospective study of nosocomial candidemia (at least one
blood culture positive for Candida spp) in 2008 at an Italian tertiary care
hospital (Trieste, Italy) with no pediatric and transplantation departments.
Results: Fifty-two cases of candidemia occurred in 52 patients (48%
males) with median age 79 years (range 33−95 years). At diagnosis
82.7% of patients were hospitalized in medical wards, 9.6% in surgical
wards, 7.7% in intensive care units. Overall hospital incidence was
1.88 episodes per 10,000 patient-days. The incidence was higher
in intensive care units (3.26 episodes per 10,000 patient-days)and
medical wards (2.35 episodes per 10,000 patient-days) than in surgical
wards (0.61 episodes per 10,000 patient-days). The most frequent
Candida species was Candida albicans (51.9%), followed by Candida
parapsilosis (32.7%) and Candida glabrata (9.6%). No patient was
neutropenic. Underlying diseases were the following: solid cancer
(37.2%), diabetes mellitus (13.7%), surgery (5.8%), HIV (2%). Twenty-
eight (54.9%)patients had a central venous catheter (CVC); of them, 63%
had proven catheter-related candidemia. 85.2% of patients with CVCs
underwent line removal with median removal time of 1.5 days (range
0−19 days) after diagnosis. During three previous weeks, potential risk
factors were: antibiotic therapy (92.3%), urinary catheter (80.8%), total
parenteral nutrition (43.3%), one or more surgical operations (13.5%),
mechanical ventilation (7.7%). The overall crude mortality at discharge
was 46.2% and was higher for Candida glabrata (60%) than for Candida
albicans (48.1%) and Candida parapsilosis (47.1%). Mortality was not
signiﬁcantly associated with isolated species (p = 0.76) and CVC removal
time (p = 0.81). 66.7% of patients received adequate antifungal therapy,
and treated patients had signiﬁcantly lower mortality than untreated
patients (p = 0.0029).
Conclusions: This study showed very high incidence of nosocomial
candidemia, especially in medical wards. Candidemia was found to
involve non neutropenic and very elderly patients, which were receiving
antibiotic therapy. Only one half of our population had CVC and severe
underlying diseases. A case–control study is warranted to deﬁne risk
factors for candidemia in this population, in order to get effective
preventive strategies.
R2290 Diversity of Pseudomonas aeruginosa isolates in sputum
samples from chronically infected patients at a university
cystic ﬁbrosis centre, Innsbruck
K. Grif °, J. Eder, M. Fille, H. Ellemunter (Innsbruck, AT)
Introduction: Pseudomonas aeruginosa (PA) remains an important
pathogen in the cystic ﬁbrosis (CF) lung. Chronic PA infection is
associated with an increased morbidity and mortality. Infection control
measures and early eradication regimen are very effective for preventing
cross infection among patients.
Objective: The aim of our study was to investigate a diversity of PA
isolates in sputum of single long-term chronically infected patients and a
change in genotypes over time. Also a determination of a possible cross
infection of PA between patients was a term of the present study.
Methods: The study was carried out prospectively on a random of
sputum isolates (n = 55) collected from chronically infected patients.
During the study period of 6 months (10/2008–5/2009) 26 of 130
CF patients, categorized as chronically infected, with PA according
to modiﬁed Leeds criteria and/or anti-pseudomonas antibodies were
included. Twenty of 26 were outpatients, 6 − inpatients. Antibiotic
therapies were recorded in our CF database and were available.
Pseudomonas aeruginosa isolates were cultured from sputum samples
and identiﬁed by standard methods. Strains were characterised by
antibiotic resistance testing using disc diffusion and E-test. All isolates
were analysed of clonal diversity using random ampliﬁed polymorphic
DNA (RAPD) − PCR with 2 different primers (P 272 and P15) as a
molecular typing method.
Results: During the study period 9 of 26 patients (34.6%) carried
multiple PA isolates. Four patients carried 2 isolates each, 2 patients −
3 isolates each, 2 patients − 4 isolates each, and one patient − 6 isolates
each. Molecular typing revealed no clonality among isolates tested. We
found no transmission of PA isolates with the same RAPD genotype
among patient collective. Only in one patient we found two genotypic
different PA in one sputum sample. A great genotypic diversity was
found in repeated sputum samples from the same patients.
Conclusion: Due to a strict patient segregation/infection control
policy in in/outpatient care and continuous education there was no
transmission of PA between the patients at the Innsbruck CF Centre.
The intensive antibiotic use seems to have a remarkable impact on
the preeminent organisms in multiple strains carriers and may induce
adaptive mechanisms such as genome rearrangement with phenotype
alteration in a subset of chronically infected PA patients.
R2291 Clinical and epidemiological characteristics of Clostridium
difﬁcile-associated diarrhoea in a tertiary hospital in Korea
J. Kim °, H. Pai, J. Kang, T. Choi (Seoul, KR)
Objectives: In order to ﬁnd the epidemiological and clinical character-
istics of Clostridium difﬁcile-associated diarrhoea (CDAD), prospective
study was performed in a tertiary hospital in Korea.
Materials and Methods: From September 2008 to August 2009, the
patients with diarrhea (stool passage 3 days for 2 days or 6 diarrhea
during 36 hours) after or during antibiotic usage were included. Stool
culture, toxin A&B assay and direct stool toxin PCR were performed for
those patients, and CDAD was deﬁned when more than one of three tests
was positive. The clinical characteristics of CDAD cases were studied.
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Using 98 strains cultured, multiplex PCR for tcdA, tcdB and binary toxin
and PCR ribotyping were performed.
Results: Incidence of CDAD was 54/100,000 patient-days in our
hospital. Among cases with positive CDAD-tests, 71% was hospital-
acquired CDAD (HA-CDAD), 19% was heath care-associated CDAD
(HCA-CDAD) and 10% was toxigenic carrier. Mean hospital days of
admission before HA-CDAD occurrence was 39.5 days (2–256). 39.7%
of HA-CDAD showed severe disease (severity score2 by Zar et al, CID
2007;45:302). Comparing the characteristics of HA-CDAD and HCA-
CDAD by univariate analysis, severity score was higher in HCA-CDAD
(P = 0.043), and more H2 blocker was used in HA-CDAD (P = 0.005).
Among 121 cases of HA- and HCA-CDAD, 17% (20/121) improved
without treatment, 47% (57/121) improved with treatment, 28% (34/121)
relapsed after treatment, 5% (6/121) died and 3% (4/121) were lost.
However, among 5 fatal cases, CDAD-attributed mortality was not
identiﬁed.
On multiplex-PCR using 98 cultured organisms, all isolates were tcdA
and tcdB-positive, and 3 isolates produced binary toxin. PCR ribotyping
of 93 isolates showed diverse ribotypes with 13 isolates for the most
common ribotype. Comparing ribotypes of 10 paired strains of relapsed
cases, the same ribotypes were observed in 5 cases and different
ribotypes were found in 5 cases, and the interval of relapse was 37.2
days (13−62) and 58.2 days (12–148), respectively. Three B1/NAP/027
strains were identiﬁed among 98 isolates; 1 was from toxigenic carrier
and 2 were from HA-CDAD cases. Severity score of the two cases was
higher than mean value of other cases; 4.5 (4−5) vs 1.63.
Conclusion: Incidence, morbidity and mortality of CDAD were not high
in our hospital. However, B1/NAP/027 strains appeared, thus, further
observation for incidence, disease severity and spread of B1/NAP/027
to community or hospital is necessary.
R2292 Incidence and aetiology of ventilator-associated pneumonia
in the intensive care units at a university hospital
E. Azak, A. Willke °, N. Altindag (Kocaeli, TR)
Objectives: The aim of this study is to determine the incidence, etiology
and antibiotic resistance patterns of ventilator-associated pneumonia
(VAP) in intensive care units (ICU) of anesthesiology and cardiothoracic
surgery.
Methods: The patients in intensive care units were applied active
prospective surveillance between January 2007 to December 2008
and VAP were deﬁned according to Centers for Disease Control and
Prevention (CDC) criteria. Ventilator utilization ratio, VAP rate were
calculated and compared using the National Nosocomial Surveillance
(NNIS) deﬁnitions.
Results: A total of 2074 patients from ICUs of cardiothoracic
surgery and anesthesiology were included in the study. 6367 patient-
days and 3863 ventilator-days were recorded. 80 cases of VAP
occured in 63 of 2074 patients (3.03%, 1.26 episodes of pneumonia
per patient). Ventilator utilization ratios were determined as 0.69
and 0.30, VAP rate/1,000 ventilator-days were determined as 19.9
and 26.2 in the anesthesiology and cardiothoracic surgery of ICUs,
respectively. S. aureus (34/101, 34%), P. aeruginosa (30/101, 30%)
and A. baumannii (15/101, 15%) were the most commonly isolated
microorganisms. Methicillin resistance were 76.4% in S. aureus
isolates. Resistance patterns of P. aeruginosa and A. baumannii strains
to ceftazidime, imipenem, meropenem, ciproﬂoxacin, piperacillin–
tazobactam, sefoperazon-sulbactam and gentamicin were 52–100, 43−94,
38−87, 30–100, 50–100, 42−77, 27−93 percent respectively.
Conclusion: VAP rates and ventilator utilization ratios were determined
as high among ICU patients in our hospital. S. aureus and P. aeruginosa
were observed main microorganisms at the VAP patients and they were
determined as quite resistant to mainly used anthibiotics. These results
emphasizes the importance of preventive measures against hospital
infections including VAP.
R2293 Nosocomial infection surveillance data of a burn centre,
2005–2009: what we have learnt
A. Candevir °, B. Kurtaran, Y. Tasova, D. Gurel, A.S. Inal, F. Kibar,
H.S. Aksu for the HEKK working group
Objective: Survival has improved due to the supportive treatment quality
and the main cause of death amongst these patients is infections. Our aim
in this study is to determine the types of infections, causative microor-
ganisms in order to guide the antimicrobial therapy an infection control.
Methods: Hospital infection control committee data was reviewed
retrospectively between years 2005 and 2009 ﬁst nine months. CDC
case deﬁnitions for nosocomial infections were used. Antimicrobial
susceptibilities were determined by VITEK 2 system. Microbiological
data, the site of isolation were extracted.
Results: Totally 381 patients were followed in 10807 patient days(pd).
General hospital infection rates and their distribution were summarized
in table 1. Infection rates in 2007 were seen to be higher with 27.03
infections/1000pd. The burn unit was temporarily closed and beds were
decreased in order to plan a revision because of the high infection rates
in 2007 and infection rates decreased dramatically. Burn infections were
increased in 2009(66.66 infections/1000pd). This increase was linked to
transferring to a temporary clinic with inappropriate conditions. Urinary
infection rates were highest in 2006(31.66 infections/1000pd) decreased
from that time. This was thought to be the result of urinary tract infection
control education all over the hospital. Blood stream infections were at
most in 2008 with a rate of 34.28%. Gram-negative microorganisms
tended to decrease until 2007 and than increased. The most prevalent
microorganism was Pseudomonas aeruginosa from 2005 to 2007(38%,
30.4% and 26.6% respectively) but Acinetobacter baumannii took place
in 2008 and 2009 with rates of 25.9%, 59.1% respectively. Extended
spectrum b lactamase rate was high in all years (60%, 70%, 59%, 45.6%,
63.2% in Escherichia coli and 78.1%, 40%, 53.5%, 56% and 68%
in Klebsiella pneumoniae respectively) and all Staphylococcus aureus
isolates were meticilline resistant. Antimicrobial resistance was also re-
markable in Gram-negatives especially in Acinetobacter baumannii spp.
Conclusion: As a conclusion high overall infection and resistance rates
were seen. Hospital infection rates, causative microorganisms tended
to be inﬂuenced from physical conditions, infection control measures
and compliance and also from overall hospital implementations. Unit
based and general standards should be established with the support and
reinforcement of hospital administration in order to decrease hospital
infections.
Table 1: General hospital infection rates and their distribution according
to years 2000–2009*
n/rate*
2005 2006 2007 2008 2009**
Number of patients 114 104 72 53 38
Patient days 2920 2912 1961 1920 1094
Nosocomial infection 74/25.3 60/20.6 53/27.03 35/18.23 18/16.45
Burn infection 35/47.29 25/41.7 27/50.9 17/48.57 12/66.66
Bloodstream infection 13/17.56 14/23.33 13/24.52 12/34.28 5/27.77
Urinary infection 17/23 19/31.66 13/24.52 6/17.14 1/5.55
Respiratory infection 9/12.2 2/3.3 − − −
*Infection rate per 1000 patient days.
**For 2009, ﬁrst nine months.
R2294 Mortality and prognosis factors for MRSA bloodstream
infections in the intensive care unit: a retrospective cohort
study
J.S. Castillo °, A.L. Leal, J.A. Cortes, C.A. Alvarez, G. Buitrago,
R. Sanchez, L.I. Barrero, D.H. Henriquez, A.L. Gonzalez on behalf
of GREBO
Objectives: To evaluate mortality and prognosis factors in a multicenter
cohort of patients with MRSA bloodstream infection in Intensive care
units (ICU) in Bogota (Colombia).
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Methods: we perform a retrospective cohort study in 16 high complexity
hospitals in the city. We include 374 patients with bloodstream infection
(BI) in ICU, identiﬁed from an antimicrobial resistance surveillance
system. A systematic chart review was performed, severity of illness,
comorbidity, type of infection, therapy and demographic variables were
collected. Attributable mortality was analyzed in a post hoc committee.
Time to event date was modeled.
Results: 187 Methicillin-Resistant Staphylococcus aureus (MRSA)
and 187 Methicillin-susceptible (MSSA) in ICU were documented.
Gross mortality 51.6%, attributable mortality to S. aureus bacteremia
25.13%. MRSA-BI attributable mortality 31% vs. 19% in MSSA-BI.
Log rank test (p< 0.05) between survival functions for MRSA and
MSSA (Figure 1). When multivariable adjusted in a proportional hazard
model, independent predictors for attributable mortality are Charlson‘s
comorbidity index >3, septic shock, no adequate clinical response in day
3 and early change in antimicrobial therapy. Meticillin resistance and
inappropriate initial therapy were not observed as signiﬁcant predictors
of attributable mortality.
Conclusion:MRSA-BI show a different survival function compared with
MSSA-BI, high gross and attributable mortality for patients with BI by
S. aureus in ICU. Some mortality predictors were comorbidity, severity,
early treatment and early response.
Figure 1. Kaplan–Meier survival estimates.
Travel medicine, tropical and parasitic
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R2295 Comparison of four methods for the detection of
Trichomonas vaginalis infection in symptomatic and
asymptomatic women in Athens, Greece
E.T. Piperaki °, M. Theodora, M. Mendris, L. Barbitsa, V. Pitiriga,
D. Patili, A. Antsaklis, A. Tsakris (Athens, GR)
Objectives: To assess the prevalence of T. vaginalis infection in
symptomatic and asymptomatic women, attending a major gynecological
hospital in Athens, Greece and to evaluate four methods for the diagnosis
of T. vaginalis infection.
Methods: Specimens were collected consecutively, from 502 women
attending the outpatient clinic of Alexandra Hospital, during the period
2006–2007. Two hundred ﬁfty-ﬁve of them were symptomatic and
247 asymptomatic. Three hundred ﬁfty-eight were Greek and 126
were immigrants. All women completed a questionnaire including
demographic data, medical history and behavioral/sexual information.
The presence of T. vaginalis in vaginal samples was assessed using
wet mount, culture in modiﬁed Diamond’s medium, antigen detection
and two PCR assays, targeting different regions of T. vaginalis genome.
Specimens were considered positive for T. vaginalis, when found positive
either by culture or by both PCRs. Kappa test for agreement between
diagnostic tests was also determined.
Results: Twenty-three women (4.6%) were found positive for T. vagi-
nalis. Infection was more prevalent in symptomatic women (6.7%)
than in asymptomatic ones (2.4%). T. vaginalis was more frequently
detected in immigrants (7.9%) than in Greek women (3.3%). Gardnerella
vaginalis infection was signiﬁcantly more frequent in women infected
with T. vaginalis. PCR was the most sensitive method (100%), followed
by culture (69.6%), wet mount (69.6%) and latex agglutination (54.6%).
The kappa index was 0.94 between culture and wet mount, 0.81 between
culture and latex agglutination and 0.79 between culture and PCR.
Conclusions: The present study indicates a relatively low percentage of
trichomoniasis in the female population living in Athens. The infection
was more prevalent among immigrants and the majority of infected
women was asymptomatic. PCR was found to considerably improve the
diagnostic yield when compared to conventional diagnostic methods.
R2296 Autochthonous taeniasis associated with intake of wild
boar meat in Asturias, Spain
A. Rodriguez-Guardado °, F. Perez, P. Capon, N. Moran, G. Martin,
J. Carton (Oviedo, ES)
Introduction: Taeniasis is the infection of humans with the adult tape-
worm of Taenia saginata or Taenia solium. Human Taeniasis is to public
health problem that affects not only endemic areas. We described the clin-
ical and epidemiological characteristics of several episodes of taeniasis
associated with the consumption of wild boar meat in Asturias, Spain.
Methods: We studied the clinical-epidemiological characteristics of
all autochtnous taeniasis diagnosed on the Tropical Medicine Unit
of Hospital Universitario Central de Asturias, a region in Northern
Spain from 2008 to 2009. The parasitological diagnostic was based on
examination of three formalin-ether concentrated stool samples and by
examination of proglottids or body segments if were availables. The
patients were following during one year before the diagnostic with
parasitological screening every 3 months. The disease was cured if two
consecutive tests were negative.
Results: We studied 8 patients that presented Taenia spp eggs in stools
samples (56% women, mean age 49 years (range 17−72). All patients
reported having eaten undercooked meat from wild boar with an average
of 187 days prior to the onset of symptoms. Two patient had urticarial
clinic, three had abdominal pain and the rest were asymptomatic except
for the broadcasting of tapeworms in stools. Not patient had eosinophilia
(mean 330 cells/mm3, limits 30–144). All patients were treated with
praziquantel 5−10mg/kg orally spaced 2 weeks apart. The parasitological
controls were negative in all patients.
Conclusions: Taeniasis is a major public health problem. In Asturias
had been considered erradicated but recently it is resurgence associated
with consumption of wild boar meat. It need epidemiological controls
to prevent the emergent aparition of this disease.
R2297 Prevention of benznidazole-associated adverse effects
using slow dose escalation and histamine H1 antagonist
(dexchlorpheniramine)
A. Rodrı´guez-Guardado °, M. Rodriguez, C. Seco, R. Ortega, N. Moran,
G. Martin, P. Capon, J. Carton (Oviedo, ES)
Introduction: The appearance of rash, haematologic or hepatic toxicity
is one of the most frequent and limiting side-effects of treatment with
benznidazole (BNZ). The slowly escalating dose has been used in other
tropical disease treatment like loiasis. We explored the efﬁcacy and safety
of a strategie for reducing the incidence of this complications.
Methods: Twelve patients diagnosed to Chagas’ disease on Tropical
Medicine Unit of Hospital Universitario Central de Asturias were treated
with BNZ in a slowly escalating dose, beginning with 100mg daily
the ﬁrs 3 days and increasing the dose by 50mg/ 3 days up to the
full daily dose of 300mg or 5mg/Kg/day; and combining the addition
of dexchlorpheniramine with the slowly escalating dose. The patients
were revised every 15 days. In all patients we realized a exhaustive
questionnaire about the apparition of any adverse effects. At each
revision we made a determination of blood count and liver function
tests. The treatment was continued during 60 days.
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Results: No patients discontinued treatment. No patients described the
apparition of rahs or other cutaneous disease during all the treatment.
The blood count and the liver function test did not changed until the end
of treatment. Two patients reported having nausea in the ﬁrst 15 days of
treatment as the only adverse effect.
Conclusion: The incidence of rash complicating the ﬁrst few weeks
of treatment with BNZ can be diminished by adding histamine H1
antagonist for 2 weeks to the standard recommendation, or by using
a slowly escalating dose. The incidence of other adverse effects
(haematological or hepatic) decreases using slowly scalating dose
too. It is necessary most studies tos proven if this slowly dose is
pharmacokinetically safe.
R2298 Epidemiological and clinical features of 111 patients with
imported chronic Chagas’ disease in Valencia, Spain
V. Abril °, M. Garcı´a-Rodrı´guez, P. Segarra, C. Parada, T. Fraile,
E. Ortega (Valencia, ES)
Background: Chagas’ disease is caused by Trypanosoma cruzi, endemic
in Latin America. 16 million people are affected by chronic disease.
The disease can develop into a cardiac form (arrhythmia, heart failure,
sudden death, thromboembolism) or a digestive form (megaesophagus,
megacolon).
Objectives: To analyze epidemiological and clinical features of patients
with imported Chagas Disease in Valencia, Spain.
Methods: Prospective study of patients with Chagas’ disease diagnosed
between January 2005 and December 2008 in Hospital General de
Valencia Tropical Medicine Division. Subjects of the study: Blood
donors or people born in Latin America, children born from chagasic
mothers, and travelers with epidemiological risk for Trypanosoma
cruzi infection. Immunological diagnosis was made using commercially
available serological tests: Recombinant ELISA (BioElisa-Chagas, Biokit
S.A.), that was the test used for serological screening, and IFI (MarDx
Diagnostic) used in addition in case of ELISA positivity. Case deﬁnition:
Any patient with epidemiological risk factors and two or more different
serological test positives. Clinical and epidemiological review, physical
examination, chest radiography, and electrocardiography (EKG) were
performed in all cases. Radiographic contrast study of esophagus and
colon and echocardiography only were performed if patient had any
symptom or EKG abnormalities.
Results: 111 cases of Chagas’ disease have been identiﬁed, all of
them Latin American immigrants. Countries of origin were: Bolivia:
95, Argentina, 2, Chile 2, Ecuador 2, N.A.10. Mean age: 38.21 years.
Gender: 66.6% females, 33.3% males. Polymerase chain reaction was
available in 65 cases, and was positive in 26, negative in 39. Chest
radiographies were normal in 96% of patients. We found abnormal
EKG in 19%, mainly branch blocks and 3 patients needed a pacemaker.
Echocardiography was abnormal in 20.3% of patients. One patient died
due to terminal cardiomyopathy. Colonic barium enema was performed
in 48 patients founded megacolon in 5 of them (10.41). Contrast
radiography of esophagus was done in 59 patients with abnormalities
in 4 (6.7%).
Conclusions: Chagas Disease is an emergent disease in Europe
because migratory movements and causes important morbidity in
young population. This situation requires improvement in clinical
and diagnostic knowledge and determine priorities on preventive and
assistencial needs.
R2299 African trypanosomiasis in the south-eastern Uganda,
Buikwe South Health sub-district, 1989–2008
S. Dobrodenkova ° (Bratislava, SK)
Background: In central and south-eastern Uganda, where the Buikwe
South Health subdistrict (HSD) is located, the acute form of sleeping
sickness, caused by Trypanosoma brucei rhodesiense, is predominant.
Here we report the incidence of T. b. rhodesiense sleeping sickness in the
last functioning treatment centre in Buikwe south HSD in south-eastern
Uganda, for a 19-year period (1989–2008), the treatment outcome,
structure of population affected, and functioning of sleeping sickness
control programme in this area.
Methods: Sleeping sickness data from 1989 to 2008 were collected
retrospectively in 2009 at Buikwe Sleeping Sickness Treatment Centre
from available sleeping sickness registers. Case deﬁnition was based on
the clinical and laboratory diagnosis, all recorded cases were included.
Data have been analysed by EpiInfo programme.
Results: In the period from 1989 to 2008, 372 cases of sleeping sickness
were diagnosed and treated. Number of patients in age 0−5 years
was 12 (3.22%), from 6 to 15 years 51 (13.7%), and above 15 years
309 (56.18%). 158 (42.5%) patients have been diagnosed in the early
stage of disease. After excluding the presence of microﬁlaria in BS was
treatment with suramin initiated and all of them recovered, except 4 men,
who escaped from the hospital. 214 patients (57.5%) had been diagnosed
in the late stage of disease. After therapy with melarsoprol 170 (79.4%)
were treated, 30 (14%) died and 14 (6.5%) were referred to other health
unit. Case fatality rate was 8%, in the late stage of the disease was case
fatality rate 14%. Median interval between the diagnosis and death was
14.4 days.
The highest incidence was in early nineties, in 1991 (83 cases). Until
2004 the incidence was decreasing, but due to closure of treatment
centers, lack of supervision and motivation of health-care workers, the
disease started to re-emerge. In 2009 5 new cases have been diagnosed.
Conclusion: Sleeping sickness still remains serious public health
problem. Since the preventive and educational activities for the control of
this neglected disease are not functioning appropriately, it can re-emerge
very easily.
R2300 Development and application of a real-time PCR assay to
detect blastocystis in human faeces
P. Poirier °, A. Albert, I. Wawrzyniak, F. Delbac, V. Livrelli (Clermont
Ferrand, FR)
Objectives: The protist Blastocystis can be found in the digestive tract
of humans with a worldwide distribution, but its clinical signiﬁcance
remains unresolved. Nine major distinct subtypes (ST) of Blastocystis
have been identiﬁed based on rRNA18S gene sequence. Recent studies
suggest an association between some subtypes of Blastocystis and acute
diarrhea or irritable bowel syndrome. However, few data are available
regarding the prevalence and the genetic diversity of Blastocytis in
France. This is probably due to the difﬁculty to point out Blastocystis
in human feces. The anaerobic culture of fresh stool sample remains the
gold standard method, but is heavy to set up for epidemiological studies.
Direct microscopy of fecal smears is frequently used but exhibits a poor
sensibility compared to the culture. The aim of this study was to develop
a sensitive real time PCR assay to detect Blastocystis directly from stools.
The PCR was used to estimate the prevalence of Blastocystis in patients
of the Clermont Ferrand hospital (France), compared to microscopy and
culture.
Methods: A couple of primers was designed to amplify a 330 bp
length fragment of the rRNA18S gene of Blastocystis. Real time
PCR assays were performed using a Rotorgen-6000® with Sybr Green
detection. DNA extract from genotypes 1 to 9 were tested. Repeatability,
reproducibility and the limit of detection were determined on fecal
samples. Finally 100 stool samples from hospitalized patients were tested
for Blastocystis using direct microscopy of fecal smears, culture in Jone’s
medium and the real time PCR assay we developed.
Results: We successfully ampliﬁed DNA extract from subtypes 1 to 9
and the lower limit of detection was 102 Blastocystis per gram of stool.
During the prospective clinical study, among 100 patients, 4 positive
samples were detected using microscopic analysis, 7 using culture and
10 using our real time PCR assay. Three samples were positive only by
PCR, indicating a better sensitivity of this method. Speciﬁcity and ST
determination were checked by sequencing of the PCR products.
Conclusion: In general population of industrialized countries, the
prevalence of Blastocystis is often considered to be about 5%. With our
sensitive quantitative PCR assay, Blastocystis was detected in 10% of
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stool samples. Our results show the usefulness of molecular PCR-based
diagnostic approaches to obtain relevant data about epidemiological
features of Blastocystis.
R2301 Dengue fever: clinical and laboratory proﬁle
A. Gogia °, A. Kakar, S. Byotra (New Delhi, IN)
Objectives:
1. To study the clinical proﬁle of patients with conﬁrmed Dengue fever.
2. To study the Laboratory proﬁle in patients with Dengue fever.
3. To study the mortality in these patients.
Methods: We enrolled all patients above the age of 15 years in our
study. They included conﬁrmed cases of Dengue fever by way of positive
Dengue IgM antibody and/or Dengue NS1 antigen. A total of 78 patients
were enrolled in the study over a period of two months and their complete
clinical and biochemical proﬁle was recorded as per a preset performa.
Results: The study showed 50 males and 38 females with a mean
age of 35±9 years. All the patients who were admitted had an initial
platelet count of less than 50000/cumm. All patients had fever for a
mean duration of 5±1 days. The mean age of the patients was 45±15
years. 70 out of 78 patients had complaints of nausea, body ache and
or vomiting. 45 out of 78 patients were recorded to have either itching
or a skin rash. 2 out of 78 patients had severe bleeding in the form that
required urgent intervention in the form of blood or platelet transfusion.
15 out of 78 patients had minor bleeding in the form of gum bleed,
petechial rash, bleeding form nose or one episode of malena. 1 out
of 78 patients died due to bleeding, aspiration and hypotension. One
of the patients had concomitant vivax malaria. 72 out of 78 patients
had raised transaminases ranging more >2 times to 5 times the upper
limit. 68 out of 78 patients had features of hepatomegaly, gall bladder
wall oedema, pleural effusion and or ascites. All patients responded to
therapy in form of IV ﬂuids, Platelet transfusion in case of bleeding or
platelet count <20,000/ul, acetaminophen and other symptomatic care.
25 of 78 patients required platelet transfusions. A total of 15 patients
required multiple platelet transfusions. All patients recovered within a
mean duration of 6±2 days.
Conclusions:
1. Dengue fever has no speciﬁc age or sex preponderance.
2. Most patients presented with fever, body ache and nausea.
3. Majority of the patients present with an elevated liver enzymes which
is a self limiting phenomenon.
4. Dengue fever in our study had very low mortality and showing that
this particular strain is self limiting disease in majority of cases if
supportive treatment is given appropriately.
5. Platelet transfusion is required in approximately 1/3rd of patients
and major bleeding is not seen in majority of cases with adequate
supportive treatment.
R2302 In vitro susceptibility test for Acanthamoeba sp. isolated
from clinical specimens against chlorhexidine, propamidine
isethionate, gentamicin and chloramphenicol
M.K. Abd Ghani °, G.H. Shirley Tang, N. Anisah, N. Putri, S. Yusof,
R. Noraina, A. Norazah (Kuala Lumpur, MY)
Objective: Acanthamoeba keratitis is one of the most severe and
potentially sight-threatening ocular parasitic infectious diseases and is
recognized as the most challenging among ocular infections. In vitro
susceptibility testing of Acanthamoeba isolates may prove beneﬁcial for
application of early treatment regimens. This study was conducted to
determine the effectiveness of the drugs in therapeutic dose and the
minimum cysticidal concentrations (MCCs) of the drugs.
Methods: Serial doubling dilutions of chlorhexidine digluconate from
200 mg/ml to 0.097 mg/ml, propamidine isethionate (Brolene) from 1000
mg/ml to 0.488 mg/ml and gentamicin from 40000 mg/ml to 19.531 mg/ml
were performed in microtiter plate and tested against 3 Acanthamoeba
isolates which were isolated from keratitis cases. After the exposure of
the cysts to the drugs for 24 hours, the cysts were washed free of drugs
by centrifugation. The deposit (cysts) was cultured onto nonnutrient agar
plates overlaid with heat-killed Escherichia coli. The replication and
growth of the trophozoites from cysts exposed to each of the dilutions
were observed and recorded microscopically for 14 days to determine
the MCC of each drug. The effectiveness of the drugs in therapeutic dose
against the cysts was tested directly without any doubling dilutions.
Results: Chlorhexidine digluconate and propamidine isethionate (Bro-
lene) successfully exhibited their cysticidal activities in therapeutic dose
but not for gentamicin and chloramphenicol. The minimum cysticidal
concentration (MCC) of chlorhexidine ranged from 25 mg/ml to 50
mg/ml, propamidine isethionate ranged from 500 mg/ml to 1000 mg/ml
and gentamicin ranged from 10000 mg/ml to 20000 mg/ml. The mean
MCC of chlorhexidine, propamidine isethionate and gentamicin on
Acanthamoeba isolates was 33.33 mg/ml, 666.66 mg/ml and 13333.33
mg/ml respectively.
Conclusion: The in vitro sensitivity test enables the determination of
MCC of drugs on Acanthamoeba isolates and can be used for the
screening of new anti-acanthamoebal therapeutic agents. Chlorhexidine
digluconate and propamidine isethionate (Brolene) have proven to be
very effective anti acanthamoebal agents.
R2303 Cryptosporidiosis in Iranian farm workers and their
household members: possible zoonotic transmission
M. Izadi, N. Jonaidi Jafari °, M. Fazel, M. Rezaiemanesh,
M. Mohammad Jonaidi, R. Ranjbar, S. Eyni (Tehran, Birjand, IR)
Objectives: The prevalence of cryptosporidium and the risk factors
of zoonotic transmission on Najafabad, Isfahan, Iran dairy farms were
examined.
Materials and Methods: Sampling and specimen processing: One
fecal sample collected from all calves less than 6 months old on 8
dairy farms around Najafabad (Isfahan province, central Iran) as well
as individuals working in these farms and their household members.
During September to March 2008, 218 and 422 fecal samples collected
from calves and humans respectively. Each specimen placed in a plastic
vial, brought immediately to laboratory and stored at 4ºC until analysis.
All of the samples were stained by the modiﬁed Ziehl–Neelsen method
and examined under bright ﬁeld microscopy.
DNA extraction: Fecal samples were subjected to six cycles of freeze-
thaw in liquid nitrogen and a 95ºC water bath to rupture the oocysts.
DNA was isolated from aliquots of frozen stool. 18S rRNA gene
ampliﬁcation and sequencing. A two-step nested PCR protocol was used
to amplify the 18S rRNAgene (830 bp). PCR products were analyzed on
1% agarose gel and visualized by ethidium bromide staining.
Results: Cryptosporidium was identiﬁed in the stool of 36 (prevalence
8.5%) of 96 farm workers and 326 household members. Furthermore,
31 (14.2%) of 218 calf samples were positive. Based on 18s rRNA gene
ampliﬁcation and sequencing, cryptosporidium parvum was identiﬁed in
72% of the positive farm workers and 65% of the positive household
members. Of the positive calves, 64.5% were infected with C. parvum,
indicating possible zoonotic transmission on these farms. Univariate
analysis of potential risk factors revealed that contact with calves
(P< 0.0001) was the most signiﬁcant risk factor of C. parvum infection.
A considerable negative association was observed between C. parvum
infection and cleaning of shoes/boots after daily work (P< 0.004),
hand washing (P< 0.013) and use of piped water (P< 0.006). In the
multivariate analysis with logistic regression, only contact with calves
was signiﬁcant.
Conclusion: Zoonotic transmission of C. parvum due to contact with
calves is predominant among farm workers and their household members
of this region and appropriate health measures must be applied to control
the infection and decrease of zoonotic transmission of this parasite.
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R2304 Fever in hospitalized travellers and migrants over 11-year
period at a teaching hospital in Italy
S. Antinori °, L. Galimberti, V. Acquaviva, L. Milazzo, E. Gianelli,
M. Corbellino, M. Galli (Milan, IT)
Objectives: To describe prevalence of hospitalization and clinical
spectrum of fever in returning travellers and migrants in Italy.
Methods: Retrospective charts review of all febrile illnesses developing
within 3 months after a stay in the tropics and hospitalised between 1998
and 2008 at the Infectious Diseases Clinic of Milan, Italy.
Results: Near 4% (270/6827) of all hospital admissions in the study
period were due to fever in travellers and migrants returning from
the tropics. 188 (69.6%) were men, the median age was 32 years
(range 16−75 years). 173 were Italian citizens, 97 (36%) were extra-
European migrants (52% classiﬁed as visiting friends and relatives).
As shown in ﬁgure 1 malaria was the most common speciﬁc etiologic
diagnosis, found in 49.5% of ill returned travellers with fever. Fifty-
three percent of all malaria cases were diagnosed in migrants. Causes
of fever varied by region visited (76% of malaria were acquired in sub-
Saharan Africa, OR 47.6, 95%CI 13.8–163.4; dengue fever was acquired
in Latin America Indian subcontinent and south-central Asia in 86%
of cases) and by time of presentation after travel (dengue accounted
for the early presentation). 9.2% of travellers with fever had a vaccine
preventable infection. Sixteen percent of patients had an acute viral
infections excluding viral hepatitis that accounted for 7.7% of all causes
of fever.
Conclusions: During a 11-year period, the number of patients returning
from tropical areas who were admitted with fever to a university hospital
in northern Italy remained stable. Malaria remains the most frequent
diagnosis accounting for near 50% of all hospitalization. Dengue fever
was the most frequent tropical infection besides malaria. The time of
presentation after travel and region visited provides important clues
toward establishing a correct diagnosis..
R2305 Unusual case report of larva migrans of Toxocara
canis with hepatic involvement, severe lumboishialgia,
lymphadenopathy and fever
J. Nikolic °, Z. Dakic, G. Stevanovic, M. Pelemis, M. Pavlovic
(Belgrade, RS)
Toxocara canis infections are uncommon in developed countries.
However sporadic cases and possibility of systemic involvement, require
considering this diagnostic possibility.
This is a case report of a 25-year old previously healthy female
from urban surroundings, who presented at our clinic with prolonged
low-grade fever, abdominal pain, severe lumboishialgia, paraesthesiae,
pruritic rash, generalized lymphadenopathy and liver damage. There were
no anamnestic data concerning recent travel or contact with animals.
Complete laboratory examination revealed hypereosinophilia (12.5%),
elevated liver enzymes (AST 246, ALT 306), hyperbilirubinemia, his-
tological non-speciﬁc lymph node inﬁltration, without any radiological
ﬁndings of focal infection.
Toxocara canis infection was conﬁrmed with positive serology tests,
and as other tests including virology (hepatitis A, B, C, HIV,
herpesviridae, Coxsackie), bacterial cultures (including serology for
B. burgdorferi, Brucellae, tests for Tuberculosis), stool tests and available
immunoserology for other parasites were negative. After a 10 day
treatment with albendazole (400mg twice a day), patient was afebrile,
without any physical complaints including normal levels of liver enzymes
and leukocyte formula.
Most cases of visceral larva migrans are mild, self-limiting and may
mimic many different conditions, but as the available treatment options
are effective, it should be suspected in patients with hypereosinophilia
and liver damage.
R2306 Prevalence of Cryptosporidium in immunocompetent
children with acute diarrhoea in Upper Normandy,
north-western France
G. Gargala, D. Leme´teil, F. Dalle, A. Bonnin, F. Louillet, I. Michelet,
E. Mallet, L. Favennec ° (Rouen, Dijon, FR)
Objective: The intestinal protozoa Cryptosporidium is increasingly
recognized as a major cause of diarrheal disease, however, the incidence
of cryptosporidiosis in children is unknown in France. This study was
conducted to assess the signiﬁcance of Cryptosporidium as causing agent
for gastro-enteritis in immunocompetent children in Upper-Normandy,
France.
Patients and Methods: The study was conducted between January
2007 and November 2009. During the 34-months period study, stool
specimens from 2,041 children (aged <16 years), all immunocompetent,
with acute diarrhea were prospectively screened for the presence of
Cryptosporidium oocysts. 85% (1,746) were patients attending the
Pediatric department of Rouen University Hospital, Upper-Normandy
(North-western France) whose stools were examined at the hospital
Parasitology laboratory. 15% (299) were patients attending general
practitioners whose stools were examined at a private clinical
laboratory in Saint Vale´ry en Caux, 60 kms from Rouen. Presence
of Cryptosporidium was assessed by microscopy with semi-quantitative
results obtained after Heine staining of faecal smears. Cryptosporidium
species and genotype determination were based on polymerase chain
reaction with PCR targeting the Hsp70 and the 18S rRNA genes followed
by 18S rRNA gene fragment sequencing.
Results: Twenty three (1.3%) out of 1746 and 3 (1%) out of 299
children seen at Rouen University Hospital and at Saint Vale´ry en Caux,
respectively, were reported to excrete oocysts. Maximum of cases (81%)
were reported in children at ages between 0.5 and 6 years. Genotyping
revealed 6 and 17 positive stools for C. hominis and C. parvum,
respectively. More than 75% of children had vomiting and 44% were
dehydrated. Other symptoms included fever and abdominal pain. 62%
of cases were reported between July and October. Four out of the six
C. hominis cases have reported travel outside France prior to illness
compared with 2 out of 17 for C. parvum. Conclusion: Few reports
are available on frequency of cryptosporidiosis in immunocompetent
children in France and this study has demonstrated the public health
importance of this parasite in Upper-Normandy. Cryptosporidiosis is
likely to be unrecognized and underdiagnosed. Diagnostic testing for
Cryptosporidium is rarely ordered, even when patients have symptoms
consistent with cryptosporidiosis, leading to a lack of speciﬁc preventive
initiatives to limit the overall health impact of cryptosporidiosis.
Resistance and mechanisms of action of
antifungals
R2307 New antifungal microbial strains effective against Candida
strains isolated from infections
I. Sarbu, O. Csutak, D. Pelinescu, I. Stoica, E. Rusu °, S. Enache-Soare,
P. Cornea, A.M. Tanase, R. Ghindea, O. Negruta, T. Vassu (Bucharest,
RO)
It is estimated that Candida species account for more than 90% of fungal
infections. Selecting microbial strains with large antifungal activity,
could represent important alternative treatment.
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Objectives: Antifungal activity studies on lactic acid bacteria (LAB) and
Metschnikowia pulcherrima yeast strains against Candida albicans (Cc,
C3), Candida parapsilosis (M6) and Candida tropicalis (OT4) strains
isolated from vaginal and oral infection.
Enhancement of antifungal activity of M. pulcherrima strains using
sodium bicarbonate (NaHCO3) and calcium chloride (CaCl2).
Methods: For this study 114 strains of lactic acid bacteria were isolated
from sourdough, newborn faeces, fermented milk and plants. Selection
of LAB strains was made by cultivation on MRS CaCO3, Gram stain
and catalase test. All strains were screened for Candida growth inhibiting
capacity by using spot agar method.
Antifungal and killer activity were tested by spoting three M. pulcher-
rima strains (SG1, SG2, CPM1) on plates ﬂooded with the Candida
isolates. For further tests cell suspensions were mixed with: NaHCO3
0.1%, 0.5%, 1%, 2%, and CaCl2 1%, 2%, 3%.
Results: Nine LAB strains were selected for high antifungal activity
against our Candida isolates. API, BIOLOG and REP-PCR analysis
allowed us to place LAB strains in Lactobacillus, Pediococcus, Weissela
and Enterococcus genera. The antifungal activity was correlated with the
biosynthesis of organic acids.
The three M. pulcherrima strains showed high killer activity against OT4
and Cc. The weakest action was recorded against M6. The best results for
antifungal activity were obtained for all three strains on OT4, with wide
halos and growth inhibition. Signiﬁcant results were observed for SG1
and SG2 against Cc. In the case of M6, only SG1 formed a shallow halo.
OT4 strain was sensible at SG1 and SG2 with 2% NaHCO3 or CaCl2
1%, while CPM1 was active only in 0.1% NaHCO3 mixture. Clear halos
were obtained on Cc plates for all three M. pulcherrima strains with 2%
NaHCO3 or 2% CaCl2. The weeker results were recorded against C3
strain.
Conclusions: The antifungal activity of the nine LAB selected strains
was correlated with the biosynthesis of organic acids.
The most important killer and antifungal activity of the three
M. pulcherrima strains were observed against OT4 and Cc, and was
enhanced in mixture with 2% NaHCO3 or 2% CaCl2. SG1 and SG2
showed the higher antagonistic potential against all the Candida isolates
tested.
R2308 Sensitivity of Candida albicans during ﬂuconazole
prophylaxis
R. Hannula ° (Trondheim, NO)
Objectives: Fluconazole prophylaxis in adult neutropenic leukemia
patients was introduced in our hospital in 2000 and continued until
2006, with the exception of a period of about 12 months. We studied
the sensitivity of Candida albicans to ﬂuconazole in adult haematologic
patients from 1998 to 2007 retrospectively. The species distribution of
yeast isolates in all samples from the haematology ward was recorded
for the study period.
Methods: 75 yeast isolates from adult haematologic patients were tested,
25 before start of prophylaxis, 25 in 2003 and 25 in 2007. Available
C. albicans isolates from any material were selected in chronologic order
from our archive. The strains were cultured on Sabouraud glucose agar
and on RPMI agar for resistance testing by Etest® (AB-Biodisk and
bioMe´rieux), according to the producer’s recommendation. The plates
were incubated for 24 hours, the MIC was read at 80% inhibition and
the result was controlled after 48 hours of incubation. Simultaneous
culture on CandidaCHROMagar® (BD Diagnostics) was made to exclude
non-albicans and mixed infections. A search in our database for yeast
isolates and species distribution in all patients admitted to the adult
haematological ward was made for the years 1998 through 2007.
Results: C. albicans was the most prevalent yeast found. The number
of samples and patients tested in the time period was increasing, in
total were 404 samples and 226 patients found. C. albicans was isolated
in 84–100% of the samples and non-albicans strains in 0.14−32%. The
number of patients with non-albicans strains, mainly C. glabrata but also
Saccharomyces cerevisiae was increasing. The small amount of samples
may have masked a preexisting prevalence of these strains.
The MIC results demonstrated low values for all years studied. In 2007,
we observed a rise in the MIC values and a higher frequency of double
inhibition zones for ﬂuconazole.
Conclusion: Fluconazole prophylaxis in haematologic patients may
induce subpopulations of C. albicans with an elevated MIC. The
prevalence of C. albicans was high in samples from the haematologic
ward. Non-albicans species were found in addition in increasing
numbers, suggesting a selection pressure induced by ﬂuconazole
prophylaxis.
R2309 In vitro susceptibilities of invasive samples isolates of
non-albicans Candida sp. to antifungal agents
M.D. Rojo °, C. Miranda, M.I. De las Heras, M.D. Pe´rez, M.L. Serrano
(Granada, ES)
Objectives: To study the susceptibility to azoles, echinocandins and
amphotericin B for Candida species other than C. albicans isolates
obtained from invasive samples over a period of four years in the
Microbiology Service, University Hospital Virgen de las Nieves, Granada
(Spain).
Methods: The susceptibility to antifungal agents for non-albicans
Candida species isolated has been studied in invasive samples obtained
between October 2005 and October 2009, generally there was a single
isolated per patient. The antifungal agents investigated were ﬂuconazole,
itraconazole, voriconazole, caspofungin and amphotericin B and the
method used was Sensititre Yeast One® (Trek Diagnostic Systems).
The results for ﬂuconazole and itraconazole were interpreted according
to the susceptibility criteria of CLSI (M27-A2). For the other antifungals,
in which there are no breakpoints, we determined the MIC90.
Results: We detected 127 invasive samples (belonging to 95 patients)
with isolates of Candida species other than C. albicans: 76 from blood
cultures (59.8%), 30 from intra-abdominal samples (23.6%), 14 from
respiratory tract samples (11%), 3 from skin / soft tissue (2.4%), 2 from
cerebrospinal ﬂuid (1.6), 1 from osteoarticular tissue (0.8%) and 1 from
cardiac valves (0.8%). From these samples we isolated 98 strains of
yeasts and their susceptibility to antifungal agents as shown in Table 1.
Conclusions:
– It has been veriﬁed that on these species ﬂuconazole and itraconazole
have a limited activity, except C. parapsilosis; voriconazole is the most
active tested azole.
– Caspofungin appears to be very effective, including azole-resistant
Candida species, like C. krusei.
– Amphotericin B is still efﬁcient on the treatment of serious infections
caused by Candida species other than C. albicans.
Table 1. Antifungal susceptibility for non-albicans Candida species
Candida species (n) Fluconazole Itraconazole Voriconazole Caspofungin Amphotericin B
%S1 %SDD2 %S % SDD MIC90 MIC90 MIC90
C. parapsilosis (32) 100 − 85.2 15 1 0.12 1
C. glabrata (28) 4.17 66.7 0 33.3 1 0.25 1
C. tropicalis (21) 83.3 − 20 40 0.5 0.25 1
C. krusei (15) 0 − 16.7 83.3 0.5 0.5 2
C. kefyr (1) 100 − 100 − 0.03 0.03 1
C. pseudotropicalis (1) 100 − 100 − 0.03 0.03 2
Total (98) 55.3 22.4 40.8 36.3 1 0.5 1
1Percentage of susceptible strains; 2Percentage of dose dependent susceptible strains.
R2310 Fungaemia by C. krusei: acquisition of voriconazole
resistance in vivo
E. Ricardo, I. Faria-Ramos, S. Costa-de-Oliveira °, A.P. Silva,
A.G. Rodrigues, C. Pina-Vaz (Porto, PT)
Fluconazole prophylaxis has been associated to an increased prevalence
of C. krusei and C. glabrata strains. C. krusei shows intrinsic resistance
to ﬂuconazole, but usually not to the other azoles such as voriconazole.
C. krusei blood isolates were recovered from a leukemia patient during
two months; during this period he was submitted to voriconazole
therapy. An increase in minimal inhibitory concentration (MIC) values
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of voriconazole was registered among consecutive isolates, which ﬁnally
developed a resistant phenotype.
Objectives: Aiming to clarify the acquired resistance mechanism, we
raised the hypothesis of such resistance being due to overespression of
efﬂux pumps.
Methods: Two clinical C. krusei isolates were studied: one susceptible
(MIC 1mg/ml) and one resistant (MIC 8mg/ml) to voriconazole. Agar
disk diffusion assay was performed in order to study the synergistic
effect between FK506 (Tacrolimus, described as an efﬂux blocker), and
voriconazole, in the resistant C. krusei isolate, as described by Ricardo E.
et al (2009). Ten-fold dilutions of FK506 ranging from 1000 to 1mg/ml
were assayed and voriconazole was added to YEPD agar plates at supra-
MIC value (1 mg/ml). In order to induce resistance, the susceptible strain
was exposed, in vitro, to sub-inhibitory concentrations of voriconazole
(1mg/ml). Every day 1ml of culture broth was transferred to new
fresh medium, with voriconazole (1mg/ml). Susceptibility proﬁles to
voriconazole were assayed until acquisition of resistance. Flow cytometry
assays using rhodamine 6G (Rd-6G) 5mM (an efﬂux pump ﬂuorescent
substrate) were performed in order to compare the resistant isolates
(in vivo and in vitro induced) with the susceptible isolate, regarding
the role of efﬂux pumps in C. krusei resistance.
Results: Agar disk diffusion assay showed growth inhibition around
the disks impregnated with the highest FK506 concentrations (100 and
1000mg/ml). At the 10th day of incubation of the susceptible strain with
voriconazole the MIC value was 64mg/ml. Both resistant strains showed
less intensity of ﬂuorescence when stained with Rd-6G 5mM comparing
to the susceptible isolate.
Conclusions: A synergistic effect was observed between voriconazole
and the highest FK506 concentrations. The resistant strains accumulate
less intracellular Rd-6G than the susceptible strain, which means that
prolonged exposition to voriconazole, in vivo and in vitro, induced
resistance associated to efﬂux pumps activity.
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R2311 Vulvovaginal candidiasis in a Kuwait hospital during a
2-year period
E. Draghijeva °, P. Egbase (Kuwait, KW)
Objectives: The purpose of this study was to determine the etiologic
agent of all vulvovaginal candidiasis (VVC) isolated in our hospital
during a two-year period.
Methods: 178 samples received in the hospital laboratory from July
2007 to July 2009 belonging to 89 women between ages 18 and 68
with a diagnose of VVC were reviewed. All samples were cultured on
Sabouraud Dextrose Agar for 24−48 hours at 37 degree C. Candida spp.
were identiﬁed on the basis of the macroscopic appearance of colonies,
Gram-stained specimens and the identiﬁcation to the species level using
the API System ID 32C (bioMe´rieux, France).
Results: From 89 isolated strains, 38 strains (43%) were identiﬁed as
Candida albicans, 27 strains (29.5%) identiﬁed as Candida glabrata, 22
strains (25%) as Candida parapsilosis and 2 strains (2.5%) as Candida
crusei. When we attemped to sort the 89 cases with Candida by age
groups, in the 13−20 years age group we included 10 samples (11.2%), in
the 21−30 years group 46 samples (51.7%), in the 31−40 years group 21
samples (23.6%), in the 41−50 years group 5 samples (5.6%).
Conclusion: VVC affects female’s everyday life. In the last years there
has been a rise in the share of VVC attributable to non-albicans Candida
species. It is important to know the etiological agents in each hospital
and in each population in order to obtain the most precise diagnosis and
treatment.
R2312 Fluconazole susceptibility testing in candidaemia isolates
L. Persijn °, A. Piette, G. Claeys (Ghent, BE)
Objectives: Candidemia is a life-threatening disease, requiring early
and correct treatment. Fluconazole is the standard antifungal therapy;
however, not all Candida isolates are susceptible. Different methods for
antifungal susceptibility testing are described. Therefore, we compared
the E-test and disk diffusion versus broth microdilution. We also
evaluated the possibility of direct susceptibility testing on positive
haemocultures.
Methods: All records from patients with candidemia from January 2005
until August 2009 were analysed and the susceptibility for ﬂuconazole
was calculated. In a substudy the ﬂuconazole E-test (on RPMI 1640 + 2%
glucose agar), disk diffusion (on Shadomy agar according Neo-Sensitabs
protocol) and a reference method (broth microdilution according CLSI
M27-A protocol) were compared.
Results: Overview of data: The total number of patients with Candida
septicemia decreased from 2005 till present: from 50 to 38 episodes
each year. C. albicans was most frequently isolated at approximately 25
times a year, almost all susceptible to ﬂuconazole (98.3%). This was
followed by C. glabrata, C. parapsilosis, C. krusei and C. tropicalis, all
with annually decreasing trend. The susceptibility of C. glabrata varied
most depending on the method used: 22.7% susceptible (S) and 36.6%
resistant (R) with disk diffusion on Shadomy and 17.2% S and 41.4%
R with broth microdilution.
Technical validation: Strains with known MIC value for ﬂuconazole
(with reference method) were used to evaluate E-test and disk diffusion.
For C. glabrata and C. parapsilosis different results were found using
different methods. Direct susceptibility testing was conducted on samples
spiked with ATCC control strains and patient haemocultures positive for
yeasts. If growth was sufﬁcient, correct results were obtained except
for C. glabrata. However in many cases growth on the RPMI agar was
insufﬁcient, so repeated standardized susceptibility testing was needed.
Conclusion: Correct and rapid identiﬁcation of Candida in septicemia
is more important than antifungal susceptibility testing. Inconsistent
results with different methods and wide MIC distribution for wild-type
C. glabrata makes the testing of ﬂuconazole susceptibility a challenge
in daily practice.
R2313 Effect of non-steroidal anti-inﬂammatory drugs on
Candida sp.
E. Rusu °, S. Enache-Soare, T. Vassu, A. Brezeanu, C. Cristescu,
V. Cristescu (Bucharest, RO)
Objectives: The aim of the study was to investigate the action of some
non-steroidal anti-inﬂammatory drugs (NSAIDs) sodium diclofenac,
aspirin and piroxicam on cells viability of planktonic cells of Candida
albicans and Candida krusei strains and possible ultra structural changes
of C. albicans cells treated with diclofenac.
Methods: Four strains of C. albicans and one C. krusei were used in
this study. Strains were isolated from pharyngeal excreta. Isolates were
identiﬁed by the conventional and molecular typing (ampliﬁcation of
ARN ribosomal 5.8S gene and restriction with enzymes Dde I, Cfo I, and
Hind III). Tests of viability of cells in the presence of three NSAIDs were
done by the serial dilution method. The standard method of electronic
microscopy was used to study the ultra structural changes in C. albicans
cells, induced by the diclofenac treatment (1mM and 2mM).
Results: The results of study identiﬁed strains through conventional and
molecular typing showed us that four strains were in C. albicans species
and one strain in C. krusei. The cells viability tests showed us a value
of this up to 38−50% for all C. albicans strains which were treated
with sodium diclofenac to plasmatic concentration (3.6 microg/ml) and
55% for C. krusei strain. In the presence of aspirin 1 mM the viability
of cells was 76−81% for C. albicans strains and up to 51−79% for
piroxicam. For C. krusei strain the cells viability was 93% for aspirin
and 80%, piroxicam respectively. The electronic microscopy study stood
out the ultra structural changes of C. albicans cells treated with sodium
diclofenac 1 mM and 2 mM. We noticed changes to the plasmalema level
(separated from the cytoplasm), to outer layer of cell wall (became more
electrono-transparent), the invaginations of plasmatic membrane and the
disorganization of cytoplasm which appeared completely damaged in the
small parts. Cells had necrotic or aged aspects.
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Conclusions: Our study stood out the effect of some NSAIDs on
Candida albicans and Candida krusei strains. The greater inhibitor effect
was obtained for Candida cells treated with diclofenac. The results of
the electronic microscopy study showed us the ultra structural changes to
C. albicans cells treated with diclofenac. We think that use of NSAIDs,
especially sodium diclofenac to the speciﬁc antifungal treatment can
cause a susceptibility of Candida cells and facilitate the action of
antifungal drugs. The results can be a successful anti-Candida therapy.
R2314 Primary cutaneous cryptococcosis due to C. laurentii in a
renal transplant recipient
S. Desai °, A. Kulkarni, M. Sinha, A. Flynn, U. Anandh (Bangalore, IN)
Objectives: We present a renal allograft recipient with primary
cutaneous cryptococcosis (PCC) by Cryptococcus laurentii, probably
caused by repeated skin injury and inoculations while injecting insulin
and low molecular weight heparin on the thigh.
Methods: Identiﬁcation of the yeast was made from the skin biopsy
stained with Gram’s stain. India ink preparation from the skin biopsy
was done. Isolated from culture on Sabourad’s dextrose agar. Serum
cryptococcus latex agglutination test was also done. Speciation was done
using Mini API (bioMe´rieux).
Results: The Gram’s stain revealed spherical and elongated budding
yeast-like cells without any pseudohyphae. Sabourad’s dextrose agar
colonies are cream coloured with a smooth mucoid texture. The fungus
was notably absent from blood and lungs. The serum cryptococcus latex
agglutination test was negative.
Conclusion: This is ﬁrst report of primary cutaneous cryptococcosis
due to C. laurentii in an immune compromised host. Reporting of
such patients might further expand the existing clinical manifestations.
Awareness and high index of suspicion might assist in early diagnosis
and hence institution of treatment.
R2315 Candidiasis associated with bacterial vaginosis in patients
from a health district in Madrid
M. Espinola °, D. Domingo, T. Alarcon, M. Lopez-Brea (Madrid, ES)
Introduction: Candida spp. is one of the most frequent microorganisms
isolated in female genital tract infections. In spite of its theorical
incompatibility with bacterial vaginosis (BV), there are certain cases
of BV in which Candida spp. is also present.
Aim of the study: The aim of this study was to see the prevalence
of candidiasis associated with bacterial vaginosis in a group of patients
from a district in Madrid.
Methods: 165 samples (7 endocervical, 158 vaginal) from patients with
bacterial vaginosis were collected from 1st March to 12th November
2009 in a hospital of Madrid. Samples came from different health care
centres associated to our hospital. These samples were taken by vaginal
or endocervical swabs. Bacterial vaginosis was diagnosed following
Nugent criteria and samples were cultured on blood and chocolate agar
at 37ºC for 48 h. Candida spp. were identiﬁed by selective culture on
CHROMagar at 37ºC for 48 h on the appearance of colonies of different
colours, being green colonies an indicator of the presence of Candida
albicans. Other species of Candida were identiﬁed by Auxacolor system,
a commercial yeast identiﬁcation kit based on colorimetric tests for
conventional assimilation substrates.
Results: We found 23/165 cases (13.9%) in which Candida spp. was
associated with bacterial vaginosis. Candida albicans was isolated in
most cases (21/23). In the two remaining cases Candida parapsilosis
and Candida sp. were isolated.
Most women who presented this association were young and in
childbearing age, being the mean age 27 years old and the standard
deviation 9.66. The youngest and oldest patients were 15 and 48 years
old respectively.
May and July were the months with the highest proportion of candidiasis
associated to BV, 23 and 27.27% respectively (see table) and the average
of this association was 3 cases per month.
Conclusion: In spite of the theorical incompatibility of yeast infection
and bacterial vaginosis, our data show that Candida spp. is present in
more cases of bacterial vaginosis than expected, being the prevalence 3
cases per month on average.
Prevalence of candidiasis associated with bacterial vaginosis
Month Samples BV Candidiasis Isolates Yeast + BV
March 12 Vaginal All 1 C. albicans 1/12 = 8.33%
April 14 Vaginal, 1 Endocervical All 0 0%
May 25 Vaginal, 1 Endocervical All 6 5 C. albicans
1 Candida sp.
6/26 = 23%
June 34 Vaginal, 2 Endocervical All 3 2 C. albicans
1 C. parapsilosis
3/36= 8.33%
July 22 Vaginal All 6 C. albicans 6/22 = 27.27%
August 14 Vaginal, 1 Endocervical All 1 C. albicans 1/15 = 6. 66%
September 12 Vaginal, 2 Endocervical All 1 C. albicans 1/14 = 7.14%
October 15 Vaginal All 3 C. albicans 3/15 = 20%
November 9 Vaginal All 2 C. albicans 2/9 = 22.22%




BV = Bacterial vaginosis.
R2316 Evalution of Candida colonization index in patients in
intensive care units
F. Ergin, M. Yetkin, C. Bulut, B. Oral, G. Ertem, N. Tulek °, A. Demiroz
(Ankara, TR)
Objectives: Nosocomial candidiasis is a great risk for the intensive
care patients. Candida infections mainly evolve from endogenous
colonization, thus the detection of the colonization is very important.
In this study; we evaluated candida colonization in the intensive care
unit patients by using candida colonization index (CI) and aimed to
predictive value of colonization index for invasive candidiasis.
Methods: From September 2008 to February 2009, 100 patients older
than 18 years of age in the intensive care unit were included in this study.
Throat, nose, skin (axilla), urine and rectal swab cultures were taken
weekly from each patients. Also tracheal aspirates, drain and central
vascular catheter cultures were taken if there were. Candida colonization
index was calculated by the ratio of the number of culture positive sites
to the number of sites cultured.
Results: Candida colonization was found in 42 of 100 patients. Of
these colonized patients, invasive candidiasis developed in nine patients,
candidemia in ﬁve and urinary tract infection in four. Most of the
colonized patients were in the surgical intensive care unit (ICU), staying
longer length in the ICU and had more invasive instrument. Additionally
candida colonization was diagnosed mostly in the patients with bacterial
sepsis and exposed to broad spectrum antibiotics. Colonization index
was found to be greater than 0.5 in 8 of 42 patients. Heavy colonization
(CI> 0.5) was only determined in one of the nine patients with invasive
candidiasis. However all of the nine patients who develop candidal
infection were colonizated before the infection. The sensitivity and
spesiﬁty of colonization index for determining invasive candidiasis were
found respectively 100% and 64%. Positive predictive value was 21%
and negative predictive value was %100.
Conclusion: Candida colonization is frequently met among the intensive
care patients. Invasive candidiasis in the intensive care unit setting is
thought to be subsequent to colonization. Candida colonization index
may be a good parameter to predict invasive candida infections.
R2317 Fast identiﬁcation and susceptibility testing to antimycotics
of Candida spp. isolates
I. Hadji-Petrusheva Meloska °, B. Curcuc Trajkovska,
A. Hadji-Petrusheva Jankijevic, B. Jaglikovski (Skopje, MK)
Introduction: Precise identiﬁcation and susceptibility testing of yeasts,
especially Candida, is essential for obtaining a prompt diagnosis and
administering a proper therapy, having in mind the actual problem with
resistance to various antimycotics.
Aim: To identify yeast isolates from lower respiratory tract (LRT), urine
and genital samples using novel yeast identifying method and to test
their susceptibility to antimycotics.
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Material and Methods: A total of 140 yeasts, isolated from LRT (41),
urine (40) and genital (59) samples in a one year period (October 2008–
October 2009), were evaluated. Conventional microbiology methods
were used for isolation of yeasts. The identiﬁcation was using both:
growth on Chromogenic Candida albicans agar (CALB) (Oxoid, UK)
and RapID (Oxoid, UK), a method that utilizes determination of yeast
enzymes and provides identiﬁcation results in only 4 hours. Disc
diffusion test was performed to determine the susceptibility to nystatin
(N), voriconasole (VOR) and ﬂuconasole (FCA) according to the CLSI
standards.
Results: RapID identiﬁed Candida albicans as the most frequent isolate
(98 strains − 70.0%), followed by 25 (17.9%) C glabrata, 10 (7.1%) C
tropicalis, 5 C crusei, and one isolate each of Trichosporon beigelii (had
turquoise colour like C albicans on CALB) and Rodothorula rubra. A
total of 82 (83.7%) C albicans were susceptible to all tested antimycotics,
11 were resistant to N. and 5 strains (urinary isolates) to N and FCA. A
total of 18 (72.0%) C glabrata strains were susceptible to all antimycotics.
Resistance to N and FCA showed 5, 7 and 6 strains of C albicans, C
glabrata and C tropicalis, respectively; 10 of those were urinary isolates.
Other 7 isolated yeasts were susceptible to all tested antimycotics.
Conclusion: RapID as fast (4 hours) and simple identifying method
meets the needs for accurate and reliable results in mycology
diagnosis. Susceptibility testing revealed that voriconasole still has good
antimycotic activity on the tested strains, but there is emergence of
ﬂuconasole and nystatin resistant strains. Therefore, especially in the
cases of urinary infections where ﬂuconasole is the only oral antimycotic
that can achieve high urine concentration, a susceptibility testing is
highly recommended.
R2318 Indication of empirical antifungal therapy in selected
patients with persistent febrile neutropenia according to
clinical criteria and risk proﬁle
A. Martı´n-Pen˜a °, M. Aguilar-Guisado, I. Espigado, E. Cordero,
J.M. Cisneros for the Spanish Network for Research in Infectious
Disease (REIPI)
Objectives: Universal empirical antifungal therapy (EAT) in every
patient with persistent febrile neutropenia (PFN) is the standard of care,
but some recent published data suggest that EAT could be applied
only in selected patients. The aim of this study is to investigate a
diagnostic and therapeutic protocol based on clinical criteria and risk
proﬁle, allowing the indication of EAT exclusively in selected patients
with PFN without impact on invasive fungal infection (IFI) incidence
and IFI-related mortality.
Methods: Prospective observational study including every persistent
febrile neutropenia episodes in patients with hematological malignancies
or stem cell transplantation (SCT) recipients admitted in the Hematology
Service from October 2007 to November 2009. A previously deﬁned
diagnostic and therapeutic approach was applied in every PFN episode
and EAT was indicated in patients with: (a) severe sepsis or septic shock;
(b) focused infection: lung, central nervous system, sinus, abdominal or
skin; (c) individualized clinical decision in patients at high risk of IFI.
A comparative analysis of incidence of proven or probable IFI and IFI-
related mortality was performed according to whether or not EAT was
indicated.
Results: Eighty-ﬁve episodes PFN in seventy-two patients were
included. The 48.2% were male and median age in years was 47
(15−75). The most frequent hematological malignancies were acute
leukemia (45.8%) and lymphoma (21.2%). Thirty-two patients were SCT
recipients, 53.1% allogeneic, the 24.7% were IFI-high risk patients. The
median of duration of neutropenia and fever were 14 days (range: 6−63)
and 10 days (range: 5−37) respectively. EAT was indicated in ﬁfty-two
episodes (61.2%) during a median of 11 days (range: 2–164); in the rest
of episodes (n = 33) EAT was no indicated. The overall IFI incidence
was 14.1% (n = 12). In the group that received EAT, twelve patients
developed IFI (23.1%), in comparison with no-one patient in the group
that did not receive EAT. The 30 days-global mortality was 16.5%, 25%
in the group that received EAT and 3% in the group that did not received
it. The IFI-related mortality was null in the group that did not receive
EAT and 3.8% (2 of 52 patients) in the group that received EAT.
Conclusion: These data suggest that, in the management of patients
with PFN, the indication of EAT just in patients selected on the basis of
clinical criteria and risk proﬁle, may be safe and avoid over-treatment.
R2319 Molecular identiﬁcation of fungi of clinical relevance
F. Unda °, J. Agu¨ero Balbin, R. Salesa, C. Farin˜as, L. Martı´nez-Martı´nez
(Santander, ES)
Objectives: Culture and conventional identiﬁcation remain the usual
basis for diagnosis of fungal infections, but they have a long response
time and a low sensitivity rate. The objectives of this study were to
perform molecular identiﬁcation of clinically relevant fungi not identiﬁed
at the species level with a conventional approach (culture, API ID32C
and morphologic criteria) and to compare the results of molecular
detection of fungi in invasive samples (other than blood) in those of
culture.
Methods: In a preliminary phase, 10 strains of international collections
were tested. After they were all correctly recognized, two prospective
studies were done in parallel during one year (Sept. 2008 to Aug.
2009): (i) 36 cultures of difﬁcult-to-identify fungi (12 yeasts and 24
moulds) obtained from different clinical samples were identiﬁed by
molecular methods, and (ii) the presence and identiﬁcation of fungi in
39 invasive samples other than blood (10 bronchoalveolar lavages, 5
bronchoalveolar brushes, 7 heart valves and 17 biopsies (joint: 8;lung:
7;brain: 2) were determined using a conventional approach and compared
with the results of a molecular method based on sequencing the Internal
Transcriber Spacer (ITS) regions 1 and 2, complemented with sequencing
the b-tubulin and the elongation factor genes, and the intergenic spacer
(IGS) region.
Results: All 36 organisms of objective (i) were identiﬁed by the
molecular method as concrete species of genera Aspergillus (9), Candida
(7), Trichosporon (5), Scedosporium (3), Alternaria (3), fusarium (3),
Microsporum (2), Penicilium (2), Sporotrichum (1) or Acremonium
(1). 35 out the 39 samples of objective (ii) were negative by both
culture and molecular methods. Moulds were identiﬁed by the molecular
approach in two cases in which the same organism grew in culture
(a joint biopsy and a heart valve from the same patient yielding
Scedosporium apiospermum). Additionally, the molecular approach
identiﬁed an Aspergillus sidowii in a lung biopsy and an A. fumigatus
in a bronchoalveolar brush in two culture-negative cases. The molecular
method allowed identiﬁcation of the organism (from either culture or
clinical samples) in 48−72 hours.
Conclusions: Molecular methods reduces the response time for identiﬁ-
cation of clinically relevant fungi (include those for which conventional
identiﬁcation is difﬁcult). This approach should be considered for the
diagnosis of fungal infections in the clinical laboratory.
R2320 Efﬁcacy and safety of anidulafungin for treatment of
candidaemia in Asian patients
P. Mootsikapun °, P.R. Hsueh, D. Talwar, V.M. Co, V. Rajadhyaksha,
M-L. Ong (Khon Kaen, TH; Taipei City, TW; Noida, IN; Makati City,
PH; Mumbai, IN; New York, US)
Objectives: To evaluate the clinical efﬁcacy and safety of anidulafungin
(ANID) in the treatment of Asian patients with proven candidemia.
Methods: Phase 3b, open-label, multicentre, non-comparative study in
adults with Acute Physiology and Chronic Health Evaluation (APACHE)
II score 20. Patients received once-daily intravenous ANID (single
200mg loading dose, followed by 100mg per day thereafter) for 5−42
days. Subsequent oral voriconazole was allowed under predetermined
conditions; total overall treatment duration was 42 days. Concomitant
medications other than systemic antifungals were permitted. The primary
endpoint was global response, deﬁned as clinical cure/improvement
together with microbiologic eradication/presumed eradication, at the end
of all therapy (EOT) in the modiﬁed intent-to-treat (MITT) population.
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The relationship between b-D-glucan assay results and response was also
examined. Safety and tolerability were assessed throughout the study.
Results: The mean age of the enrolled patients (n = 43, from 13 centres
in India, Philippines, Taiwan, and Thailand) was 56.5 (±18.5) years and
54% were male. Global response rate in the MITT population (n = 42)
at EOT was 86.1% (95% conﬁdence interval: 70.5%, 95.3%); secondary
response rates are listed in the table below. Global response rates at EOT
were 72.7% (13/18) for Candida tropicalis, 71.4% (10/14) for C albicans,
66.7% (4/6) for C glabrata, and 100% (4/4) for C parapsilosis. In the 21
patients with a central venous catheter up to 1 month before baseline,
global response rate at EOT was 81.0%. Global responses in predeﬁned
populations were as follows: neutropenic patients 50.5% (n = 2), patients
aged 65 years 58.8% (n = 17), and patients with renal insufﬁciency
54.5% (n = 11). In the overall MITT population, patients with clinical
response at EOT had lower mean b-D-glucan levels at baseline than
those with clinical failure. Treatment-related adverse events were mild
to moderate; the most common were diarrhea and rash, in 2 subjects
each.
Conclusions: ANID was effective for the treatment of candidemia in
Asian patients with APACHE II scores 20. No new safety concerns
were identiﬁed. These results can likely be extrapolated to a wide
population with candidemia, both in the intensive care unit and medical
wards.
MITT population (N= 42)







End of all therapy (EOT) 32/34 (94.1%), 34/35 (97.1%), 31/36 (86.1%),
(80.3, 99.3) (85.1, 99.9) (70.5, 95.3)b
End of IV therapy 34/35 (97.1%), 36/37 (97.3%), 33/37 (89.2%),
(85.1, 99.9) (85.8, 99.9) (74.6, 97.0)
2 weeks after EOT 26/28 (92.9%), 25/29 (86.2%), 24/29 (82.8%),
(76.5, 99.1) (68.3, 96.1) (64.2, 94.2)
6 weeks after EOT 17/18 (94.4%), 17/18 (94.4%), 17/19 (89.5%),
(72.7, 99.9) (72.7, 99.9) (66.9, 98.7)
12 weeks after baseline 17/20 (85.0%), 16/19 (84.2%), 16/22 (72.7%),
(62.1, 96.8) (60.4, 96.6) (49.8, 89.3)
aMissing/indeterminate responses excluded. bPrimary endpoint.
R2321 Comparative pharmacodynamic characteristics of ampho-
tericin B against Aspergillus fumigatus, A. ﬂavus and A. ter-
reus using an in vitro pharmacokinetic/pharmacodynamic
system simulating amphotericin B human pharmacokinetics
J. Meletiadis °, R. Al-Saigh, L. Zerva (Athens, GR)
Background: In conventional antifungal susceptibility testing method-
ologies of Aspergillus species, conidia are exposed to constant drug
concentrations. However, in clinical practice, antifungal drugs are
administered as intravenous boluses resulting in decreasing plasma
concentrations. In order to describe the pharmacodynamics (PD) of
amphotericin B (AMB) with a clinically relevant model, we developed
an in vitro dialysis system simulating human pharmacokinetics (PK)
after bolus administration and we studied the effect of standard dosing
regimens of amphotericin B against A. fumigatus, A. ﬂavus and
A. terreus.
Methods: AMB standard dosing of 1 and 0.5mg/kg resulting in peak
plasma concentrations of 2.4 and 1.2mg/l, respectively and half-lives
of 24 h were simulated in a central compartment (CC) with 700ml
RPMI1640+0.165M MOPS. After injecting the drug, a peristaltic pump
pumps into CC fresh medium and pumps out the content of the CC at the
same rate as the clearance of the drug. Lung bronchiole was simulated
with a dialysis tube (within the CC), which allows free diffusion of
molecules smaller than 20kD comprising the peripheral compartment
(PC). Different dialysis tubes were inoculated with 105CFU/ml of
A. fumigatus, A. ﬂavus and A. terreus conidia with CLSI MICs of
AMB of 0.5, 0.5 and 1mg/l, respectively and incubated at 37ºC for
48 h. For PK studies, 200ml were sampled from the CC and the PC
and drug concentrations were determined with a bioassay utilizing an
AMB susceptible Paecilomyces variotii strain. For PD studies, 200 ml
from the inoculated dialysis tubes were sampled regularly to determine
the galactomannan (GM) levels with the ELISA Platelia (Biorad). All
experiments were performed at least twice.
Results: The drug concentration-time proﬁle in CC and PC simulated
reproducibly the plasma-concentration proﬁles of AMB (intra- and inter-
day variation <10%). The simulated AMB dosing of 1mg/kg inhibited
completely A. fumigatus, partially A. ﬂavus but not A. terreus. The
simulated AMB dosing of 0.5mg/kg did not have any effect against
A. terreus and A. ﬂavus whereas A. fumigatus was only inhibited for
48 h.
Conclusion: AMB levels from standard dosing of 1mg/kg were
efﬁcient in inhibiting the growth of A. fumigatus but not A. ﬂavus and
A. terreus. The new in vitro PK/PD system reliably simulates human
pharmacokinetics of AMB and it can be used to investigate alternative
dosing regimens which may improve AMB activity.
R2322 Fungaemia in an intensive care unit in a tertiary care
hospital: a 5-year survey
P. Giannopoulou, N. Charalambaki, G. Vrioni, K. Konstantinou,
I. Grafakos, A. Kyratsa, A. Velegraki, F. Klouva-Molyvda,
E. Trikka-Graphakos °, A. Tsakris (Athens, GR)
Objectives: Fungaemia represents an important cause of morbidity and
mortality in critical ill patients. The aim of the study was the evaluation
and retrospective analysis of fungaemias in the intensive care unit (ICU)
of a tertiary care hospital.
Methods: Patients hospitalized in the ICU longer than 48 h were
included in this study, over a 5-year period (2004–2009). Demographic
characteristics, predisposing factors, incidence of fungaemia, susceptibil-
ity proﬁle, therapy and outcome were analyzed. Laboratory investigation
was performed by conventional methods. Chromogenic medium and API
32C were used for the identiﬁcation, while antifungal susceptibility was
assessed by MICs determination using a broth microdilution method
according to CLSI recommendations.
Results: In total, 74 strains were isolated from 70 patients. The mean
age was 59 years and 55 were male. In 8 patients, the same pathogen was
isolated from both blood and i.v. catheter cultures. Predisposing factors
included cardiovascular disorders (n = 20), diabetes mellitus (n = 13),
malignancy (n = 12), respiratory failure (n = 8), burns (n = 6), chronic
alcohol consumption and alcoholic cirrhosis (n = 5) and chronic renal
failure (n = 3). Six patients suffered from hematological malignancies,
and one was HIV positive. Non-albicans Candida strains were the most
frequent isolates (n = 39, 53%): C. parapsilosis 20 (27%), C. tropicalis 9
(12%), C. glabrata 9 (12%) and C. dubliniensis 1 (1.3%). Thirty strains
(40.5%) were identiﬁed as C. albicans. Thee strains Saccharomyces
bullardii (4%), one strain Zygosaccharomyces spp. (1.3%) and one
Rhodotorula mucinanginosa (1.3%) were also isolated. All antifungal
agents showed excellent activity against most of these potentially
lethal pathogens. However, two strains of C. glabrata were resistant to
itraconazole and ﬂuconazole, three strains of C. albicans were resistant to
caspofugin and two strains of C. tropicalis were resistant to itraconazole.
R. mucinanginosa was sensitive only to amphotericinB, ﬂuconazole
and ketoconazole. All patients were treated with amphotericinB and/or
caspofungin. Case fatality was 38%.
Conclusion: Candidemia was the most common fungal nosocomial
infection among ICU patients with high mortality rate. Candida non-
albicans were the most prevalent strains (53%). Early diagnosis and
initiation of antifungal therapy, as well as control of the underlying
predisposing factors, are the only potentially curative options for this
emerging invasive infection.
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R2323 Utility of rapid HIV-test conducted in pharmacies
X. Camino °, D. Zulaica, M. Goenaga, J. Iribarren, M. von Wichmann,
F. Rodriguez, J. Arrizabalaga (San Sebastian, ES)
Background: One of the main problems today is the late diagnosis of
HIV. Perhaps closer to the people the possibility to realize a rapid HIV
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test at a pharmacy to contribute to the further spread of the test and
allow earlier diagnosis of HIV.
Methods: The 1−4 2009 is put into practice a pilot in 20 pharmacies in
the BAC to perform rapid HIV tests. It analyzes all tests since that date
to 15.9.2009.
Results: In that time period 1708 tests have been performed: 608 in
Gipuzkoa, 884 in Bizkaia and 206 in Alava. Some 67% of people are
men. The average age is 35 years and the age distribution 40% of patients
are between 30 and 40. Around 69% of the patients was the ﬁrst time they
were tested. 15 people have positive results: 12 true and 3 false positives.
8 of them have a good immune status (more than 350 CD4/ml) and 4
others not found to have consulted with an HIV specialist consultation.
The negative predictive value of the test is 99%.
Conclusions:
– It appears that facilitate the implementation of HIV rapid tests can
contribute to a further universalization of the test.
– The negative predictive value of the test is high: 99%.
– It is important to ensure the pharmacy-access medical consultation to
avoid loss among patients.
R2324 Bulge of syphilis among HIN-infected patients:
epidemiological data from a Greek hospital
O. Tsachouridou °, S. Metallidis, T. Chrysanthidis, I. Bakaimi,
P. Kollaras, D. Karapiperis, T. Karagiozis, P. Nikolaidis (Thessaloniki,
GR)
Objectives: To describe an outbreak of early syphilis in HIV seropositive
patients treated in the Infectious Diseases Unit in AHEPA University
Hospital of Thessaloniki, Greece in 2008.
Methods: A review of infectious syphilis cases in a HIV Unit in 2008.
Demographics were recorded with details of presentation, results of
diagnostic tests, concurrent infections and treatments, likely route and
place of acquisition, and details of contact tracing.
Results: Of 640 patients, 152 were checked and 27 of them (4.2%)
were syphilis positive. All were homo- or bisexual men with a median
age of 41 years old (range, 27−75 years).16 patients (58%) stated
unprotected oral intercourse. 11 patients (42%) reported unprotected anal
intercourse. HIV-positive serologic status was known for a median of
8.8 years (range, 0−19 years), only 2 (7.4%) individuals receiving the
diagnosis simultaneously. 21 patients (77.7%) were under antiretroviral
(ARV) therapy; median time under ARV treatment was 8 years (range,
0−16 years). At time of syphilis seropositivity, median CD4-cells count
was below 500/mm3 (~459/mm3, range, 77–840/mm3) and median
plasmatic HIV-RNA virus load was 3.0 log/mL (range, −1.8 to −5.8
log/mL). Secondary syphilis was more frequent (9 patients, 33%)
than primary (7 patients, 26%), latent syphilis (10 patients, 37%) and
symptomatic neurosyphilis (1 patient, 4%). Overall, 20 patients (74%)
received parenteral treatment and 7 (26%) oral for 21 days. Lumbar
puncture was performed in 17 neurologically asymptomatic (63%) and
1 symptomatic patient (4%). 10 patients (37%) denied undergoing the
procedure. 10 (37%) were diagnosed with neurosyphilis. Satisfactory
serologic response was observed in 10 patients (37%) at 6 and 9 months
follow up and in 17 (63%) at 6−9-12 months follow up, respectively.
Discussion:Multiple sexual partners, unprotected oral sex, and increased
age among MSM were the predominant risk factors contributing to this
syphilis epidemic. The overall high rate of unprotected sex demonstrates
an increasing prevalence of unsafe sexual practices among MSM
attributed to faith in antiretroviral therapy (simpliﬁed regimen) and to
mental fatigue arising from years of protected sex to reduce the risk
of HIV. Therefore, it is essential that prompt diagnosis, treatment, and
contact tracing occur in order to control this major outbreak.
R2325 Expanded post-exposure prophylaxis for simultaneous
multiple source HIV exposure in a healthcare worker
I.G. Baraboutis °, V. Papastamopoulos, O. Georgiou, M. Kotsianopoulou,
E. Vrionis, M. Samarkos, A.T. Skoutelis (Athens, GR)
Background: Guidelines about post-exposure prophylaxis (PEP) in
healthcare workers are mostly based on retrospective data and expert
opinion. The role of new drug classes in PEP is largely undeﬁned.
Materials and Methods: We report an extreme case of high-grade
needlestick exposure of a healthcare worker to serum from multiple
HIV-infected patients after trying to prematurely remove the respective
tubes from an automated biochemical analyzer.
Results: After review of the medical records of the 8 source
patients (Table 1), we offered the healthcare worker an expanded
PEP regimen including the entry inhibitor enfuvirtide. She refused
to take subcutaneous injections, so we recommended use of the
integrase inhibitor raltegravir. The CCR5 inhibitor maraviroc was not
commercially available at that time. She completed therapy without
problems and periodic evaluation for HIV transmission up to 9 months
after the incident was negative.
Conclusions: We believe there are several important issues pertinent to
this extremely unusual event. These include 1. the choice of PEP in cases
of exposure to potentially resistant HIV virus(es), 2. the use of newer
classes of antiretroviral drugs for PEP and the theoretical advantages of
some of them in the PEP setting due to their mechanisms of action and
3. the practice of differential labeling of specimens from HIV-infected
patients, applied for a long time in several hospitals in our country.
Year of HIV diagnosis (range) 1994–2008 Patients with undetectable HIV viral load (<50
copies/mL) on last measurement
7/8
Age range (years) 36−82 Patients with available HIV viral load measurement
within last 3 months
4/7
Hellenic ethnicity 8/8 Range of most recent CD4 count (cells/mL) 119–1294
MSM as risk factor 8/8 Range of baseline CD4 count (cells/mL) 126/1060
Patients receiving ART 7/8 Patients with baseline CD4 count below 350 cells/mL 5/8
Patients receiving stable ART last 3 months 7/8 Patients with AIDS-deﬁning illness last 6 months 1/8
Patients with recent satisfactory compliance
with ART (clinician’s judgment)
8/8 Other signiﬁcant illnesses/malignancies last 6 months 2/8
Current NNRTI-based regimen 3/8 Known chronic hepatitis B and/or C 0/8
Current PI-based regimen 5/8 Evaluation for hepatitis C last 3 months 1/8
Patients with history of ART failure 2/8 Failed ART regimens Pt1: AZT/3TC;
Pt2: D4T/3TC/EFV,
D4T/DDI/NFV
Year of ART failure 1999,
2000–2001
Available genotype resistance testing during failure 0/2
R2326 Tuberculosis in HIV–HCV co-infected patients
A. Moradi, S.A. Nadji °, S. Ehteshamiafshar, P. Tabarsi, D. Mansouri
(Tehran, IR)
Objectives: Coexistence of tuberculosis (TB) in human immunodeﬁ-
ciency virus and hepatitis C virus (HIV–HCV) co-infected patients, is a
unique clinical and public health challenges. Medications for treatment
of TB, HIV and HCV are hepatotoxic. So this condition made us to
determine prevalence, risk factors and factors that may predispose for
anti-tuberculosis therapy induced hepatoxicity.
Methods: In a retrospective study medical records of all hospitalized
HIV–HCV co-infected patients from January 2001 to December 2009
at the National Research Institute of Tuberculosis and Lung Disease
(NRITLD) were reviewed. A standardized case record form was applied
to collect demographic, clinical, laboratory and microbiologic data.
Patients with coexisting TB were identiﬁed as a case group and patients
who were not infected with TB considered as the control group.
Presenting signs and symptoms, and co-morbidities and widespread lab
data (including biochemical, haematologic and serologic assay) in both
groups were measured.
Results: 126 HIV–HCV co-infected patients (all of them were smoker
males, 25.5% jobless, 47.7%single, 43.1%Married, 9.2% divorced,
80% IVDU, 84.6% opium user, 13.8% HBsAg+, 84.6% imprison and
12.3% in hospital mortality) were recruited in this study.60 out of them
had coexisting TB. Signiﬁcant statistical differences were seen in marital
status, hospitalization length, CD4 count, clinical sings and symptoms
(cough, sputum, fever, weight loss) microcytic anemia, ESR and CRP
between TB and non-TB groups.
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Conclusion: In multivariable analysis, injection drug use and imprison
were signiﬁcant independent risk factors for HIV–HCV co-infection.
Among HIV–HCV-infected patients admitted in NRITLD, TB was
a common infection. No signiﬁcant difference in LFT and other
biomarkers found in TB and non-TB infected patients. Tuberculosis
infection was not associated with in hospital mortality. These ﬁndings
imply that as the rate of anti-tuberculosis therapy induced hepatoxicity
in HCV-HIV co-infected patients is similar to other patients, standard
treatment could be pursued in the usual manner.
R2327 Genetic characterization of Trypanosoma cruzi isolated
from HIV patients with reactivation and its correlation
with kDNA proﬁles and LTCD4+ counts
E. Lages-Silva °, J.M. Marson, D. Stefani Marquez, R. Molina,
L.E. Ramirez, D. Correia Filho (Uberaba, BR)
Objectives: The factors involved in chagas disease reactivation are not
clear, they may be related to selective host immune depletion and/or
to speciﬁc parasite populations. Herein, the characterization of T. cruzi
DNA nuclear and kDNA was performed in samples from HIV patients
with blood and / or central nervous (CNS) system reactivation, HIV
patients not reactivated and from HIV negative chagasic patients.
Methods: The parasite characterization was performed by ampliﬁcation
of the D7 domain of the gene 24S, 18S rRNA and the mini-exon
gene intergenic region, and kDNA using low stringency single speciﬁc
primer - PCR. T. cruzi populations were classiﬁed according to the new
nomenclature (Consensus 2009).
Results: T. cruzi reactivation was detected in 10 patients HIV
positive and two HIV negative immunocompromised by chemoterapy or
transplants, 91.7% (11/12) T. cruzi II and 8.3% (1/12) T. cruzi V. Parasite
kDNA showed high variability, but identical genetic proﬁles in blood and
CNS ﬂuid from a same patient. These populations were clustered in to
three branches, two with 72.7% of isolates and low LTCD4+ counts (42.0
cells/mm3) and the other with 27.3% of samples and 158.0 cells/mm3.
Among the 29 HIV co-infected patients not reactivated the T. cruzi I
was detected in 6.9% (2/29); T. cruzi II in 86.2%(25/29) and T. cruzi V
in 6.9% (2/29). In 50 HIV negative patients, T. cruzi I was found in 4%
(2/50), T. cruzi II in 94% (47/50) and T. cruzi V in 2.0% (1/50).
Conclusions: There was no difference in the distribution of T. cruzi
groups among HIV positive and HIV negative patients (ﬁscher test
p = 0.7791), or between HIV reactivated and not reactivated patients
(ﬁscher test p = 0.8281) or associated with blood and/or CNS invasio´n
in reactived patients. Both T. cruzi II and T. cruzi V had potential
for reactivation and were associated with speciﬁc kDNA proﬁles and
LTCD4+ counts.
Support: Programa Nacional de DST/AIDS − Ministe´rio da Sau´de–
UNESCO (VS0106/2006) − FUNEPU − CNPq (Universal 2008).
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R2328 Evaluation of three immunoassays for hepatitis C virus
antibody detection
V. Polymerou, G. Kargiolakis °, D. Lavranos, L. Fountas, I. Plianos
(Athens, GR)
Objective: Hepatitis C Virus is a major cause of acute hepatitis and
chronic liver disease, worldwide. Diagnostic tests for hepatitis C include
serological assays that detect antibodies to hepatitis C virus (anti-HCV).
Various automated immunoassays are widely used in clinical laboratories
in order to detect anti-HCV. The aim of this study is to compare
the sensitivity and speciﬁcity of three different immunoassays for the
detection of HCV antibodies.
Methods: Sera were obtained from 320 adult patients (both sexes,
aged 25 to 75 years old) of unknown serological status. All samples
were screened for anti-HCV using Chemiluminescent Microparticle Im-
munoassay (CMIA), Microparticle Enzyme Immunoassay (MEIA) and
Electrochemiluminescence Immunoassay (ECLIA). Architect i2000SR
(Abbott), Axsym Plus (Abbott), and Elecsys 2010 (Roche) were the
automated analyzers used respectively. Prevalences were calculated
according to S/CO ratio. Any positive or dubious (low S/CO ratio) result
was conﬁrmed using the Line Immunoassay INNO-LIA HCV.
Results: Among the 320 samples tested, 18 were found to be positive for
anti-HCV by all three methods (S/CO> 200 for ECLIA, S/CO> 10 for
MEIA and S/CO> 5 for CMIA). The positive samples were subsequently
tested using INNO-LIA and were all conﬁrmed showing 100% sensitivity
for all three assays. Moreover, 6 samples were found positive with a low
S/CO ratio by ECLIA and CMIA (S/CO< 200 for ECLIA and S/CO< 5
for CMIA) and 4 of them were also found positive with a low S/CO
ratio by MEIA (S/CO< 10). INNO-LIA conﬁrmed that two of the above
samples were positive (2 out of six for ECLIA and CMIA, 2 out of 4 for
MEIA), showing an overall speciﬁcity of 98.7% for ECLIA and CMIA
and 99.3% for MEIA.
Conclusions: Our study suggests that MEIA, CMIA and ECLIA
indicated excellent sensitivity and almost identical high speciﬁcity. Thus,
any of the above methods can be used for routine detection of HCV
antibodies in serum samples. Supplemental anti-HCV tests such as
INNO-LIA, could also be used in order to resolve false-positive testing.
R2329 Initial laboratory predictors of severe hepatitis in patients
with acute hepatitis A
S. Cho °, S. Choi, J. Kim, J. Chung (Seoul, KR)
Objectives: Hepatitis A virus (HAV) infection commonly causes acute
self-limited hepatitis. However, severe hepatic or renal dysfunction
may occur infrequently. We investigated the initial predictors for the
development of severe acute hepatitis A (S-AHA) and acute renal failure
(ARF) in patients with AHA.
Methods: We retrospectively reviewed the medical records of patients
with AHA, from January 2007 to March 2009, at Chung-Ang University
Medical Center. The deﬁnition of AHA was based on the detection of
IgM antibody against HAV using enzyme immunoassay. S-AHA was
deﬁned as prothrombin time (PT) <40% of control activity during the
course of AHA and ARF was deﬁned as the increase of serum creatinine
>0.5mg/dL over the baseline level.
Results: During the study period, 192 patients developed AHA. The
majority of patients were young adults (<40 years of age, 91.7%) without
underlying illness. S-AHA and ARF developed in 22 (11.4%) and 10
(5.2%) patients, respectively. The patients with S-AHA more frequently
had male gender (86.4% vs. 62.1%, p = 0.025) and ARF (19.0% vs.
3.6%, p = 0.015) than non-severe groups. The following initial laboratory
ﬁndings were more commonly observed in patients with S-AHA;
lactate dehydrogenase (LDH) >660 IU/L (90.5% vs. 40.0%, p< 0.001),
C-reactive protein (CRP) >20mg/L (52.9% vs. 19.2%, p = 0.005),
albumin <3.4 g/dL (68.2% vs. 26.6%, p< 0.001), total cholesterol
<95mg/dL (81.8% vs. 26.5%, p< 0.001) and platelet <150,000/mL
(95.4% vs. 39.0%, p< 0.001). Independent predictors for S-AHA were
high LDH (OR, 11.35; 95%CI, 2.00–64.38; p = 0.006), low albumin
(OR, 12.67; 95%CI, 3.54–45.29; p< 0.001) and thrombocytopenia
(OR, 17.16; 95%CI, 1.99–148.10; p = 0.01) in multivariate analysis.
Patients with ARF had following initial laboratory ﬁndings more
commonly than patients without ARF; LDH >660 IU/L (100% vs. 42%,
p = 0.001), CRP >20mg/L (57.1% vs. 20.9%, p = 0.047), total cholesterol
<95mg/dL (70.0% vs. 30.3%, p = 0.014) and platelet <150,000/mL
(80.0% vs. 42.8%, p = 0.045).
Conclusion: Thrombocytopenia, high LDH and low albumin at
admission were independent predictors for S-AHA. Initial laboratory
proﬁles may provide useful information for predictor of subsequent
development of S-AHA.
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R2330 Retrospective study of increasing incidence of acute hepati-
tis A in Area 2 of Madrid. A report from the microbiology
department at a university hospital, Madrid, Spain
M. Moreno °, A. Pe´rez Pe´rez, M. Martı´nez, S. Agudo, M. Lo´pez-Brea,
C. Casal (Madrid, ES)
Objectives: Study of incidence of acute hepatitis A (AHA) during the
period of 4 years. (January 2006 to November 2009).
Methods: 12666 serum samples obtained from Outpatients, Hospitalized
Patients (HP) and patients from Primary Care (PC) were analyzed.
HA-IgM antibody, by enzimoimmunoassay (EIA, Arquitect Abbott
Diagnostic) was determinated.
Results: In 2006, of the 2794 samples studied, 3 males cases were
reported: 1 of SC, 1 of HP and 1 of PC. In 2007, of the total of 3094,
15 were reported: 9 PC, 3 SC, 3 HP (ages 14−52 years, 4 females/11
males). In 2008, we reported 32 cases of 3235 samples: 18 PC, 12 SC,
2 HP (ages 16−46 years, 10 females/22 males). And in 2009 of the total
of 3544 samples, we obtained 17: PC 8, SC 9, HP 1 (ages 20−29 years,
17 males). With our results of 67 positive samples, in patients with
sintomatology of acute disease, an important group mentioned high-
risk sexual practices with other persons of the same/different sex, with
prevalence of same sex.
Conclusions: An increase of AHA was observed since May of 2007 to
July of 2009, and is becoming more pronunced between september of
2008 to July of 2009. Furthermore we observed the transmission was in
most of cases due to sexual practices. In the future, the epidemiological
anamnesis of sexual transmission should be considered.
Year Total
(n = 12666)
Positive PC OP HP Range M/F
2006 2794 3 1 1 1 2/1
(33.33%) (33.33%) (33.33%)
2007 3094 15 9 3 3 14–52 11/4
(60%) (20%) (20%)
2008 3235 32 18 12 2 16–46 10/22
(56.25%) (37.50%) (6.25%)
2009 3543 17 7 9 1 20–29 17/0
(41%) (53%) (6%)
R2331 Effect of changes in bio-energy on the severity of the
disease in patients with chronic hepatitis C
S. Gramatiuk ° (Kharkiv, UA)
Currently, biological oxidation is deﬁned as a set of substrate oxidation
reactions in living cells whose primary function − providing energy
metabolism. Oxygen consumption of tissues depends on the intensity of
the reactions of tissue respiration. The highest rate of tissue respiration
characterized by kidney, brain, liver, and the lowest − skin, muscle
tissue (at rest). Multilevel control of cellular metabolism, providing
maintenance of homeostasis under changing environmental conditions,
including as one major factor regulation of redox potential and redox
state of nicotinamide nucleotides, which can be measured by the ratio
of oxidized and reduced kofermentov. Ustanovleno that the increase
in the ratio of oxidized coenzymes to Retreaded increases oxidative
properties of tissues and body ﬂuids, activates the functioning of
glycolysis, tricarboxylic acid cycle, while inhibition of lipogenesis and
gluconeogenesis reaction.
Aims: To deﬁne the mechanisms by which NADH/ NAD and of lactate/
pyruvate plays an antiﬁbrogenic role.
Methods: Examination of lactate and pyruvate levels was carried out
by enzymatic method which is based on the oxidation of lactic acid to
pyruvic by enzyme lactate dehydrogenase with the parallel reduction of
NAD+ to NADH2.
Results: Metabolic disorders, which are characterized by the correlation
NAD+/NADH2 and increase of NAD+ (0.494+0.03mmole/l) concentra-
tion in comparation with NADH2 (0.002+0.001 mmole/l) what makes
the reaction slower in connecting with acceleration of lactate/pyruvate
correlation and in result the speed of gluconeogenesis is decreased, are
observed at the patients with the chronic hepatitis C. The most excessive
metabolic disorders are observed at the patients with virus genotype 1b,
which can be undesired sign of antivirus therapy and can require of its
correction.
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R2332 Mumps infection in the period 2007–2009
D. Balalovski °, D. Galovska, E. Dimitrovska, M. Paspalova,
R. Petkovska, V. Malevska, D. Ristevska (Bitola, MK)
Objectives: To present the most common clinical manifestations and
epidemiological characteristics of mumps infection in our patients, in
period of two years (2007–2009).
Methods: 632 patients had been analyzed. 138 (22%) of them,
were hospitalized. They were diagnosed according to the clinical
manifestations, epidemiological characteristics, biochemical analyses
and ELISA (IgM Ab and IgG Ab).
Results: 470 (74.5%) patients were male, and 162 (25.5%) were female.
According to age, most of the patients were from 15 to 19 years
old − 252 (39.5%). The largest frequency of patients was registered
in the months from September till March. In hospitalized 138 patients,
the most common clinical manifestations were: parotitis in 88 patients
(63.7%) − bilateral 65 (73.8%) and unilateral 23 (26.13%); orchitis in
44 patients (31.8%) − bilateral 17 (29.7%) and unilateral 27 (61.3%);
mumps meningitis in 3 patients (2.2%); oophoritis in 3 patients (2.2%).
Hepatic lesions appeared in 82 patients (59.4%).
Conclusion: Most common clinical expressions of the mumps infection
are parotiits (63.7% of patients) and orchitis (31.8% of patients). There
is also high percentage of hepatic lesions (59.4% of patients). According
to age, most of the patients were from 15 to 19 years of age (39.5%). The
epidemics in our region started in march 2007 in non-immunized child
from gipsy population, with tendency to spread, and was terminated in
the spring of 2009. Most of the infected patients were non-immunized or
not completely immunized, and mostly people from the gipsy population.
R2333 DNA-based drug against DNA virus infections
E. Kaplina °, D. Nosik, N. Nosik, T. Sologub, M. Tishenko (Moscow,
St. Petersburg, RU)
Objective: There are certain problems in ethiotropic therapy of viral
infections caused by DNA viruses: herpes simplex virus (HSV) and
human papillomavirus (HPV). Therefore, the use of immunomodulators
seems perspective. Previously, it was found that immunomodulator
ferrovir (FV) (sodium salt of DNA from salmon’s milt conjugated
with Fe3+) induced production of inﬂammation cytokines and antiviral
factor with low m.m. (Acta Virologica, 1999;43:32−7) and was effective
in immunocompromised patients with human immunodeﬁciency virus
infection and hepatitis C infection. The aim of the study was to analyze
the efﬁciency of FV against HSV- and HPV-infection.
Methods: FV was used as monotherapy in open clinical study enrolled
305 adult patients (pts) with genital HSV-infection with no less than 6
recidivations per year and as the part of complex therapy in 63 pts with
HPV-infection. Pts were treated with 75mg FV twice daily during 10
days in the enema per rectum or intramuscular injections.
Results: FV administration was well tolerated and no side effects were
observed. In 87.8% cases of pts with HSV-infection long remission (only
1−2 recedivations per year) was registered and shortening of time of
recidivation was found. In pts with HPV-infection FV also provided
long period (12 months) without recidivation which had happened only
in 6.4% of cases.
Conclusion: FV demonstrated good antiviral properties; is well tolerated
by patients, is useful in case of HSV- and HPV-infection, and the low
price makes it accessible to population in limited resources context.
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R2334 Efﬁcacy and safety of topical acyclovir/hydrocortisone 1%
formulation for the treatment of recurrent labial herpes
simplex in adolescents
N. Petrochenkova °, O. Sivaya (Smolensk, RU)
Objective: To investigate efﬁcacy and safety of topical acyclovir /
hydrocortisone 1% formulation for the treatment of recurrent labial
herpes simplex in adolescents.
Methods: Non-immunocompromised subjects 12−17 years old who had
more than 2 episodes of recurrent labial herpes during the previous 12
months were eligible. Patients were not allowed to use systemic or topical
antivirals and steroid agents two weeks prior and during the study drug
treatment period. The study drug was administered for the new episode
of labial herpes simplex and was applied 5 times per day for 5 days.
Clinical assessment was performed daily for 5 days, 1 week, 3±1 weeks
and 6 months after the last dose of the study drug.
Results: A total of 22 patients (11 boys and 11 girls) were treated with
the study drug. The labial herpes simplex recurrence rate during the last
year in most patients varied from 4 to 8 times, one patient had 12 relapses
during the previous year. During the new episode of labial herpes simplex
all patients noted disappearance of clinical symptoms (pain, burning) on
the second day of the study treatment. Eighteen of 22 subjects had non-
ulcerative herpetic lesions − the process stopped on papule stage. In most
patients (12 persons) the symptoms of relapse resolved on the forth day,
in 5 persons − on the ﬁfths day, and in one person − on the sixths day.
The skin was normal during the ﬁrst week and 3±1 weeks after the last
dose of the study medication in all patients. Four patients have been
diagnosed a recurrence of herpes leading to development of a lesion
with vesicle, ulcer and hard crust. They had hard crust stage of labial
herpes simplex on the end of treatment period. On the ﬁrst week after
last dose of study drug there were determined residual abnormalities in
those patients and the normal skin was ﬁxed on 3±1 week visit. None
subjects had adverse events related with the study drug. Phone contact
was performed post 6 months after last dose of the study drug and all
of treated patients had no recurrence labial herpes during the period.
Conclusions: Topical acyclovir/1% hydrocortisone showed good efﬁcacy
for the treatment of recurrent labial herpes simplex. All patients noted
quick resolving of symptoms (pain, burning). Application of the drug
stopped the recurrence process on the papule stage. There were no
adverse events due to study drug.
R2335 Inﬂuenza A H1N1: Shell vial culture vs. PCR
E.M. Gonzalez Barbera °, B. Acosta Boga, G. Fagundez Machain,
J.M. Molina Moreno, M. Gobernado Serrano (Valencia, ES)
In the beginning of the H1N1 Inﬂuenzavirus pandemia, we started
working with PCR, culture and antigen detection (the last was refused
due to its low sensibility), but culture was performed in certain
circumstances like immunocompromised or admitted in Intensive Care
Units patients.
Objectives: To compare shell-vial culture and PCR for Inﬂuenza AH1N1
detection considering PCR as “gold standard”.
Methods: 214 samples were processed during the period April-
November 2009 by PCR [AgPath-ID™One-Step RT-PCR Kit (Ambion
Applied Biosystem), artus® Inﬂuenza/H1 LC/RG RT-PCR-Kit (Qiagen)]
and cultured in MDCK cell line shell-vial (Vircell™) with Trypsine,
incubated at 35−37ºC for 24 or 48 hours, and stained with monoclonal
antibody against respiratory viruses, including Inﬂuenza A (Chemi-
con™).
Results: See Table 1.
We also observed that 24 hours of incubation are enough and correlates
with 50−75% cell monolayer infection (detected by monoclonal antibody
stain).
Conclusion: MDCK cell line is an adequate cell line for Inﬂuenzavirus
H1N1 isolation and Inﬂuenza A monoclonal antibody stain identiﬁes
it correctly in a pandemic situation (without distinguish between virus
subtypes).
We consider that virus isolation is necessary for later studies.
Furthermore, we may identify other viruses when we are not looking
for them on purpose or in samples not considered at ﬁrst.
Table 1. Culture and PCR comparison results
Culture + Culture − Total
PCR + 102 32 134
PCR − 2 78 80
Total 104 110 214
Shell-vial culture sensibility 76.12%
Shell-vial culture speciﬁcity 97.5%
Shell-vial culture positive predictive value 98.08%
R2336 The usefulness of IgG avidity for determining primary
cytomegalovirus infection in pregnant women
C. Karachristou °, A. Armelidou, V. Dinopoulou, M. Traki,
I. Minopoulos (Athens, Alimos, GR)
Objectives: The diagnosis of infection with human cytomegalovirus
remains difﬁcult on symptoms alone as many of them are mild and
asymptomatic. Primary CMV infection in early pregnancy bears a high
risk of fetal damage. The prenatal diagnosis of CMV has focused on
ﬁrst-trimester screening since the time of maternal CMV infection is an
important variable and the rate of transmission from mother to fetus is
much higher. If fetal infection occurs earlier in gestation, it appears to
present a greater threat to the fetus.
Methods: 8.768 pregnant women in the ﬁrst trimester of the pregnancy
were tested for CMV during the last 18 months May 2008 − Oct 2009
in “Mitera” general, maternity & children hospital. Women were aged
between 23 and 44 (mean age 33.5 years). Samples positive for CMV
IgG were tested farther for IgM antibodies. Finally samples positive
in both CMV IgG and IgM antibodies were farther tested for CMV
IgG avidity. All tests were performed by chemiluminescent microparticle
immunoassay (CMIA, Abbott Park, US).
Results: Of the 8.768 women tested, 3.558 (40.6%) had never been
infected with CMV, 5.082 (58.0%) found to be positive in CMV IgG
and negative in IgM. 117 (1.3%) samples found to be positive in both
CMV IgG and IgM and 11 (0.1%) were in the CMV IgM grayzone. Of
the 117 positive samples, 23 (19.7%) had a low avidity and 93 (79.5%)
had a high avidity. One sample (0.8%) was in the grayzone. All samples
with CMV IgM in the grayzone had high avidity.
Conclusions: Measurement of CMV IgG avidity may help to improve
the serodiagnosis of CMV infected women by determining the time of
infection. The presence of high avidity indicates that primary infection
occurred well before conception and the fetus is most likely protected
against debilitating CMV infection. This information is important in
the clinical management of pregnant women found to be positive for
CMV antibodies at their ﬁrst-trimester of gestation when the risk of
fetal damage is greater.
R2337 Patients with 2009 inﬂuenza A/H1N1 virus in a tertiary
hospital in Spain, April-October 2009
G. Fagu´ndez Machaı´n °, A.W. Rosingh, J.J. Co´rdoba, J.M. Molina,
R. Mene´ndez, A. Salazar, M. Gobernado (Valencia, ES)
Background: During the ﬁrst weeks of April 2009 North America
and Mexico detected the initial cases of a novel swine-origin
Inﬂuenza A/H1N1 virus: a triple-reassortant Inﬂuenza A virus. This was
quickly followed by detection in other countries and by the end of April,
the virus had spread to over 123 countries.
Methods: Using medical charts, we collected data on 212 patients who
were attended for inﬂuenza-like illness (fever, cough, sore throat) in our
Hospital and who tested positive for the 2009 H1N1 virus; we regarded
age, hospitalization (at least 24 hs), and underlying diseases.
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Two types of real-time reverse-transcriptase–polymerase-chain-reaction
assays, were used; Inﬂuenza RT-PCR Kit RUO (Artus) as a screening
test and a conﬁrmatory RT-PCR (Applied Biosystems ™), according to
the CDC protocol.
Results: Of the 190 patients for whom data were available, 134 (70.5%)
were admitted to the domiciliary hospitalization unit, 55 (28.9%) were
hospitalized (median age 27.07, range 2−85), 4 (2.1%) were admitted
to an intensive care unit (median age 30, range 14−51), and 2 (1.05%)
died (median age 18.5 range 14−23): 110 (57.8%) were adult patients,
between 18 and 65 years of age, 74 (38.9%) were children under the
age of 18 years, and 5 (2.6%) were adults 65 years of age or older. 80
(42.1%) of the patients had at least one underlying medical condition;
asthma; diabetes; heart, lung disease, obesity and pregnancy, considered
risk factors for severe disease 26 (13.6%), had recently traveled to
Mexico. (including the ﬁrst reported case at the Valencian Community)
21 (38.9%) of the 55 hospitalized patients and 1 of the 4 (7.2%) admitted
to an intensive care unit patients did not have any risk factors for severe
illness.
Conclusions: During the evaluation period, 212 patients tested positive
for the 2009 A/H1N1 Inﬂuenza. More than 95% of the affected patients
were under 65 years; 55 (29.1%) patients required hospitalization
because of severe illness. 21 (38.9%) of these hospitalized patients as
well as 1 of the ICU admitted patients, did not have any risk factors for
severe illness. It’s seems to be important to continue advancing in the
knowledge of the pathogenicity of this microorganism.
R2338 Different clinical presentation between male and female
patients with Puumalavirus infection. Are the clinical
differences related to expression of different oestrogen
receptor subtypes?
P. Brundin °, C. Zhao, K. Dahlman-Wright, C. Ahlm, B. Evenga˚rd
(Umea˚, Stockholm, SE)
Objectives: To investigate the expression of estrogen receptor (ER)
mRNA in peripheral blood mononuclear cells during Puumala virus
infection (nephropathia epidemica).
Methods: Ambulatory and in-patients (n = 20, male/female: 10/10) at
Umea˚ university hospital with conﬁrmed nephropathia epidemica (NE)
were followed with routine blood chemistry and sampled for peripheral
blood mononuclear cells (PBMC) during day 1 and 3 and a follow-up
convalescent sample after 12 weeks. The PBMC were stored in −70ºC
until RNA was extracted using RNeasy kit (Quiagen). cDNA synthesis
was performed and expression of ER a, ER b and ER b cx (mRNA
splice variant of ER b) were quantitatively estimated using real-time PCR
(Applied Biosystems). The multiple variables from the blood chemistry,
relative expression levels of ERs mRNA, sex, and day of onset of the
disease were related to each other in a principal component analysis
(PCA)(SIMCA-P, v 11.5.0.0).
Results: ER a is expressed in higher quantities than ER b cx. ER b
(wild type) could not be detected. ER a is correlated to a rise in white
blood cells (WBC) (p = 0.0004) in the total group of patients (n = 20) and
divided into males (n = 10) and females (n = 10), a correlation is seen
between ER a and urea (p = 0.03), C-reactive protein (CRP) (p = 0.04)
and WBC (p = 0.01) in the male patient group, compared to a correlation
between ER a and WBC (p = 0.04) in the female patient group. The PCA
show a distinct dichotomy of male and female samples. Female samples
tend to be correlated to a higher level of ER a, and male samples to
higher levels of ER b cx.
Conclusion: Our results from the PCA indicate a different clinical
presentation in men and women with NE. This could explain that more
men than women (2−5:1) receive the clinical diagnosis NE although
the serological distribution is 1:1. Females were associated with higher
levels of ER a and males with ER b cx. ER b cx is known to dimerize
with ER a and thereby prevent the normal function of ER a. A larger
study is needed to conﬁrm the role of ER a and ER b cx in this disease.
R2339 Nosocomial transmission of Crimean-Congo haemorrhagic
fever
R. Caylan °, D. Yapar, S. Keske, I. Hasanoglu, M.A. Tasyaran (Ankara,
TR)
Introduction: Crimean-Congo haemorrhagic fever is a tick-borne viral
disease. The virus is acquired by the bite of infected ticks. Transmission
also may occur from direct or aerosol contact of blood or secretions
of infected patients. Health-care workers are at increased risk of
acquired infection while caring for haemorrhagic patients. Nosocomial
CCHF mortality rate is higher than the other routes (respectively 80%,
10−50%). Ribavirin is recommended during postexposure prophylaxis
and treatment of CCHF, however it is controversial.
Case report: In June 2009, 56-year-old female patient who was diag-
nosed as CCHF with positive PCR result from Reﬁk Saydam National
Public Health Agency, was developed oral mucosal and vaginal bleeding,
melena during the sixth day of therapy. Patient was confused and she had
seizures due to intracranial haemorrhage in sixth day of hospitalization.
The patient’s existing oral and nasal haemorrhagies increased during
these seizures. Physician intervented only with disposable gloves because
the patient needed emergency airway management and placed oral airway
immediately without surgical mask or eye protection. Patient died after
a few hours with widespread bleeding.
Five days after this intervention 33-year-old female physician presented
fever, headache, myalgia and malaise. Her temperature was 38ºC, pulse
88 beats/min; blood pressure was 90/60mmHg. Laboratory ﬁndings;
Blood biochemical tests were normal, haemoglobin 11 g/dL leukocytes
900 K/mcL and platelet count of 76000 K/mcL. Oral ribavirin started
quickly for the possible nosocomial transmission. The ribavirin dose
was 2 g for loading, followed by 4 g/day for 4 days and 2 g/day
for 3 days. She had no history of percutaneous exposure. Probably
close contact with aerosolisation of blood or excretions are suspected
route of transmission. Diagnosis was conﬁrmed by RT-PCR. During
the follow-up platelet counts persisted on decreasing and the liver
enzymes slightly increased. No fever was detected after the third day.
Haemorrhagic manifestations didn’t develop. Signiﬁcant side effects of
ribavirin were not observed. Patient’s symptoms improved after seventh
day of admission. In conclusion, to prevent transmission of CCHF in
close contact with haemorrhagic patients, droplet and contact precautions
must be performed. Although it is controversial early onset of ribavirin
had been found to be effective in our case.
R2340 Evaluation of Crimean-Congo haemorrhagic fever patients:
epidemiological, clinical and laboratory features
R. Caylan °, S. Keske, D. Yapar, T. Arslan, M.A. Tasyaran (Ankara, TR)
Introduction: Crimean Congo haemorrhagic fever (CCHF) is a disease
caused by CCHF virus of family Bunyaviridae and transmitted to humans
generally by Hyalomma tick bites or by direct contact with blood or
other excretes of infected humans. There has been annual increases in
case numbers in Turkey since 2002.
Materials and Methods: From April 2007 to September 2009 CCHF
virus ELISA and/or RT-PCR conﬁrmed cases in Ankara Ataturk
Education and Research Hospital were included in the study. All the
informations of the patients have been provided from patient charts.
Results: From 2007 to 2009, 94 comﬁrmed cases were hospitalized
in our hospital. Female to male ratio was 1.14. Median age was 49
(15−76 years) years. 93% of the cases were from rural areas. 74%
of patients had tick bite or contact history. Of these 94 patients one
(1.06%) was nosocomial infection. The most seen clinical complaints
were malaise (90%), fever (85%) and myalgia (81%). Cholecystitis were
seen in 6 patients (6.4%). The mean hospitalization duration was 10
(1−62 days) days. Mortality rate was 6.4% (6/94). Ribavirin treatment
were administered at 26 patients and also supportive treatment to all
patients.
Discussion: CCHF is a big seasonal health problem for Turkey with
increasing cases annually. The main risk factor for transmission of
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disease is mostly tick bite. The cholecystitis seems to be a new deﬁned
clinical ﬁnding in CCHF. There is not a speciﬁc treatment for CCHF;
efﬁcacy of ribavirin treatment is controversial. The mortality rate was
similiar with those reported in literature from Turkey.
R2341 Assessment of serological markers for Epstein–Barr virus
in patients for transplantation
P. Genova-Kalou °, G. Ivanova, A. Toshev (Soﬁa, BG)
Objectives: Viral infections constitute the single greatest cause of
infectious-disease related morbidity and mortality in organ transplant
recipients. Cytomegalovirus (CMV), which frequently causes latent
asymptomatic infection in healthy adults, may evade immune surveil-
lance in immune compromised patients, as well as in renal transplant
recipients and to start to replicate. Epstein–Barr virus (EBV) infection
sometimes results in clinical symptoms (fever, leucopenia, pharyngitis,
hepatitis, lymphadenopathy) and eventually may lead to uncontrolled
proliferation of B cells terminating in post-transplant lymphoproliferative
disease (PTLD). The risk of PTLD is mostly determined by the
prevalence of anti-EBV sero-positivity in transplanted patients.
Methods: This prompted us to investigate the serum samples submitted
to our laboratory from 25 post transplanted patients (18–35 years old)
and 30 healthy blood donors (20–42 years old). Serum samples were
collected from all patients before transplantation and at three months
after transplantation. Sera were stored at −70ºC. The samples were
tested for EBV- and CMV-speciﬁc serology, including VCA IgM, VCA
IgG, early antigen (EA) and EBNA antibody. The levels of antibodies
were determined using commercially available sensitive enzyme-linked
immunosorbent assay (ELISA) method.
Results: Antibody avidity test results were added to provide an expanded
serological proﬁle in which patients with low antibody afﬁnity were
deﬁned as having primary infections while those with high antibody
afﬁnity were regarded as having past infections. 25 samples (48.2%) were
found to be seropositive. Recent infection was diagnosed in 32.6% of
patients while prior infection in 15.6%. Past infection was diagnosed by
detecting VCA IgM antibodies in 20.5% of the examined samples. Our
results conﬁrm the thesis that VCA IgM in the absence of antibody to EB
nuclear antigen (EBNA) is regarded as suggestive of acute primary EBV
infection because EBNA antibodies develop only in late convalescence.
Conclusions: In conclusion, speciﬁc serological anti-EBV IgG markers
(EBNA and EA) must be used for the serological diagnosis of EBV
infectious mononucleosis. In order to obtain the highest sensitivity, VCA
IgM, VCA IgG, EBNA and EA antibodies need to be measured.
R2342 Unusual nosocomial transmission of Crimean-Congo
haemorrhagic fever; two cases report from Turkey
N. Tulek °, C. Bulut, F. Ergin, G. Tuncer Ertem, C. Ataman Hatipoglu,
B. Oral (Ankara, TR)
Objectives: Crimean Congo Hemorrhagic Fever (CCHF) is a severe
hemorrhagic fever caused by a Nairovirus, belonging to the family
Bunyaviridae. In the spread of this zoonosis to humans, the main role is
that of ticks; however, transmission is also possible via blood, tissue and
bodily ﬂuids of infected people or animals. Nosocomial transmission is
also possible and, health care workers are one of the major risk groups
for CCHF virus acquisition especially when caring for patients with
hemorrhages from different body sites. In this paper we are reporting
CCHF in two health care workers whose did not have any contact to
blood or body ﬂuids of a patient.
Case 1: 30 years old and pregnant nurse (ten weeks) admitted to our
clinic with sudden onset high fever, myalgia, arthralgia and fatigue. She
was caring the patients with CCHF in our clinic. Four days ago, in
her shift, one patient died because of CCHF, the patient had respiratory
symptoms and renal insufﬁciency. Although we don’t have negative-
pressure room, all the patients had to be isolated in a private room, and
all healthcare workers are using barrier-nursing techniques that include
disposable gloves, masks and goggles and hand-washing or use of alcohol
based desenfectans are the main way of protection. We isolated the
nurse and sent serum samples to the national reference laboratory for
CCHF tests. Next day she was diagnosed as CCHF with positive PCR
and with her informed consent, ribavirin treatment was given. On the
following days, fever was continued and alanine aminotransferase, lactat
dehydrogenase, creatine phosphokinase levels were increased. After ﬁve
days, clinical and laboratory ﬁndings improved and she discharged with
a medical abortus decision.
Case 2: 26 years old, male resident admitted to our clinic with the
same complaint after two days of nurse’s admission. He had cared the
same patient on same day with the nurse. He was diagnosed CCHF with
laboratory RT-PCR test. He had been taking the oral ribavirin with a
decision of himself and we continued the therapy. His symptoms began
to resolve in third day and he discharged from hospital.
The only history of their contacts to inside the patient’s room without
mask once or twice.
Conclusion: Although the main way of transmission of CCHF to health
care workers is close contact to blood and other body ﬂuids, transmission
with aerosol or air droplets may be possible.
R2343 Central nervous system infections due to herpesviruses in
immunocompetent population
F. Kamaria °, L. Skoura, K. Dumaidi, A. Papa, F. Frantzidou
(Thessaloniki, GR)
The objectives of the present study were the detection of the most
common herpesviruses from cerebrospinal ﬂuid (CSF) samples of
patients with central nervous system (CNS) infections from Northern
Greece, in order to:
1. estimate the incidence of CNS infections caused by herpesviruses.
2. correlate the causative viruses with clinical manifestations and CSF
laboratory ﬁndings.
3. compare the results of this study with results published from other
countries.
Methods: From March 2003 to June 2008, 156 immunocompetent
patients with possible viral CNS infection, hospitalized at Northern
Greece hospitals, were included in this study. From these patients,
60 (39%) had encephalitis, 64 (41%) patients had meningitis, 7 (4%)
patients had encephalomyelitis, 4 (2%) patients had Guillen-Barre
syndrome and 21 (14%) patients had various unspeciﬁed neurological
diseases. Polymerase chain reaction (multiplex consensus nested PCR),
as well as serology, were performed for the detection of herpesviruses
in CSF.
Results: Herpesviruses from CSF were detected in 11 of 156 (7%)
patients. Ten of them were adults and one was child. Herpesvirus
genome was detected by PCR from 10 patients and there was a patient
with encephalitis, the etiologic agent of which, HSV, was identiﬁed by
intrathecal andibobies production.
From 11 patients with herpetic CNS infection 6 had encephalitis, 4
had meningitis and one patient had Guillain–Barre syndrome. Herpes
simplex virus type 1 (HSV-1) genome was detected from 5 patients
with encephalitis and a patient with Guillain–Barre, herpes simplex virus
type 2 (HSV-2) from a patient with meningitis and varicella-zoster virus
(VZV) was detected from 3 patients with meningitis. From a patient with
encephalitis, the diagnosis was established by HSV intrathecal antibodies
detection. The detection of herpesvirus genome from this patient’ CSF
was impossible.
The incidence of herpes simplex encephalitis in our study was 1 patient
per 1.000.000 people per year. All patients with meningitis had excellent
outcome; however, poor outcome, which led to death, was observed in
two of six patients with encephalitis, (mortality 33%). The poor outcome
was associated with low Glascow coma scale at the admission to the
hospital.
In conclusion, HSV-1 was the most common herpesvirus detected in this
study, which was the cause of encephalitis with high mortality. HSV-2
and VZV were less frequently detected and caused milder disease, with
good outcome.
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Mycobacterial infections (including
diagnosis)
R2344 Miliary TB-mimicking advanced ovarian cancer with
osteolytic lesions of the spine
K. Ntinos °, M. Astriti, K. Sarri, P. Bounas, G. Adamis, T. Isopoulos,
M. Littos, P. Gargalianos (Athens, GR)
Objective: to present a case of miliary TB mimicking advanced ovarian
cancer with thoracic spine metastases.
Results: A 24-year old Somalian female complained for backache,
constipation and low grade fever for the last 5 months. Basic laboratory
tests revealed anemia (Hb = 9.7mg/dl) and severe thrombocytosis (PLT =
1027×103). She also had an elevated CA-125 of 982 U/ml (<35U/ml)
and a positive tuberculin test (17mm). She underwent C/T scan which
revealed pleural effusions, ascites, a solid lesion of the right ovary
and osteolytic and slerosing lesions of the lower thoracic vertebrae,
and transvaginal ultrasound which showed a large cystic mass arising
from the right ovary. Paracentesis of the ascites was performed; the
ﬂuid was an exudate with positive cytology for atypic cells, possibly
adenocarcinoma, and negative for AFB. Gastroscopy and barium enema
were normal. As the above ﬁndings suggested of an advanced ovarian
cancer, laparotomy was performed; the macroscopic picture was of
multiple whitish lesions over the peritoneum and the intestines (omental
cake). Two liters of ascetic ﬂuid were removed and an ADA test was
done which came back positive: 55U/ml (13−23U/ml). The right ovary
and salpynx were removed; the biopsy showed granulomatous tissue. C/T
guided biopsy of the vertebral lesions was performed, and PCR for Myc.
tuberculosis on the material was done which was positive. The patient
was put on anti-TB treatment with isoniazid, rifampicin, pyrazinamid,
and ethambutol with gradual improvement.
Conclusions: As TB is rare in the developed world, ovarian and
peritoneal TB is often misdiagnosed as advanced ovarian cancer, leading
young women to unnecessary laparotomy and surgery. Ascites, peritoneal
nodules and elevated CA-125, even in the presence of osteolytic lesions
of the vertebrae, do not necessarily indicate malignancy. Tuberculosis
should always be suspected, especially in young women from endemic
countries. As cultures for mycobacterium are time consuming tests, and
peritoneal ﬂuid is often negative for AFB, PCR and ADA are useful
tools for the differential diagnosis.
R2345 Evaluation of Alpha Tec Nac-Pac™ mycobacteria digestion
and decontamination system on pulmonary samples
S. Naidoo ° (Johannesburg, ZA)
Objectives: Clinical samples sent to the Mycobacteria Laboratory for
culture conﬁrmation of Mycobacterial infection are contaminated by
non-mycobacterial organisms and require digestion and decontamination
to allow effective diagnosis of mycobacterial infection. The optimal
recovery of mycobacteria requires a tightly regulated pH. A basic pH
quickly eliminates non-mycobacterial organisms from the patient sample.
However, prolonged exposure to a high pH is toxic to Mycobacterial
organisms. A carefully controlled pH through-out samples preparation
is essential.
Methods: We assessed the performance of the Alpha Tec NAC-
PAC™ Digestion and Decontamination System in a high throughput
laboratory in Johannesburg, South Africa, in 100 pulmonary samples.
The NAC-PAC™ method was compared to the currently implemented
BD MycoPrep™ Kit.
The pH of the decontaminated specimen should be less than 8.1
immediately after buffering and maintained between 6.8−7.1 for
culturing and diagnosis. At these pH levels optimum survival of the
Mycobacterial organisms can be ensured. The Alpha Tec NAC-PAC™
system is the only commercially available system that can effectively
control pH and help reduce Mycobacteria die-off during the specimen
preparation process. Samples were split and processed using BD’s
MycoPrep™ system and Alpha Tec’s NAC-PAC™ system. Both methods
were performed as per the manufacturers’ procedure and assessed in the
BACTEC™ System.
Results: Of the 100 samples processed using the Alpha Tec NAC-PAC™
kit contamination levels decreased signiﬁcantly: 90 samples were positive
for TB, 8 were MOTTs and a 2% contamination rate was noted. The
same 100 samples processed using the BD MycoPrep™ kit showed a 7%
contamination rate, 90 samples were positive for Mycobacteria infection,
of which 8% had to be re-cultured.
Conclusion: The advantage of Alpha Tec NAC-PAC™ vs. BD
MycoPrep™: contamination rate decreased from 7% to 2%; Recovery
time improved by 3−5 days, decreasing TAT for results. NAC-
PAC™ NALC-NaOH reagent is stable for up to 72 hours after
preparation, whereas MycoPrep™ needs to be used within 24 hours
of reagent reconstitution. Pellet Resuspension Buffer allowed for tight,
standardized, reproducible pH which increased specimen uniformity
for growth detection, molecular procedures and conventional culture
techniques.
R2346 Characterization of multidrug-resistant strains of
M. tuberculosis in Bulgaria
E. Bachiyska °, A. Ivanova, D. Merdjanov, T. Kantardjiev, E. Borrone,
P. Miotto, D. Cirillo (Soﬁa, BG; Milan, IT)
Background: The rate of MDR TB in Bulgaria continue to be high
(WHO, 2009). Here we report about results of a ﬁrst study on the MDR
TB strains from the clinical isolates in 2008 in the country.
Methods: The study panel included 26 MDR TB strains isolated from
new and retreated patients from all over the country. MGIT 960® ﬁrst
and second line drugs and Geno Type MTBDR plus® were used to strain
characterization.
Results: A collection of 26 strains shoved a phenotypical resistance at
least to INH and RMP by MGIT 960®. MDR TB strains were conﬁrmed
as: 9 resistant to STR, INH, RMP and EMB; 9 to STR, INH and RMP;
3 to INH, RMP and EMB; 5 to INH and RMP. All the MDRTB strains
were retested by Geno Type MTBDR plus® and were INH and RMP
resistant. Second line drugs testing shoved only one strain resistant to
OFL. All others 25 MDRTB strains were fully susceptible to OFL, AMK,
KNM, CAP.
Conclusion: Using the classical methods was conﬁrmed that no XDR TB
cases was found in last year in Bulgaria. To complete the characterization
of Multi-Drug resistant strains of M. tuberculosis MIRU-VNTR analysis
are performing.
R2347 Identiﬁcation and major antituberculous drug sensitivities
of 2,301 Mycobacterium tuberculosis strains by TK
automated system
U. Tozalgan °, G. Sengoz, K. Kart Yasar, F. Pehlivanoglu, M. Bakar
(Istanbul, TR)
Objective: A tuberculosis (TB) laboratory for diagnosis, drug resistance
tests and treatment follow are necessary to achieve the goals that
WHO deﬁnes. In developing countries diagnosis of TB which is
an air-borne infection; rapid, easily performed, inexpensive tests are
important. We evaluated major antituberculous drug sensitivities of 2301
Mycobacterium tuberculosis (MTB) strains by TK automated system.
Methods: Mycobacterium strains isolated from sputum between August
2006 and September 2009 were studied identiﬁcation and antibiotic
susceptibilities by TK automated system (Salubris, Inc. MA, USA)
in class 2 biosafety cabins. One susceptibility test was performed on
recurrent positive culture for each patient except treatment follow culture
positive cases.
Results: 62012 sputum samples were examined in a three year period.
AFB positivity was 13.3% and culture positivity was 11.3%. Smear
negative culture positive cases were 1146, smear positive culture negative
cases were 2218. Strains susceptible to all 4 drugs were found 1833
(79.6%). Resistance to one drug were found isoniazid (INH) 5.9%,
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rifampicin (RIF) 1.7%, streptomycin (SM) 3.2% and ethambutol (EMB)
2.1%. Multidrug resistance (MDR) rate was 6%.
Conclusion: Around the same time TB laboratory was instituted, direct
observation therapy (DOT) was started on all the TB dispenceries in
Istanbul. The data to evaluate the positive effects of DOT was not ready
yet. Istanbul is a metropolis which has majority of the TB cases. Rapid
diagnosis, treatment follow and drug resistance tests has an important
role in controlling the disease.










2006 5171 672 460 131 3 1.5 9.1 0 5.3
2007 17701 2585 1391 898 6.6 2.2 2.5 7 7.1
2008 20633 2715 1108 661 7.8 1.5 1 1.3 6.2
2009 18507 2291 1019 611 6.2 1.6 0.4 0.4 5.5
Total 62012 8263 3978 2301 5.9 1.7 3.2 2.1 6.0
AFB: Acid fast bacilli.
R2348 Synergistic activity of three antituberculous drug
combinations against clinical isolates of Mycobacterium
tuberculosis resistant to different drugs
E. Rey, G. Tudo´ °, S. Borrell, J. Gonza´lez (Barcelona, ES; London, UK)
Objectives: To determine the synergistic activity of 3 drug combinations:
isoniazid (H) plus rifampicin (R) plus ethambutol (E), oﬂoxacin (O) plus
R plus E and O plus R against M. tuberculosis clinical isolates resistant
to different drugs compared with drug susceptible isolates.
Methods: Clinical isolates were collected in the Hospital Clinic of
Barcelona: HRE combination: 11 H-resistant isolates; OER combination:
12 H-resistant and 3 multiresistant isolates (MDR); OR combination: 21
H-resistant isolates; and the 3 combinations: 11 drug susceptible isolates.
The individual MICs of the isolates studied were evaluated with the
proportional method in 7H11 solid medium. The above combinations
were studied crossing 7 concentrations of each antibiotic (corresponding
to their MIC, two greater and four lesser dilutions), with a 2-dimensional
chequerboard assay and an adaptation to a 3-antibiotic chequerboard
assay in 7H11 medium. After analysing the results of all the combi-
nations, the fractional inhibitory concentration (FIC) was calculated.
Two-dimensional chequerboard assay: the FIC was calculated as FIC
index=MICA in combination/MICA alone+MICB in combination/MICB
alone where A and B were the two respective antimicrobial agents
tested. The FIC index was interpreted as FIC index0.5, synergistic
activity, FIC> 0.5−4, indifference and FIC> 4 antagonistic activity.
Three-dimensional chequerboard assay: was calculated as above adding
one more drug, C. In this case, the FIC index was interpreted as
FIC0.75, synergistic activity. As a control a 1/100 inoculum was seeded
in antibiotic-free medium. All the plates were incubated at 37ºC, being
read at the end of 3 and 4 weeks.
Results: HRE Combination: Most H and R MICs of the H-resistant
isolates decreased up to 3 dilutions compared to their individual MIC
displaying synergism of all the H-resistant isolates. OR Combination:
No strain showed synergism or antagonism in either the drug resistant
or the susceptible isolates. OER Combination: Most O, E and R MICs
of H-resistant and MDR isolates decreased up to 2 or 3 dilutions
compared to their individual MIC. Therefore, most of these isolates
showed synergism and susceptible isolates.
Conclusions: The isolates studied did not show antagonism in either the
HRE, OR or OER combination. Accordingly, the HRE regimen may be
effective against low-grade H-resistant isolates (MIC=0.8mcg/ml). The
OER combination is more effective in susceptible isolates than the HRE
combination.
R2349 Evaluation of Chromogenic in situ hybridization method
as a new tool for Mycobacterium tuberculosis detection in
samples from tissue embedded in parafﬁn
J.E. Herna´ndez °, J. Amaya, A. Sanchez, M. Murcia (Bogota, CO)
Objective: To establish the utility of Chromogenic In Situ Hybridization
(CISH) methodology forM. tuberculosis detection in samples from tissue
embedded in parafﬁn (TEP).
Methods: As control positive we used a biopsy of lymphatic nodule
embedded in parafﬁn previously obtained in Pathology laboratory from
a patient with tuberculosis (TB) diagnosis and negative control was
skin biopsy from a patient with Leprosy. Initially, we conﬁrmed the
TB diagnosis trough both histopathology (Hematoxilin-Eosin stain and
Ziehl Neelsen stain) and molecular methods (PCR IS6110). In order to
obtain an adequate material for the last method we started for evaluate
different sizes (5, 10 and 15mm) in the TEP cuts, and methods of DNA
extraction: CHELEX, CHELEX-Triton, Inorganic solvents and Quiagen
columns were evaluated. Standardizing conditions for CISH included
evaluation the follow variables: enzyme digestion (Pepsin or Proteinase
K), formamide concentration, the detection system (Peroxidase or
Alkaline Phosphatase), chromogen (Diaminobenzidine or Texas red),
microwave treatment on samples and for probes four different probes
Biotin labeled and based in IS6110 sequence were evaluated. Final
evaluation was realized by visual examination at light microscope.
Results: The tissue cuts from 5mm showed the best results and the
best method for DNA extraction from TEP and for use in PCR was
CHELEX. The CISH conditions standardized in our laboratory included:
Pepsin digestion, Formamide 50%, Peroxidase, Diaminobenzidine and
microwave treatment as easy and useful option to improve the
hybridization. Regarding probes, all probes showed positive results for
CISH, however the best results regarding bacilli number detected were
obtained with Probe 4(see ﬁgure 1).
Conclusions: We selected CHELEX as simple and economic tool for
DNA extraction from TEP. The method CISH was standardized for
M. tuberculosis detection in TEP.
We established for ﬁrst time the potential utility from CISH method using
a fragment of IS6110 for M. tuberculosis detection in TEP. Other assays
with higher number of samples and bacilli number known are necessaries
in order to establish the CISH impact as new tool for tuberculosis
diagnosis.
Figure 1. CISH results. (A) Probe 1; (B) Probe 4.
R2350 Utility of molecular biology in the diagnosis of
mycobacterial infections
D. De Vito °, M. Santantonio, V. Cristallo, M.F. Coscia, R. Monno,
G. Miragliotta, G. Rizzo (Bari, IT)
Objectives: The emergence of tubercolosis/HIV co-infection and the
increase in the number of cases of infection with nontuberculous
mycobacteria (NTM) require rapid laboratory test results in the isolation
and identiﬁcation of mycobacteria. The objective of this study was
to evaluate the identiﬁcation of mycobacteria by Real-Time PCR and
Microarray in comparison with that obtained using classical biochemical
methods.
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Methods: Between 2007 and 2009, 195 clinical specimens were
analyzed using Ziehl–Neelsen staining, culture by Migit (Becton
Dickinson, Italy), Real-Time PCR for M. tuberculosis (Quiagen SpA,
Italy) and microarray method (LCD-Array Myco Direct 1.7 Chipron,
Germany).
Results: Of the 195 patients, 30 (15.4%) were positive for Mycobac-
terium tuberculosis complex by Real-Time PCR and 28 (14.4%) were
positive for NTM by microarray.
M. tuberculosis complex was found in 20 (66.67%) pulmonary
specimens and in 10 (33.33%) nonpulmonary specimens (liquor, urine,
stool and others).
The microarray method identiﬁed: 9 (32.14%) M. avium complex,
5 (17.86%) M. xenopi and M. chelonae, 3 (10.72%) M. kansasii,
2 (7.14%) M. gordonae and M. phlei, 1 (3.57%) M. genavense and
M. marinum.
When comparing the methods, the sensitivity of the Ziehl–Neelsen
staining, culture and Real-Time PCR were 16.66%, 83.33% and 100%
respectively.
The sensitivity of Ziehl–Neelsen staining, culture and microarray was
10.71%, 82.14% and 100% respectively.
Conclusions: Despite the cost, the identiﬁcation of mycobacteria using
the molecular technique is faster: maximum 6 h vs. 28−30 days for
classical methods.
These methods have high speciﬁcity and sensitivity, this justiﬁes its
implementation and routine use in referral laboratories, since it facilitates
the diagnosis providing opportune treatment. Current recommendations
advice that, in general, the use of molecular tests for the diagnosis of
tuberculosis should always be interpreted together with patient clinical
information.
Infection in the immunocompromised host
and transplant recipients
R2351 Galactomannan detection in bronchoalveolar lavage ﬂuid
and serum in critically ill adult liver transplant recipients
on mechanical ventilation at risk for invasive aspergillosis
L. Barrado, M.S. Cue´tara, M.E. Alvarez, M. Catala´n, J.C. Montejo,
J. Ponto´n, A. del Palacio ° (Madrid, Lejona, ES)
Objectives: To prospectively assess and compare the galactomannan
(GM) diagnostic performance on bronchoalveolar lavage ﬂuid (BALF)
and serum samples in critically ill liver transplant recipients (LTR) at
risk for invasive aspergillosis (IA). GM performance in BALF remains
poorly deﬁned as a diagnostic adjunct in LTR at risk for IA.
Methods: Conventional microbiologic methods, tissue biopsies and
necropsies, with the assessment of risk factors, signs, symptoms and
radiologic imaging were used for the diagnosis of IA as deﬁned by the
Pauw et al (Clin Infect Dis 2008; 46:1813). GM detection (cutoff above
0.500) in BALF and serum samples was performed at the discretion of
the Intensive Care Unit clinical team. Patients were stratiﬁed in 3 groups
(high, intermediate and low risk) as proposed by Hellinger et al (Liver
Transpl 2005; 11:656).
Results: There were 5 and 7 patients in the low and high risk group
respectively. 4 patients were colonized on respiratory samples with
Aspergillus (1 A. terreus, 1 A. fumigatus, and 2 A. niger). A total of 36
GM serum and 12 BALF samples were performed for 12 LTR patients on
mechanical ventilation at risk for IA. There was 1 proven disseminated
IA. The sensitivity (S), speciﬁcity (SP), positive and negative predictive
values (PPV and NPV) for GM on BALF were 100, 90.90, 50 and
100% respectively and in serum samples were 100, 100, 100 and 100%
respectively.
Conclusions: In this small LTR cohort there was one false positive
GM assay on BALF in a patient colonized with A. niger. GM detection
appears to be a good diagnostic adjunct for IA on LTR with a suggestive
clinical syndrome and high probability of IA. Further investigations
including a larger number of patients are needed to establish the
usefulness of the GM assay in LTR on mechanical ventilation at risk
for IA.
Acknowledgments: This investigation was supported by grants Fondo
de Investigacion Sanitaria, Instituto de Salud Carlos III, Proyecto
Investigacion PI 070134 (to MSC), PI 070107 (to A d P) and PI 070376
(to JP), grant IT-26407 of Departamento de Educacion, Universidades e
Investigacion del Gobierno Vasco (to JP) and Saiotek from Departamento
de Industria, Comercio y Turismo del Gobierno Vasco (to JP) and an
Educational grant from Pﬁzer (to A d P) and Gilead Spain (to A d P).
R2352 Gram-positive nosocomial infections in patients in a general
intensive care unit
E. Chinou °, G. Krimpeni, P. Giannakakos, A. Georgouli, E. Skouteli
(Athens, GR)
Objectives: To access the incidence, to recognize risk factors and to
determine the rates of antimicrobial resistance in nosocomial Gram-
positive strains isolated from patients treated in ICU.
Methods: This is a retrospective study of 277 patients who were
hospitalized in a seven bed ICU during one year period (July 2008
to July 2009). Data on demographic characteristics, primary diagnosis,
comorbidity, number of indwelling devices and current antibiotics
were cross-tabulated according to the presence and type of Gram
(+) pathogens isolated. The identiﬁcation and antimicrobial sensitivity
of Gram-positive pathogens were performed with MicroScan (Dade
Behring) according to CLSI instructions.
Results: Sixty patients (49, 6% of 121 with documented nosocomial
infection) with gram (+) isolates were identiﬁed. Methicillin-resistant
Staphylococcus epidermidis (MRSE, n = 33) and methicillin-resistant
Staphylococcus aureus (MRSA, n = 18) were most commonly isolated,
followed by E. faecalis (n = 5) and E. faecium (n = 4). There were no
signiﬁcant differences between the groups according to demographic
characteristics. The following independent risk factors for Gram (+)
nosocomial infection were identiﬁed. For MRSE: chronic obstructive
pulmonary disease comorbidity, previous isolation of Acinetobacter sp.
and Pseudomonas sp. and previous/current treatment with carbapenem,
and for enterococcus sp. previous/current treatment with third generation
cephalosporins. The number of indwelling devices was not linked
with increased risk of coagulase negative staphylococcal infections.
All staphylococci strains were sensitive to vancomycin, teicoplanin and
linezolid while three strains of enterococci (one E. faecalis and two
E. faecium) were resistant to vancomycin and teicoplanin.
Conclusion: To reduce the emergence and spread of antimicrobial
resistant Gram (+) pathogens in ICU, monitoring and optimisation
of antimicrobial use should be considered carefully. Identiﬁcation of
associated risk factors for Gram positive nosocomial infections would
aid initial antibiotic choice in such patients at risk.
R2353 Rhodococcus equi infections among hospitalized
HIV-infected patients in a new infectious disease centre in
Malaysia: a 2-year analysis
A. Adnan, F. Mohd Nor, C. Leong, Z. Abdul Wahab ° (Shah Alam,
Sungai Buloh, MY)
Objective: Rhodococcus equi infection has been regarded as an oppor-
tunistic infection in immunocompromised hosts. Although the organism
is easily cultivated from specimens, it may be misdiagnosed as a
contaminant or commmensal due to its diphteroid appearance. The AIDS
epidemic has resulted in an increase in awareness on the part of the mi-
crobiology laboratory in identifying cases of R. equi infections. A preva-
lence study of R. equi infections in our 3 year-old institution is presented.
Methodology: Clinically signiﬁcant isolates of R. equi that were cultured
in the Microbiology Laboratory of Sungai Buloh Hospital, Malaysia
between January 2008 until October 2009 were included. The laboratory
used the Analytical Proﬁle Index (API) system for the identiﬁcation of
the organism. The case ﬁles of the patients were reviewed and discussions
with the physician were done to determine the clinical signiﬁcance of
the isolates.
Results: R. equi that was deemed clinically signiﬁcant was isolated
from 10 patients over a two-year period (2007–2009). The organism
was cultured from blood, sputum and bronchoscopy specimens. All
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the isolates were recovered from HIV-infected patients. Pneumonia was
the main manifestation with fever and productive cough being the
presenting complaints. Two patients developed the infections while being
treated for underlying pulmonary tuberculosis while another two patients
had underlying histoplasmosis. Chest radiographs revealed consolidation
(without lobar predilection) and in half of the cases, cavitations were
seen. Pleural effusion was not present in any of the cases. The average
CD4 lymphocyte count at the time of presentation was 10 cells/ml. All
the patients were treated with a combination of vancomycin plus either
imipenem or erythromycin. No mortality was seen.
Conclusion: Our observation underlines the importance to suspect
R. equi pneumonia in patients with HIV who have low CD4 lymphocytes
count (<20 cells//ml) and presence of lung cavities on chest radiograph.
The microbiology laboratory plays an important role in the diagnosis
of R. equi infection as its diagnosis ultimately relies on the isolation
of the organism. A prompt identiﬁcation and notiﬁcation helps in the
management of the patient.
R2354 Clinical experience of daptomycin use on a haematology
unit in the United Kingdom
A. Hames °, K. Chew, T. Oswald, A. Jones, A. Galloway (Newcastle
upon Tyne, Malton, UK)
Background: In 2007, following an outbreak of glycopeptide-resistant
Enterococcus rafﬁnosus involving 18 patients on a haematology unit, a
decision was made to exclude the use of glycopeptides on the unit in
an attempt to limit the spread of this organism. Daptomycin (DAP) and
taurolidine line locks replaced intravenous teicoplanin and vancomycin
line locks in March 2008. Here we report the clinical outcomes of 25
haematology patients with catheter-related bacteraemia (CRB) treated
with daptomycin and enrolled in the UK EU-CORE programme between
March and August 2008.
Methods: EU-CORE is a retrospective, non-interventional records
review evaluating outcomes of patients (pts) treated with DAP in
Europe. Data is collected on patient demographics, antibiotic usage,
microbiological and clinical outcomes and adverse events from pts
treated with DAP between January 2006 and August 2008. Pts from
Newcastle with CRB were entered into the database. All pts had received
at least one dose of DAP. Outcomes were assessed as cured, improved,
failure and non-evaluable.
Results: Data from 25 haematology pts were collected. All pts were
included in the safety population. Most pts had signiﬁcant underlying
disease. Clinical outcomes were success, deﬁned as ‘cure plus improved’
(88%), failure (4%) and non-evaluable/switched therapy (8%). The most
frequently isolated pathogens were coagulase-negative staphylococci
(CoNS) (18/26) of which 7 were Staphylococcus epidermidis. Oxacillin-
or penicillin-resistant organisms were isolated from 14 patients and 3
patients were culture negative. Doses of DAP ranged from 4.5 to 8mg/kg.
DAP was frequently used as ﬁrst-line therapy (76%). 9 patients had
received prior antibiotics. Duration of therapy ranged from 3 to 21 days.
3 patients received DAP as out-patient parenteral therapy (OPAT). One
patient who had improved on therapy later died from a herpes simplex
viral infection.
Conclusions: DAP was administered in both the hospital and out-patient
settings. The overall clinical success rate in this population was 88%.
After the introduction of DAP, glycopeptide resistant enterococcal (GRE)
colonisation declined signiﬁcantly. Since August 2008, no new GRE have
been isolated on the Unit.
R2355 The challenge of respiratory viral infections in
onco-haematological patients
V. Chebotkevich ° (St. Petersburg, RU)
Objectives: Respiratory virus infections in immunocompromised
patients with haemoblastosis have been associated with signiﬁcant
morbidity and mortality. While inﬂuenza, parainﬂuenza viruses and
respiratory syncytial virus (RSV) are well known for their potential
to cause severe pneumonia, information has only recently emerged
regarding the signiﬁcance of the newly discovered viruses such as human
coronaviruses NL63, HKU1 (CoV), Bocavirus (HBoV) and human
metapneumovirus (HMPV).
Methods: Two cohorts of patients (pts) with different forms of
haemoblastosis were studied during the period from 2008–2009. Group 1
(n = 34) had clinically diagnosed infection complications, the second
(group 2) (n = 14) had no clinical symptoms of infection. Diagnosis
of viral, mycoplasmal and chlamidial infections was based on positive
PCR test. Clinical specimens (nasal and throat swabs and blood) were
collected in these groups of pts and studied in PCR for detecting genomes
of RSV, inﬂuenza virus A and B (IVA, IVB), parainﬂuenza 1, 2, 3, 4
(PIV-1, -2, -3, -4), rhinoviruses (rhV), adenoviruses (Ads), CoV, HBoV,
HMPV, Mycoplasma pneumoniae (Mp) and Chlamydophila pneumoniae
(Chp). Herpes viruses − herpes simplex 1,2; human herpes virus 6;
cytomegalovirus (CMV) and Epstein–Barr virus (EBV), were detected
only in blood by means of PCR.
Results: In group 1 respiratory viral infections (RVI) were diagnosed in
14 (41.2%) pts: IVA − 4 (28.6%), rhV − 4 (28.6%), CoV − 3 (21.4%),
PIV-3 − 1 (7.1%), HMPV − 1 (7.1%) cases. Interestingly that herpes
viruses (CMV and EBV) in blood were detected in 37.5% cases of
etiologically determined episodes of respiratory viral infections. Bacteria
(Escherichia coli) was isolated in one patient. In this case neither
respiratory viruses, nor herpes viruses were detected. In group 2 RVI
were diagnosed in 3 (21.4%) cases − 1 CoV, 1 − rhV and in 1 case − IVA
and HMPV were detected simultaneously. It is important that in latter
case the clinical material was received during the period of intensive
anticytostatic treatment and profound neutropenia. So that the clinical
diagnostic of infection in the case was very difﬁcult.
Conclusion: Our data suggest that respiratory infections as well
as herpes group viruses must be controlled in immunocompromised
leukaemia patients. PCR is adequate method for detecting viral
infections.
R2356 Differences in resistance pattern of urinary pathogens of
hospital inpatients with diabetes mellitus at a 6-year interval
I. Daniil, A. Papazaﬁropoulou, S. Konstantopoulou, A. Sotiropoulos,
V. Pantiora, T. Peppas °, D. Petropoulou, S. Pappas (Athens, GR)
Objectives: To estimate differences regarding resistance (R) to
antimicrobials of urinary tract infection (UTI) pathogens in patients with
Diabetes Mellitus (DM) at a 6 year interval.
Methods: Prospective demographic and microbiology data entry of
hospital patients with DM documented UTI. The periods of study were
2001−02 (period A) and 2007−08 (period B). Data entry and analysis
in IBM compatible PC using SPSS programme; sensitivity as by Kirby-
Bauer, statistics by Yates corrected x2.
Results: We studied 58 urine culture specimens from patients (36 F-22
M, mean age±SD: 74.6±14.8 years) hospitalized for UTIs in period A
and 148 (99 F/ 49 M, mean age±SD: 72.9±11.6 years) in period B.
The most frequent UTI pathogens for periods A and B respectively
were: E. coli (55.1% vs. 44.6%, P = 0.17), Klebsiella spp. (15.5%
vs. 15.2%, P = 0.81), Pseudomonas spp. (12.1% vs. 13.5%, P = 0.78),
Proteus mirabilis (6.9% vs. 9.5%, P = 0.56), Enterobacter spp. (6.9%
vs. 2.1%, P = 0.09), Enterococcus spp. (1.7% vs. 14.2%, P = 0.008) and
Acinetobacter spp. (3.4% vs. 1.4%, P = 0.33). The rates of antimicrobial
resistance between periods A and B were: ampicillin 70.2% vs.
72.8% (P = 0.77), 1st /2nd generation cephalosporins 51.4% vs. 47.1%
(P = 0.57), cotrimoxazole 36.8% vs. 34.6% (P = 0.83), ciproﬂoxacin
22.8% vs. 32.9% (P = 0.14), gentamicin 16.8% vs. 21.1% (P = 0.36) and
imipenem 2.7% vs. 11.2% (P = 0.03).
Conclusion: The constant variability of UTI pathogens, others rising,
others decreasing, the appearance of unexpected ones, and mainly R
proﬁle changes deem continuous surveillance and awareness, to ensure
the optimal empirical antimicrobial choice based on the most recent data
at the given milieu. Designing and implementing guidelines for hospital,
but also the community, setting is obviously warranted. Most resistance
rate did not vary considerably, but the overall resistance rate is justiﬁably
alarming.
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R2357 Bacterial bloodstream infections in neutropenic children
with haematologic/oncologic disorders at a tertiary care
centre in Saudi Arabia
I. Bin-Hussain °, I. Barron (Riyadh, SA)
Background: The aim of this study is to determine predominant
pathogens and their susceptibility patterns among our pediatric
neutropenic patients for proper selection of empiric antibiotic therapy.
Methods: Retrospective chart review of pediatric patients with
hematologic/oncologic disorders with bacteremia between January 1998
and December 2008. Demographic data, underlying diseases, bacterial
isolates, and antibiotic susceptibility were analyzed.
Results: One thousand eight hundred and eighty nine (1889) bacteremia
episodes were identiﬁed. Gram negative bacteria (GNB) were more
frequently isolated causing 954 episodes (51%). Of these, E. coli (23%),
P. aeruginosa (21%), K. pneumoniae (18%), Enterobacter spp (7.9%),
and S. maltophilia (7%). Seventy four percent of GNB were susceptible
to pipracillin/tazobactam, 66% to ceftazidime, 66% to gentamicin and
41% to pipracillin. Eighty-seven percent of those tested were sensitive
to imipinem/meropenem. Gram positive bacteria (GPC) caused 935
episodes (49%). Of these, coagulase negative staphylococcus was the
most frequent (30%), followed by S. aureus (24%), S. pneumoniae
(17%), viridans streptococcus (13%), and Enterococcus spp (10%). No
VRE was isolated.
Conclusion: Our results concur with observations of other studies that
GNB is emerging as major cause for bacteremia in children with cancer.
This supports not including vancomycin in the initial empiric therapy for
febrile neutropenic patients. Further, there is a potential need for better
utilization of conjugate pneumococcal vaccine to decrease the incidence
of invasive pneumococcal diseases in our patient population.
R2358 Parvovirus B19 infection in patients with colo-rectal cancer
S. Kozireva °, O. Bratslavska, D. Uzameckis, S. Donina, A. Lejnieks,
M. Murovska (Riga, LV)
Objectives: The study was designed to determine the prevalence of
parvovirus B19 (B19) infection in patients with colorectal cancer and
to investigate the hematologic and immunologic features related to B19
infection.
Subjects and Methods: 39 primary diagnosed colorectal cancer patients
and 32 sex and age matched apparently healthy persons were enrolled
in this study. Speciﬁc B19 IgM and IgG antibodies were assessed by
enzyme-linked immunosorbent assay, presence of B19 DNA in serum
samples − by nested polymerase chain reaction and viral load − by real
time PCR. Clinical and laboratory data including haemoglobin value,
number of leukocytes, lymphocyte, monocyte and neutrophile were
collected by examination. The CD3, CD4, CD8, CD19, CD38, CD16,
CD95 and CD25 subpopulations were determined in the patients by
cytoﬂuorimetry. The IL-6 level in patients’ serum samples was assessed
using quantitative ELISA.
Results: B19 DNA was detected in 14 (35.9%) patients with viral
load 382 − 1.5×105 copies/ml and 3 (9.4%) controls with viral load
350–475 copies/ml. B19 speciﬁc IgM antibodies have been revealed
in 2 (5.1%) patients and 2 (9.3%) controls while IgG antibodies in
21 (56.4%) patients and 21 (65.6%) controls persons. The frequency
of active B19 infection was signiﬁcantly higher in patients with
colorectal cancer compared with control persons (p = 0.01176). The
patients had signiﬁcantly higher frequency of anaemia and signiﬁcantly
lower haemoglobin value compared with control persons (p = 0.019 and
p = 0.025, respectively). The PCR positive patients had also signiﬁcantly
lower number of CD16 cells and signiﬁcantly higher IL-6 level compared
with control persons (p = 0.010 and p = 0.001, respectively).
Conclusion: The results of this study suggest that patients with
colorectal cancer may have a signiﬁcantly increased risk of B19
reactivation and B19 infection have impact on haematological and
immunological parameters in these patients. Screening of these patients
with PCR is recommended when infection is suspected.
R2359 The incidence, epidemiology and risk factors of bloodstream
infections in febrile neutropenic patients with haematologic
malignancies
C. Erol, E. Senol °, O. Guzel Tunccan, M. Dizbay, G. Sucak,
Z.N. Ozkurt (Ankara, TR)
Objectives: Bacteremia is considered as the most signiﬁcant cause
of mortality and morbidity in febrile neutropenic patients. The
epidemiology and risk factors might differ among institutions and over
the time period. The aim of this study is to evaluate the frequency,
epidemiology and factors predictive of bacteremia in neutropenic
patients in Gazi University Hematology and Hematopoietic Stem Cell
Transplantation (HSCT) units.
Methods: Between November 2007 and November 2008, 177 febrile
neutropenic episodes of 115 patients with hematological malignancies
were included in this study. Cases were deﬁned as patients with
bloodstream infection and controls were the patients without bloodstream
infections. We evaluated the cases and controls for the risk factors,
complications and mortality rates. Microorganisms isolated from blood
samples and their susceptibility patterns were also analysed.
Results: The prevalence of bacteremia was 61% and mortality rate was
12.4%. Duration of severe neutropenia (neutrophile count <100/mm3),
underlying hematologic malignancy, stem cell transplantation, relapsing
or refractory disease, presence of central venous catheter and presence
of mucositis were signiﬁcant predictive factors for bacteremia. Presence
of central venous catheter and relapsing or refractory disease were
independent risk factors. The incidence of hypotension and intensive
care necessity were higher in cases. Candidemia and Gram-negative
bacteremia were signiﬁcantly associated with higher mortality rates.
Gram-positive microorganisms were the most common isolates (76.8%)
with the predominance of coagulase negative staphylococci (63.6%) with
methicillin resistance rate of 64%. The most frequent Gram-negative
pathogen was E. coli with extremely high quinolon resistance rate of
82.1% and the resistance rate of 50% to 3−4th-generation cephalosporin.
Conclusion: Monitorization for the epidemiology of bacteremia and
prediction of signiﬁcant factors associated with bacteremia in febrile
neutropenic patients are considered to be important for the choice of
initial antibiotic therapy.
R2360 Epstein–Barr virus-associated post-transplant lymphoma
G. Terhes °, B. Kele, O. Szaka´l, C. Bereczki, K. Bartyik, S. Tu´ri,
J. Dea´k (Szeged, HU)
Objectives: As the number of transplant patients is increasing, the
prevalence of malignancies after transplantation is getting more and
more common. Among post-transplant malignancies, the importance of
lymphomas is signiﬁcant, because of their increasing prevalence and their
poor prognosis; most cases are of B-cell origin, and EBV-associated. Our
aim was to show an EBV-associated lymphoma in a kidney transplant
patient.
Case description and Methods: A 12-year-old boy underwent kidney
transplantation because of congenital urologic malformation. After
this, the patient received immunosuppressive treatment and urinary
chateterization was necessary due to bladder dysfunction. However the
graft function was appropriate, urinary tract infection was diagnosed
about 4−5 times a year. In June, 2009 the patient was admitted
to the Department of Paediatrics, because of sudden grand mal
seizure. Brain MRI examination revealed blood-brain injury, and the
possibility of multifocal, granulomatous encephalitis or lymphoma has
been arisen, this affects white matter and cortex too. PCR for EBV
(Artus® EBV LC PCR Kit, Qiagen) was performed from CSF and
brain biopsy specimen, and these gave positive results 1464 copies/ml
and 49 200 copies/ml, respectively while CMV PCR (Artus® CMV
LC PCR Kit, Qiagen) was negative. After this, the EBV viral load
was determined once a week. Cytologic examination justiﬁed post-
transplant lymphoproliferative disease (PTLD). According to these
ﬁndings, parenteral acyclovir and rituximab treatments were started,
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besides these everolimus and mycophenolic acid as immunosuppression
was applied. During the therapy, the viral load was decreased and after
6 weeks negative EBV PCR result was obtained. Control brain MRI
exam revealed total regression of previously recognised abnormalities.
Recently, the patient was treated with valagancyclovir.
Conclusions: Due to the increasing number of immunosuppressed
patients, the occurrence of post-transplant lymphoproliferative diseases
becomes more frequent and we have to pay attention to the emergence
of EBV-associated cases. To achieve correct diagnosis in these cases,
besides serology, molecular methods have crucial role in the detection
of pathogen and monitoring the effectiveness of antiviral therapy. This
case may draw attention to the fact that screening for EBV in transplant
patients should be considered.
R2361 Procalcitonin in neutropenic patients with sepsis
N. Kmet Lunacek °, M. Lukic, M. Jereb, I. Muzlovic (Ljubljana, SI)
Objectives: Procalcitonin (PCT) concentrations increase in a setting of
systemic bacterial infection and may be used as a marker of the severity
of sepsis. Studies showed that its levels are elevated also in neutropenic
patients with sepsis and can be used as a prognostic factor of febrile
neutropenia. The aim of our retrospective study was to ﬁnd out whether
PCT levels are a prognostic factor for multi-organ failure and mortality
in neutropenic patients with sepsis.
Methods: 57 adult patients admitted to the intensive care unit with a
diagnosis of sepsis participated in this retrospective study. Based on their
absolute neutrophil count the patients were divided into two groups of
27 neutropenic patients and 30 non-neutropenic patients. Neutropenia
was deﬁned as the absolute neutrophil count below 1×109.
Results: The average PCT level in sepsis patients was 15.6 ng/ml
(range 0.08–129 ng/ml) for the neutropenic and 14.6 ng/ml (range 0.08–
161.1 ng/ml) for the non-neutropenic group. This difference was not
signiﬁcant (p = 0.45). In the group of neutropenic patients the average
PCT concentration was higher for those with multi-organ failure than
for those without (21.37 ng/ml vs. 4.67 ng/ml), but the difference was
not signiﬁcant (p = 0.07). Among neutropenic patients who died the
average PCT concentration was 12.9 ng/ml (range 0.29–50.6 ng/ml) and
among survivors it was 18.2 ng/ml (range 0.08–129 ng/ml), however the
difference was not signiﬁcant (p = 0.32).
The group of 11 neutropenic patients with septic shock was further
analysed. Among them there was found to be no signiﬁcant difference in
PCT levels between those who died and survivors (p = 0.07) and between
those with and without multi-organ failure (p = 0.11). When this group
was compared to neutropenic patients without septic shock, however,
they were found to have signiﬁcantly higher values in PCT level (26.4
ng/ml (range 0.42–129 ng/ml) vs. 6.3 ng/ml (range 0.1–36.5 ng/ml),
p< 0.05), mortality rate (69.2% vs. 35%, p< 0.05) and rate of multi-
organ failure (84.6% vs. 35%, p< 0.05).
Conclusion: Our retrospective study conﬁrmed previous ﬁndings that
PCT levels are increased also in neutropenic patients with sepsis. PCT
concentrations in neutropenic and non-neutropenic patients with sepsis
are similar. However, our study shows that increased PCT concentrations
in neutropenic patients with sepsis can be used as a prognostic factor
for septic shock, but not for multi-organ failure and mortality.
R2362 Development of a uniﬁed febrile neutropenia policy for
adult and paediatric haematology/oncology patients
G. Boyd °, N. Young, T. Collyns (Leeds, UK)
Objective: In our paediatric and adult (P&A) haematology/oncology
(H/O) unit in Leeds we treat various groups of patients (young adults,
older teenagers both H/O) forming the Teenage & Young Adult unit
(TYA). We aim to simplify the management of these patients by
unifying 3 policies, deﬁning febrile neutropenia and identifying potential
antimicrobial agents for use as empirical monotherapy aiming for one
FN policy across all 3 groups (P&A&TYA). We collected data relating to
Gram-negative bacteraemias aiming to review the feasibility of a suitable
agent for monotherapy for all 3 patient groups. Certain patients may
need to be managed differently e.g. post allogeneic stem cell transplant
(SCT). We will present this data and our lessons learned in achieving
this important goal of uniﬁcation of policies.
Methods: From our computerised microbiology database we identiﬁed
all Gram-negative bacteraemias in our patient group between February
2008 and May 2009. For each organism we recorded susceptibilities to
7 antimicrobial agents (gentamicin, tobramycin, piperacillin/tazobactam,
aztreonam, ceftazidime, meropenem and ciproﬂoxacin). We recorded the
absolute neutrophil count (ANC) at the time of bacteraemia, diagnosis
and treatment received. Where the isolate was resistant to piperacillin/
tazobactam, we determined the initial antimicrobial therapy prescribed
and subsequent changes made including the reason for change.
Results: We identiﬁed 192 bacteraemias in adult haematology patients
and 54 bacteraemias in paediatric H/O patients. 93 adult patients had
a ANC of <0.1 (48%), with 74 having a ANC of >1 (39%). Of
these isolates 12 (6%) were resistant to piperacillin/tazobactam. In the
paediatric group, 54 bacteraemias were identiﬁed. 24 (44%) had a ANC
of <0.1, with 19 (35%) having a ANC >1. In adult patients who
were post allogeneic stem cell transplant, the incidence of resistance to
piperacillin/tazobactam was higher (15%) as compared to other groups
of patients.
Conclusion: We have shown that the majority of Gram-negative
bacteraemias in P&A&TYA H/O patients occur in either severely
neutropenic patients or patients who are not neutropenic. In the majority
of patients, single agent piperacillin/tazobactam is a suitable agent as
monotherapy. Patients who have undergone allogeneic SCT may need to
be risk stratiﬁed to receive different antimicrobial therapy. A uniﬁed
policy is feasible and we will share the valuable lessons learned in
achieving this goal.
R2363 Infectious complications in children with acute myelogenous
leukaemia in a Mexican hospital: a 5-year analysis
R. Farfan °, M. Perez, M. Nava, M. Caniza (Mexico City, MX;
Memphis, US)
Objective: To know the epidemiology and microbiology of the infectious
complications that the patients with acute myeloid leukemia (AML)
during the treatment in Hospital Infantil De Me´xico (HIM), and this
way to improve the management in these children.
Method: We conducted a retrospective, observational study, and
included all consecutive patients with AML that presented to the hospital
with the diagnosis fever and neutropenia (FAN) from January 2004
through December 2008 in HIM. We collected information regarding
AML treatment phase, type of infections and its severity (septic shock),
number of infections in each patient for each infectious event, number
of infectious events in each patient, infectious agents isolated, site of
isolation and chemotherapy phase, and number of hospitalization days
for infectious events. Descriptive statitistical ana´lisis were done.
Results: Fifty children suffered 164 infectious events. The most frequent
AML type was the M4 in 30%; then M3 and M2 (18%). Average FAN
event per patient were 3.28 (n 1−7). We analyzed 164 infectious events,
32.9% (n = 54) were events of FAN without an identiﬁable focus. Among
the infectious complications; septic shock and colitis were the most
frequent complications with 21.3% (n = 35). Nosocomial pneumonia and
infections related to catheter were 12.8% for both diseases (n = 21); these
pathologies were the second most important; severe sepsis and mucositis
grade II where the third most frequent complications (8.5% n= 14).
A total of 59% (n = 158) of the infectious complications happened in
induction and 40.3% (n = 106) occurred in maintenance. Infections were
clinically and microbiologically documented in 46% (n = 76) of cases.
Coagulase Negative Staphylococcus (CNS) represented the major cause
of septicemia (25%), whereas Escherichia coli were the second pathogen
most frequently isolated from blood 13.6%). Gram-negative bacteria
accounted for 41.8% of all isolates and Gram-positive accounted for
37.5%. Fungal infections were observed in 15.6%.
Conclusions: Our results indicate that the main infectious complications
in AML at HIM were tiphlytis, nosocomial pneumonia, septic shock, and
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community acquired pneumonias. Septic shock was more frequent during
maintenance; the most common pathogens were E. coli, Coagulase
Negative Staphylococcus, P. aeruginosa, S. aureus, S. pneumoniae.
R2364 Are respiratory infections related to immunological and
genetic data in common variable immunodeﬁciency, IgG
subclass deﬁciency and IgA deﬁciency?
L. Mateu °, M.L. Pedro-Botet, M.J. Herrero, E. Ruiz, I. Garcia Olive´,
C. Rey-Joly, M. Sabria` for the CIBERES
Background: Patients with common variable immunodeﬁciency
(CVID), IgG subclass deﬁciency and IgA deﬁciency have clinical
heterogeneity not always related to immunoglobulin concentrations. Few
studies have evaluated the relationship between immunological data and
respiratory tract infections. Genetic or immunological markers combined
with IgG concentrations may be useful to establish the prognosis and
treatment of these patients. We describe clinical, immunological and
genetic variables in patients with CVID, IgG subclass deﬁciency and
IgA deﬁciency and evaluate whether the number of IgM memory B and
dendritic cells and TACI mutations justify the clinical heterogeneity.
Methods: Prospective observational study of patients with CVID, IgG
subclass and IgA deﬁciency from 1989–2008 with descriptive analysis
of clinical, immunological and genetic variables. Two groups were made
according to clinical manifestations: Group 1 with high illness burden;
Group 2 with low illness burden. We compared IgG concentrations, IgM
memory B and dendritic cell count and TACI mutations in both groups
with Fisher statistics.
Results: 20/29 patients were evaluated: 9 CVID, 9 IgG subclassdeﬁ-
ciency, 2 IgA deﬁciency. Recurrent lung infections (85%) were the most
common manifestation. 9 (45%) patients were included in group 1. The
rate of B memory IgM cells <15% and dendritic cell count <5 cells/mL
were signiﬁcantly more frequent in group 1. Mutations encoding for
TACI were only detected in Group 1. The sensitivity and speciﬁcity
of at least 1/3 positive tests to detect patients with high illness burden
were 100% and 90.9%, respectively. There was no signiﬁcant correlation
between IgG< 500mg/dL and illness burden.
Conclusions: Immunological and genetic variables allow better charac-
terization of CVID, IgG subclass and IgA deﬁciency. IgG concentration
alone is not sufﬁcient to predict patient outcome.
R2365 Clinical characteristics and B cell immunology in patients
with functional or anatomic asplenia
C. Theilacker °, M. Rizzi, H. Eibel, W. Kern (Freiburg, DE)
Objective: Asplenia is an immunodeﬁciency that predisposes to life-
threatening infectious complications, also known as overwhelming post-
splenectomy infection (OPSI) with severe sepsis and septic shock
as clinical sequelae. The information from recent studies on clinical
characteristics of asplenic patients and infectious complications in this
cohort are limited. One of the most likely reason for the highly increased
incidence of infections by pneumoocci and other encapsulated bacteria
relates to the function of the spleen as it is the only secondary lymphoid
organ which allows the generation of plasma cells producing antibodies
against bacteria bearing a polysaccharide capsule.
Methods: Since beginning of 2009, all asplenic patients treated
at the University Medical Center Freiburg including those recently
splenectomized have received care by a specialized outpatient clinic
and were followed up prospectively. Patient demographics, comorbidity,
reason for splenectomy, vaccination status and infectious complications
were documented using a structured questionnaire. Pneumococcal
antibodies and B cell phenotype were measured.
Results: During the study period, 23 patients were seen in our outpatient
clinic. The mean age of asplenic patients was 59 (range 19−88). The most
frequent reason for splenectomy was abdominal malignancies (35%),
followed by benign tumors (14%), iatrogenic surgical complications
(12%), trauma (9%) and lymphoma (9%). 4 patients with previous
OPSI were seen. Three of these patients had OPSI due to pneumonia
and one due to meningitis. Complete compliance with current vaccine
recommendations and patient awareness was overall low. Compared to
individuals with intact spleen, asplenic patients had lower marginal zone
B cells.
Conclusions: Follow up of this cohort of asplenic patients offers the
unique possibility to study clinical and immunologic risk factors for
infectious complications prospectively.
Community-acquired infections including
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R2366 Rectal Chlamydia, an underdiagnosed infection in men who
have sex with men
A. Loy °, M. Kelleher, F. Lyons, F. Mulcahy (Dublin, IE)
Objective: To determine the number of rectal Chlamydia (CT) screens
carried out in men who have sex with men (MSM) attending an urban
sexually transmitted infection (STI) clinic between the 1st January 2005
and the 30th of June 2009. Also to determine the prevalence of rectal
CT in the screened population, the indication for screening for rectal
CT, concurrent STI’s and the HIV status of those who tested positive for
rectal CT.
Methods: A retrospective analysis of all STI screens on MSM’s attending
the clinic between 1st of January 2005 and the 30th of June 2009
was carried out. All positive rectal CT samples were identiﬁed and the
medical notes were reviewed to determine the indication for rectal CT
testing, symptoms, HIV status and concurrent STI’s. Rectal swabs had
been tested for Chlamydia using three different assays in the time frame.
From January 2005 to June 2005 Abbott LCR was used. From June
2005 to June 2008 Becton Dickenson ProbeTec CT Assay was used
with positives conﬁrmed by Roche Cobas Amplicor. From June 08 June
2009 Abbott Real time CT PCR assay was used.
Results: A total of 1991 MSM STI screens were carried out. 310 (15.6%)
were tested for rectal CT. Of those tested, 33(10.6%) were positive for
rectal CT. The majority, 22/33 (67%) were asymptomatic. Only 2/33
(6%) had concurrent urethral chlamydia infection. However 32/33 (97%)
had a concurrent STI. 12/33 (36.3%) were HIV positive. There were no
cases of lymphogranuloma venereum.
Conclusion: Our data shows a high rate of rectal CT in the cohort of
MSMs screened, the majority of which were asymptomatic. It identiﬁes
that routine rectal CT screening has not been carried out on this
population, but would now be recommended. We also identiﬁed a high
rate of rectal CT occurring with concurrent STI’s, including HIV.
R2367 Neonatal sepsis in a tertiary care hospital of eastern Nepal:
laboratory perspective of ﬁve years duration
N. Gyawali °, S. Shrestha, N.K. Bhatta (Dharan, NP)
Objectives: Present study was undertaken to determine the prevalence of
bacterial etiological agents associated with neonatal sepsis and pattern in
the antimicrobial susceptibility over the duration of last ﬁve years in BP
Koirala Institute of Health Sciences (BPKIHS), a tertiary care hospital
in eastern Nepal.
Materials and Methods: All the blood culture samples obtained
from suspected cases of neonatal sepsis and submitted to microbiology
department of BPKIHS for culture and sensitivity over the duration
of ﬁve years were included. Isolation, identiﬁcation and antimicrobial
susceptibility testing was done by standard microbiological method.
Results: A total of 39542 blood culture specimens were received in
microbiology laboratory from the year 2005 to 2009 which included
9090(22.98%) samples from the suspected cases of neonatal sepsis.
Fifteen hundred thirty two (16.8%) samples yielded the growth
of bacteria which was slightly higher (22.5%) in the year 2005.
Rate of positivity in the following years ranged from 14.4% to
17%. Common Gram-positive organism isolated were Staphylococcus
aureus 38.5%, followed by CoNS 9.6% and Enterococcus spp 8.9%.
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Whereas Acinetobacter spp (13.5%), Klebsiella pneumoniae (9.9%),
Enterobacter spp (9.3%) remained the most common Gram-negative
organisms.
During the period of 5 years prevalence of S. aureus increased from
28.2% of total culture positivity in 2005 to 53.5% in 2009, similarly
Enterococci raised from 2.5% to 13%. Coagulase negative Staphylococci
declined from 21.7% to 1.2%.Prevalence of other bacteria remained more
or less same during the study period.
Most of the bacteria exhibited resistance to commonly used antimicro-
bials. Methicillin resistant S. aureus(MRSA), Vancomycin intermediate
S aureus (VISA), Vancomycin resistant Enterococci (VRE). High level
gentamicin resistant enterococci (HLGR) and ESBL producing Gram
negative bacilli were found to be emerging specially in later part of the
study.
Conclusion: Neonatal blood stream infection is common in our set up.
Various bacteria were associated as etiological agents. Predominance
of Gram positive cocci was observed.. Resistance to commonly used
antimicrobial is an emerging problem. Continuous monitoring and
rational use of antimicrobial and strict adherence to infection control
practice may prove useful for prevention and spread of antimicrobial
resistance.
R2368 Predictive factors for quinolone resistance in Escherichia coli
strains isolated from men with febrile urinary tract infection
M. Sanchez °, C. Chico, A. Smithson, M.T. Bastida, R. Porron,
L. Fornes, L.M. Sarmiento (Santa Coloma Gramenet, ES)
Background: Most febrile urinary tract infection (FUTI) in men are
acute prostatitis. Although quinolones are the indicated therapy, about
20−30% of our community Escherichia coli (E. coli) strains are
quinolone-resistant (QR). The aim of the study was to assess the risk
factors for QR in males with FUTI.
Methods: This was an ambispective study (January 2008 to October
2009) in which we collected clinical data from 90 males (mean
age 59.7+16.6 years; mean Charlson score 2.7+2.6) with community
acquired FUTI due to E. coli. Inclusion criteria were age >18 years
and clinical symptoms of FUTI (armpit temperature >38ºC, urinary
symptoms) and a positive urine culture to E. coli. Susceptibilities
to pipemidic acid and to ciproﬂoxacin were tested by disk diffusion
techniques. A strain was considered susceptible if the inhibition zone
was below CLSI limit and resistant if otherwise. Statistical analysis was
performed by the chi-square or Fisher exact test. Variables associated
to QR in the univariate analysis were included in a binary logistic
regression analysis with QR as the dependent variable. In the logistic
models, age and Charlson score were analyzed with the median as the
dichotomizing value. Statistical signiﬁcance was deﬁned as a two-tailed
P value of <0.05.
Results: Among E. coli isolates, 26.6% were resistant to pipemidic
acid and 15.5% resistant to ciproﬂoxacin. In the univariate analysis
compared to the quinolone susceptible strains the following variables
were associated with QR: older age (39.4% vs 79.2%; P = 0.01), diabetes
mellitus (DM) (12.1% vs 33.3%; P = 0.029), high Charlson score (51.5%
vs 83.3%; P = 0.006), past urinary tract infection (UTI) (13.6% vs
66.7%; P< 0.001), urinary catheterization (1.5% vs 16.7%; P = 0.017),
urinary tract abnormalities (43.9% vs 70.8%; P = 0.024), recent antibiotic
treatment (9.1% vs 45.8%; P< 0.001) urological manipulation (3% vs
20.8%; P = 0.013) and previous hospitalization (3% vs 16.7%; P = 0.041).
In the logistic model factors that remained associated to QR were DM
(OR 4.78, 95%CI 1.03–22.16, P = 0.045), past UTI (OR 8.15, 95%CI
2.04–32.5, P = 0.003) and recent antibiotic treatment (OR 5.94, 95%CI
1.23–28.76; P = 0.027).
Conclusions: Our study shows that FUTI that occur in males with
DM, past history of urinary infection or recent antibiotic treatment
have a higher risk to be caused by QR E. coli strains and therefore
ﬂuorquinolones are probably not the best therapeutic empirical option in
these patients.
R2369 Clinical outcome of anal HPV-associated cancer in
HIV-infected patients
P. Cellerino, M. Milanesi, R. Beretta, M. Fasolo, G. Orlando ° (Milan, IT)
Objectives: Anal HPV infection and HPV related cancers are
increasing among HIV infected people despite the introduction of
HAART. Screening and treatment strategies are still undeﬁned. In this
retrospective study we investigated the outcome characteristics of 20
HIV infected patients with anal cancer diagnosed at L Sacco University
hospital in the period 1998–2008.
Methods: Clinical, immuno-virological and treatment parameters for
HIV infection and anal cancer were collected from clinical records of 20
HIV infected patients admitted in the II Surgical Unit of our hospital.
HPV DNA tests for high and low risk HPV genotypes was performed
on ﬁxed histological samples.
Results: HIV infection was acquired by sexual route in 70% of the
16 males and 4 females included in this study. At time of anal cancer
diagnosis, 80% of the patients were on-HAART and 4 patients were
off-HAART according to national guidelines for antiretroviral treatment
of HIV infected patients; 13 patients had a previous diagnosis of
AIDS. Median CD4 count was 379.7 cells/microL (range 87–863) and
median viral load 7421.4 copies/mL (range 50–26000). HPV infection
by a combination of high and low risk genotypes was detected on
histological samples in 80% of patients. Combination therapy (radio
and chemotherapy) was performed in 13 patients, 2 patients received
only surgical treatment, 2 patients only radiotherapy and 3 patients only
chemotherapy. Median survival after anal cancer diagnosis was 26.9
months (range 6−69) with 13 patients alive after 12 months of follow
up and 8 patient disease free after 12 months. Survival rate was slightly
higher in patients treated with combination therapy than those treated
with a single intervention.
Conclusions: HIV positive patients remains at high risk of HPV anal
related cancers also in the HAART era. Survival rate is closely related
to the treatment regimen, to the HIV immunovirological parameters ant
to the stage of the disease at time of diagnosis. There is a need of
anal cancer screening programs for HIV infected people for the early
diagnosis and treatment of HPV related anal cancers.
R2370 First report of Helicobacter cinaedi infective endocarditis
N. Matsunaga °, K. Ohkusu, I. Nakamura, K. Koshihara, Y. Takei,
Y. Takada, A. Yamashina, T. Matsumoto (Tokyo, Gifu, JP)
Objective: Helicobacter cinaedi is a Gram-negative spiral rod, and was
initially isolated from homosexual men with proctocolitis. H. cinaedi has
been reported as a causative agent of enteritis, cellulitis, bacteraemia,
arthritis, and meningitis. We experienced a case of infective endocarditis
(IE) due to H. cinaedi infection, which has not been reported previously.
Case report: A 71-year-old female with end-stage renal disease on
haemodialysis, aortic valve stenosis, abdominal aortic aneurysm was
transferred from a haemodialysis clinic because of low-grade fever for
5 days and elevated C-reactive-protein (CRP) levels for 10 days. On
admission, the patient complained of fatigue, WBC was 9.6×109/L,
and CRP was 150mg/L. Transthoracic echocardiogram showed a 8mm
vegetation on the tricuspid valve. Vancomycin was started empirically.
On day 12 a Gram-negative spiral rod was recovered from blood cultures
collected on the day of admission and day 2. The antibiotic was
switched to ceftriaxone 2g once daily and gentamicin 80mg after every
haemodialysis for empirical coverage of Campylobacter fetus, a Gram-
negative spiral rod known as a cause of IE. The organism grew on a
blood agar at microaerophilic condition at 35 degrees Celsius but could
not be identiﬁed at that time. Despite the administration of the antibiotics,
fatigue and the level of CRP did not improve, ESR was elevated from
35 to 54mm/hr, and the size of vegetation was increased to 17mm.
The isolate was analyzed by polymerase chain reaction (PCR) using
16S rDNA universal bacterial primers and gyrB gene-based H. cinaedi
speciﬁc primers, and was concluded to be H. cinaedi. Based on this
result, the antibiotic regimen was switched on day 32 to intravenous
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ampicillin 2g once daily and gentamicin 80mg after every haemodialysis.
The levels of ESR and CRP 28 days after the commencement of the
new regimen were decreased to 12mm/hr and 7mg/L, respectively. The
size of vegetation was decreased to 3mm, and eventually disappeared
with no obvious embolic events. The new regimen of antibiotics was
administered for 42 days and the patient was discharged.
Conclusion: To our knowledge this is the ﬁrst report of H. cinaedi
IE. The patient was initially covered for Campylobacter fetus, which is
known as a Gram-negative spiral rod causing IE. PCR analysis guided
the correct diagnosis of H. cinaedi IE and the appropriate treatment.
Six weeks course of ampicillin and gentamicin was effective against
H. cinaedi IE.
R2371 Emergence of vancomycin intermediate resistance in
community-acquired methicillin-resistant Staphylococcus
aureus
E. Tzampaz °, E. Protonotariou, C. Antachopoulos, G. Meletis,
E. Roilides, D. Soﬁanou (Thessaloniki, GR)
Objectives: Community-acquired methicillin-resistant Staphylococcus
aureus (CA-MRSA) is well recognised as an important pathogen that
causes predominantly skin and soft-tissue infections and infrequently
life-threatening infections, mostly among children. Vancomycin (VA) is
the drug of choice for the treatment of these infections. We describe
the isolation of a CA-MRSA with intermediate resistance to VA from a
4-year old girl admitted to the hospital with sepsis and severe multifocal
infections including pericarditis, pleural effusions, septic arthritis and
osteomyelitis. She was initially treated with combination of VA and
clindamycin and had a long complicated course.
Methods: Three CA-MRSA strains were isolated from blood, wound
and pericardial pus. Bacterial identiﬁcation and initial susceptibility
testing was performed with the VITEK2 automated system. MICs of van-
comycin, teicoplanin, erythromycin, clindamycin, daptomycin, linezolid
and tigecycline were determined by E-test. All isolates were subjected
to PCR in order to identify the presence of Staphylococcal Cassette
Chromosome type IV (SCCmecIV), Panton-Valentine leukocidin (PVL)
and Van A and B genes.
Results: Susceptibility testing results demonstrated that two isolates
had intermediate susceptibility to VA (MIC, 3mg/L). All three were
susceptible to erythromycin, clindamycin (both MIC, 0.25mg/L),
teicoplanin (MIC, 1−1.5mg/L), daptomycin (MIC, 0.19–0.25mg/L),
linezolid (MIC, 2mg/L) and tigecycline (MIC, 0.25–0.38mg/L).
According to the updated CLSI and EUCAST interpretive criteria the
isolates recovered from blood and wound ﬂuid are considered as VISA.
All isolates carried SCCmecIV and PVL genes. No isolate was positive
for Van genes.
Conclusions: The emergence of VISA in CA-MRSA is of great
concern. These isolates are not easily detected with routine laboratory
antimicrobial testing. As outcome of severe staphylococcal infections
depends on the rapid and appropriate therapy, investigation for the
presence of VISA in cases of CA-MRSA infections is warranted.
R2372 Clinical characteristics and treatment of prostatic abscess
in Korea
E. Lee °, T. Kim, E. Choo, M. Jeon (Seoul, Bucheon, Cheonan, KR)
Objectives: Prostatic abscess can cause signiﬁcant morbidity and
mortality in elderly patients usually with diabetes mellitus. But little
is known concerning the epidemiology of prostatic abscess because of
it’s low incidence. We evaluated the pathogen, clinical characteristics and
treatment associated with prostatic abscess in Korea.
Methods: This descriptive study was based on a retrospective review of
clinical records from January, 1985 to October, 2009 at 3 university
hospitals in Korea. Diagnosis of prostatic abscess was based on
enlarged gland with ring enhancement lesions on computed tomography,
hypoechoic area with thick walls on transrectal ultrasound, or pathologic
ﬁndings.
Results: Were identiﬁed 31 patients. Most of patients were elderly
(mean age 63±11.86). Underlying conditions included diabetes mellitus
(15/31, 48%), hypertension (12/31, 39%), benign prostatic hypertrophy
(11/31, 35%) and stroke (4/31, 13%). The common symptoms were
fever (14/31, 45%) and dysuria (14/31, 45%). Pyuria was found in 27
(87%) patients. Serum level of prostate-speciﬁc antigen were determined
in 26 (84%, mean 10.76 ng/ml±16.16) patients and were elevated
in 14 (54%) of these patients. Initial digital rectal examination were
performed in 9 (29%) patients. The prominent ﬁnding was tenderness
(3, 33%). Causative pathogens (Table1) isolated from blood (8/24),
urine (15/31) or prostate aspiration (5/7) were K. pneumoniae (8/19,
42%), E. coli (5/19, 26%), P. aeruginosa (3/19, 16%), P. mirabilis (1/19,
5%) and MSSA (2/19, 11%). Fourteen patients had undergone invasive
procedures, including transurethral resection of the prostate(12/31, 39%),
transrectal needle aspiration (2/31, 6%). All patients were cured.
Conclusions: K. penumoniae is the major pathogen of prostatic abscess
in Korea. Prostatic abscess should be considered in old patients with
unexplained fever and nonspeciﬁc urinary symptoms.
Table 1. Bacterial isolates and treatment of 31 patients with prostatic
abscess





1 K. pneumoniae NG ND CT TURP Ciproﬂoxacin (28)
2 NG E. coli ND CT, TRUS ND Ciproﬂoxacin (54)
3 NG K. pneumoniae ND CT ND Ciproﬂoxacin (24)
4 K. pneumoniae K. pneumoniae ND CT ND Ciproﬂoxacin (23)
5 E. coli NG K. oxytoca CT TURP Ceftriaxone (14)
6 NG ND ND TRUS TURP Cefotiam (27)
7 K. pneumoniae K. pneumoniae ND CT ND Ciproﬂoxacin (26)
8 P. mirabilis P. mirabilis ND CT ND Meropenem (55)
9 K. pneumoniae K. pneumoniae ND CT ND Ciproﬂoxacin (61)
10 K. pneumoniae K. pneumoniae ND CT ND Ceftriaxone (43)
11 NG ND ND TRUS ND Levoﬂoxacin (9)
12 NG ND ND TRUS ND Cefotaxime (9)
13 P. aeruginosa NG ND TRUS ND Levoﬂoxacin (48)
14 K. pneumoniae NG ND TRUS ND Ciproﬂoxacin (22)
15 NG NG ND CT ND Ciproﬂoxacin (21)
16 NG NG K. pneumoniae CT TURP Levoﬂoxacin (23)
17 NG ND ND TRUS ND Ampicillin+AG (13)
18 P. aeruginosa ND ND TRUS ND Cefomenoxime (6)
19 NG ND ND TRUS ND Cefuroxime (28)
20 P. aeruginosa ND ND CT, TRUS TRNA, TURP Ceftazidime+AG (34)
21 NG ND E. coli, MRSA TRUS TRNA Vancomycin+AG (11)
22 NG NG ND TRUS ND Ceftriaxone+AG (9)
23 P. aeruginosa NG ND CT TURP Levoﬂoxacin (7)
24 NG NG ND CT ND Levoﬂoxacin (15)
25 MSSA MSSA MSSA CT TURP Levoﬂoxacin (17)
26 E. coli NG ND CT TURP Ceftriaxone +
metronidazole (16)
27 NG NG K. pneumoniae CT TURP Moxiﬂoxacin (30)
28 NG NG ND CT ND Levoﬂoxacin (29)
29 NG NG ND CT TURP Ciproﬂoxacin (58)
30 MSSA ND ND CT TURP Levoﬂoxacin (57)
ND: not done. NG: no growth. TRUS: transrectal ultrasound. CT: computed tomography. TRNA: transrectal needle
aspiration. TURP: transurethral resection of the prostate. MSSA: methicillin sensitive S. aureus. MRSA: methicillin
resistant S. aureus. AG: Aminoglycoside.
R2373 Brucellar spondylitis: review of 22 cases
S. Alp-Cavus, Z. Karlibas, Z. Kuruuzum, A. Yuce ° (Izmir, TR)
Objectives: Osteoarticular disease is the most common complication of
brucellosis, and spondylitis is the most prevalent and important clinical
form of osteoarticular involvement in adults with infections due to
Brucella species. This study was carried out to describe the demographic,
clinical, laboratory ﬁndings and treatment modalities of patients with
brucellar spondylitis.
Methods: The clinical and laboratory characteristics of 22 patients
with brucellar spondylitis followed in our clinic between January 2005
and October 2009 were evaluated retrospectively. The diagnosis was
established on the basis of standard tube agglutination titre of 1/160
of antibodies for brucellosis and/or positive blood sample cultures. The
diagnosis of spondylitis was based on clinical symptoms conﬁrmed by
Magnetic Resonance Imaging.
Results: In the study period, 64 patients were diagnosed as brucellosis.
Twenty-two patients had spondylitis (%50 male). The mean age was
58.64±14.42 (17−81). All patients except one were over the age of
40. Nearly half of patients (45%) were over the age of 60. Acute,
subacute and chronic forms of infection’s rates were 36.4%, 59.1% and
4.5%, respectively. Severe back pain (100%), fever (63.6%), weight loss
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(63.6%) were the most common clinical symptoms. Lumbar vertebrae
were the most frequently involved regions (54.5%). Thoracolumbar,
thoracal and cervical involment were seen in the 4, 4, and 2 patients,
respectively. Spinal epidural abscess was found seven cases (31.8%).
One patient had a psoas abscess. Standart tube agglutination test was
positive (1/160) in 68.2% of the patients. Total culture positivity was
45.5% (blood 8, abscess specimen 2). Three patients underwent surgical
intervention for diagnostic purposes. Other three patients required
surgical treatment for vertebral stabilization. Nineteen patients (86.4%)
received a combination of gentamycine (3mg/kg/day for the initial 14
days) plus doxycycline (100mg bid), and rifampicine (600mg/day).
Two patients received doxycycline plus rifampicine, one patient received
doxycycline plus streptomycin. Duration of therapy varied according to
clinical response and the presence of epidural and psoas abscess. The
shortest duration of treatment was three months.
Conclusion: Brucellosis should be included in the differential diagnosis
of back pain especially in the countries such as Turkey where this
infection is endemic.
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R2374 Epidemiological and clinical characteristics of inﬂuenza A
(H1N1) V infection in Isfahan, Iran, July–October 2009
A. Babak °, E. Akhtar, R. Fadaei Nobari (Isfahan, IR)
Objectives: Following the declaration by the World Health Organization
(WHO) of human cases of infection with a new inﬂuenza A (H1N1)
virus, the Iranian Ministry of Health (MoH) launched a system to
monitor and report the presence of this new virus on 10 May 2009. Here
we report the conﬁrmed cases of this new virus identiﬁed in Isfahan, a
province in Iran.
Methods: In a laboratory-based reporting system, the Provincial Health
Centers were supplied by the MoH with case deﬁnition and patient
information forms to be disseminated to all health care institutions in
their province. Any person who fulﬁlled the case deﬁnition criteria was
directed to one of the three designated health facilities that were prepared
to receive suspected cases. The nasopharyngeal samples were sent to
the National Inﬂuenza Reference Laboratory at Tehran school of Public
Health in a viral transport medium (virocult, Medical wire & Equipment,
UK) and were tested with the real time RT-PCR protocol and reagents
supplied by the WHO.
Results: A total of 376 samples were taken from suspected cases between
1 July and 21 October 2009.50 from these samples were positive for
inﬂuenza A (H1N1). The date of symptoms onset of the ﬁrst conﬁrmed
case of pandemic H1N1 inﬂuenza was 13 July 2009. She had traveled
to Mecca (Saudi Arabia) and had already become symptomatic while
staying there. 58% of the cases were female. The median age was 27
years (range: 10−75 years). The majority of cases (34%) were from 25
to 29 years old. 9 of them (18%) were hospitalized. 58% of the patients
had a travel history to other affected areas. Most travel-associated cases
had been returning travelers from Saudi Arabia (55.2%), followed by
Malaysia (17.24%).12.24% had close-contact with other patients. The
Median duration between developing symptoms and referring to health
centers was 3 days (range: 0−9 days). Fever was the most common
symptom, presented in 95.9% of the cases, followed by cough (85.7%)
and myalgia (77.5%). One death was reported.
Conclusion: Inﬂuenza A (H1N1) v entered Isfahan through travelers,
mainly coming from Saudi Arabia. The Majority of the conﬁrmed cases
consisted of young adults as reported from other countries. They mainly
manifested clinical symptoms were similar to those reported in other
areas. Because of many patients with inﬂuenza like symptoms may
not visit the physicians, it is possible that the cases have been under
diagnosed.
R2375 Clinical manifestations of Lyme borreliosis in Bulgaria −
comparison with tick studies
I. Trifonova °, I. Christova, T. Gladnishka, E. Taseva, V. Ivanova (Soﬁa,
BG)
Objectives: Lyme borreliosis is endemic in Bulgaria. About 1000 cases
are ofﬁcially reported every year giving an incidence of 12/100,000.
Methods: Using ELISA with recombinant B. burgdorferi antigens, a
total of 1257 patients were diagnosed.
Results: The main part of them (857/68.2%) presented with erythema
migrans. The second most common clinical manifestation was neu-
roborreliosis, detected in 239 (19%) of the patients − radiculoneuritis,
cranial neuritis, encephalopathy, meningoradiculoneuritis and myelitis
were found in 13.7%, 2.3%, 1.8%, 0.9% and 0.3% of the patients
resp. Lyme arthritis was much less common − found in only 101 (8%)
of the patients, followed by heart and ocular manifestations, borrelial
lymphocytoma and acrodermatitis chronica atrophicans. Borrelia garinii
is the species most frequently associated with neuroborreliosis. On
the contrary, when 202 Bulgarian Ixodes ricinus ticks collected from
vegetation were examined by PCR for infection with different Borrelia
species, Borrelia afzelii but not B. garinii was found to be predominant,
found in 17% of the ticks, followed by B. burgdorferi sensu stricto
(5.4%), B. garinii (1.8%), B. valaisiana (1.8%), and B. lusitaniae (0.9%).
Conclusion: To what extent this discrepancy could be due to a higher
pathogenic potential of B. garinii or to variations in host susceptibility
remains to be determined.
R2376 Evaluation of H1N1 pandemic inﬂuenza cases hospitalized
in an infectious diseases clinic
E. Akinci, B.U. Kayaaslan, M.A. Yetkin °, S. Yilmaz, D. Aliravci, S. Yildiz,
F. Ulgen, S.S. Eren, A. But, G.R. Yilmaz, H. Bodur (Ankara, TR)
Objective: The H1N1 pandemic inﬂuenza virus is a new inﬂuenza virus
causing illness in people. This virus was ﬁrst detected in Mexico in April
2009. It is spreading from person-to-person worldwide. In Turkey, the
number of cases is increasing day by day and 73 patients died until 16th
October.
Methods: In this prospective study, H1N1 pandemic inﬂuenza cases
hospitalized in our clinic between October and November 2009 were
evaluated. During this period, totally 85 patients having severe disease
were hospitalized with suspicion of H1N1 pandemic inﬂuenza. Of these
patients, 40 had positive nasopharyngeal swab specimen for H1N1 virus
by PCR test.
Table 1: Risk factors for development of pneumonia in H1N1 pandemic
inﬂuenza







Female gender 21 (80.8%) 9 (64.3%) 0.220
Pregnancy 8 (38.1%) 4 (44.4%) 0.528
Underlying disease 6 (22.9%) 6 (42.9%) 0.047
Initiation of oseltamivir in 48 h 13 (50%) 9 (64.3%) 0.386
Hyperglycemia 1 (5.3%) 7 (50%) 0.005
Results: The age range of the H1N1 cases were between 17−77 years
and 30 (75%) were female. Twelve (40%) patients were pregnant.
Underlying disease was present in 12 (30%) patients. Fifteen patients
(38%) had history of contact with H1N1 positive people. At the
admission, the duration of complaints was between 1−10 days. The
most frequent complaints were fever (90%), myalgia (90%), cough
(85%), headache (85%) and sore throat (75%). Physical examination
revealed fever (85%), oropharingeal hyperemia (60%), shortness of
breath (18%) and crepitan rales (28%) on lung auscultation. In laboratory
tests, leucopenia (20%), thrombocytopenia (15%), elevation of liver
enzymes (18%), and hyperglycemia (24%) were detected. Most of the
patients (80%) were treated with oseltamivir and 55% were given the
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treatment in the ﬁrst 48 hours. The only complication of H1N1 infection
was pneumonia. Pneumonia was detected in 35% of the patients and
60% were administered antibiotics. Two patients needed mechanical
ventilation and one died. The risk factors for development of pneumonia
during H1N1 pandemic inﬂuenza infection are shown in table 1.
Conclusion: Pneumonia is the most important complication of H1N1
pandemic inﬂuenza and the risk is high in the patients with
hyperglycemia or an underlying disease.
R2377 Lyme borreliosis in the United Kingdom: trends and travel
R.M. Smith, S. O’Connell ° (Cardiff, Southampton, UK)
Lyme borreliosis (LB) is not notiﬁable under general public health
legislation in England and Wales. Case ascertainment is based on
voluntary reports to the Health Protection Agency’s Centre for Infections
(CfI), supplemented by direct reporting from the HPA Lyme Borreliosis
Unit. Laboratory-conﬁrmed cases of LB in England and Wales have
increased year-on-year with 813 cases identiﬁed in 2008 (1.52/100,000
total population, including cases known to have been acquired overseas).
The age, sex and seasonal distributions of serologically conﬁrmed cases
in 2008 were similar to those seen in previous years. Tick bites were
reported by 342 (42%) patients and erythema migrans by 268 (35%)
patients. Neuroborreliosis was identiﬁed in 83 (10%) patients, of whom
43 (43/83) (52%) had a facial palsy. Arthritis was identiﬁed as a clinical
presentation in 10 (1.2%) patients. No clinical details were available for
350 (43%) patients.
LB occurs only in people who have been bitten by an infected ixodid
tick, the vector host. Peak feeding times for tick blood meals are late
spring, early summer and autumn, coinciding with peak periods for many
countryside leisure activities at home and, increasingly, abroad. Over half
of all patients undergo serological testing in the months of July, August
and September; representing a likely peak onset of symptoms in the early
summer months.
Popular UK holiday destinations such as Exmoor, the New Forest, the
Lake District, the Yorkshire moors and the Highlands and Islands of
Scotland, are areas where ticks are abundant and from where cases of LB
are often reported. Cases are not conﬁned exclusively to these regions,
but any area, large or small, which provides suitable environmental
conditions for Ixodes ricinus and their bird and small mammal hosts,
may be a local LB focus.
In recent years, there has been a signiﬁcant rise in the number of
infections acquired overseas (15−20% annually), especially in North
America, France, Germany, Austria, Italy, Hungary, Poland, Slovenia,
Bulgaria, Slovakia, Croatia, Romania, Scandinavia and the Baltic
republics. These are all countries which have been identiﬁed in case-
reports from England and Wales residents, a signiﬁcant proportion of
whom were on activity holidays such as walking, trekking or mountain
biking. Some travel-associated cases occurred in migrants from other
European countries who acquired infections prior to moving to the UK
or during holidays in their home countries.
Antimicrobial clinical trials
R2378 Efﬁcacy and safety of linezolid compared with vancomycin
for treatment of methicillin-resistant Staphylococcus aureus
complicated skin and skin structure infections in patients
from long-term care facilities
D.R. Luke, A. Reisman, B. Capitano, D.B. Huang ° (New York, US)
Objective: The long-term care facility (LTCF) patient presents unique
challenges for the treatment of complicated skin and skin structure
infections (cSSSI). The objective of the present analysis was to examine
the efﬁcacy and safety of linezolid (LZD) versus vancomycin (VAN) in
LTCF compared with non-LTCF patients with culture-proven methicillin-
resistant Staphylococcus aureus (MRSA) cSSSI.
Methods: Data from a multicentre, prospective clinical study were
evaluated based upon origin of the patients from LTCF compared
with non-LTCF. Patients received either LZD 600mg PO/IV every
12 h or VAN 15mg/kg every 12 h with doses adjusted for creatinine
clearance. Clinical efﬁcacy was evaluated in the modiﬁed intent-to-treat
(mITT) population, which required a baseline culture-proven diagnosis
of MRSA. Safety was assessed from the intent-to-treat (ITT) population.
Results: Nineteen of the 640 mITT patients presented with MRSA cSSSI
from LTCF: 10 and 9 randomised to LZD and VAN, respectively. Average
age was 75 y compared with 49 y from non-LTCF. Surgical wound
infections were the most frequent cSSSI in LTCF whereas abscesses
were most frequent in non-LTCF. Duration of treatment was 1.5 d
less for LZD compared with VAN (7.8 d vs 9.4 d) in LTCF patients.
Clinical and microbiological outcomes at end-of-study (EOS) are shown
in the table below. Twenty-ﬁve of the 1052 ITT patients presented with
MRSA and were evaluated for safety. Two of 16 LZD patients reported
treatment-related adverse events (TRAE) of nausea; both cases were
mild in severity. No TRAE were reported in the VAN group (n = 9). In
non-LTCF patients, 24% reported TRAE, independent of treatment.
Conclusion: The percentage of TRAE was numerically lower among
MRSA cSSSI LTCF patients compared with non-LTCF patients. The
clinical success rate was also numerically lower among LTCF patients
treated with both LZD and VAN; however, the numbers in the LTCF
group are small. Further research needs to be completed to conﬁrm
these pilot data in this critically important patient population.
Table: Clinical and microbiological success rates at EOS
LTCF Non-LTCF
Treatment LZD VAN LZD VAN
Clinical success (%) 50a 62.5 81.7b 74
Microbiological success (%) 50a 62.5 74.3b 66.2
aNS; bP< 0.05.
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R2379 Improving clinical quality and patient safety in cystic
ﬁbrosis paediatric patients: ﬁrst multidisciplinary clinical
audit at a large district hospital of northwest England
E. Chong, S.C. See, R. Sharma °, A. Guleri (Blackburn, Blackpool, UK)
Cystic ﬁbrosis (CF) is a multisystem disorder with pulmonary disease
the leading cause of morbidity and mortality. Royal Blackburn
hospital in northwest England has a large paediatric CFunit. Prelim-
inary to proposing an integrated care pathway for management of
CF − a multidisciplinary clinical audit was undertaken. Standards
were recommendations of cystic ﬁbrosis trust consensus (CFTC)
[www.cftrust.org.uk].
Methods: Between Jan-Dec 2008, clinical data and laboratory database
on 24 CF patients was audited. Information on demographics, screening,
testing protocols, reporting and management of these patients was
obtained and compared against guidance from CFTC. The data speciﬁc
to Pseudomonas aeruginosa [PSA], MRSA and Burkholderia cepacia
complex [Bcc] is presented here.
Results: 24 paediatric patients aged 1−17yrs [male − 37.5% and female
62.5%] were included in this audit. Data on PSA, MRSA and BCC
is presented here. 33 − organism were isolated [PSA − 36% (12/33);
MRSA − 9% (3/33) and BCC − 6% (2/33)]. Respiratory samples must be
screened every 2-months − a compliance of 71% (17/24) was observed.
All new isolated of BCC and PSA must be sent to a reference laboratory
for genotyping − 100% compliance with BCC and 100% non-compliance
with PSA was noted.
Absolute compliance was noted for use of a combination of nebulised
colistin and oral ciproﬂoxacin for 3-weeks for new isolates of PSA. The
standard has no ﬁrm consensus on screening from non-respiratory sites
or eradication of MRSA. Compliance to screening of non-respiratory
sites [nose and groin] as per local policy remains variable; however cough
swabs and/or sputum are collected on every visit [100% compliance].
IV teicoplanin or vancomycin is used locally for eradication.
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62.5% compliance to a turn-around-time of 72-hours was achieved while
the average time to reporting of samples was 77.6-hours. Signiﬁcant non
compliance was observed in local standard operating procedures [SOP]
for processing of samples from cystic patients [to be presented].
Conclusions: CF is one of UK’s most common life-threatening inherited
diseases. A multi-disciplinary team initiated integrated care pathway
for enhancing clinical quality and patient safety was envisaged. Results
from this audit have been used to draw up an action plan. Signiﬁcant
non-compliance were observed with laboratory SOPs; screening of non-
respiratory sites for MRSA; referring new PSA isolates for genotyping.
Details of result to be presented.
R2380 Human metapneumovirus and human bocavirus infections
among children in Russia
I.S. Kozulina °, E.I. Isaeva, G.A. Samsygina (Moscow, RU)
Objective: to determine the role of HMPV and HBoV in pattern
respiratory illnesses among children in Russia.
Methods: 2826 children in the age from 1 month to 15 years hospitalized
with upper and lower respiratory tract illnesses in children’s hospitals of
Moscow city were examined for 2004–2009. Virological diagnosis was
made with a polymerase chain reaction on specimens obtained from
nasopharyngeal washing (primers got from Gen-Bank).
Results: HMPV was identiﬁed in 340 of 2826 children (12.0%) and
HBoV in 306 of 2189 children (14.0%). Detection frequency of these
viruses ﬂuctuated during different years of investigation from 8.3% till
14.2% for HMPV and from 9.6% till 17.0% for HBoV. The presence of
viruses in population was registered during all calendar year. The highest
detection of these viruses was occurred between March and June, and
between September and December.
A majority of children who was positive for HMPV were aged <12
months and for HBoV were aged from 1 to 3 years.
New viruses were detected in patients with both upper and lower
respiratory tract illnesses. HMPV was associated predominately with
pneumonia (29%), bronchitis (29%), bronchiolitis (16.7%), croup (14%),
and, and HBoV − with croup (19%).
Clinical symptoms of HMPV infection such as rhinorrhea, cough,
wheezing and fever are similar to those of respiratory syncitial viral
infection. The most severe course was observed among children aged up
to 6 months. The duration of HMPV infection was 3−20 days.
HBoV infection is clinically similar to typical acute respiratory viral
infections, however, in the most cases it resulted in obstructive syndrome
evolution and was frequently characterized by dyspepsia. The duration
of HBoV infection was 3−16 days.
Conclusions: HMPV and HBoV are the important cause of acute
respiratory infections in hospitalized children in Russia. HMPV and
HBoV circulate in Moscow (Russia) during all calendar year and have
seasonal peaks. Morbidity peak of these viral infections is observed twice
a year. These viruses are more frequently detected among children aged
up to 3 years. HMPV and HBoV are associated with both upper and
lower respiratory tract illnesses, but HMPV is mainly associated with
pneumonia and bronchitis, and HBoV − with croup.
R2381 Prevalence of urinary tract infections in neonates
L. Hernandez, J. Diaz de Tuesta, J. Sanchez, R. Cisterna ° (Bilbao, ES)
Objectives: Describe the prevalence of urinary tract infections and
distribution of common pathogens in neonates in our hospital.
Methods: Retrospective study of urinary tract infections in neonates
from January 2004 to October 2009.
Results: We analyzed all the urine cultures from neonatal units
and neonatal emergencies. The total samples were 699, of which
464 (66.40%) from neonates admitted and 235 (33.60%) of out-
patients. In-patients 589 (84.30%) samples were negatives with positives
87 (12.40%) and urine contaminated 21 (3%). Samples represented the
385 (55.10%) were obtained by suprapubic puncture urine by catheter
217 (31%), urinary catheterization in patients 10 (1.40%), pediatric bag
12 (1.70%) and spontaneous voiding urine 75 (10.70%). The distribution
of UTI by gender, showed that the positive results were more common in
males (55.70% vs 44.30%, p< 0.01). Considering the age of the patients,
we have seen that are more frequent in infants under 15 days ( 69.8%).
The most common organism was E. coli (63.20%) followed by E. faecalis
(10.30%), E. faecium (4.60%), K. pneumoniae (4.60%), and followed by
a smaller percentage for P. mirabillis (2.30%), S. epidermidis (2.30%),
E. cloacae, (2.30%). E. aerogenes (1.10%), C. albicans (1.10%),
M. morganii (1.10%) S. agalactiae (1.10%), ESBL E. coli (1.10%)
and BLEA K. pneumoniae (1.10%). In 90% of patients, treatment was
used intravenous ampicillin and cefotaxime. In the 7 patients in whom
bacteremia was detected had a history of prematurity and abnormal
urinary passages, still causing Gram negative bacilli, E. coli being the
most frequent, followed by K. pneumoniae (p< 0.01).
Conclusion: In our hospital, (1) urinary tract infections in infants
are more common in males and under 15 days. (2) The predominant
organism in the etiology of urinary tract infections in infants remain
Gram-negative bacilli, E. coli being the most frequent, followed by
Enterococcus. (3) It is conﬁrmed that prematurity and abnormalities in
nephrourological via are risk factors for urinary infection.
R2382 Bacillus pumilus bacteraemia in a term neonate
M. Papadopoulou, M. Kimouli, N. Rekliti, A. Konstantinidi,
S. Tadros, V. Souniadis, O. Dedousi, C. Trompoukis °, D. Petropoulou,
I. Lambadaridis, A. Gounaris (Athens, GR)
Objectives: Despite the widespread distribution of Bacillus spp (aerobic
spore-forming rods) in nature, they rarely cause infection. They can be
pathogenic in immunocompromised hosts. We report for the ﬁrst time a
case of bacillus pumilus bacteremia in a term neonate in Greece.
Methods: A female neonate, 38 wks of gestation, weighting 3390 g was
born by caesarean section and Apgar Score at 1′ − 7 and at 5′ − 8, was
admitted to the NICU, with abdominal distention and gastric residue.
At day 2, milk was commenced, which she tolerated well. On the 8th
day, she looked unwell, became lethargic, and hypotonic. Her condition
deteriorated and required Dopamine and FFP transfusion.
Results: A full septic screen was carried out. Total leukocyte count
20,180/mm (neutrophils − 89%, lymphocytes − 6%, monocytes − 5%),
Hb − 12 g/dl, Hct − 36%, PLT − 28,000/mm, CRP − 120mg/L. Chest
radiograph was normal. Blood culture grew a motile Gram positive rod
and the identiﬁcation with API 50 CHB (bioMe´rieux, France) show
bacillus pumilus which was reported as a contaminate. The organism was
susceptible to penicilline, vancomycin, trimethoprim/sulfomethoxazole,
erythromycin, chloramphenicol, tetracycline, ciproﬂoxacin, cefalothin,
gentamycin, rifambicine with the disc diffussion and Etest method
according to the CLSI guidelines. Urine culture was negative. CSF study
was negative. Blood culture repeated two days latter continued to grow
the same organism. By now, it was apparent that the isolate could not be
considered a contaminant. Vancomycin − cefotaxime were started, based
on susceptibility pattern. There was clinical and laboratory response to
the antibiotics, which she received for a total of 10 days.
Conclusion: Despite the presence of Bacillus spp. in air, soil and
dust these organisms have rarely been implicated in human disease.
Predisposing risk factors include prematurely, mechanical ventilation
and indwelling catheters. We describe a rare case of bacillus pumilus
bacteremia in a term neonate with no predisposing factors.
R2383 Meningococcal sepsis in children − a 15-year review
R. Nemescu °, D. Mihalache, C. Dorobat (Iasi, RO)
Meningococcal sepsis (meningococcaemia) is a rare disease that affects
primarily the paediatric population. Because of its rapid onset and
devastating consequences it represents an important paediatric health
concern.
Objectives: To assess the epidemiologic features, clinical presentation,
bacteriological and therapeutic ﬁndings and outcome in children with
meningococcal sepsis admitted to the Hospital of Infectious Diseases of
Iasi during the last 15 years.
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Methods: Retrospective study including all children aged 18 years,
with meningococcaemia, hospitalised in our clinic from 1994 through
2008.
Results: We found 311 cases with invasive meningococcal disease
treated in last 15 years. Clinically, 61 of patients with age 18 years
presented with meningococcaemia (95% from all sepsis cases). Yearly
incidence was about 4 cases (range, 0−7) and 61% of patients were
from rural communities. Peak incidence (69%) was recorded in the late
winter and early spring months. More than half of the cases (77%)
occurred in the ﬁrst three years of life and median age of patients was
2 years. Clinical condition at admission, included after a sudden onset,
manifestations such as: fever (38ºC) (57%), petechial rash (100%),
hypotension (54%), meningitis (43%), respiratory failure (16.4%), septic
arthritis (3.3%). The blood culture was positive in 35% of the patients
(16 from 45). Microbiological conﬁrmation was also based on direct
microscopic examination after Gram staining (28% positive), culture
(23% positive), and detection of soluble antigens in cerebrospinal ﬂuid
(42% positive from 14 cases). Serogrouping was available only to 25%
of the patients, the most frequent being group B (67%) of 15 patients.
The clinical form was severe in 26 cases (43%). Unfavourable outcomes
occurred in 22 of 61 patients, all with purpura fulminans. Death
appeared at around 17 hours from admission, by endotoxic shock and
disseminated intravascular coagulation (mortality rate of 36%). Among
survivors, one patient had gangrene. Only 46% of all cases were treated
before admission, 89% of them receiving preadmission blactamins. The
treatment was based upon penicillin G (68%). All isolates were sensitive
to penicillin. The average duration of antibiotic therapy was 5.9±4.3 days
(m±SD). In all cases, we administrated cortisone therapy.
Conclusion: Prompt recognition of the signs and symptoms of the
disease and aggressive treatment remain the mainstay of survival in
meningococcaemia.
R2384 Antimicrobial susceptibility of invasive Streptococcus
pneumoniae isolates from children in Athens, 2003–2008
M. Matsas, G. Kalogeras, G. Antonaki, M. Papadimitriou, E. Lebessi °,
M. Foustoukou, K. Kallergi (Athens, GR)
Objectives: To investigate the resistance patterns of S. pneumoniae
isolates from patients with invasive pneumococcal disease (IPD),
hospitalized at “P.&A. Kyriakou” Children’s Hospital during a six-year
period (Jan 2003 to Dec 2008).
Methods: Invasive isolates were reviewed using the laboratory
archives and the patient charts. Susceptibility to penicillin (PN),
cefotaxime (CTX), erythromycin (ER), clindamycin (CL), trimethoprim-
sulfamethoxazole (SXT), tetracycline (TE), rifampin (RF), chloram-
phenicol (C), vancomycin (VAN), oﬂoxacin (OFL) was tested using
the disk diffusion method, following the CLSI guidelines. MICs to PN,
amoxicillin (AMX) and CTX were determined using Etest.
Results: During the study period, 126 invasive pneumococcal isolates
(IP) were identiﬁed (114 blood, 9 CSF, 3 pleural ﬂuid). Yearly
distribution of IP from 2003 to 2008 was as follows: 30, 20, 21, 20,
20, 15. Susceptible to all antimicrobials tested were found to be 60%
(76/126). Non-susceptible to PN (PNSP) were 18% (23/126). According
to the MICs 21/23 (91.3%) were intermediate and 2/23 (8.7%) were fully
resistant to PN. Resistance rates to other antimicrobials were signiﬁcantly
higher in the group of PNSP isolates in correlation with PN susceptible
isolates (p< 0.05). Analytically, among the PNSP isolates, resistance to
ER, CL, SXT, and TE was 56.5%, 34.7%, 43.4%, and 17.3%, while
among PN susceptible isolates resistance to ER, CL, SXT, and TE was
20.3%, 4.8%, 6.8%, and 2.9%, respectively. Multidrug resistance reached
47.8% of PNSP strains, but only 3.8% of PN susceptible isolates. Various
antibiotic resistant phenotypes were observed. Macrolide-resistance
was 27% [M-phenotype 62% (21/34), MLSBc 38% (13/34)]. Yearly
incidence of PNSP from 2003 to 2008 was as follows: 7%, 20%, 14%,
30%, 10%, 40%. Yearly incidence of ER − resistant isolates was: 3%,
20%, 14%, 15%, 0%, 13%. The most active antimicrobials were AMX,
CTX, VAN, RF, C to which no resistance was found.
Conclusions: Antimicrobial resistance of S. pneumoniae remains a
signiﬁcant problem in our area. The increase of penicillin and macrolide
resistance from 2003 through to 2008 was worrisome. The decrease of
resistance observed during 2007 could be related with the introduction
of PCV7 into the national immunization program in 2006. Continuous
surveillance of antimicrobial resistance is needed to determine the impact
of PCV7 and other newer vaccines in pediatric population.
R2385 Common pathogens isolated from wound infections in
children in western Greece
P. Michail, D. Garantziotou °, N. Giormezis, M. Karamitsou,
C. Panagiotopoulos, E. Petropoulou, A. Spiliopoulou, A. Gatopoulou
(Patras, GR)
Objectives: Wound infections are common in children. The aim of this
study is to record the most frequent microorganisms isolated from wound
infections of children who were examined or hospitalized in a paediatric
hospital in Western Greece.
Methods: A total of 991 clinical samples were collected from children
0−15 years old, during a two year period (2007–2009). The samples were
cultured in the conventional growth materials. Isolates were identiﬁed at
species level by conventional tests and the antibiotic susceptibility by
the disk diffusion method (Kirby-Bauer), according to the guidelines of
CLSI.
Results: From the 991 cultures, 553 (55.8%) were positive for
microbial etiologic agents. The most commonly isolated microorganisms,
according to their frequency were: S. aureus 373 strains (67.4%),
CNS (coagulase-negative staphylococci) 55 strains (9.9%), S. pyogenes
34 strains (6.1%), P. aeruginosa 23 strains (4.1%) and E.Coli 20
strains (3.6%). From the 55 CNS, 20 (36.36%) were considered to be
contaminations, based on the patient’s symptoms and clinical history.
From the 373 S. aureus strains, 212 strains (56.8%) were methicillin
resistant (MRSA), and 122 of them (57.5%) were collected from children
hospitalized in the orthopaedic, surgical or paediatric clinic, whereas 90
strains (42.5%) were community-acquired.
Conclusions: S. aureus seems to be the most common cause of wound
infections in children. It is worth to mention the high percentage of
methicillin-resistant strains (MRSA-56.8%), as well as their prevalence
in hospitalized patients in comparison to those of the community. Among
the Gram(−) microorganisms, there is a prevalence of Pseudomonas
aeruginosa, which was isolated in 23 cases (4.1%), mainly from ear
secretions.
R2386 Clinical aspects of boutonneuse fever in children
C.S. Cambrea °, S. Halichidis, M. Ilie, D. Tanase, I. Cretu, C. Marcas
(Constanta, RO)
Background: The disease caused by Rickettsia conorii is known
by various geographically recognized names, including Mediterranean
spotted fever, boutonneuse fever, Kenya tick typhus, Indian tick typhus,
Israeli spotted fever, and Astrakhan fever. It is a moderately severe
vasculotropic rickettsiosis that is often initially associated with an eschar
at the site of the tick bite.
Objective: Retrospective analysis of 63 children and 18 adolescents
hospitalized with boutonneuse fever in Children Infectious Diseases
Clinic of Clinical Infectious Diseases Hospital of Constanta.
Material and Method: Retrospective analysis of boutonneuse fever
hospitalized in Children Infectious Diseases Department during a period
of 6 years (2003–2008). We evaluate demographic, clinic, serologic and
therapeutic data.
Results: During a period of 6 years (January 2003-December 2008)
in Children Infectious Diseases Department we followed 81 cases of
boutonneuse fever. From the total of cases 61.27% were from urban
area, 53.08% were male. The majority of cases were registered in warm
season. The eschar (tache noir) was present in 56 patients. Fever had a
6 days mean duration and disappears often in ﬁrst 3−4 days of etiologic
treatment. Maculopapular rash with nodular boutonneuse lesions was
detected in 72 cases, 5 having petechial lesions. Only 34 children
had leucocytosis, 9 with thrombocytopenia. Serological diagnosis was
accomplished in 61 patients. Etiologic treatment was done for 5−7
days with Chloramphenicol in 61 patients, Clarithromycine in 5 cases;
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Ciproﬂoxacine in 6 cases, and Azithromycine in 9 cases. Mean duration
of the illness was of 7 days, especially in moderate disease.
Conclusions: From the total of cases with boutonneuse fever childrens
represents 13.25%. Boutonneuse fever is a problem of actuality in
the urban areas, of our county, especially in warm season. The
epidemiological and clinical diagnosis, conﬁrmed by ELISA for
R. conorii requires beginning of etiologic treatment.
R2387 Prevalence of toxocariasis in paediatric population
G. Sonmez Tamer ° (Kocaeli, TR)
Objective: Toxocariasis is one of the most common zoonotic
helminthiasis that is frequent in Turkey. Clinical signs are often non-
speciﬁc, thus, its diagnosis is made by speciﬁc serology, such as ELISA
and Western blot (WB). The serological diagnosis remains the main tool
for the diagnosis of toxocariasis. The objectives of our study was to
determine the frequency and distribution of toxocara seroprevalence in
the paediatric population.
Methods: From January to October 2008, a total of 267 sera were
collected from children with asymptomatic for toxocariasis (mean age,
8.5±2.3 years, range: 4−16 years).
Eosinophilia counts were performed by using automatic blood cell
counter (Kell-dyn 3500).
Toxocara seroprevalence was measured with ELISA IgG kit (CELISA,
Cellabs, Australia). In cases where negative or low-positive values
obtained by ELISA, the results were conﬁrmed by WB (LDBIO, France).
Results: The sera of 78 people of 267 asymptomatic individuals were
found to be positive for Toxocara IgG antibody (29.21%). Seropositivity
rapidly increased by age reaching 25.65% at the age of 12−16
years. The borderline anti-Toxocara IgG ELISA results were positive
with WB. A signiﬁcantly higher percentage (26%, P = 0.01) of Toxocara
seropositivity was found in children with eosinophilia when compared
with 13% seropositivity measured in children without eosinophilia. The
borderline anti-Toxocara IgG ELISA results were positive with WB.
Conclusions: The highest positivity (18.11%) were found mostly under-
developed regions and the lowest positivity (11.10%) were found in
and around the center of the city. Probably, this reﬂects the differences
in hygienic conditions. The Toxocara seroprevalence rapidly increasing
with aging within the age limits of this study. This can be explained by
the frequent contact of children with contaminated soil. A signiﬁcantly
higher percentage of Toxocara seropositivity was found with eosinophilia
compared with the asymptomatic children. The western blot technique
was very useful in conﬁrming the borderline and negative anti-Toxocara
IgG values obtained by ELISA method.
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R2388 Evolution of serotype distribution of pneumococcal
infections among children in the region of Tarragona,
Spain, 2002–2008
X. Raga °, E. Salsench, A. Guzman, A. Vila-Corcoles, X. Cliville,
J. Tapiol (Tarragona, ES)
Objective: To know the evolution of the distribution of different
serotypes causing pneumococcal infections among infants and analyze
possible serotype replacement after the introduction of the 7-valent
conjugate pneumococcal vaccine (CPV-7).
Methods: Retrospective cohort including all cases of invasive infections
which had a serotype of Streptococcus pneumoniae identiﬁed during
2002–2008 among patients 14 years of age from the region of
Tarragona (Catalonia, Spain). Prevalence of infections caused by
serotypes included in CPV-7 (types 4, 6B, 9V, 14, 18C, 19F and 23F)
was determined for early cases (2002–2005) and contemporary cases
(2006–2008).
Results: During the total study period, 72 cases were included (19
early and 53 contemporary cases). The most dominant serotypes were
type 1 in 19 cases (26.4%), type 14 in 15 cases (21%), type 19A in 9
cases (12.5%) and type 6A in 4 cases (5.6%). Globally, 32% (23/72) of
cases were due to vaccine serotypes, 21 (15/72) due to vaccine-related
serotypes and 47.2% (34/72) due to non-vaccine serotypes. Cases caused
by serotypes included in CPV-7 were 63.2% in 2002–2005 and 20.8%
in 2006–2008 respectively (p = 0.002). Infections due to vaccine-related
serotypes represented 10.5% and 24.5% in early and contemporary cases,
respectively (p = 0.336). Infections caused by serotypes 1 (from 10.5%
to 32%) and serotype 19A (from 5.3% to 15%) increased between 2002–
2005 and 2006–2008 periods, whereas infections caused by serotype 14
(from 36.8% to 15%) and serotype 19F (from 10.5% to 1.9%) decreased
during the study period.
Conclusions: In our population, although the potential impact of the
CPV in preventing pneumococcal infections is considerable, it still
remains a large proportion of cases not covered by the currrent seven-
valent vaccine. Some serotypes not included in the vaccine (especially
types 1 and 19A) have increased, which point to a certain degree of
serotype replacement after the introduction of conjugate vaccine.
R2389 Serotypes distribution and susceptibility to antibiotics
of Streptoccus pneumoniae isolated in blood cultures in
Madrid, Spain
M. Moreno °, C. De Las Cuevas, S. Agudo, M. Martı´nez,
M. Lo´pez-Brea, J. Sanz (Madrid, ES)
Objective: This study was to determine the serotypes distribution of
Streptoccus pneumoniae isolated from adult patients with bacteremia
for three years.
Methods: 77 samples were isolated from blood cultures in adult patients.
Samples were received at the Department of Microbiology (Hospital
Universitario de la Princesa, Madrid, Spain) from January 2007 to
November 2009. Seventy seven patients were studied of whom 41 males
and 36 females and were a age range between 25−98. The microorganism
was identiﬁed by being susceptibility to optochin and soluble to bilis.
Susceptibility to penicillin, cefotaxime, erithromicin and levoﬂoxacin
was determined by E-test. Clinical resistance was based on CLSI
(M100S13) 2008 breakpoints. Serotype was determined using rapid latex
agglutination (Pneumotest Latex, Statens Serum Institut, Denmark) and
speciﬁc factors of serotyping were performed through Quellung reaction.
Results: Seventy nine strains (89.6%) were included in the 23 valent
vaccine (VP23V) and 15 (19.5%) were included in the 7 valent vaccine.
Four serotypes were the most frequently found in our strains: 7F (14.3%),
22F (11.7%), 3(10.4%) and 1 (6.5%). The thirteen valent conjugate
vaccine confers efﬁcacy against four of these serotypes (7F, 3, 19A and
1). The percentages of no susceptibility to penicillin and cefotaxime and
resistant to erithromicin and levoﬂoxain were 2.6%, 3.9%, 19.5% and
0%, respectively. Strains no susceptibility to penicillin or cefotaxime
were included in the serotypes 14 and 6B. Thirty three percentage of
erithromicin resistant strains were included in the serotype 19 A.
Conclusions: Serotypes most frequent found (7F, 22F, 3, 19A and 1),
are included in the VP23 vaccine but no in VC7 vaccine. The thirteen
valent conjugate vaccine confers efﬁcacy against four of these serotypes
(7F, 3, 19A and 1). The percentage of no susceptibility to b-lactams is
low and it is in relation with the serotypes 14 and 6B. The erithromicin
resistant is high and it is relation with the serotype 19A.
R2390 Streptococcus pneumoniae isolates in paediatric population:
evaluation of emerging serotypes in the era of 7-valent
pneumococcal conjugate vaccine and their antibiotic
susceptibility
R. Bandettini °, L. Pescetto, L. Ricagni, F. Ansaldi, P. Canepa,
G. Icardi, M. Santolini, V. Turello, M.C. Diana (Genoa, IT)
Objectives: To estimate the serotype distribution of pneumococci and
their antibiotic susceptibility patterns among paediatric patients.
Methods: Clinical isolates were obtained from 84 children, aged 4
months to 8 years, between March and October 2009. Vaccination
with 7-valent pneumococcal conjugate vaccine (PCV7) was considered
appropriate if it was done according to the following scheme: a three-
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dose series if starting vaccination at 12 months of age; a two-dose
series if starting vaccination at 12–24 months of age; and one-dose series
if starting vaccination at 24 months of age. Streptococcus pneumoniae
strains were collected from the following clinical cases: acute otitis
media (69.0%), pneumonia (14.3%), sepsis (7.1%), conjunctivitis (2.4%),
acute tracheitis (2.4%), acute sinusitis (1.2%), acute tonsillitis (1.2%),
bronchiectasis (1.2%). Antimicrobial susceptibility of all isolates was
tested by the disk diffusion method in accordance with the guidelines
of CLSI, against erythromycin, clindamycin, vancomycin. Penicillin
and ceftriaxone MICs were determined by E-test. Pneumococci were
serotyped by primer speciﬁc PCR.
Results: Of 84 children, 73 (87.0%) were vaccinated with PCV7, 9
(10.7%) were not vaccinated, 2 (2.3%) dropped-out. Of 84 strains, 61
(72.6%) were serotyped and 4 of them (6.5%) belonged to vaccine
type (4, 9V, 14, 23F). A total of 10 (16.4%) isolates were serotype
19A, all susceptible to penicillin, while 4 of them were resistant to
erythromycin and clindamycin (phenotype C). A total of 7 (11.5%) were
resistant to penicillin, erythromycin and clindamycin and belonged to 7
different non-vaccine types. All isolates were susceptible to vancomycin
and ceftriaxone.
Conclusions: Pneumococcus is a leading cause of invasive and non-
invasive infection among children and its seriousness is the increasing
prevalence of drug-resistant strains. As reported in literature although
the widespread PCV7 vaccination, an increase in non-vaccine types has
been observed also in our study. Moreover the proportion of resistant
pneumococci was higher among non-vaccine types. This study could be
the a platform for future surveillance.
Internet and electronic resources
R2391 Application of information and communication technologies
in the course “Cultivation of viruses, riketsii, chlamids in
the laboratory conditions”
K. Yotovska °, P. Genova-Kalou (Soﬁa, BG)
Introduction: The development and distribution of information and
communication technologies and Internet expand the opportunities
for communication, exchange of information and change the work
environmental and life style to everyone. The Blended learning is
characterized by integration of different information and communication
technologies in a traditional educational context. Regarding the content
and organization this integration may be very diverse in different
co-relation of the traditional and online educational technologies.
The technologies can be used to support the teaching, learning and
pedagogical communication.
Objective: The objective of the research is to perform on mosaic
organized online educational resources with the relevant structure
corresponding to the goals of the course “Cultivation of viruses, riketsii,
chlamids in the laboratory conditions” from the post graduated education
of masters’ and bachelors’ medical specialists. In this publication we
propose a technology with description of the steps for developing a web-
based course with a dynamic content with interactive possibilities. The
course also integrates the legal documentation and includes the following
topics: general theory, main terms of virus vaccines production and their
application in practice, and therapy of the virus infections.
Materials and Methods: Theoretical analysis and synthesis, question-
naire, information and communication technologies.
Results: Full with content resources were created as a decision of some
lections and practical lessons. They could be obtained from online re-
sources, adapted and amended as well as tasks on different education ac-
tivities. The text resources and cases are oriented to self education for ﬁ-
nalizing of learning in regard with speciﬁcation in the students education.
Conclusion: The new information and communication technologies
allow the places, time, speed and level of the education to be deﬁned
by the student. It gives a different overview of the educational process,
leading to faster results with lower expenses, free access to educational
materials and clear concept of every participant in the educational
process.
